record_id,cited_intake_markers_and_metrics,confidence_level_from_source_type,contraindications,created,created_by,effect_strength,effect_strength_note,id,intake_markers_raw,intake_metrics_raw,last_modified,last_modified_by,link,name_title,pmids,recommendation,recommendations_v2,ref_check,screening_compliance,source,source_type,summary,therapeutics_matrix
recGJY1un7AAAGhBy,,Anecdotal,,2025-07-28T18:08:36.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Mechanistic and clinical outcomes support impact on glycemic control and CVD risk, but remission data less directly tested in trials.",LI001,,,2025-07-28T18:38:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.endocrinepractice.org/article/S1530-891X(23)00034-4/fulltext,American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update,PMID: 37150579,,,True,,American Association of Clinical Endocrinology,recYhFTRFUPeMb1fL,"Algorithmic guidance integrating recent CVOTs, individualized strata, and comorbidities to inform T2D pharmacotherapy and lifestyle sequencing.",
recvslo3KUvZqwuD2,,High,,2025-07-28T18:08:37.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Strong RCT evidence that lifestyle change reduces incidence of T2D with moderate-to-large effect sizes.,LI002,,,2025-07-28T18:39:54.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://diabetesjournals.org/care/article/48/Supplement_1/S50/157550/3-Prevention-or-Delay-of-Diabetes-and-Associated,Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2025,PMID: 39651971,,,True,,American Diabetes Association,rec4qqncSQrMbfAph,Lifestyle and pharmacologic interventions recommended to prevent progression from prediabetes to diabetes and mitigate comorbid risks.,
recNAA8F1W5cTM6Jd,,Anecdotal,,2025-07-28T18:08:37.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Established diagnostic cutpoints validated in large cohorts; effect strength is indirect via enabling early treatment.,LI003,,,2025-07-28T18:38:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://diabetesjournals.org/care/article/48/Supplement_1/S27/157566/2-Diagnosis-and-Classification-of-Diabetes,Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025,PMID: 39651986,,,True,,American Diabetes Association,recYhFTRFUPeMb1fL,"Defines thresholds (A1c, FPG, OGTT) and subtypes; emphasizes early detection to guide intervention.",
recBUmAn8hrxlm48a,,High,,2025-07-28T18:08:43.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Multiple RCTs and meta-analyses document robust lipid, BP, and ASCVD benefits.",LI004,,,2025-07-28T18:40:13.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ahajournals.org/doi/10.1161/01.cir.0000437740.48606.d1?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed,2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,PMID: 24222015,,,True,,AHA|ASA Journals,rec4qqncSQrMbfAph,"Recommends DASH/Mediterranean diets, sodium reduction, weight‑loss, exercise, and behavioral strategies.",
recem1dsaoeWjKqGZ,,High,,2025-07-28T18:08:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Proven long-term reductions in incidence of CHD/stroke from lifestyle and pharmacotherapy.,LI005,,,2025-07-28T18:40:17.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ahajournals.org/doi/10.1161/CIR.0000000000000678?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed,2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines,PMID: 30879355,,,True,,AHA|ASA Journals,rec4qqncSQrMbfAph,"Emphasizes healthy lifestyle, team-based care, and selective statin/aspirin use for ASCVD prevention.",
recY1vdUqN18YkcMf,,High,,2025-07-28T18:08:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Strong evidence supports lifestyle in secondary prevention, though summary data limited in public abstracts.",LI006,,,2025-07-28T18:40:19.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ahajournals.org/doi/10.1161/CIR.0000000000001168?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed,2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines,PMID: 37471501,,,True,,AHA|ASA Journals,rec4qqncSQrMbfAph,"Ongoing guideline includes continued emphasis on lifestyle, meds, revascularization, and secondary prevention.",
recYDmBfi9e3ajb7k,,High,,2025-07-28T18:08:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Demonstrated remission in clinical series and compelling prevention data; high net benefit. (PMC, American College of Lifestyle Medicine, USPSTF)",LI007,,,2025-07-28T18:40:26.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC11949759/pdf/10.1177_15598276251325802.pdf,Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: Implications for Clinicians,PMID: 40161282,,,True,,American Journal of Lifestyle Medicine,rec4qqncSQrMbfAph,"Lifestyle-based programs (plant-predominant diet, coaching, activity) aimed at glycemic control and remission.",
recBPXoMeDMgGmUVn,,High,,2025-07-28T18:08:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"“A” = high certainty substantial benefit; “B” = moderate certainty of moderate‑to‑substantial benefit. (USPSTF, USPSTF)",LI008,,,2025-07-28T18:40:35.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations,"A & B Recommendations
A listing of all the Recommendations with a grade of either A or B.
A and B grade recommendations are services that the Task Force most highly recommends implementing for preventive care and that are also relevant for implementing the Affordable Care Act. These preventive services have a high or moderate net benefit for patients.",,,,True,,U.S. Preventive Services Task Force,recRIfCU2PF5bhkmW,"Preventive services rated A or B—high or moderate net benefit—strongly recommended (e.g. screening, counseling).",
recZVx4pJNZtJpTtF,,Moderate,,2025-07-28T18:08:45.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Observational data show dose–response HRs (e.g., moving from low to above average reduces mortality by ~60–70%). (Peter Attia, Wikipedia, PubMed)",LI009,,rec0v0JrVS6xu5Dcj,2025-07-28T18:40:39.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.imrpress.com/journal/FBL/23/8/10.2741/4657,"Survival of the fittest: VO2max, a key predictor of longevity?",PMID: 29293447,,,True,,Frontiers in Bioscience-Landmark,recuux8z8gb0e5MPU,Review highlighting VO₂max as one of the strongest predictors of mortality and lifespan.,
recVTb17HRPx1rtBv,,Anecdotal,,2025-07-28T18:08:45.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Clinical trials support insomnia improvement; epidemiological associations link poor sleep to chronic disease. (Cell, CDC)",LI010,,,2025-07-28T18:38:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://cdn.mdedge.com/files/s3fs-public/aclm_2022_final_set_0.pdf,Sleep and Health-A Lifestyle Medicine Approach,PMID: 35389841,,,True,,The Journal of Family Practice,recYhFTRFUPeMb1fL,"Expert perspective placing sleep hygiene/CBT‑I as fundamental for metabolic, cognitive, cardiovascular health.",
rec6WdSiOY2f3CmQe,,Anecdotal,,2025-07-28T18:08:45.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Clinical and mechanistic studies support reduction in inflammation and mental health improvements; long‑term clinical trials limited.,LI011,,,2025-07-28T18:38:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://cdn.mdedge.com/files/s3fs-public/aclm_2022_final_set_0.pdf,Lifestyle Medicine and Stress Management,PMID: 35389841,,,True,,The Journal of Family Practice,recYhFTRFUPeMb1fL,"Highlights importance of stress reduction (meditation, mindfulness, social support) in lifestyle medicine.",
recdQsJFFTK7zZFmm,,Anecdotal,,2025-07-28T18:08:45.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Based on expert Delphi process and clinical experience; not driven by RCT outcomes.,LI012,,,2025-07-28T18:38:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://journals.sagepub.com/doi/10.1177/15598276231202970,American College of Lifestyle Medicine Expert Consensus Statement: Lifestyle Medicine for Optimal Outcomes in Primary Care,PMID: 38559790,,,True,,American College of Lifestyle Medicine,recYhFTRFUPeMb1fL,"Consensus recommendations to integrate lifestyle medicine into primary care (six‑pillar model, clinician training).",
rec4FGgf9RNdUhODC,,Anecdotal,,2025-07-28T18:08:46.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"The tool is educationally useful, but lacks validated clinical trials linking score to health outcomes.",LI013,,,2025-07-28T18:38:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://gutbites.org/wp-content/uploads/2024/12/NCS-at-a-Glance-4.pdf,NUTRIENT CONSUME SCORE at a Glance,,,,True,,,recYhFTRFUPeMb1fL,Dietary quality scoring tool to guide healthier eating choices based on nutrient intake.,
recVxtcVC62AM528G,,Moderate,,2025-07-28T18:08:46.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Dose-response data show consistent reductions in mortality, T2D, CVD, cognitive decline with increasing walking. (PubMed, PMC)",LI014,,,2025-07-28T18:40:58.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://link.springer.com/article/10.1007/s11357-023-00873-8,The multifaceted benefits of walking for healthy aging: from Blue Zones to molecular mechanisms,PMID: 37495893,,,True,,GeroScience,recuux8z8gb0e5MPU,"Review of walking’s cardiovascular, metabolic, cognitive, and longevity benefits including mechanistic insights.",
rec4dcu2mt298Spa8,,Moderate,,2025-07-28T18:08:46.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant associations in neuropathologic-confirmed cohorts; causality not proven. (News-Medical, Nature)",LI015,,,2025-07-28T18:41:01.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://jamanetwork.com/journals/jamaneurology/fullarticle/2814688,Healthy Lifestyle and Cognition in Older Adults With Common Neuropathologies of Dementia,PMID: 38315471,,,True,,JAMA,recODsYatCgd7j2Vr,Cohort data showing healthy lifestyles linked to better cognition even with Alzheimer’s pathology present.,
recFgfMdD7fP1FoFl,"LDL, ApoB, Total Cholesterol, Triglycerides, hsCRP",High,,2025-06-03T21:31:05.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,19% reduction in CHD events when saturated fat replaced with PUFA,LI016,"recBA3iQ4lGJtC2nM, recw2hqgZfllcjFso, recDBJLAkc5CAfBm3, receYj9nbAEGPBxFl, recPiW3K4dhWi31Xh",,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000252,Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,PMID: 20351774,"recHzb6cKfnSgyEzu, rec949y9L8RuJ25yP, recIRf5TBEMboKqVm","recL0zctdlOG9ciJL, recdvxEqeeiiCGJI6, recMiDba4KdZho45D",True,,PLoS One,recRIfCU2PF5bhkmW,Systematic review and meta-analysis of RCTs showing that replacing saturated fat with polyunsaturated fat reduces CHD risk by ~19%.,
rec5OI0Ed5fbJiJeC,"LDL, ApoB, Total Cholesterol, Triglycerides, hsCRP, Fasting Glucose, Fasting Insulin, HOMA-IR, BMI",High,recMORgJhxNNgSxe0,2025-06-03T21:31:05.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,30% reduction in CV events in high-risk individuals on Mediterranean diet vs. control,LI017,"recBA3iQ4lGJtC2nM, recw2hqgZfllcjFso, recDBJLAkc5CAfBm3, receYj9nbAEGPBxFl, recPiW3K4dhWi31Xh, recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI",reccxH7AESy9vvBPo,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nejm.org/doi/10.1056/NEJMoa1800389?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov,Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts,PMID: 29897866,"recHzb6cKfnSgyEzu, rec949y9L8RuJ25yP, recIRf5TBEMboKqVm","recL0zctdlOG9ciJL, recdvxEqeeiiCGJI6, recMiDba4KdZho45D",True,,The New England Journal of Medicine,reclYXy0udvjr66Xa,Corrected RCT showing that a Mediterranean diet with extra-virgin olive oil or nuts significantly reduced major cardiovascular events (~30%) in high-risk adults.,
recNVh2E7o0SHwcbc,"LDL, ApoB, Total Cholesterol, Triglycerides, hsCRP, Fasting Glucose, Fasting Insulin, HOMA-IR",High,,2025-06-03T21:31:05.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Statistically significant reductions in CRP and IL-6 with PUFA and MUFA intake,LI018,"recBA3iQ4lGJtC2nM, recw2hqgZfllcjFso, recDBJLAkc5CAfBm3, receYj9nbAEGPBxFl, recPiW3K4dhWi31Xh, recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC4198773/,"Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies",PMID: 25274026,"recHzb6cKfnSgyEzu, rec949y9L8RuJ25yP, recIRf5TBEMboKqVm","recL0zctdlOG9ciJL, recdvxEqeeiiCGJI6, recMiDba4KdZho45D",True,,PubMed,rec4qqncSQrMbfAph,"Systematic review linking high unsaturated fat intake to lower markers of systemic inflammation (CRP, IL-6).",
recZ6C0tsTPiDOfwE,"Fasting Glucose, Fasting Insulin, HOMA-IR, HbA1c, Total Cholesterol, LDL, Blood Pressure - Systolic, Blood Pressure - Diastolic, hsCRP",High,,2025-06-09T00:20:57.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,~9% CVD risk reduction per 7g fiber/day from pooled trial evidence,LI019,"recBA3iQ4lGJtC2nM, recw2hqgZfllcjFso, recPiW3K4dhWi31Xh, recC0mB1LyNGjDyld, recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9511151/,Associations between dietary fiber intake and cardiovascular risk factors: An umbrella review of meta-analyses of randomized controlled trials,PMID: 36172520,"rec51TDeLYX6vOI1v, recj4S8iGZ5mXx4NS, recu8nVY5FrP2YCVR, recMfTk8ITmrFJowR, recz8gAMEHUAYrsVo, recvv2HVgKwsoHdQD, rec9qkWiu9H6o4rZk","rec9shJve4oUosmbM, recnvgez95waQbIX9, recyzL1fyLSDVCg58, recQGhqpbZNfyn2G8, recDzEG37NloR565F, reczWqNcJQXghlR0U",True,,PubMed,reccTfrcrIEsBwBO4,Every 7 g/day increase in total fiber (including soluble) correlates with a ~9% reduction in cardiovascular disease (CVD) risk,"recLSE9drrQavNmkC, recFE14qL0S8sFnSB"
rec2IGmKG5X9WXA7w,"HbA1c, Fasting Glucose, HOMA-IR, BMI",Moderate,,2025-06-09T00:20:58.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Clinically relevant reductions in HbA1c, glucose, insulin resistance, and BMI",LI020,"recC0mB1LyNGjDyld, recf4HtvFUqMhyhdh, recAdUWMgWMZS3qKI",reccxH7AESy9vvBPo,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.clinicalnutritionjournal.com/article/S0261-5614(20)30575-6/abstract,Effects of soluble fiber supplementation on glycemic control in adults with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials,PMID: 33162192,"rec51TDeLYX6vOI1v, recj4S8iGZ5mXx4NS, recu8nVY5FrP2YCVR, recMfTk8ITmrFJowR, recz8gAMEHUAYrsVo, recvv2HVgKwsoHdQD, rec9qkWiu9H6o4rZk","rec9shJve4oUosmbM, recnvgez95waQbIX9, recyzL1fyLSDVCg58, recQGhqpbZNfyn2G8, recDzEG37NloR565F, reczWqNcJQXghlR0U",True,,Clinical Nutrition,reclqQn6EV0azXdYf,"Soluble fiber supplements reduce HbA1c by 0.63%, fasting glucose by ~0.9 mmol/L, HOMA-IR (insulin resistance) by about 0.58, and BMI by –0.31 kg/m²","recLSE9drrQavNmkC, recFE14qL0S8sFnSB"
recf93QJMEMOKjUWm,"LDL, ApoB",Moderate,,2025-06-09T00:20:59.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Robust LDL, apoB, and non-HDL cholesterol reduction at clinically relevant dosages",LI021,"recw2hqgZfllcjFso, receYj9nbAEGPBxFl",,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/effect-of-oat-glucan-on-ldlcholesterol-nonhdlcholesterol-and-apob-for-cvd-risk-reduction-a-systematic-review-and-metaanalysis-of-randomisedcontrolled-trials/60A75CB215602240E9363D49DCB690ED,"The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials",PMID: 27724985,"rec51TDeLYX6vOI1v, recj4S8iGZ5mXx4NS, recu8nVY5FrP2YCVR, recMfTk8ITmrFJowR, recz8gAMEHUAYrsVo, recvv2HVgKwsoHdQD","rec9shJve4oUosmbM, recnvgez95waQbIX9, recyzL1fyLSDVCg58, recQGhqpbZNfyn2G8, recDzEG37NloR565F, reczWqNcJQXghlR0U",True,,Cambridge University,reclqQn6EV0azXdYf,"Intake of ≥3 g/day oat β‑glucan significantly lowers LDL, non–HDL cholesterol, and apoB across randomized controlled trials",
recbJUBCTioWkdQ6B,VO2 Max,Moderate,,2025-06-09T00:21:00.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Small sample but measurable improvements in aerobic markers from Zone 2-based training.,LI022,,rec0v0JrVS6xu5Dcj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC6355121/,Heart Rate Acquisition and Threshold-Based Training Increases oxygen uptake at metabolic threshold in triathletes: a pilot study,PMID: 30761193,"recyCjSxWdLGZfHwI, recqj8q9IIWoThFkG, recx4JdeaTZgIVoZ3, recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w","recC3HYOpjcuSTlGZ, recuKwwqbOncMVjuX, recBv7jvDZq4Bz29k, recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN",True,,PubMed,recUA6YRlFh3Dsje5,Threshold-based aerobic training (Zone 2) improved VO2max and metabolic threshold in triathletes over an 8-week protocol.,
recIAReXwwNzDc7gX,"Fasting Glucose, Fasting Insulin, HOMA-IR, HDL, Triglycerides, hsCRP",Moderate,,2025-06-10T00:31:51.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Mechanistic support for Zone 2 as the optimal fat oxidation and lactate threshold zone.,LI023,"recq0JX3QgFBo5mm4, recDBJLAkc5CAfBm3, recPiW3K4dhWi31Xh, recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI",recVHWlB26jWt9Ij9,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://escholarship.org/uc/item/5cz1v976,"Assessment of metabolic flexibility by means of measuring blood lactate, fat, and carbohydrate oxidation responses to exercise",PMID: 28623613,"recyCjSxWdLGZfHwI, recqj8q9IIWoThFkG, recx4JdeaTZgIVoZ3, recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w","recC3HYOpjcuSTlGZ, recuKwwqbOncMVjuX, recBv7jvDZq4Bz29k, recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN",True,,UC Berkeley,reclqQn6EV0azXdYf,Zone 2 intensity promotes metabolic flexibility via fat oxidation and lactate suppression in both elite and less-fit athletes.,
recn5E9AOd7x4wlxI,"LDL, HDL, Triglycerides, hsCRP, ApoB",Moderate,,2025-06-10T00:41:25.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Highlights Zone 2-type adaptations as a foundational trait in metabolically healthy individuals.,LI024,"recw2hqgZfllcjFso, recq0JX3QgFBo5mm4, recDBJLAkc5CAfBm3, receYj9nbAEGPBxFl, recPiW3K4dhWi31Xh","recVHWlB26jWt9Ij9, rec0v0JrVS6xu5Dcj",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC5513193/,Metabolic flexibility in health and disease,PMID: 28467922,"recyCjSxWdLGZfHwI, recqj8q9IIWoThFkG, recx4JdeaTZgIVoZ3, recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w","recC3HYOpjcuSTlGZ, recuKwwqbOncMVjuX, recBv7jvDZq4Bz29k, recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN",True,,PubMed,recuux8z8gb0e5MPU,Fat oxidation and metabolic switching are key longevity biomarkers—enhanced through Zone 2 cardio intensity.,
recgnnM5MBKJjYDmF,,High,,2025-06-10T00:41:26.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Short and long sleep linked to 1.1–1.3x higher risk for stroke, CHD, diabetes, and death",LI025,,recxJqmq5ipZMLJsj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/34435311/,Sleep duration and health outcomes: an umbrella review,PMID: 34435311,"recbbFVlKZwQNf0EX, recXuOWpl8orK06ul, recrAMEvn6TQqpIMf","recfC31Cd5XEGTEOe, rec1Vc2GOePfDEKEC, recv1aKMQckEj3mWw",True,,PubMed,recA1EVfrjrmEMho8,"Systematic synthesis of 69 meta-analyses showing both short (<7 h) and long (>9 h) sleep durations are associated with increased risk for cardiovascular disease, diabetes, depression, and all-cause mortality.",
recv9Z6URcMhhsDlz,,Moderate,,2025-06-10T00:41:26.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Higher sleep regularity predicted longevity more than sleep duration alone,LI026,,recxJqmq5ipZMLJsj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://link.springer.com/article/10.1007/s11325-021-02458-1,Sleep regularity is a stronger predictor of mortality risk than sleep duration: A prospective cohort study,PMID: 37738616,recrAMEvn6TQqpIMf,recv1aKMQckEj3mWw,True,,PubMed,recDDHykOzWxwMnyv,"Analysis of 60,000+ UK Biobank participants found that individuals with more regular sleep schedules had 20–48% lower all-cause mortality risk compared to the most irregular group.",
recOREaCk8aeVqvwc,"ALT, AST, GGT, hsCRP, Sleep Quality",Moderate,,2025-07-17T11:20:57.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Strong correlations between alcohol consumption, liver enzymes, inflammatory cytokines, and sleep quality in AUD population",LI027,"recfQt6B5C5wmZDqn, recHHlPLn8pdw89yH, rec0mt0T6zXGg2XeQ, recPiW3K4dhWi31Xh",recxJqmq5ipZMLJsj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9405018/,"An exploratory study of pro-inflammatory cytokines in individuals with alcohol use disorder: MCP-1 and IL-8 associated with alcohol consumption, sleep quality, anxiety, depression, and liver biomarkers",PMID: 36032219,"recRsxAqRnyD0hIL5, recKkP3TAlDTtLiuo, rec2JL5kJJ1pJCPL1, recAaYIO7j0kgDYbf","recVTVGHktZrTVmVm, recOLd9a3r4HmpWEF, rec6a9bBcPsdCgtVi, recEBmO5Apr89hClw",True,,PubMed,recDDHykOzWxwMnyv,"Study of 50 individuals with alcohol use disorder found significant associations between alcohol consumption and elevated inflammatory cytokines (MCP-1, IL-8), poor sleep quality, and liver biomarkers (ALT, AST, GGT, ALP). Higher alcohol consumption correlated with poorer sleep quality and increased inflammatory markers.",
recJwR1IJSbmAV5Pu,"Sleep Quality, REM Sleep Duration",High,,2025-07-17T11:21:06.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Dose-response relationship with REM sleep disruption occurring even at low alcohol doses,LI028,,"recxJqmq5ipZMLJsj, rec8o1wlo0olBMl8A, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S1087079224001345?via%3Dihub,The effect of alcohol on subsequent sleep in healthy adults: A systematic review and meta-analysis,PMID: 39631226,"recRsxAqRnyD0hIL5, recKkP3TAlDTtLiuo, rec2JL5kJJ1pJCPL1, recAaYIO7j0kgDYbf","recVTVGHktZrTVmVm, recOLd9a3r4HmpWEF, rec6a9bBcPsdCgtVi, recEBmO5Apr89hClw",True,,PubMed,recRIfCU2PF5bhkmW,"Systematic review and meta-analysis of 27 studies found that alcohol consumption causes dose-dependent disruptions to sleep architecture, including delayed REM sleep onset and reduced REM sleep duration. Low doses (≤0.5 g/kg, ~2 drinks) negatively impact REM sleep, with effects worsening at higher doses.",
rec22M6G8mG8TZ46c,"Testosterone, Free Testosterone, SHBG, Estradiol",High,,2025-07-17T11:21:18.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Significant reduction in testosterone and increase in estradiol with chronic alcohol consumption in healthy men,LI029,"recL8dpnjNSzBJp2L, recX6IiQRem8pQ14z, recZd7qSsYU2dqSw0, recUzK4L9enpnuWG8",,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://onlinelibrary.wiley.com/doi/10.1111/andr.13526,The chronic alcohol consumption influences the gonadal axis in men: Results from a meta-analysis,PMID: 37705506,"recRsxAqRnyD0hIL5, recKkP3TAlDTtLiuo, rec2JL5kJJ1pJCPL1, recAaYIO7j0kgDYbf","recVTVGHktZrTVmVm, recOLd9a3r4HmpWEF, rec6a9bBcPsdCgtVi, recEBmO5Apr89hClw",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 21 studies (10,199 subjects) showed chronic alcohol consumption significantly reduces total testosterone (MD = -4.02), free testosterone (MD = -0.17), and SHBG (MD = -1.94), while increasing estradiol (MD = 7.65). Effects observed only in healthy men with chronic consumption, not acute intake.",
recA4Hpf2p4NtBNvL,"Lean Body Mass, Muscle Mass, Body Weight, BMI",High,,2025-07-17T11:26:03.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,0.39 kg lean body mass increase per 0.1 g/kg/day protein increment below 1.3 g/kg threshold. Significant effects even with supplementation <0.3 g/kg/day,LI030,recAdUWMgWMZS3qKI,"reccxH7AESy9vvBPo, recyKRTIlX4Jux2W0",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7727026/,Dose–response relationship between protein intake and muscle mass increase: a systematic review and meta-analysis of randomized controlled trials,PMID: 33300582,"recMV3jzfb4sKW5vY, receDJo2S8FqzNOrm, recnSEMu0buoaCSvm, receIFIO0xrD92Ym4","recQmrpQIhvgDAJFf, reci47ujle6esrsBD, recrj2SLthVc3gwFD",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 105 RCTs (5,402 participants) demonstrated a dose-response relationship between protein intake and lean body mass increase. Mean increase in LBM was 0.39 kg per 0.1 g/kg/day protein increment below 1.3 g/kg/day threshold. Even small increases in protein (0.1 g/kg/day) significantly increased muscle mass over several months.",recQaZVJXPAHgLTHm
recqBdEjgop9phdvP,"HOMA-IR, Fasting Glucose, HbA1c, LDL, Total Cholesterol, Triglycerides, HDL",High,,2025-07-17T11:26:37.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant reduction in HOMA-IR and lipid parameters in T2DM patients, though no significant effect on fasting glucose or HbA1c",LI031,,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.clinicalnutritionjournal.com/article/S0261-5614(19)33020-1/abstract,"Effects of high-protein diet on glycemic control, insulin resistance and blood pressure in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials",PMID: 31466731,"recMV3jzfb4sKW5vY, receDJo2S8FqzNOrm, recnSEMu0buoaCSvm, receIFIO0xrD92Ym4","recQmrpQIhvgDAJFf, reci47ujle6esrsBD, recrj2SLthVc3gwFD",True,,PubMed,recRIfCU2PF5bhkmW,"Systematic review and meta-analysis of RCTs in type 2 diabetes patients found that high-protein diets significantly reduced HOMA-IR (insulin resistance), LDL cholesterol, total cholesterol, and triglycerides. While glycemic control was not significantly improved, metabolic parameters showed clear benefits.",recQaZVJXPAHgLTHm
recTiKjrzULUKQ5KR,"Body Weight, BMI, Body Fat Percentage, Lean Body Mass, Waist Circumference",High,,2025-07-17T11:27:09.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,1.6 kg additional weight loss with increased protein intake; greater benefits in prediabetic individuals and those without obesity risk alleles,LI032,,"reccxH7AESy9vvBPo, recVHWlB26jWt9Ij9, recHOTAk6Lpmb9uUz, recbIfUESzC18eAIL",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8468854/,Are Dietary Proteins the Key to Successful Body Weight Management? A Systematic Review and Meta-Analysis of Studies Assessing Body Weight Outcomes after Interventions with Increased Dietary Protein,PMID: 34578994,"recMV3jzfb4sKW5vY, receDJo2S8FqzNOrm, recnSEMu0buoaCSvm, receIFIO0xrD92Ym4","recQmrpQIhvgDAJFf, reci47ujle6esrsBD, recrj2SLthVc3gwFD",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 37 studies found that increased protein intake (18-59% of energy) resulted in 1.6 kg greater weight loss compared to controls. Higher protein diets consistently showed beneficial effects on body composition, satiety, and thermogenesis. Effects were particularly pronounced in individuals with prediabetes.",recQaZVJXPAHgLTHm
recSt0kpdic90vIRf,"Cardiovascular Disease Risk, Coronary Heart Disease, Stroke, Cancer Risk, All-Cause Mortality",High,,2025-07-17T11:33:32.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Dose-response relationship showing 8-16% risk reduction per 200g daily intake increase, with optimal benefits at 800g/day for most outcomes",LI033,recPiW3K4dhWi31Xh,"recVHWlB26jWt9Ij9, reccxH7AESy9vvBPo",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC5837313/,"Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies",PMID: 28338764,"rec3vdJyRz5x9yYJ6, recMWhvrT57rQOSyU, recTnxfnpWuWO6CRg, recUk7Y0cYFgRAOg5, recWJPLkPnQbaX9eI, recGQyztbSj4MyEaU","rec7WBPPkFwl2cCTn, recQnFBImbyfJswIb, recXOVlES2VKHKg1x, recYLv4hF464Kesqm, rec0adRBithZ3BNoZ, recKhWFKEYKSFcikb",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 95 studies (142 publications) found that for every 200g/day increase in combined fruit and vegetable intake, there was an 8% reduced risk of coronary heart disease (RR 0.92), 16% reduced risk of stroke (RR 0.84), 8% reduced risk of cardiovascular disease (RR 0.92), 3% reduced risk of total cancer (RR 0.97), and 10% reduced risk of all-cause mortality (RR 0.90). Benefits were observed up to 800g/day for most outcomes.",
recT56eCMlF2NZwyV,"Body Weight, BMI, Energy Intake",High,,2025-07-17T11:33:41.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Modest but consistent effects on body weight and energy intake when vegetables/fruits are added without restricting other foods,LI034,,reccxH7AESy9vvBPo,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC4158137/,Systematic review and meta-analysis of the effect of increased vegetable and fruit consumption on body weight and energy intake,PMID: 25168589,"rec3vdJyRz5x9yYJ6, recMWhvrT57rQOSyU, recTnxfnpWuWO6CRg","rec7WBPPkFwl2cCTn, recQnFBImbyfJswIb, recXOVlES2VKHKg1x",True,,PubMed,rec4qqncSQrMbfAph,Systematic review of randomized controlled trials found that interventions to increase vegetable and fruit consumption (without advice to reduce other foods) led to weight loss and improved body composition. Increased vegetable and fruit consumption was associated with moderate but significant improvements in body weight and reduced energy density of the overall diet.,
recg0m8SO9oCbBDcu,"Cardiovascular Disease, Stroke, Coronary Heart Disease, Type 2 Diabetes, Cancer Risk, All-Cause Mortality",High,,2025-07-17T11:33:53.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Comprehensive evidence across 29 diseases showing consistent 4-15% risk reductions with most protective associations showing RR 0.87-0.96 per serving,LI035,"recPiW3K4dhWi31Xh, recC0mB1LyNGjDyld, recf4HtvFUqMhyhdh","recVHWlB26jWt9Ij9, reccxH7AESy9vvBPo",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.jandonline.org/article/S2212-2672(18)31342-X/fulltext,The Associations of Fruit and Vegetable Intakes with Burden of Diseases: A Systematic Review of Meta-Analyses,PMID: 30639206,"rec3vdJyRz5x9yYJ6, recMWhvrT57rQOSyU, recTnxfnpWuWO6CRg, recUk7Y0cYFgRAOg5, recWJPLkPnQbaX9eI, recGQyztbSj4MyEaU","rec7WBPPkFwl2cCTn, recQnFBImbyfJswIb, recXOVlES2VKHKg1x, recYLv4hF464Kesqm, rec0adRBithZ3BNoZ, recKhWFKEYKSFcikb",True,,Journal of the Academy of Nutrition and Dietetics,recA1EVfrjrmEMho8,"Systematic review of 64 meta-analyses found significant protective associations between fruit and vegetable intake and 29 different diseases. Most associations showed 4-15% risk reduction per serving increase. Strong evidence for protection against cardiovascular disease, stroke, coronary heart disease, diabetes, and certain cancers. Dose-response relationships were identified for 31 negative associations.",
rec194G0qZ9wySSrU,"Fasting Glucose, Insulin Sensitivity, Type 2 Diabetes Risk, Insulin Resistance",High,,2025-07-17T11:41:11.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,36% lower risk of type 2 diabetes with 2 servings fruit/day vs <0.5 servings/day; significant reduction in fasting glucose in diabetic patients,LI036,"recf4HtvFUqMhyhdh, recC0mB1LyNGjDyld",recVHWlB26jWt9Ij9,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10198260/,Effect of fruit on glucose control in diabetes mellitus: a meta-analysis of nineteen randomized controlled trials,PMID: 37214237,"recGXWM4L7vUbxfCd, recMEPqal9VglyK6U, rechz1JGiQJCv9YJo","recKokSledWI4bTMu, recQ5dwrOfm4ecogb, recl0pPXLWaqoNCTF",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 19 RCTs found that fruit consumption significantly reduced fasting blood glucose in diabetic patients. Australian Diabetes Study of 7,675 participants showed 36% lower risk of developing type 2 diabetes in those eating 2 servings/day vs <0.5 servings/day. Clear negative correlation between fruit intake and insulin sensitivity markers, meaning people who eat more fruit require less insulin to lower blood glucose.",
recVJ94O76ZoE8v54,"Cardiovascular Disease, Coronary Heart Disease, Stroke, Cancer Risk, All-Cause Mortality, Vitamin C",High,,2025-07-17T11:41:33.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Consistent 7-12% risk reductions across multiple disease endpoints per 100mg vitamin C daily; stronger effects with blood concentrations,LI037,recPiW3K4dhWi31Xh,recVHWlB26jWt9Ij9,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC6250988/,"Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies",PMID: 30475962,"recGXWM4L7vUbxfCd, recMEPqal9VglyK6U, rechz1JGiQJCv9YJo","recKokSledWI4bTMu, recQ5dwrOfm4ecogb, recl0pPXLWaqoNCTF",True,,PubMed,recRIfCU2PF5bhkmW,"Systematic review and meta-analysis of 69 prospective studies found that higher dietary intake of vitamin C (per 100mg/day increment) was associated with 12% reduced risk of coronary heart disease (RR 0.88), 8% reduced stroke risk (RR 0.92), 11% reduced cardiovascular disease (RR 0.89), 7% reduced total cancer (RR 0.93), and 11% reduced all-cause mortality (RR 0.89). Blood vitamin C concentrations showed even stronger associations.",
recmI6RqZl1EAT7OZ,"Immune Function, Infection Susceptibility, Neutrophil Function, T-cell Function, B-cell Function",Moderate,,2025-07-17T11:41:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Well-established mechanisms for immune enhancement with adequate vitamin C intake from fruits; prevents infection susceptibility,LI038,recPiW3K4dhWi31Xh,recVHWlB26jWt9Ij9,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC5707683/,Vitamin C and Immune Function,PMID: 29099763,"recGXWM4L7vUbxfCd, recMEPqal9VglyK6U, rechz1JGiQJCv9YJo","recKokSledWI4bTMu, recQ5dwrOfm4ecogb, recl0pPXLWaqoNCTF",True,,PubMed,recuux8z8gb0e5MPU,"Comprehensive review showing vitamin C contributes to immune defense by supporting both innate and adaptive immune system functions. Vitamin C enhances neutrophil chemotaxis, phagocytosis, and microbial killing. It supports epithelial barrier function against pathogens and enhances differentiation and proliferation of B- and T-cells. Deficiency results in impaired immunity and higher infection susceptibility. Prophylactic prevention requires 100-200mg/day to optimize cell and tissue levels.",
recvtmz36mUxThUpc,"Triglycerides, Total Cholesterol, LDL Cholesterol, HDL Cholesterol, Systolic Blood Pressure, Diastolic Blood Pressure",High,,2025-07-17T11:45:26.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Significant increases in triglycerides, total cholesterol, and LDL cholesterol with higher sugar intakes, particularly when energy balance maintained",LI039,"recDBJLAkc5CAfBm3, recw2hqgZfllcjFso, recq0JX3QgFBo5mm4","reccxH7AESy9vvBPo, recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S0002916523046750?via%3Dihub,Dietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids,PMID: 24808490,"recCqwYvk7o9NLZye, rec4hs6FOKci6FcHD, receMjPXD2cZs6rer","recGRU4MNdPXGpDIv, rec8IQcWhQD6ZjQRU, recidHVe68DNlK5oI",True,,Science Direct,recRIfCU2PF5bhkmW,"Meta-analysis of 39 randomized controlled trials found that higher compared with lower sugar intakes significantly raised triglyceride concentrations (MD: 0.11 mmol/L), total cholesterol (MD: 0.16 mmol/L), low-density lipoprotein cholesterol (MD: 0.12 mmol/L), and high-density lipoprotein cholesterol (MD: 0.02 mmol/L). Effects were most marked when energy balance was maintained, indicating sugar-specific effects independent of weight change.",
rec0v741flomoT38y,"Body Weight, BMI, Body Fat Percentage, Energy Intake",High,,2025-07-17T11:45:38.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Moderate effect on body weight mediated primarily through increased energy intake rather than unique metabolic effects,LI040,recAdUWMgWMZS3qKI,"reccxH7AESy9vvBPo, recVHWlB26jWt9Ij9",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.bmj.com/content/346/bmj.e7492.long,Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies,PMID: 23321486,"recCqwYvk7o9NLZye, rec4hs6FOKci6FcHD, receMjPXD2cZs6rer","recGRU4MNdPXGpDIv, rec8IQcWhQD6ZjQRU, recidHVe68DNlK5oI",True,,The BMJ,recRIfCU2PF5bhkmW,"Systematic review and meta-analysis of 60 trials found that when free sugars or sugar-sweetened beverages were consumed ad libitum, they were a determinant of body weight. The change in body fatness occurred through changes in energy intake rather than unique metabolic effects of sugars. Isoenergetic exchange of sugars with other carbohydrates showed no significant effect on body weight.",
rec2JJk3W8WMoOoZV,"Cardiovascular Disease, Type 2 Diabetes, Depression, Uric Acid, Nonalcoholic Fatty Liver Disease",High,,2025-07-17T11:45:54.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Convincing evidence for cardiovascular disease, type 2 diabetes, and depression associations; highly suggestive evidence for NAFLD",LI041,"recPiW3K4dhWi31Xh, recC0mB1LyNGjDyld, recf4HtvFUqMhyhdh, reckGxzoaJGEmBptC",recVHWlB26jWt9Ij9,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.annualreviews.org/docserver/fulltext/nutr/44/1/annurev-nutr-062322-020650.pdf?expires=1753374503&id=id&accname=guest&checksum=C94F91CA23E9DC7430CA5E0429867188,Sugar-Sweetened Beverages and Adverse Human Health Outcomes: An Umbrella Review of Meta-Analyses of Observational Studies,PMID: 39207876,"recCqwYvk7o9NLZye, rec4hs6FOKci6FcHD, receMjPXD2cZs6rer","recGRU4MNdPXGpDIv, rec8IQcWhQD6ZjQRU, recidHVe68DNlK5oI",True,,Annual Review of Nutrition,recA1EVfrjrmEMho8,"Umbrella review of 47 meta-analyses encompassing 22,055,269 individuals found that 79% of analyses indicated direct associations between greater sugar-sweetened beverage consumption and higher risks of adverse health outcomes. Convincing evidence supported direct associations with depression, cardiovascular disease, type 2 diabetes mellitus, and higher uric acid concentrations. Highly suggestive evidence supported associations with nonalcoholic fatty liver disease.",
recbFt8PUUzhXoC6K,"Cancer Risk, Colorectal Cancer, Colon Cancer, Rectal Cancer, Breast Cancer, Lung Cancer",High,,2025-07-17T16:45:31.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Processed meat showed consistent 6-22% increased cancer risk across multiple cancer types with strongest associations for rectal (22%) and colon (21%) cancers,LI042,recPiW3K4dhWi31Xh,recVHWlB26jWt9Ij9,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://link.springer.com/article/10.1007/s10654-021-00741-9,Consumption of red meat and processed meat and cancer incidence: a systematic review and meta-analysis of prospective studies,PMID: 34455534,"recPnCzFAy0LTJ9C1, recf94WHfCkB3aoTA, recq2dRUP4FLao9gd","recTO0FW3ErzMnNMi, recjAs2YIILpWO23R, recutBXbia6z32Nqu",True,,Springer Nature,rec4qqncSQrMbfAph,"Comprehensive systematic review of 148 studies found processed meat consumption significantly associated with increased cancer risk: 6% higher breast cancer risk, 18% higher colorectal cancer risk, 21% higher colon cancer risk, 22% higher rectal cancer risk, and 12% higher lung cancer risk. Meta-analysis provides strong evidence supporting dietary guidelines to limit processed meat intake for cancer prevention.",
recqngw2TdjzBdBGQ,"Type 2 Diabetes Risk, Insulin Resistance, Glucose Metabolism",High,,2025-07-17T16:45:42.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,15% increased diabetes risk per 50g/day processed meat intake; 10% increased risk per 100g/day unprocessed red meat,LI043,"recC0mB1LyNGjDyld, recf4HtvFUqMhyhdh",recVHWlB26jWt9Ij9,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00179-7/fulltext,"Meat consumption and incident type 2 diabetes: an individual-participant federated meta-analysis of 1.97 million adults with 100,000 incident cases from 31 cohorts in 20 countries",PMID: 39174161,"recPnCzFAy0LTJ9C1, recf94WHfCkB3aoTA, recq2dRUP4FLao9gd","recTO0FW3ErzMnNMi, recjAs2YIILpWO23R, recutBXbia6z32Nqu",True,,The Lancet,recRIfCU2PF5bhkmW,"Largest federated meta-analysis on meat and diabetes risk with nearly 2 million participants found processed meat associated with 15% higher type 2 diabetes risk per 50g/day (HR 1.15, 95% CI 1.11-1.20), unprocessed red meat with 10% higher risk per 100g/day (HR 1.10, 95% CI 1.06-1.15). Results were consistent across geographical regions and robust to sensitivity analyses.",
recpicUapbnuS1yzI,"All-Cause Mortality, Cardiovascular Mortality, Cancer Mortality",High,,2025-07-17T16:45:55.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Consistent 8-15% increased mortality risk per serving/day processed meat with strongest effects on all-cause and cardiovascular mortality,LI044,recPiW3K4dhWi31Xh,reccxH7AESy9vvBPo,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10270853/,Red and processed meat consumption and mortality: dose-response meta-analysis of prospective cohort studies,PMID: 26143683,"recPnCzFAy0LTJ9C1, recf94WHfCkB3aoTA, recq2dRUP4FLao9gd","recTO0FW3ErzMnNMi, recjAs2YIILpWO23R, recutBXbia6z32Nqu",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 17 prospective cohorts (150,328 deaths) found processed meat consumption associated with 15% higher all-cause mortality (RR 1.15, 95% CI 1.11-1.19), 15% higher cardiovascular mortality (RR 1.15, 95% CI 1.07-1.24), and 8% higher cancer mortality (RR 1.08, 95% CI 1.06-1.11) per serving per day. Dose-response relationships demonstrated for all outcomes.",
recHqDbS86331GBBd,"Colorectal Cancer Risk, Colon Cancer, Rectal Cancer",High,,2025-07-17T16:46:05.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,17% increased colorectal cancer risk per 100g/day intake with evidence of dose-response relationship,LI045,recPiW3K4dhWi31Xh,recVHWlB26jWt9Ij9,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC3108955/,Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies,PMID: 21674008,"recPnCzFAy0LTJ9C1, recf94WHfCkB3aoTA, recq2dRUP4FLao9gd","recTO0FW3ErzMnNMi, recjAs2YIILpWO23R, recutBXbia6z32Nqu",True,,PubMed,recRIfCU2PF5bhkmW,"Updated meta-analysis of prospective studies found strong evidence that processed meat increases colorectal cancer risk. For every 100g/day increase in red and processed meat, colorectal cancer risk increased by 17% (RR 1.17, 95% CI 1.08-1.26). Non-linear dose-response analyses confirmed risk increases even at moderate intake levels, supporting dietary guidelines to limit processed meat consumption.",
reci4L7v62HGE6DId,"C-reactive Protein, Inflammatory Markers, White Blood Cell Count",Moderate,,2025-07-17T16:46:17.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,38% increase in CRP per 50g/day processed meat intake; largest magnitude among all meat types studied,LI046,"recPiW3K4dhWi31Xh, reckGxzoaJGEmBptC",reccxH7AESy9vvBPo,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8754571/,"Higher Meat Intake Is Associated with Higher Inflammatory Markers, Mostly Due to Adiposity: Results from UK Biobank",PMID: 34587250,"recPnCzFAy0LTJ9C1, recf94WHfCkB3aoTA, recq2dRUP4FLao9gd","recTO0FW3ErzMnNMi, recjAs2YIILpWO23R, recutBXbia6z32Nqu",True,,PubMed,recDDHykOzWxwMnyv,"Large cross-sectional study of 403,886 UK Biobank participants found processed meat consumption associated with 38.3% higher C-reactive protein (CRP) per 50g/day intake (95% CI 36.0-40.7%) and 6.5% higher white blood cell count (95% CI 6.1-6.9%). Associations remained significant but were attenuated after adjustment for adiposity, indicating both direct inflammatory effects and indirect effects through body weight.",
recfnNXFUSSo7MKze,"Cardiovascular Disease Risk, Coronary Heart Disease, All-Cause Mortality, Cancer Risk",High,,2025-07-17T16:50:59.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,6-8% risk reduction per 30g/day whole grain intake with dose-response relationship up to 90g/day optimal intake,LI047,recPiW3K4dhWi31Xh,"recVHWlB26jWt9Ij9, reccxH7AESy9vvBPo",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC11044462/,"Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies",PMID: 38664726,"rectiHMpuqUW6EpOg, recDVZeEtpOMlhHaY, recIoVf6FOKFcUX8p","recxJ5SGXwlKZi3Yx, recHmnkVWvfAeVlkf, recMPjln8Ubt5yBiG",True,,PubMed,recRIfCU2PF5bhkmW,"Comprehensive meta-analysis of 45 studies (786,076 participants) found that per 30g/day increase in whole grain consumption, risks were reduced for: coronary heart disease by 6% (RR 0.94, 95% CI 0.92-0.97), cardiovascular disease by 8% (RR 0.92, 95% CI 0.88-0.96), and all-cause mortality by 6% (RR 0.94, 95% CI 0.92-0.97). Optimal benefits achieved at 90g/day (3 servings) whole grains.",
recQqC977SU1fqMpF,"Type 2 Diabetes Risk, Fasting Glucose, HbA1c, HOMA-IR, Insulin Resistance",High,,2025-07-17T16:51:11.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,25% diabetes risk reduction with 50g/day intake; significant improvements in glycemic biomarkers with 150g/day,LI048,"recC0mB1LyNGjDyld, recf4HtvFUqMhyhdh, recierVNozpgZdLZH",recVHWlB26jWt9Ij9,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://nutritionj.biomedcentral.com/articles/10.1186/s12937-024-00952-2,Effects of whole grains on glycemic control: a systematic review and dose-response meta-analysis of prospective cohort studies and randomized controlled trials,PMID: 38679758,"rectiHMpuqUW6EpOg, recDVZeEtpOMlhHaY, recIoVf6FOKFcUX8p","recxJ5SGXwlKZi3Yx, recHmnkVWvfAeVlkf, recMPjln8Ubt5yBiG",True,,BMC Nutrition Journal,recRIfCU2PF5bhkmW,"Meta-analysis of prospective cohorts showed 50g/day whole grain intake provided 25% reduction in type 2 diabetes risk. RCTs demonstrated that 150g/day whole grain intake improved fasting blood glucose, HbA1c, and insulin resistance (HOMA-IR). Combination of different whole grain types achieved greater glycemic benefits than single grain sources.",
recfUyUU5uBf7lhug,"LDL Cholesterol, Total Cholesterol, C-reactive Protein, Body Weight",High,,2025-07-17T16:51:24.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Modest but clinically meaningful reductions in LDL-C and total cholesterol; significant anti-inflammatory effects in at-risk populations,LI049,"recBA3iQ4lGJtC2nM, recDBJLAkc5CAfBm3, recPiW3K4dhWi31Xh, recAdUWMgWMZS3qKI",reccxH7AESy9vvBPo,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S0002916523126955?via%3Dihub,Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies,PMID: 26269373,"rectiHMpuqUW6EpOg, recDVZeEtpOMlhHaY, recIoVf6FOKFcUX8p","recxJ5SGXwlKZi3Yx, recHmnkVWvfAeVlkf, recMPjln8Ubt5yBiG",True,,Science Direct,recRIfCU2PF5bhkmW,Meta-analysis of 24 RCTs found whole grain intake significantly reduced LDL cholesterol by 0.09 mmol/L (3.5 mg/dL) and total cholesterol by 0.12 mmol/L (4.6 mg/dL) compared to refined grain controls. Whole grain oats showed the most effective cholesterol-lowering effects. Additional meta-analysis showed C-reactive protein reduction of 0.36 mg/L in overweight/obese adults.,
recTPRsOdrE2WTOFc,"Cardiovascular Disease Risk, Coronary Heart Disease Risk, Stroke Risk",High,,2025-07-17T16:54:11.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,6% CVD risk reduction and 10% CHD risk reduction with highest vs lowest legume intake; optimal benefits at 400g/week,LI050,recPiW3K4dhWi31Xh,recVHWlB26jWt9Ij9,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nmcd-journal.com/article/S0939-4753(22)00418-5/fulltext,Intake of legumes and cardiovascular disease: A systematic review and dose-response meta-analysis,PMID: 36411221,"recn4eGEOf9XA0tat, recApH4t4nFb8maup, reckLfq4q5YH3ChjU, recUk7Y0cYFgRAOg5, recWJPLkPnQbaX9eI, recGQyztbSj4MyEaU","recrvCMVhlALtE7kK, recEQ5aKxt6Z10OEG, recocDwlTbpvWgVtb, recYLv4hF464Kesqm, rec0adRBithZ3BNoZ, recKhWFKEYKSFcikb",True,,"Nutrition, Metabolism and Cardiovascular Disease",recPTVJvlU8ZpgeS3,"Meta-analysis of 26 observational studies (22,831 articles screened) found legume consumption inversely associated with CVD (RR = 0.94; 95%CI: 0.89-0.99) and CHD (RR = 0.90; 95%CI: 0.85-0.96) when comparing highest vs lowest intake categories. Dose-response analysis identified 400g/week as optimal intake level for cardiovascular benefit. No significant association found with stroke risk.",
recT48LgHRU99I98j,"Fasting Glucose, HbA1c, Post-Prandial Glucose, Insulin Resistance, HOMA-IR",High,,2025-07-17T16:54:23.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Significant reduction in post-prandial glucose peaks in T2D patients; improvements in long-term glycemic control markers,LI051,"recf4HtvFUqMhyhdh, recC0mB1LyNGjDyld, recierVNozpgZdLZH",recVHWlB26jWt9Ij9,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8854292/,Pulse consumption improves indices of glycemic control in adults with and without type 2 diabetes: a systematic review and meta-analysis,PMID: 34585281,"recn4eGEOf9XA0tat, recApH4t4nFb8maup, reckLfq4q5YH3ChjU","recrvCMVhlALtE7kK, recEQ5aKxt6Z10OEG, recocDwlTbpvWgVtb",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 65 RCTs (2,102 individuals) found pulse intake significantly reduced peak post-prandial glucose concentration in participants with T2D (ES -2.90; 95%CI -4.60, -1.20). Long-term pulse consumption improved fasting glucose, HbA1c, and insulin resistance markers. Acute post-prandial trials showed immediate glucose response benefits.",
recBFu5ba1vaqbnzm,"LDL Cholesterol, Total Cholesterol, HbA1c, Gut Microbiome Diversity, SCFA Production",High,,2025-07-17T16:54:36.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Significant improvements in cholesterol and glycemic markers with legume diet mediated through gut microbiome changes and SCFA production,LI052,"recBA3iQ4lGJtC2nM, recDBJLAkc5CAfBm3, recC0mB1LyNGjDyld",recVHWlB26jWt9Ij9,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC11754483/,A legume-enriched diet improves metabolic health in prediabetes mediated through gut microbiome: a randomized controlled trial,PMID: 39843443,"recn4eGEOf9XA0tat, recApH4t4nFb8maup, reckLfq4q5YH3ChjU, recUk7Y0cYFgRAOg5, recWJPLkPnQbaX9eI, recGQyztbSj4MyEaU","recrvCMVhlALtE7kK, recEQ5aKxt6Z10OEG, recocDwlTbpvWgVtb, recYLv4hF464Kesqm, rec0adRBithZ3BNoZ, recKhWFKEYKSFcikb",True,,PubMed,reclYXy0udvjr66Xa,"16-week RCT in 127 Chinese prediabetes participants found legume-enriched calorie-restricted diet significantly improved LDL cholesterol (β = -0.16), total cholesterol (β = -0.16), and HbA1c compared to control diet. Gut microbiome analysis showed increased carbohydrate fermentation capacity, higher SCFA production pathways, and beneficial microbial species changes including increased Bifidobacterium and improved fiber-degrading enzyme activity.",
recpm16Bx8TW3s09V,"Total Sleep Time, Sleep Efficiency, Sleep Onset Latency, Deep Sleep Duration, Light Sleep Duration",High,,2025-07-17T17:02:09.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"45-minute reduction in total sleep time, 7% reduction in sleep efficiency, significant disruption of sleep architecture",LI053,,"recxJqmq5ipZMLJsj, rec8o1wlo0olBMl8A, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S1087079223000205?via%3Dihub,The effect of caffeine on subsequent sleep: A systematic review and meta-analysis,PMID: 36870101,"recPgYrf87WKNpens, recgFS8idJ1Rz8Msu, recvLB6CCcDJhm1Fx","reczcZcT5i4xa0FPO, reck6gezGPsFsMqCL, recTHmxwBdnyG3SxJ",True,,Science Direct,recRIfCU2PF5bhkmW,"Meta-analysis of 24 studies found caffeine consumption reduced total sleep time by 45 minutes and sleep efficiency by 7%, with increased sleep onset latency of 9 minutes and wake after sleep onset of 12 minutes. Deep sleep (N3/N4) duration decreased by 11.4 minutes while light sleep increased. Coffee (107mg) should be consumed at least 8.8 hours before bedtime to avoid sleep reductions.",
recazXCH83ljjJoLr,"Anxiety Levels, Stress Response, Mood Stability",High,,2025-07-17T17:02:20.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Significant anxiety increases with caffeine intake, particularly pronounced with doses >400mg",LI054,,"recLuAlDIETnvUUtO, recqea20SA5Y5BaIw",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10867825/,Caffeine intake and anxiety: a meta-analysis,PMID: 38362247,"recPgYrf87WKNpens, recgFS8idJ1Rz8Msu, recvLB6CCcDJhm1Fx","reczcZcT5i4xa0FPO, reck6gezGPsFsMqCL, recTHmxwBdnyG3SxJ",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 8 studies with 546 participants found caffeine consumption significantly increased anxiety risk [SMD = 0.94, 95%CI = (0.28, 1.60), p < 0.05]. Subgroup analysis revealed low-dose caffeine moderately increased anxiety risk [SMD = 0.61], while high-dose caffeine (>400mg) had highly significant anxiety increases [SMD = 2.86]. Effects mediated through adenosine receptor blockade reducing cerebral blood flow.",
recMJH9tTOHPdM5CJ,"Systolic Blood Pressure, Diastolic Blood Pressure, Cardiovascular Health",High,,2025-07-17T17:02:30.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Modest but consistent blood pressure increases with chronic caffeine intake across multiple studies,LI055,,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://journals.lww.com/jhypertension/abstract/2005/05000/blood_pressure_response_to_chronic_intake_of.3.aspx,Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials,PMID: 15834273,"recPgYrf87WKNpens, recgFS8idJ1Rz8Msu, recvLB6CCcDJhm1Fx","reczcZcT5i4xa0FPO, reck6gezGPsFsMqCL, recTHmxwBdnyG3SxJ",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 16 randomized controlled trials (1,010 subjects) found chronic coffee/caffeine intake increased systolic blood pressure by 2.4 mmHg and diastolic blood pressure by 1.2 mmHg. Effects were dose-dependent and primarily mediated by caffeine rather than other coffee compounds. Cardiovascular effects related to increased systemic vascular resistance through adenosine receptor blockade.",
recsdPLR5Wpx2F4fl,"Sleep Duration, Sleep Quality, All-Cause Mortality, Cardiovascular Disease Risk, Coronary Heart Disease Risk",High,,2025-07-17T18:03:18.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Strong dose-response relationship with 14-47% increased mortality risk for long sleep durations and 44% increased CHD risk for poor sleep quality,LI056,,,2025-09-23T23:50:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC6201443/,Self-Reported Sleep Duration and Quality and Cardiovascular Disease and Mortality: A Dose-Response Meta-Analysis,PMID: 30371228,"rec0j9ruDrnh2P6gG, rec4AEbFQJsIeCNOD, recKLti4nzfTo8acc",,True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 74 studies including 3.3 million participants found sleep duration >8 hours associated with increased mortality risk (RR=1.14 for 9 hours, RR=1.30 for 10 hours, RR=1.47 for 11 hours). J-shaped relationship with optimal sleep duration 7-8 hours. Poor sleep quality increased coronary heart disease risk by 44% (RR=1.44; 95% CI: 1.09-1.90).",
recNqwwshD3IuGtkv,"Sleep Apnea Severity, Cardiovascular Disease Risk, Stroke Risk, All-Cause Mortality, Sleep Quality",High,,2025-07-17T18:03:46.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Strong dose-response relationship with severe OSA showing 79% increased CVD risk, 115% increased stroke risk, and 92% increased mortality",LI057,,,2025-09-23T23:50:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.internationaljournalofcardiology.com/article/S0167-5273(13)01671-9/fulltext,Obstructive sleep apnea and risk of cardiovascular disease and all-cause mortality: A meta-analysis of prospective cohort studies,PMID: 24161531,"rec0j9ruDrnh2P6gG, rec4AEbFQJsIeCNOD, recKLti4nzfTo8acc",,True,,International Journal of Cardiology,recPTVJvlU8ZpgeS3,"Meta-analysis of 12 prospective cohort studies with 25,760 participants found severe OSA significantly increased CVD risk by 79% (RR=1.79; 95% CI: 1.47-2.18), stroke risk by 115% (RR=2.15; 95% CI: 1.42-3.24), and all-cause mortality by 92% (RR=1.92; 95% CI: 1.38-2.67). Moderate OSA showed positive association with CVD but mild OSA did not.",
rec8hgkasCsRwSrVv,"Sleep Consistency, Sleep Duration Variability, Sleep Timing Variability, Cardiovascular Disease Risk, Circadian Rhythm Health",Moderate,,2025-07-17T18:03:58.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"27% increased CVD risk per hour of sleep duration variability, with sleep irregularity potentially more important than sleep duration",LI058,,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7237955/,Sleep Irregularity and Risk of Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis,PMID: 32138974,"rec0j9ruDrnh2P6gG, rec4AEbFQJsIeCNOD, recKLti4nzfTo8acc, recqGyakXN5etEtZk, recuLDdQ8KbpeyEPc, reckWMg3144Ab2593","recu7WgBqTw2mi79B, recyc1j7BQCd7ciZt, reconamkuavo4GJjk",True,,PubMed,recDDHykOzWxwMnyv,"Prospective cohort study of 1,992 participants found sleep irregularity significantly increased cardiovascular disease risk. Each 1-hour increase in sleep duration variability was associated with 27% higher CVD risk (HR=1.27; 95% CI: 1.03-1.55). Sleep timing irregularity showed similar associations. Irregular sleep patterns represent chronic circadian disruption that may be more strongly associated with CVD than short sleep duration.",
recqns27bBblGOhy5,"Systolic Blood Pressure, Diastolic Blood Pressure, Cardiac Output, Cardiovascular Health",High,,2025-07-18T11:51:26.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Consistent moderate increases in blood pressure and cardiac output with acute energy drink consumption,LI059,"recr9ZjdfpVef9KJR, recTyoThcQqCihtey","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://academic.oup.com/nutritionreviews/article-abstract/82/8/1028/7268826?redirectedFrom=fulltext&login=false,Acute effects of energy drink consumption on cardiovascular parameters in healthy adults: a systematic review and meta-analysis of randomized clinical trials,PMID: 37695306,"recs1Yx1aoyTCalz2, recxd0ZkIKfdSxVMp, recr7AtTCj4d026By","recwsmDiDuZHvOZJj, recBEo5BbQG1LbzWG, recvyYza5pv1TGKLP",True,,Nutrition Reviews,recRIfCU2PF5bhkmW,"Meta-analysis of 17 RCTs found energy drink consumption significantly increased systolic blood pressure by 4.71 mmHg (95% CI: 2.97-6.45), diastolic blood pressure by 4.51 mmHg (95% CI: 2.60-6.42), and cardiac output by 0.43 L (95% CI: 0.08-0.77) compared to control beverages. Effects were most pronounced at 60-80 minutes for SBP and 120 minutes for DBP.",
rec1lk6xXygU3EpSK,"Sleep Quality, Anxiety Levels, Stress Response, Mood Stability",High,,2025-07-18T11:51:39.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,5-fold increased odds of insomnia and 3.5-fold increased odds of jitteriness with energy drink consumption,LI060,"recDwWAHjdIXhMhSV, recq0JX3QgFBo5mm4","recLuAlDIETnvUUtO, rec8o1wlo0olBMl8A",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8083152/,Energy Drinks and Their Adverse Health Effects: A Systematic Review and Meta-analysis,PMID: 33211984,"recs1Yx1aoyTCalz2, recxd0ZkIKfdSxVMp, recr7AtTCj4d026By","recwsmDiDuZHvOZJj, recBEo5BbQG1LbzWG, recvyYza5pv1TGKLP",True,,PubMed,rec4qqncSQrMbfAph,"Systematic review of 32 studies with 96,549 individuals found energy drinks significantly increased odds of insomnia (OR=5.02; 95% CI: 1.72-14.63) and jitteriness/activeness (OR=3.52; 95% CI: 1.28-9.65). Among 9,816 individuals, 165 required medical attention (1.7%). Authors recommend avoiding frequent energy drink consumption (5-7 drinks/week) and co-consumption with alcohol.",
rec3HzEzFAdG3j4GF,"QT Interval, Heart Rate Variability, Cardiovascular Health",Moderate,,2025-07-18T11:51:52.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Energy drinks caused greater cardiac electrophysiological changes than equivalent caffeine dose alone,LI061,"recr9ZjdfpVef9KJR, recTyoThcQqCihtey","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC5524057/,Randomized Controlled Trial of High-Volume Energy Drink Versus Caffeine Consumption on ECG and Hemodynamic Parameters,PMID: 28446495,"recs1Yx1aoyTCalz2, recxd0ZkIKfdSxVMp, recr7AtTCj4d026By","recwsmDiDuZHvOZJj, recBEo5BbQG1LbzWG, recvyYza5pv1TGKLP",True,,PubMed,reclqQn6EV0azXdYf,"RCT in 18 healthy volunteers found energy drinks (320mg caffeine) caused significantly greater QT interval prolongation compared to caffeine alone (0.44±18.4 ms vs -10.4±14.8 ms at 2 hours; P=0.02). Energy drinks increased cardiovascular risk beyond caffeine effects alone, suggesting non-caffeine ingredients contribute to adverse effects.",
recKlpLhow3LSHksK,"Autonomic Function, Heart Rate Variability, Cardiovascular Health",Moderate,,2025-07-18T11:52:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Energy drinks caused significant autonomic dysfunction while coffee with same caffeine dose did not,LI062,"recr9ZjdfpVef9KJR, recTyoThcQqCihtey","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9279225/,Impact of energy drink versus coffee consumption on periodic repolarization dynamics: an interventional study,PMID: 35266046,"recs1Yx1aoyTCalz2, recxd0ZkIKfdSxVMp, recr7AtTCj4d026By","recwsmDiDuZHvOZJj, recBEo5BbQG1LbzWG, recvyYza5pv1TGKLP",True,,PubMed,reclqQn6EV0azXdYf,"Interventional study in 16 healthy individuals found energy drinks (240mg caffeine) significantly increased periodic repolarization dynamics (PRD) levels (3.64 vs 5.85 deg2; p<0.001), while coffee consumption (240mg caffeine) did not alter PRD levels (3.47 vs 3.16 deg2, p=0.63). Suggests sympathetic activation from energy drinks is mediated by non-caffeine substances.",
rec6fhVSRKY4OMFko,"Cardiovascular Disease Risk, Endothelial Function, Insulin Resistance, Blood Pressure",Moderate,,2025-07-18T11:52:13.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Consistent associations between moderate coffee/tea consumption and cardiovascular benefits,LI063,"recr9ZjdfpVef9KJR, recTyoThcQqCihtey, recLJcUUTL1szyE8Z","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10769121/,Is Coffee and Tea a Threat or Ally to Cardiovascular Health?,PMID: 38186410,"recs1Yx1aoyTCalz2, recxd0ZkIKfdSxVMp, recr7AtTCj4d026By","recwsmDiDuZHvOZJj, recBEo5BbQG1LbzWG, recvyYza5pv1TGKLP",True,,PubMed,recuux8z8gb0e5MPU,"Comprehensive review found coffee and tea consumption (2-3 cups daily) associated with cardioprotective effects including reduced cardiovascular disease risk, improved endothelial function, and favorable impact on insulin resistance. Polyphenols and antioxidants in coffee/tea provide protective mechanisms beyond caffeine effects. Moderate consumption appears harmless and potentially beneficial for cardiovascular health.",
recyOdJVziH7kO0FW,"Sleep Quality, Sleep Duration, Sleep Efficiency, Sleep Onset Latency",High,,2025-07-18T11:54:24.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,45-minute reduction in total sleep time and 8.8-hour cutoff recommendation for morning coffee consumption,LI064,recDwWAHjdIXhMhSV,"recLuAlDIETnvUUtO, rec8o1wlo0olBMl8A, recxJqmq5ipZMLJsj",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S1087079223000205?via%3Dihub,The effect of caffeine on subsequent sleep: A systematic review and meta-analysis,PMID: 36870101,"recRbJX726D4FBznW, recCAuXnKTEfdVA0Q, recTJviRFoOIYipZZ","recVC73ovc4Syfdxd, recG1S3EdZ536zea7, recXaTo88ufwRW39g",True,,Science Direct,recRIfCU2PF5bhkmW,"Meta-analysis of 24 studies found caffeine consumption reduced total sleep time by 45 minutes and sleep efficiency by 7%, with increased sleep onset latency of 9 minutes and wake after sleep onset of 12 minutes. To avoid reductions in total sleep time, coffee (107 mg per 250 mL) should be consumed at least 8.8 hours prior to bedtime. Deep sleep (N3 and N4) decreased by 11.4 minutes while light sleep increased.",
recPgx5VRop788CTk,"Sleep Quality, Sleep Duration, Sleep Onset Latency, Sleep Architecture",Moderate,,2025-07-18T11:54:34.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"High-dose caffeine (400mg) disrupted sleep when consumed within 12 hours of bedtime, while typical coffee dose (100mg) safe until 4 hours before bed",LI065,recDwWAHjdIXhMhSV,"recLuAlDIETnvUUtO, rec8o1wlo0olBMl8A, recxJqmq5ipZMLJsj",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC11985402/,Dose and timing effects of caffeine on subsequent sleep: a randomized clinical crossover trial,PMID: 39377163,"recRbJX726D4FBznW, recCAuXnKTEfdVA0Q, recTJviRFoOIYipZZ","recVC73ovc4Syfdxd, recG1S3EdZ536zea7, recXaTo88ufwRW39g",True,,PubMed,reclqQn6EV0azXdYf,"RCT in 23 males found 400 mg caffeine consumed within 12 hours of bedtime significantly disrupted sleep, while 100 mg dose had no significant effects. Significant delays in sleep initiation and alterations to sleep architecture occurred when 400 mg was consumed 4, 8, or 12 hours before bedtime. A 100 mg dose can be consumed up to 4 hours prior to bedtime without objective sleep disruption.",
recEcPuqbHG96wmmz,"Circadian Rhythm, Melatonin Rhythm, Sleep Timing",Moderate,,2025-07-18T11:54:46.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,40-minute delay in circadian melatonin rhythm equivalent to modest jet lag effect,LI066,"recDwWAHjdIXhMhSV, recwtXkPSEQgyddmt","recLuAlDIETnvUUtO, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC4657156/,Effects of caffeine on the human circadian clock in vivo and in vitro,PMID: 26378246,"recRbJX726D4FBznW, recCAuXnKTEfdVA0Q, recTJviRFoOIYipZZ","recVC73ovc4Syfdxd, recG1S3EdZ536zea7, recXaTo88ufwRW39g",True,,PubMed,reclqQn6EV0azXdYf,Double-blind placebo-controlled study found caffeine equivalent to a double espresso consumed 3 hours before bedtime induced a 40-minute phase delay of the circadian melatonin rhythm in humans. This effect was approximately half the magnitude of bright light exposure. Study demonstrates caffeine affects human circadian timing through adenosine receptor/cAMP-dependent mechanisms beyond just sleep disruption.,
recXEZ94kHXkuwW9j,"Body Weight, BMI, Fat Mass, HbA1c, Fasting Glucose",High,,2025-07-18T11:57:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,1.85 kg greater weight loss with lower meal frequency; benefits sustained over 12+ weeks,LI067,"recAdUWMgWMZS3qKI, recC0mB1LyNGjDyld, recf4HtvFUqMhyhdh","reccxH7AESy9vvBPo, recVHWlB26jWt9Ij9",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC11530941/,Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis,PMID: 39485353,"recdOj8Nr8NO1FwR6, recuXJOhYT3ZVrOfD, recXYBL9UD1QWCF3t","rechfHe4UeeCUja1n, recyo7UyrZuNO5spU, rec1pZRqnJsEPgjdK",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 29 randomized clinical trials (2,485 individuals) found lower meal frequency achieved greater weight loss (MD: -1.85 kg; 95% CI: -3.55 to -0.13 kg) compared to higher meal frequency interventions over 12+ weeks. Time-restricted eating, lower meal frequency, and earlier caloric distribution showed consistent benefits for weight management and metabolic health.",
recaje3Tkx97MUsCG,"Body Weight, BMI, Fat Mass, Blood Glucose, Insulin, Triglycerides, Total Cholesterol, LDL Cholesterol, HDL Cholesterol",High,,2025-07-18T11:57:17.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,No significant differences in weight or cardiometabolic outcomes between meal frequencies when energy controlled,LI068,"recAdUWMgWMZS3qKI, recBA3iQ4lGJtC2nM, recw2hqgZfllcjFso, recDBJLAkc5CAfBm3, recq0JX3QgFBo5mm4, recf4HtvFUqMhyhdh, recierVNozpgZdLZH","reccxH7AESy9vvBPo, recVHWlB26jWt9Ij9, recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10647044/,The effects of eating frequency on changes in body composition and cardiometabolic health in adults: a systematic review with meta-analysis of randomized trials,PMID: 37964316,"recdOj8Nr8NO1FwR6, recuXJOhYT3ZVrOfD, recXYBL9UD1QWCF3t","rechfHe4UeeCUja1n, recyo7UyrZuNO5spU, rec1pZRqnJsEPgjdK",True,,PubMed,recRIfCU2PF5bhkmW,Systematic review and meta-analysis of 16 trials found no significant difference between restricted (≤3 meals/day) vs unrestricted (≥4 meals/day) eating frequency for weight change (MD: -0.62 kg; 95% CI: -2.76 to 1.52 kg) or other cardiometabolic markers. Very low certainty evidence suggests meal frequency alone does not determine health outcomes when energy intake is controlled.,
recYI4TAnlYTTNwNx,"Glucose AUC, Insulin Response, Satiety, Resting Metabolic Rate, Protein Oxidation",Moderate,,2025-07-18T11:57:29.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Lower glucose AUC and increased satiety with 3 vs 14 meals/day; metabolic flexibility benefits from intermittent fasting periods,LI069,"recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI","recVHWlB26jWt9Ij9, recqea20SA5Y5BaIw",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC3374835/,Effects of Meal Frequency on Metabolic Profiles and Substrate Partitioning in Lean Healthy Males,PMID: 22719910,"recdOj8Nr8NO1FwR6, recuXJOhYT3ZVrOfD, recXYBL9UD1QWCF3t","rechfHe4UeeCUja1n, recyo7UyrZuNO5spU, rec1pZRqnJsEPgjdK",True,,PubMed,recW2EC7hY2K4pp0I,"Controlled chamber study in 12 healthy males found low meal frequency (3 meals/day) compared to high frequency (14 meals/day) resulted in lower glucose AUC, increased satiety, and higher resting metabolic rate and protein oxidation. Higher meal frequency maintained continuous postprandial status while lower frequency allowed periods of fasting state, supporting metabolic flexibility.",
recSbMYYLInM0r3oQ,"Waist Circumference, Fat Mass, Fasting Insulin, LDL Cholesterol, Total Cholesterol, Triglycerides, HDL Cholesterol, Fat-Free Mass",High,,2025-07-18T11:59:59.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Consistent beneficial effects on multiple cardiometabolic parameters with high certainty evidence from comprehensive umbrella review,LI070,"recAdUWMgWMZS3qKI, recw2hqgZfllcjFso, recq0JX3QgFBo5mm4, recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recDBJLAkc5CAfBm3, recBA3iQ4lGJtC2nM","reccxH7AESy9vvBPo, recVHWlB26jWt9Ij9, recSy02sgRnjfOkHE, recELBnyZAf0mIQH6",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10945168/,Intermittent fasting and health outcomes: an umbrella review of systematic reviews and meta-analyses of randomised controlled trials,PMID: 38500840,"recXiFdoZPO8ahvNU, rec33mt1Ib40viKUU, recMC1NC2ymnw4oc0","rec1J3jFsVfW3V9Xb, rec7uKzibhvOoWo4b, recQ3pTTvENbpI2mh",True,,PubMed,recA1EVfrjrmEMho8,"Umbrella review of 23 meta-analyses with 351 associations found intermittent fasting significantly reduced waist circumference (MD = −1.02 cm), fat mass (MD = −0.72 kg), fasting insulin (SMD = −0.21), LDL cholesterol (SMD = −0.20), total cholesterol (SMD = −0.29), and triglycerides (SMD = −0.23) while increasing HDL cholesterol and fat-free mass in adults with overweight/obesity. High certainty evidence from 91% of meta-analyses rated as high confidence.",
recLMoXQhF63THQM6,"Body Weight, BMI, Body Fat, HbA1c, Insulin Resistance, Fasting Glucose",High,,2025-07-18T12:00:12.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Network meta-analysis showed differential effects between IF types with ADF superior for weight/fat loss,LI071,"recAdUWMgWMZS3qKI, recw2hqgZfllcjFso, recf4HtvFUqMhyhdh, recC0mB1LyNGjDyld","reccxH7AESy9vvBPo, recVHWlB26jWt9Ij9",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC11559166/,Effects of different types of intermittent fasting on metabolic outcomes: an umbrella review and network meta-analysis,PMID: 39533312,"recXiFdoZPO8ahvNU, rec33mt1Ib40viKUU, recMC1NC2ymnw4oc0","rec1J3jFsVfW3V9Xb, rec7uKzibhvOoWo4b, recQ3pTTvENbpI2mh",True,,PubMed,recRIfCU2PF5bhkmW,"Network meta-analysis comparing alternate-day fasting (ADF), time-restricted eating (TRE), and 5:2 diet showed all forms of intermittent fasting improved body weight, BMI, body fat, HbA1c, and insulin resistance compared to usual diets. ADF demonstrated superior effects for weight loss and fat reduction compared to other IF forms, while TRE showed benefits for glucose control and insulin sensitivity.",
rec3MI6XxARP9QXwq,"Fasting Glucose, HbA1c, Fasting Insulin, HOMA-IR, Total Cholesterol, LDL Cholesterol, Triglycerides",High,,2025-07-18T12:00:26.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Significant improvements in glucose metabolism, insulin resistance, and lipid profiles",LI072,"recf4HtvFUqMhyhdh, recC0mB1LyNGjDyld, recierVNozpgZdLZH, recq0JX3QgFBo5mm4, recDBJLAkc5CAfBm3","recVHWlB26jWt9Ij9, recSy02sgRnjfOkHE, recELBnyZAf0mIQH6",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8970877/,Effect of Intermittent Fasting Diet on Glucose and Lipid Metabolism and Insulin Resistance in Patients with Impaired Glucose and Lipid Metabolism: A Systematic Review and Meta-Analysis,PMID: 35371260,"recXiFdoZPO8ahvNU, rec33mt1Ib40viKUU, recMC1NC2ymnw4oc0","rec1J3jFsVfW3V9Xb, rec7uKzibhvOoWo4b, recQ3pTTvENbpI2mh",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 10 RCTs found intermittent fasting significantly reduced fasting glucose by 0.15 mmol/L (95% CI: -0.23; -0.06), HbA1c by 0.08 (95% CI: -0.25; -0.10), fasting insulin by 13.25 uUI (95% CI: -16.69; -9.82), and HOMA-IR by 0.31 (95% CI: -0.44; -0.19). Also improved total cholesterol by 0.32 mmol/L, LDL-C by 0.22 mmol/L, and triglycerides.",
reccJPHtH90pdldDh,"Energy Expenditure, Appetite Hormones, Hunger Response, Gene Expression",High,,2025-07-18T12:03:10.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,6% decrease in daytime energy expenditure with late eating; significant changes in appetite hormones and adipose gene expression,LI073,"recAdUWMgWMZS3qKI, recf4HtvFUqMhyhdh","recqea20SA5Y5BaIw, recVHWlB26jWt9Ij9",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10184753/,"Late isocaloric eating increases hunger, decreases energy expenditure, and modifies metabolic pathways in adults with overweight and obesity",PMID: 36198293,"recUXhRwOBdDmwIz0, recjqayDOdtqvgy74, reciMtPp6Py82USrr","recYoFXNhHErfamJh, recnRyEUhjUeoUchl, recmdRVGzVZWVywBI",True,,PubMed,reclYXy0udvjr66Xa,"Randomized crossover trial in 16 participants found that late eating (versus early eating) increased hunger, modified appetite-regulating hormones, decreased daytime energy expenditure by approximately 6%, and altered adipose gene expression consistent with increased adipogenesis and decreased lipolysis. Late eating shifted circadian metabolism patterns and may explain increased obesity risk in late eaters.",
recaPLCGyMyWkgGWF,"Fasting Glucose, HOMA-IR, Insulin Resistance",Moderate,,2025-07-18T12:03:20.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,0.6% higher glucose and 3% higher HOMA-IR per hour delay in eating start time,LI074,"recf4HtvFUqMhyhdh, recierVNozpgZdLZH",recVHWlB26jWt9Ij9,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9919634/,Associations between Timing and Duration of Eating and Glucose Metabolism: A Nationally Representative Study in the U.S,PMID: 36771435,"recUXhRwOBdDmwIz0, recjqayDOdtqvgy74, reciMtPp6Py82USrr","recYoFXNhHErfamJh, recnRyEUhjUeoUchl, recmdRVGzVZWVywBI",True,,PubMed,recDDHykOzWxwMnyv,"Cross-sectional analysis of nationally representative U.S. data found that earlier eating start time was significantly associated with lower fasting glucose and improved insulin resistance (HOMA-IR). Every hour later that eating commenced was associated with approximately 0.6% higher glucose level and 3% higher HOMA-IR. These associations remained significant after excluding people with diabetes, indicating that meal timing is an important characteristic of dietary patterns influencing metabolism.",
recSlYOSuk79wZOXJ,"Glucose Rhythms, Circadian Clock Genes, PER2 Expression",Moderate,,2025-07-18T12:03:34.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,5.69-hour delay in glucose rhythms and 4.7% decrease in glucose concentration with delayed meals; molecular clock disruption,LI075,"recf4HtvFUqMhyhdh, recwtXkPSEQgyddmt","recVHWlB26jWt9Ij9, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC5483233/,Meal Timing Regulates the Human Circadian System,PMID: 28578930,"recUXhRwOBdDmwIz0, recjqayDOdtqvgy74, reciMtPp6Py82USrr","recYoFXNhHErfamJh, recnRyEUhjUeoUchl, recmdRVGzVZWVywBI",True,,PubMed,recW2EC7hY2K4pp0I,"Controlled laboratory study in 10 healthy men found that a 5-hour delay in meals significantly delayed plasma glucose rhythms by 5.69 hours and decreased average glucose concentration by 0.27 mM (4.7%). Adipose tissue PER2 mRNA rhythms were delayed by 0.97 hours, indicating that meal timing can regulate human molecular clocks and may underpin plasma glucose changes. Timed meals play a role in synchronizing peripheral circadian rhythms in humans.",
recvIILjA2Bl1u16j,"Weight Loss, Metabolic Function, BMI",High,,2025-07-18T12:08:48.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Small but consistent weight loss and metabolic benefits with earlier caloric distribution across multiple trials,LI076,"recAdUWMgWMZS3qKI, recw2hqgZfllcjFso","reccxH7AESy9vvBPo, recVHWlB26jWt9Ij9",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC11530941/,Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis,PMID: 39485353,"rece1ITrYjtv2h2G9, rec3SLnheYd7g7voW, rec6gzOrneb26gUk8","recis6ZIrpUjVVGQq, rec7j9tyH4EV9L9yd, recaHXUIQkCQZUyup",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 29 randomized clinical trials involving 2485 individuals found that time-restricted eating, lower meal frequency, and consuming calories earlier in the day were associated with weight loss and improved metabolic function. Although effect sizes were small, these strategies may be plausible for sustained weight reduction when implemented for a minimum duration of 12 weeks.",
recwLUGPJyY8uSH8p,"Sleep Architecture, Sleep Quality, EEG Power Spectrum",Moderate,,2025-07-18T12:09:01.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,No adverse sleep architecture changes; modest EEG power spectrum changes that attenuated over time,LI077,recPiW3K4dhWi31Xh,rec8o1wlo0olBMl8A,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8131073/,Effects of Dinner Timing on Sleep Stage Distribution and EEG Power Spectrum in Healthy Volunteers,PMID: 34017207,"rece1ITrYjtv2h2G9, rec3SLnheYd7g7voW, rec6gzOrneb26gUk8","recis6ZIrpUjVVGQq, rec7j9tyH4EV9L9yd, recaHXUIQkCQZUyup",True,,PubMed,recW2EC7hY2K4pp0I,"Randomized crossover trial in 20 healthy volunteers found that eating dinner 1 hour versus 5 hours before sleep did not result in adverse changes in sleep architecture. Spectral analysis revealed eating right before sleep increased delta power and decreased alpha and beta power early in the night, with effects gradually attenuating over time.",
recV5XBV0K44OW4ig,"Sleep Efficiency, Sleep Quality, Nighttime Awakenings",Moderate,,2025-07-18T12:09:10.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Decreased sleep efficiency and increased nighttime awakenings with meals close to bedtime,LI078,recPiW3K4dhWi31Xh,rec8o1wlo0olBMl8A,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7215804/,Does the Proximity of Meals to Bedtime Influence the Sleep of Young Adults? A Cross-Sectional Survey of University Students,PMID: 32295235,"rece1ITrYjtv2h2G9, rec3SLnheYd7g7voW, rec6gzOrneb26gUk8","recis6ZIrpUjVVGQq, rec7j9tyH4EV9L9yd, recaHXUIQkCQZUyup",True,,PubMed,recDDHykOzWxwMnyv,Cross-sectional study of university students found that consuming the final meal within 3 hours of bedtime was associated with more frequent nighttime awakenings and decreased sleep efficiency. Individuals who ate within 30-60 minutes before sleep showed negative effects on sleep quality as measured by polysomnography.,
reciu7VbN4NRqCzkf,"Cardiovascular Mortality, All-Cause Mortality, Water Intake",High,,2025-07-18T12:11:53.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,3% lower CVD mortality risk per additional cup of water daily; 14% reduction in CVD mortality with high vs low water intake,LI079,"recq0JX3QgFBo5mm4, recwIwB9znK0kB3Xg","recELBnyZAf0mIQH6, recLuAlDIETnvUUtO",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/34525269/,Total and drinking water intake and risk of all-cause and cardiovascular mortality: A systematic review and dose-response meta-analysis of prospective cohort studies,PMID: 34525269,"recB2JtyJ9bvr8qWT, recdUipe4wxEhf4uC, recUROIBVBAObV7l2","recFt7zPcfCjkM46a, rechlGvvxCYsaTIET, recYicOSoH1C4zLvj",True,,PubMed,recRIfCU2PF5bhkmW,"Systematic review and meta-analysis of 7 prospective cohort studies (116,816 participants) found that each additional cup of total water intake per day was associated with 3% lower risk of cardiovascular mortality (ES: 0.97; 95% CI: 0.96-0.98). High total water consumption was significantly associated with lower CVD mortality risk (ES: 0.86; 95% CI: 0.78-0.95) with dose-response relationship.",
recg7RJzhF6WymPkz,"Cognitive Function, Hydration Status, Serum Osmolarity",Moderate,,2025-07-18T12:12:04.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Dehydrated individuals showed accelerated cognitive decline over 2-year period; 56% of participants were physiologically dehydrated,LI080,"recwtXkPSEQgyddmt, recwIwB9znK0kB3Xg",recLuAlDIETnvUUtO,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9993798/,"Water intake, hydration status and 2-year changes in cognitive performance: a prospective cohort study",PMID: 36882739,"recB2JtyJ9bvr8qWT, recdUipe4wxEhf4uC, recUROIBVBAObV7l2","recFt7zPcfCjkM46a, rechlGvvxCYsaTIET, recYicOSoH1C4zLvj",True,,PubMed,recODsYatCgd7j2Vr,"Prospective cohort study of 1,957 older adults (55-75 years) found that reduced physiological hydration status (higher serum osmolarity) was associated with greater decline in global cognitive function over 2 years (β: -0.010; 95% CI: -0.017 to -0.004). Lower hydration status significantly predicted cognitive decline in adults with metabolic syndrome.",
recgAx10UJ8Wh3FnV,"Cognitive Performance, Mood State, Hydration Status, Water Intake",Moderate,,2025-07-18T12:12:15.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Dose-dependent cognitive improvements with water supplementation; significant mood benefits with even modest 200 mL intake,LI081,"recwtXkPSEQgyddmt, recwIwB9znK0kB3Xg",recLuAlDIETnvUUtO,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7662706/,"Different Amounts of Water Supplementation Improved Cognitive Performance and Mood among Young Adults after 12 h Water Restriction in Baoding, China: A Randomized Controlled Trial",PMID: 33114364,"recB2JtyJ9bvr8qWT, recdUipe4wxEhf4uC, recUROIBVBAObV7l2","recFt7zPcfCjkM46a, rechlGvvxCYsaTIET, recYicOSoH1C4zLvj",True,,PubMed,reclqQn6EV0azXdYf,"Randomized controlled trial of 64 young adults found that water supplementation (200-500 mL) significantly improved cognitive performance and mood after 12-hour water restriction. 500 mL water was necessary to improve working memory and attention, while 200 mL improved hydration status and reduced negative mood states including anger and fatigue.",
recOR8MxVdNG9casD,"Kidney Stone Risk, Fluid Intake, Urine Volume",High,,2025-07-18T12:12:26.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,60% reduction in kidney stone risk with high fluid intake; even greater benefits for recurrent stone prevention,LI082,"recLJcUUTL1szyE8Z, recwIwB9znK0kB3Xg",recLuAlDIETnvUUtO,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC4831051/,"Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis",PMID: 26022722,"recB2JtyJ9bvr8qWT, recdUipe4wxEhf4uC, recUROIBVBAObV7l2","recFt7zPcfCjkM46a, rechlGvvxCYsaTIET, recYicOSoH1C4zLvj",True,,PubMed,rec4qqncSQrMbfAph,"Meta-analysis of 9 studies (2 RCTs with 269 patients; 7 observational studies with 273,685 individuals) found high fluid intake significantly reduced kidney stone risk by 60% in RCTs (RR: 0.40; 95% CI: 0.20-0.79) and 51% in observational studies (RR: 0.49; 95% CI: 0.34-0.71). High fluid intake was even more effective for recurrent stone prevention.",
recIgrU7fy9VPAMwu,"All-Cause Mortality, Ultra-Processed Food Consumption, hsCRP, Fasting Insulin, HOMA-IR, HbA1c",High,,2025-07-18T12:15:57.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,15% increased all-cause mortality risk with highest vs lowest UPF consumption; dose-response relationship confirmed,LI083,"recPiW3K4dhWi31Xh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI, recC0mB1LyNGjDyld","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC11874696/,Ultra-processed foods and risk of all-cause mortality: an updated systematic review and dose-response meta-analysis of prospective cohort studies,PMID: 40033461,"reciGprkevaemYHuP, recIO41LpxD5gj47B, recxoe009Z2wEIjIq, recXEzuSgRogrTVp5, recCGSspjFrrF9fg3, reczMIC9rZdAuBwLG","recm7NxBHBB2fClE6, recMfs72SD4T9XIhS, recBPC6hC5tkxmXSH, rec15XA9JXP4kxzzm, recG7gyGMLSfyNTqk, recDd6IqU5EonfaVX",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 18 prospective cohort studies with 1,148,387 participants (173,107 deaths) found that participants with highest ultra-processed food consumption had 15% increased risk of all-cause mortality (HR=1.15; 95% CI: 1.09-1.22) compared to lowest consumption. Dose-response analysis showed 10% increase in UPF consumption associated with 6% higher mortality risk.",
rec6u1FM84A2jUPIM,"BMI, Total Cholesterol, HbA1c, Quality of Life, hsCRP, Fasting Insulin",High,,2025-07-18T12:16:07.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant improvements in BMI, cholesterol, and HbA1c; reduced medication usage in community-based intervention",LI084,"recPiW3K4dhWi31Xh, recC0mB1LyNGjDyld, recierVNozpgZdLZH","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC5380896/,"The BROAD study: A randomised controlled trial using a whole food plant-based diet in the community for obesity, ischaemic heart disease or diabetes",PMID: 28319109,"reciGprkevaemYHuP, recIO41LpxD5gj47B, recxoe009Z2wEIjIq, recUk7Y0cYFgRAOg5, recWJPLkPnQbaX9eI, recGQyztbSj4MyEaU","recm7NxBHBB2fClE6, recMfs72SD4T9XIhS, recBPC6hC5tkxmXSH, recYLv4hF464Kesqm, rec0adRBithZ3BNoZ, recKhWFKEYKSFcikb",True,,PubMed,reclYXy0udvjr66Xa,"Randomized controlled trial in 65 participants (35-70 years) with obesity and/or diabetes, ischaemic heart disease, hypertension or hypercholesterolaemia found that a whole food plant-based diet intervention significantly reduced BMI, total cholesterol, and HbA1c at 6 months. Participants showed improved quality of life, self-efficacy, and reduced medication usage (94 to 74 medications in intervention group).",
recVAW8Oobp853XGn,"IL-6, IL-1β, C-Reactive Protein (hsCRP), Inflammatory Biomarkers, Systolic Blood Pressure, Diastolic Blood Pressure",High,,2025-07-18T12:16:17.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant reductions in multiple inflammatory biomarkers with whole food dietary patterns; Mediterranean diet most effective,LI085,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8803482/,Effects of Dietary Patterns on Biomarkers of Inflammation and Immune Responses: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,PMID: 34607347,"reciGprkevaemYHuP, recIO41LpxD5gj47B, recxoe009Z2wEIjIq","recm7NxBHBB2fClE6, recMfs72SD4T9XIhS, recBPC6hC5tkxmXSH",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 22 randomized controlled trials found that Mediterranean diet showed most prominent reductions in inflammatory biomarkers including IL-6 (MD: -1.07 pg/mL; 95% CI: -1.94, -0.20), IL-1β (MD: -0.46 pg/mL; 95% CI: -0.66, -0.25), and C-reactive protein (MD: -1.00 mg/L; 95% CI: -2.02, 0.01). Plant-based dietary patterns with high consumption of whole grains, vegetables, and fruits showed anti-inflammatory potential.",
recO2sTC2EBHxLWg4,"Cardiovascular Disease, Coronary Heart Disease, Stroke Risk, Ultra-Processed Food Consumption, hsCRP, Systolic BP, Diastolic BP",High,,2025-07-18T12:27:23.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"17% increased CVD risk, 23% increased CHD risk with highest UPF consumption; consistent across multiple large cohorts",LI086,"recPiW3K4dhWi31Xh, recq0JX3QgFBo5mm4","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC11403639/,Ultra-processed foods and cardiovascular disease: analysis of three large US prospective cohorts and a systematic review and meta-analysis of prospective cohort studies,PMID: 39286398,"recXEzuSgRogrTVp5, recCGSspjFrrF9fg3, reczMIC9rZdAuBwLG, reciGprkevaemYHuP, recIO41LpxD5gj47B, recxoe009Z2wEIjIq","recm7NxBHBB2fClE6, recMfs72SD4T9XIhS, recBPC6hC5tkxmXSH, rec15XA9JXP4kxzzm, recG7gyGMLSfyNTqk, recDd6IqU5EonfaVX",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 22 prospective studies with 207,000+ participants found that highest vs lowest UPF consumption was associated with 17% higher CVD risk (HR=1.17; 95% CI: 1.11-1.24), 23% higher CHD risk (HR=1.23; 95% CI: 1.12-1.34), and 9% higher stroke risk (HR=1.09; 95% CI: 1.03-1.15). Three large US cohorts showed similar patterns with over 30-year follow-up.",
reci85XjmgHjnCB9m,"Type 2 Diabetes, Fasting Glucose, HbA1c, Fasting Insulin, HOMA-IR, Ultra-Processed Food Consumption",High,,2025-07-18T12:27:41.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,46% increased T2D risk in US cohorts; 40% increased risk in meta-analysis across multiple populations,LI087,"recf4HtvFUqMhyhdh, recC0mB1LyNGjDyld, recierVNozpgZdLZH, recAdUWMgWMZS3qKI","reccxH7AESy9vvBPo, recbIfUESzC18eAIL",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10300524/,Ultra-Processed Food Consumption and Risk of Type 2 Diabetes: Three Large Prospective U.S. Cohort Studies,PMID: 36854188,"recXEzuSgRogrTVp5, recCGSspjFrrF9fg3, reczMIC9rZdAuBwLG, recoQ4M1UFDYTpRtz, recRqbE5GobS5ypJO, recvISUhZ3bLfwmRd","rec15XA9JXP4kxzzm, recG7gyGMLSfyNTqk, recDd6IqU5EonfaVX",True,,PubMed,recRIfCU2PF5bhkmW,"Analysis of 3 large US cohorts (198,636 participants, 5,187,678 person-years, 19,503 T2D cases) found that highest vs lowest quintile of UPF consumption was associated with 46% increased T2D risk (HR=1.46; 95% CI: 1.39-1.54). Meta-analysis of 12 studies showed 40% increased risk (HR=1.40; 95% CI: 1.23-1.59).","rectSvR0DGkWchk46, rec0ioZWRXM208MOR"
recPHOP0KcGMI5EqS,"Cancer Risk, Breast Cancer, Colorectal Cancer, Pancreatic Cancer, Ultra-Processed Food Consumption, hsCRP",High,,2025-07-18T12:27:55.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,13% increased overall cancer risk per 10% UPF increment; significant associations with multiple cancer types,LI088,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.clinicalnutritionjournal.com/article/S0261-5614(23)00099-7/abstract,Ultra-processed food consumption and cancer risk: A systematic review and meta-analysis,PMID: 37087831,"recXEzuSgRogrTVp5, recCGSspjFrrF9fg3, reczMIC9rZdAuBwLG","rec15XA9JXP4kxzzm, recG7gyGMLSfyNTqk, recDd6IqU5EonfaVX",True,,Clinical Nutrition,recRIfCU2PF5bhkmW,"Meta-analysis of 11 studies (8 case-control, 3 prospective cohorts) found that 10% increment in UPF consumption was associated with 13% increased overall cancer risk (HR=1.13; 95% CI: 1.07-1.18), 11% increased breast cancer risk (HR=1.11; 95% CI: 1.01-1.21), 30% increased colorectal cancer risk (OR=1.30; 95% CI: 1.11-1.51), and 49% increased pancreatic cancer risk (HR=1.49; 95% CI: 1.07-2.07).",
rec1sX1mavklMg1wp,"Body Weight, BMI, HOMA-IR, Insulin Resistance, Fast Food Frequency, Type 2 Diabetes Risk",Moderate,,2025-07-20T20:04:12.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,4.5kg greater weight gain and 104% greater increase in insulin resistance with frequent vs infrequent fast-food consumption over 15 years,LI089,"recAdUWMgWMZS3qKI, recierVNozpgZdLZH, recf4HtvFUqMhyhdh, recC0mB1LyNGjDyld","reccxH7AESy9vvBPo, recVHWlB26jWt9Ij9",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(04)17663-0/abstract,"Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis",PMID: 15639678,"recqGXj1oW94w3reg, recDZahYDWNJwuytg, recYmmhm1c1ibQ8h3","recu7lpiR2ASpH5ox, recHqynf62exp8cDx, rec2NKnDuis64uMrk",True,,The Lancet,recODsYatCgd7j2Vr,"Prospective study of 3,031 young adults followed for 15 years found that frequent fast-food consumption was strongly associated with weight gain and insulin resistance. Participants with frequent fast-food use at baseline and follow-up gained 4.5kg more weight and had 104% greater increase in insulin resistance compared to those with infrequent use. Results suggest fast food increases risk of obesity and type 2 diabetes.",
recG3FP9YwzSEPGph,"Cardiovascular Disease, Type 2 Diabetes, Metabolic Syndrome, Inflammatory Markers, Body Weight, Insulin Resistance",Moderate,,2025-07-20T20:04:26.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Consistent associations across multiple studies showing increased risk of diabetes, metabolic syndrome, CVD, and inflammatory markers",LI090,"recPiW3K4dhWi31Xh, recC0mB1LyNGjDyld, recAdUWMgWMZS3qKI, recierVNozpgZdLZH","reccxH7AESy9vvBPo, recVHWlB26jWt9Ij9, recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC4772793/,Fast Food Pattern and Cardiometabolic Disorders: A Review of Current Studies,PMID: 26933642,"recqGXj1oW94w3reg, recDZahYDWNJwuytg, recYmmhm1c1ibQ8h3","recu7lpiR2ASpH5ox, recHqynf62exp8cDx, rec2NKnDuis64uMrk",True,,PubMed,recuux8z8gb0e5MPU,"Comprehensive review found that frequent fast food consumption was associated with overweight, abdominal fat gain, impaired insulin and glucose homeostasis, lipid disorders, systemic inflammation, and oxidative stress. Higher fast food consumption significantly increases risk of diabetes, metabolic syndrome, and cardiovascular disease. Fast foods are characterized by poor diet quality with higher calories, fat intake, and lower micronutrient density.",
recwNDEfyChhZkJsI,"Total Calories, Fat Intake, Sugar Intake, Fast Food Frequency, Diet Quality, Ready-to-Eat Meals",Moderate,,2025-07-20T20:04:37.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"573 fewer daily calories, 51g less fat, and 51g less sugar with frequent home cooking vs infrequent cooking",LI091,"receYj9nbAEGPBxFl, recAdUWMgWMZS3qKI","reccxH7AESy9vvBPo, recVHWlB26jWt9Ij9",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8728746/,Is cooking at home associated with better diet quality or weight-loss intention?,PMID: 25399031,"recqGXj1oW94w3reg, recDZahYDWNJwuytg, recYmmhm1c1ibQ8h3","recu7lpiR2ASpH5ox, recHqynf62exp8cDx, rec2NKnDuis64uMrk",True,,PubMed,recDDHykOzWxwMnyv,"Cross-sectional analysis of 9,569 US adults found that cooking dinner at home frequently (6-7 times/week) was associated with significantly better diet quality compared to low cooking frequency (0-1 times/week). High home cooks consumed 573 fewer calories, 51g less fat, and 51g less sugar daily, plus fewer fast food meals and ready-to-eat meals. Benefits were consistent regardless of weight-loss intention.",
reczPK7nVx8KXN0BX,"Cardiovascular Disease Mortality, Stroke Risk, Type 2 Diabetes Prevalence, Fast Food Access",Moderate,,2025-07-20T20:04:51.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant positive associations between fast-food density and CVD mortality, stroke mortality, and diabetes prevalence at population level",LI092,"recPiW3K4dhWi31Xh, recq0JX3QgFBo5mm4, recC0mB1LyNGjDyld","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE, recVHWlB26jWt9Ij9",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC6015353/,"Association of Fast-Food and Full-Service Restaurant Densities With Mortality From Cardiovascular Disease and Stroke, and the Prevalence of Diabetes Mellitus",PMID: 29802148,"recqGXj1oW94w3reg, recDZahYDWNJwuytg, recYmmhm1c1ibQ8h3","recu7lpiR2ASpH5ox, recHqynf62exp8cDx, rec2NKnDuis64uMrk",True,,PubMed,recDDHykOzWxwMnyv,"Cross-sectional study across mainland United States found that fast-food restaurant density was positively associated with cardiovascular disease mortality (β=1.104, R²=2.3%), stroke mortality (β=0.841, R²=1.4%), and type 2 diabetes prevalence (β=0.578, R²=0.6%) after adjusting for poverty, ethnicity, education, physical inactivity, and smoking. Higher availability of fast food outlets increases population-level disease risk.",
rech8FSHZDSWHSEZp,"Body Weight, Weight Loss, Cooking Frequency, Food Agency, Diet Quality",High,,2025-07-20T20:05:10.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,2.2% greater weight loss with active cooking intervention vs demonstration-only; both groups increased home cooking frequency,LI093,"recAdUWMgWMZS3qKI, receYj9nbAEGPBxFl","reccxH7AESy9vvBPo, recVHWlB26jWt9Ij9",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7761020/,Cooking as a Health Behavior: Examining the Role of Cooking Classes in a Weight Loss Intervention,PMID: 33260523,"recqGXj1oW94w3reg, recDZahYDWNJwuytg, recYmmhm1c1ibQ8h3","recu7lpiR2ASpH5ox, recHqynf62exp8cDx, rec2NKnDuis64uMrk",True,,PubMed,reclYXy0udvjr66Xa,Randomized controlled trial in overweight and obese adults found that active cooking intervention led to significantly greater weight loss compared to demonstration-only condition (7.3% vs 5.1% body weight) at 6 months. Both groups increased home cooking frequency and improved food agency scores. Results suggest hands-on cooking skills training enhances weight management outcomes beyond passive nutrition education.,
recdnrJtTA8PQt7QS,"CVD incidence, Systolic BP, Diastolic BP, LDL cholesterol, hsCRP",High,,2025-07-20T20:10:00.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,16% reduction in CVD risk with highest vs lowest plant-based diet adherence,LI094,"recPiW3K4dhWi31Xh, recw2hqgZfllcjFso","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8624676/,Association between Plant-Based Dietary Patterns and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Studies,PMID: 34836208,"recUk7Y0cYFgRAOg5, recWJPLkPnQbaX9eI, recGQyztbSj4MyEaU","recYLv4hF464Kesqm, rec0adRBithZ3BNoZ, recKhWFKEYKSFcikb",True,,PubMed,reclYXy0udvjr66Xa,"Meta-analysis of 10 studies with 698,707 participants found highest adherence to plant-based diets was associated with 16% lower CVD risk (RR 0.84; 95% CI 0.79-0.89) compared to lowest adherence. Healthful plant-based diet index showed stronger protective effects than overall plant-based diet index.",
rec2GcaMk0aHmqTtN,"HbA1c, Fasting Glucose, Fasting Insulin, HOMA-IR, BMI, hsCRP",High,,2025-07-20T20:10:12.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,1.3% reduction in HbA1c; 4.0 mmol/L reduction in fasting glucose within 2 weeks,LI095,"recC0mB1LyNGjDyld, recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI, recPiW3K4dhWi31Xh",reccxH7AESy9vvBPo,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC11732952/,"A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial",PMID: 39305340,"recUk7Y0cYFgRAOg5, recWJPLkPnQbaX9eI, recGQyztbSj4MyEaU","recYLv4hF464Kesqm, rec0adRBithZ3BNoZ, recKhWFKEYKSFcikb",True,,PubMed,reclYXy0udvjr66Xa,"Randomized controlled trial of 169 adults with type 2 diabetes found whole-food, plant-based intervention decreased HbA1c by additional 1.3% (14 mmol/mol) at week 12 compared to standard medical care. Fasting glucose improved by 4.0 mmol/L within 2 weeks, suggesting diet quality effects independent of weight loss.",
recE0U3SFy6Axtnr8,"CRP, IL-6, TNF-alpha, Inflammatory Biomarkers",High,,2025-07-20T20:10:24.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,0.54 mg/L reduction in CRP with vegan diet; 0.25 mg/L reduction with vegetarian diet,LI096,recPiW3K4dhWi31Xh,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7730154/,Systematic review and meta-analysis of the associations of vegan and vegetarian diets with inflammatory biomarkers,PMID: 33303765,"recUk7Y0cYFgRAOg5, recWJPLkPnQbaX9eI, recGQyztbSj4MyEaU","recYLv4hF464Kesqm, rec0adRBithZ3BNoZ, recKhWFKEYKSFcikb",True,,PubMed,reclYXy0udvjr66Xa,"Meta-analysis of 21 cross-sectional studies found vegan diet was associated with 0.54 mg/L lower CRP compared to omnivores (95% CI: -0.79 to -0.28, p<0.0001). Vegetarian diet showed 0.25 mg/L lower CRP (95% CI: -0.49 to 0.00, p=0.05). Strongest anti-inflammatory effects observed in patients with impaired kidney function.",
recqrlUH0j4GXytz8,"Mitochondrial Oxidative Capacity, VO2max, ATP Synthesis, Cardiovascular Disease Risk",High,,2025-07-20T20:13:37.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,High effect size on mitochondrial oxidative capacity improvements in CVD patients with exercise training,LI097,recPiW3K4dhWi31Xh,rec0v0JrVS6xu5Dcj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9603958/,The Effects of Exercise Training on Mitochondrial Function in Cardiovascular Diseases: A Systematic Review and Meta-Analysis,PMID: 36293409,"recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w, recZwg1aLhDGK0Ugs, recIjaRnoGtCO8uXx, rec3OiCYCwdkEUVOC","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, rec3XE7ren4uDEyqJ, recMKyXERMUqHM87O, rec7fGIf5CE8xyzYT",True,,PubMed,recRIfCU2PF5bhkmW,"Systematic review and meta-analysis evaluating exercise training effects on mitochondrial function in cardiovascular disease patients found high effect size improvements in mitochondrial oxidative capacity in individuals with heart failure, stroke, and peripheral artery disease. Exercise intensity was identified as the key factor, with both moderate and high-intensity training promoting mitochondrial biogenesis, fusion, and ATP synthesis capacity.",
rec03Pz5MWKx6RTtA,"Fasting Glucose, Fasting Insulin, HOMA-IR, HbA1c, Muscle Glucose Uptake, Insulin Sensitivity",Anecdotal,,2025-07-20T20:13:50.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"5-fold increase in muscle glucose uptake during exercise, with enhanced insulin action lasting up to 48 hours post-exercise",LI098,"recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI, recC0mB1LyNGjDyld",rec0v0JrVS6xu5Dcj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC6908414/,Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association,PMID: 27926890,"recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w, recZwg1aLhDGK0Ugs, recIjaRnoGtCO8uXx, rec3OiCYCwdkEUVOC","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, rec3XE7ren4uDEyqJ, recMKyXERMUqHM87O, rec7fGIf5CE8xyzYT",True,,PubMed,recYhFTRFUPeMb1fL,"Comprehensive position statement from American Diabetes Association found that aerobic exercise acutely increases muscle glucose uptake up to 5-fold through insulin-independent mechanisms. After exercise, glucose uptake remains elevated for up to 48 hours. Regular training increases muscle capillary density, oxidative capacity, lipid metabolism, and insulin signaling proteins. Moderate-intensity continuous training showed beneficial effects on insulin sensitivity and glucose metabolism.",
recfqVDl2MWUTUOzI,"VO2peak, Cardiorespiratory Fitness, Cardiovascular Disease Risk",High,,2025-07-20T20:14:03.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Moderate effect size (SMD = 0.71) for VO2peak improvement with moderate-intensity exercise in CVD patients,LI099,recPiW3K4dhWi31Xh,rec0v0JrVS6xu5Dcj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8037098/,Exercise Intensity in Patients with Cardiovascular Diseases: Systematic Review with Meta-Analysis,PMID: 33808248,"recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w, recZwg1aLhDGK0Ugs, recIjaRnoGtCO8uXx, rec3OiCYCwdkEUVOC","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, rec3XE7ren4uDEyqJ, recMKyXERMUqHM87O, rec7fGIf5CE8xyzYT",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 16 randomized controlled trials found that exercise interventions significantly increased VO2peak across all intensity categories. Moderate-intensity interventions were associated with moderate increase in relative VO2peak (SMD = 0.71 mL/kg/min; 95% CI = 0.27-1.15). The most effective doses for optimizing cardiorespiratory fitness were moderate-to-vigorous and vigorous-intensity exercises, being more effective when conducted for 6 to 12 weeks.",
recfdroibJ5TUsTC0,"Insulin Sensitivity, Fasting Glucose, Fasting Insulin, HOMA-IR, Type 2 Diabetes Risk, Metabolic Syndrome",Moderate,,2025-07-20T20:14:15.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,10-48% enhancement in insulin sensitivity with regular exercise training; dose-response relationship with exercise volume,LI100,"recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI, recC0mB1LyNGjDyld",rec0v0JrVS6xu5Dcj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC5569266/,Update on the effects of physical activity on insulin sensitivity in humans,PMID: 28879026,"recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w, recZwg1aLhDGK0Ugs, recIjaRnoGtCO8uXx, rec3OiCYCwdkEUVOC, recHS5DnujbLJGA0X, recUcK9hjmH56wFZf, rec8lDzP6nNsCQFUK","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, rec3XE7ren4uDEyqJ, recMKyXERMUqHM87O, rec7fGIf5CE8xyzYT, recLjtJEXpCzCkeae, recYD8fyMs8TZaj9w, reccM1F6ztegvuj41",True,,PubMed,recuux8z8gb0e5MPU,"Comprehensive review found that both aerobic and resistance exercise can induce improvements in glycemic regulation, with some evidence that exercise regimens including both may be more efficacious. Regular physical activity reduces risk of insulin resistance, metabolic syndrome and type 2 diabetes, with insulin sensitivity improving when individuals comply with exercise guidelines. Many studies indicate a dose-response relationship, with higher energy expenditures and moderate exercise intensities producing benefits on whole-body insulin sensitivity.",
recNdboQ8rDmirQpT,"All-Cause Mortality, Cardiovascular Disease Risk, Daily Step Count, hsCRP, Insulin Sensitivity",High,,2025-07-20T20:17:05.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"60% reduction in all-cause mortality at 8,763 steps/day; 51% reduction in CVD risk at 7,126 steps/day with clear dose-response relationship",LI101,recPiW3K4dhWi31Xh,rec0v0JrVS6xu5Dcj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.jacc.org/doi/10.1016/j.jacc.2023.07.029,Relationship of Daily Step Counts to All-Cause Mortality and Cardiovascular Events,PMID: 37676198,"recZwg1aLhDGK0Ugs, recIjaRnoGtCO8uXx, rec3OiCYCwdkEUVOC, recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, rec3XE7ren4uDEyqJ, recMKyXERMUqHM87O, rec7fGIf5CE8xyzYT",True,,JACC Journals,recRIfCU2PF5bhkmW,"Meta-analysis of 12 studies with 111,309 individuals found minimal doses of 2,517 steps/day associated with 8% reduction in all-cause mortality (aHR: 0.92; 95% CI: 0.84-0.999) and 2,735 steps/day with 11% reduction in CVD risk (aHR: 0.89; 95% CI: 0.79-0.999) compared to 2,000 steps/day. Optimal doses were 8,763 steps/day for all-cause mortality (60% risk reduction) and 7,126 steps/day for incident CVD (51% risk reduction).",
recNIM5X6p8K0Ed1p,"All-Cause Mortality, Cardiovascular Mortality, Daily Step Count, hsCRP",High,,2025-07-20T20:17:17.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,12% mortality reduction per 1000 steps/day; 6% CV mortality reduction per 500 steps/day with clear dose-response benefits,LI102,recPiW3K4dhWi31Xh,rec0v0JrVS6xu5Dcj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://academic.oup.com/eurjpc/article/30/18/1975/7226309?login=false,The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis,PMID: 37555441,"recZwg1aLhDGK0Ugs, recIjaRnoGtCO8uXx, rec3OiCYCwdkEUVOC, recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, rec3XE7ren4uDEyqJ, recMKyXERMUqHM87O, rec7fGIf5CE8xyzYT",True,,European Journal of Preventative Cardiology,recRIfCU2PF5bhkmW,"Meta-analysis of 18 cohort studies with 67,111 participants found 1000-step increment associated with 12% decreased all-cause mortality risk (HR 0.88; 95% CI: 0.85-0.91) and 500-step increment with 6% decreased CV mortality risk (HR 0.94; 95% CI: 0.91-0.97). Significant inverse association with cut-off point of 3,867 steps/day for all-cause mortality and 2,337 steps/day for CV mortality.",
rec32XOJvmFahyakJ,"Type 2 Diabetes Risk, Fasting Glucose, Insulin Sensitivity, HOMA-IR, Daily Step Count",Moderate,,2025-07-20T20:17:32.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,2% diabetes risk reduction per 1000 steps/day; stronger associations in high-risk populations with obesity or prediabetes,LI103,"recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI, recC0mB1LyNGjDyld",rec0v0JrVS6xu5Dcj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9013106/,Associations of steps per day and step intensity with the risk of diabetes: the Hispanic Community Health Study,PMID: 35428253,"recZwg1aLhDGK0Ugs, recIjaRnoGtCO8uXx, rec3OiCYCwdkEUVOC, recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, rec3XE7ren4uDEyqJ, recMKyXERMUqHM87O, rec7fGIf5CE8xyzYT",True,,PubMed,recODsYatCgd7j2Vr,"Prospective cohort study of 6,634 adults found suggestive 2% lower diabetes risk per 1000 steps/day (HR = 0.98; 95% CI 0.95-1.00) over 6 years. Inverse associations between steps/day and diabetes incidence were observed across cohort characteristics, with strongest effects among adults at high risk - those who were older, had obesity, or prediabetes. Mechanisms include enhanced glucose uptake and improved insulin sensitivity.",
recuAS1B0QgdBInB3,"Depression Symptoms, Mental Health, Daily Step Count, Mood Distress",High,,2025-07-20T20:17:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,9% reduction in depression risk per 1000 additional steps/day; consistent inverse associations across multiple population subgroups,LI104,recq0JX3QgFBo5mm4,rec0v0JrVS6xu5Dcj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC11650418/,Daily Step Count and Depression in Adults: A Systematic Review and Meta-Analysis,PMID: 39680407,"recZwg1aLhDGK0Ugs, recIjaRnoGtCO8uXx, rec3OiCYCwdkEUVOC","rec3XE7ren4uDEyqJ, recMKyXERMUqHM87O, rec7fGIf5CE8xyzYT",True,,PubMed,recPTVJvlU8ZpgeS3,"Systematic review and meta-analysis of 33 observational studies involving 96,173 adults found higher daily step counts significantly associated with fewer depressive symptoms in cross-sectional and longitudinal studies. Adults with ≥7,500 steps/day had significantly lower depression scores compared to <7,500 steps/day. Even modest increases of 1,000 steps/day potentially reduce depression risk by 9%.",
recMgAfNHQysFM3lG,"Body Weight, BMI, Waist Circumference, Depression, Anxiety, Mood States, Daily Step Count",High,,2025-07-20T20:17:55.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Significant improvements in multiple mood domains and body composition markers with 10,000 steps/day intervention over 12 weeks",LI105,"recAdUWMgWMZS3qKI, recq0JX3QgFBo5mm4","reccxH7AESy9vvBPo, recbIfUESzC18eAIL, rec0v0JrVS6xu5Dcj",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC5015672/,Effects of 10000 steps a day on physical and mental health in overweight participants,PMID: 27556393,"recZwg1aLhDGK0Ugs, recIjaRnoGtCO8uXx, rec3OiCYCwdkEUVOC","rec3XE7ren4uDEyqJ, recMKyXERMUqHM87O, rec7fGIf5CE8xyzYT",True,,PubMed,reclYXy0udvjr66Xa,"Randomized intervention study of 30 overweight adults found that accumulating 10,000 steps/day over 12 weeks significantly reduced anxiety, depression, anger, fatigue, confusion, and total mood distress scores while improving vigor. Physical benefits included significantly lower body weight, waist circumference, BMI, and body fat percentage. Changes in waist circumference were negatively associated with depression and mood distress.",
recLqVjeoctsCwdvB,"All-Cause Mortality, Cardiovascular Mortality, Cancer Mortality, hsCRP, Muscle Strength, Physical Function",High,,2025-07-21T14:53:04.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"15% reduction in all-cause mortality, 17% reduction in cardiovascular mortality with any resistance training",LI106,recPiW3K4dhWi31Xh,"recyKRTIlX4Jux2W0, recVHWlB26jWt9Ij9",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ajpmonline.org/article/S0749-3797(22)00176-3/abstract,Resistance Training and Mortality Risk: A Systematic Review and Meta-Analysis,PMID: 35599175,"recHS5DnujbLJGA0X, recUcK9hjmH56wFZf, rec8lDzP6nNsCQFUK, recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w, recIHhi5vLgm1yazl, recWoGmJUWm4wpggn, recuzoqjqJctR7ahw","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, recLjtJEXpCzCkeae, recYD8fyMs8TZaj9w, reccM1F6ztegvuj41, recM8FomYRHaUcOJC, rec0P4s0n2NSp3UqE, recy0MwATPDhKLOrN",True,,American Journal of Preventative Medicine,recRIfCU2PF5bhkmW,"Meta-analysis of 10 studies found resistance training reduced risk of all-cause mortality by 15% (RR = 0.85; 95% CI: 0.77-0.93), cardiovascular mortality by 17% (RR = 0.83; 95% CI: 0.71-0.97), and cancer mortality by 12% (RR = 0.88; 95% CI: 0.75-1.03) compared to no resistance training. Benefits observed with any amount of resistance training, with optimal effects around 2-3 sessions per week.",
reckzygPmlvVZEX2N,"Insulin Sensitivity, Fasting Insulin, Fasting Glucose, HOMA-IR, HbA1c, Type 2 Diabetes Risk",High,,2025-07-21T14:53:17.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Significant improvement in insulin sensitivity (ES = -0.588) with exercise training; effects lasted 48-72 hours post-exercise,LI107,"recierVNozpgZdLZH, recAdUWMgWMZS3qKI, recf4HtvFUqMhyhdh, recC0mB1LyNGjDyld",rec0v0JrVS6xu5Dcj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC4995180/,The Effect of Regular Exercise on Insulin Sensitivity in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis,PMID: 27535644,"recHS5DnujbLJGA0X, recUcK9hjmH56wFZf, rec8lDzP6nNsCQFUK, recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w, recIHhi5vLgm1yazl, recWoGmJUWm4wpggn, recuzoqjqJctR7ahw","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, recLjtJEXpCzCkeae, recYD8fyMs8TZaj9w, reccM1F6ztegvuj41, recM8FomYRHaUcOJC, rec0P4s0n2NSp3UqE, recy0MwATPDhKLOrN",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 14 randomized controlled trials found regular exercise training significantly improved insulin sensitivity in adults with type 2 diabetes (ES = -0.588; 95% CI: -0.816 to -0.359; P<0.001). Benefits persisted 48-72 hours after last exercise bout, with resistance training showing comparable effects to aerobic training on glucose control.",
recNhs2QUHpqqExiT,"Bone Mineral Density, Femoral Neck BMD, Lumbar Spine BMD, Total Hip BMD, Muscle Strength, Physical Function",High,,2025-07-21T14:53:29.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Moderate effect sizes for BMD improvements: femoral neck g=0.378, total hip g=0.387, lumbar spine g=0.429",LI108,"recL8dpnjNSzBJp2L, recX6IiQRem8pQ14z, recLJcUUTL1szyE8Z","recyKRTIlX4Jux2W0, recVHWlB26jWt9Ij9, reccxH7AESy9vvBPo, recHOTAk6Lpmb9uUz",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9222380/,The Effect of Resistance Training on Bone Mineral Density in Older Adults: A Systematic Review and Meta-Analysis,PMID: 35742181,"recHS5DnujbLJGA0X, recUcK9hjmH56wFZf, rec8lDzP6nNsCQFUK, recIHhi5vLgm1yazl, recWoGmJUWm4wpggn, recuzoqjqJctR7ahw","recLjtJEXpCzCkeae, recYD8fyMs8TZaj9w, reccM1F6ztegvuj41, recM8FomYRHaUcOJC, rec0P4s0n2NSp3UqE, recy0MwATPDhKLOrN",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 7 studies involving 370 older adults found resistance training significantly improved bone mineral density with moderate effect sizes at femoral neck (g = 0.378; 95% CI: 0.167-0.588), total hip (g = 0.387; 95% CI: 0.095-0.678), and lumbar spine (g = 0.429; 95% CI: 0.222-0.636). Optimal protocols used 2-3 sets, 8-12 repetitions at 70-90% 1RM, 2-3x per week.",
recR3kn2j2mAsoctc,"Depression, Quality of Life, Mental Health, Muscle Strength, Physical Function, Upper Limb Strength, Lower Limb Strength",High,,2025-07-21T14:53:41.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Large depression reduction (SMD=-1.13); substantial strength gains: upper-limb +15.26kg, lower-limb +48.46kg",LI109,recq0JX3QgFBo5mm4,"recyKRTIlX4Jux2W0, recVHWlB26jWt9Ij9",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://journals.sagepub.com/doi/10.1177/10998004221120945?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed,"A Systematic Review and Meta-Analysis of Resistance Training on Quality of Life, Depression, Muscle Strength, and Functional Exercise Capacity in Older Adults Aged 60 Years or More",PMID: 35968662,"recHS5DnujbLJGA0X, recUcK9hjmH56wFZf, rec8lDzP6nNsCQFUK, recIHhi5vLgm1yazl, recWoGmJUWm4wpggn, recuzoqjqJctR7ahw","recLjtJEXpCzCkeae, recYD8fyMs8TZaj9w, reccM1F6ztegvuj41, recM8FomYRHaUcOJC, rec0P4s0n2NSp3UqE, recy0MwATPDhKLOrN",True,,Sage Journals,recRIfCU2PF5bhkmW,"Meta-analysis of 21 studies (N=1610) found resistance training significantly improved multiple quality of life domains: physical functioning (SMD=0.31), mental health (SMD=0.44), general health (SMD=0.43), and mental component score (SMD=0.51). Depression significantly decreased (SMD=-1.13), while muscle strength increased substantially: upper-limb (MD=15.26 kg), lower-limb (MD=48.46 kg), and handgrip (MD=1.35 kg).",
recjsF4imkG9TJdRP,"Lean Body Mass, Fat-Free Mass, Skeletal Muscle Mass, Muscle Hypertrophy",High,,2025-07-21T14:53:50.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,1.53 kg muscle mass increase with resistance training; dose-response relationship with training volume,LI110,receYj9nbAEGPBxFl,"recVHWlB26jWt9Ij9, reccxH7AESy9vvBPo",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7068252/,A Systematic Review with Meta-Analysis of the Effect of Resistance Training on Whole-Body Muscle Growth in Healthy Adult Males,PMID: 32079265,"recHS5DnujbLJGA0X, recUcK9hjmH56wFZf, rec8lDzP6nNsCQFUK, recIHhi5vLgm1yazl, recWoGmJUWm4wpggn, recuzoqjqJctR7ahw","recLjtJEXpCzCkeae, recYD8fyMs8TZaj9w, reccM1F6ztegvuj41, recM8FomYRHaUcOJC, rec0P4s0n2NSp3UqE, recy0MwATPDhKLOrN",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 111 studies (158 groups, 1927 participants) found resistance training significantly increased muscle mass by 1.53 kg (95% CI: 1.30-1.76, p<0.001) with no heterogeneity (I²=0%). Meta-regression revealed excessive sets per workout negatively affected muscle mass gain (estimate: -0.03, 95% CI: -0.05 to -0.001, p=0.04), indicating optimal training volume exists.",
rec5jtPqAkLCmxtmR,"Muscle Hypertrophy, Muscle Strength, Training Volume, Training Duration, Lean Body Mass",Moderate,,2025-07-21T15:04:32.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Time-efficient training achieves similar hypertrophy and strength gains as traditional longer sessions when volume is matched,LI111,receYj9nbAEGPBxFl,"recyKRTIlX4Jux2W0, recVHWlB26jWt9Ij9",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8449772/,No Time to Lift? Designing Time-Efficient Training Programs for Strength and Hypertrophy: A Narrative Review,PMID: 34125411,"recIHhi5vLgm1yazl, recWoGmJUWm4wpggn, recuzoqjqJctR7ahw","recM8FomYRHaUcOJC, rec0P4s0n2NSp3UqE, recy0MwATPDhKLOrN",True,,PubMed,recuux8z8gb0e5MPU,Comprehensive narrative review found that time-efficient strength training can achieve comparable results to longer sessions when volume is equated. Key findings: minimum 4 weekly sets per muscle group using 6-15 RM range is effective; bilateral multi-joint exercises maximize time efficiency; advanced techniques like supersets and drop sets roughly halve training time while maintaining volume; single sessions of 13 minutes can be effective for beginners.,
rec8GtJTGvnWfUkd2,"Muscle Mass, Muscle Hypertrophy, Lean Body Mass, Training Volume Response",High,,2025-07-21T15:04:45.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Dose-response relationship confirmed between weekly volume and muscle mass gains; ≥10 sets per week superior to <5 sets,LI112,receYj9nbAEGPBxFl,"recVHWlB26jWt9Ij9, reccxH7AESy9vvBPo",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/27433992/,Dose-response relationship between weekly resistance training volume and increases in muscle mass: A systematic review and meta-analysis,PMID: 27433992,"recIHhi5vLgm1yazl, recWoGmJUWm4wpggn, recuzoqjqJctR7ahw","recM8FomYRHaUcOJC, rec0P4s0n2NSp3UqE, recy0MwATPDhKLOrN",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 15 studies (34 treatment groups) found a positive dose-response relationship between weekly resistance training volume and muscle hypertrophy. Studies showed greater increases in muscle mass with ≥10 sets per muscle per week compared to <5 sets. However, the relationship showed diminishing returns at higher volumes, suggesting optimal training efficiency occurs within moderate volume ranges.",
rec1q2DG3EF9Gv6o8,"Muscle Thickness, Muscle Hypertrophy, Muscle Strength, Training Duration, Lean Body Mass",High,,2025-07-21T15:05:03.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Strength gains similar across all durations (13-68 min); muscle hypertrophy showed dose-response: 5.3% vs 8.6% vs 13.5%,LI113,receYj9nbAEGPBxFl,"recyKRTIlX4Jux2W0, recVHWlB26jWt9Ij9, reccxH7AESy9vvBPo",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC6303131/,Resistance Training Volume Enhances Muscle Hypertrophy but Not Strength in Trained Men,PMID: 30153194,"recIHhi5vLgm1yazl, recWoGmJUWm4wpggn, recuzoqjqJctR7ahw","recM8FomYRHaUcOJC, rec0P4s0n2NSp3UqE, recy0MwATPDhKLOrN",True,,PubMed,reclYXy0udvjr66Xa,"RCT comparing 1-set (13 min), 3-set (40 min), and 5-set (68 min) training sessions in resistance-trained men over 8 weeks found dose-response relationship for muscle hypertrophy but not strength. All groups achieved significant strength gains regardless of session duration. Muscle thickness increased progressively: 1-set (+5.3%), 3-set (+8.6%), 5-set (+13.5%), demonstrating time-efficient training can provide substantial benefits.",
recYmQgtaxPq2hr8E,"VO2max, Blood Pressure, Insulin Sensitivity, HbA1c, hsCRP, Body Composition",High,,2025-07-23T19:05:19.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Significant improvements across 14 cardiometabolic parameters in large pooled analysis of 3,399 participants",LI114,"recPiW3K4dhWi31Xh, recC0mB1LyNGjDyld, recierVNozpgZdLZH, recAdUWMgWMZS3qKI","rec0v0JrVS6xu5Dcj, recELBnyZAf0mIQH6, recSy02sgRnjfOkHE, recVHWlB26jWt9Ij9",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://link.springer.com/article/10.1007/s40279-023-01863-8,High-Intensity Interval Training and Cardiometabolic Health in the General Population: A Systematic Review and Meta-Analysis of Randomised Controlled Trials,PMID: 37204620,"rec6T5WTFPHuxI0HV, rec6akLmENMwA5UR0, recdyxjcVFX1IiJmB, recgd6FoSRpsXFwGa, rec365bl5v5RJHmG9, recu6msvuyAWfCw4s, recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, recakt2a8V8iqmERc, recaBIRD7TdktJy1h, rechZVptoLoPBWnwS, reckEuLFlXQgQjaQr, rec7xthCyBwFCl0Qq, recyxKyMXE1K8gaeJ",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 97 RCTs with 3,399 participants found HIIT produced significant improvements in 14 clinically relevant cardiometabolic health parameters, including peak aerobic capacity (VO2max), blood pressure, insulin sensitivity, and lipid profiles. HIIT demonstrated superior time efficiency compared to traditional exercise while providing substantial health benefits across multiple systems.",
recifkDoAK6SpqKRg,"VO2max, Body Fat Percentage, Waist Circumference, Body Mass Index, Cardiorespiratory Fitness",High,,2025-07-23T19:05:33.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"HIIT superior to MICT for waist circumference, percent fat mass, and VO2peak; demonstrated time-efficiency advantages",LI115,receYj9nbAEGPBxFl,"rec0v0JrVS6xu5Dcj, recVHWlB26jWt9Ij9, reccxH7AESy9vvBPo",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10048683/,Effect of High-Intensity Interval Training vs. Moderate-Intensity Continuous Training on Fat Loss and Cardiorespiratory Fitness in the Young and Middle-Aged: A Systematic Review and Meta-Analysis,PMID: 36981649,"rec6T5WTFPHuxI0HV, rec6akLmENMwA5UR0, recdyxjcVFX1IiJmB, recgd6FoSRpsXFwGa, rec365bl5v5RJHmG9, recu6msvuyAWfCw4s, recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, recakt2a8V8iqmERc, recaBIRD7TdktJy1h, rechZVptoLoPBWnwS, reckEuLFlXQgQjaQr, rec7xthCyBwFCl0Qq, recyxKyMXE1K8gaeJ",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 29 studies found HIIT superior to MICT for waist circumference, percent fat mass, and VO2peak improvements. Both interventions improved body composition, but HIIT showed significant benefits for WC, PFM, and VO2peak compared to MICT. HIIT appears more time-efficient while delivering equal or superior results to traditional continuous training.",
recS0KcnINWKIWpM7,"VO2max, Waist Circumference, Body Fat Percentage, Total Cholesterol, LDL Cholesterol, Quality of Life",High,,2025-07-23T19:05:47.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Both 2x/week and 3x/week HIIT effective; 3x/week showed additional metabolic benefits including fat reduction and cholesterol improvements,LI116,receYj9nbAEGPBxFl,"rec0v0JrVS6xu5Dcj, recVHWlB26jWt9Ij9, reccxH7AESy9vvBPo",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0043-125074,High-intensity Interval Training Frequency: Cardiometabolic Effects and Quality of Life,PMID: 29396978,"rec6T5WTFPHuxI0HV, rec6akLmENMwA5UR0, recdyxjcVFX1IiJmB, recgd6FoSRpsXFwGa, rec365bl5v5RJHmG9, recu6msvuyAWfCw4s","recakt2a8V8iqmERc, recaBIRD7TdktJy1h, rechZVptoLoPBWnwS, reckEuLFlXQgQjaQr, rec7xthCyBwFCl0Qq, recyxKyMXE1K8gaeJ",True,,International Journal of Sports Medicine,reclYXy0udvjr66Xa,"RCT of 35 healthy inactive adults comparing HIIT performed 2x/week vs 3x/week for 8 weeks. Both frequencies improved VO2peak similarly (HIIT-2: 10.8%, HIIT-3: 13.6%), waist circumference, and quality of life. However, HIIT-3 provided additional benefits including reduced total body and trunk fat percentage, and improved cholesterol profiles, suggesting dose-response relationship for some outcomes.",
recughuAlrMC7JFIv,"Insulin Sensitivity, HOMA-IR, Fasting Insulin, VO2max, Glucose Metabolism",High,,2025-07-23T19:06:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,20% improvement in peripheral insulin sensitivity with both HIIT and MICT; demonstrates time-efficient metabolic benefits of HIIT,LI117,"recierVNozpgZdLZH, recAdUWMgWMZS3qKI",rec0v0JrVS6xu5Dcj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7347288/,Moderate-Intensity Exercise and High-Intensity Interval Training Affect Insulin Sensitivity Similarly in Obese Adults,PMID: 32492705,"rec6T5WTFPHuxI0HV, rec6akLmENMwA5UR0, recdyxjcVFX1IiJmB, recgd6FoSRpsXFwGa, rec365bl5v5RJHmG9, recu6msvuyAWfCw4s, recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, recakt2a8V8iqmERc, recaBIRD7TdktJy1h, rechZVptoLoPBWnwS, reckEuLFlXQgQjaQr, rec7xthCyBwFCl0Qq, recyxKyMXE1K8gaeJ",True,,PubMed,reclYXy0udvjr66Xa,"RCT of 31 obese adults comparing 12 weeks of HIIT vs MICT found both interventions improved peripheral insulin sensitivity by ~20% compared to pretraining, with no difference between groups. Despite large differences in training intensity and time commitment, both HIIT and MICT induced similar metabolic adaptations in skeletal muscle and insulin-sensitizing effects, demonstrating HIIT's time efficiency.",
recpk94bx9h2yF8kg,"Cardiovascular Disease Risk, All-Cause Mortality, Sedentary Time, Physical Activity Duration, C-Reactive Protein",High,,2025-07-23T19:12:31.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,30% increased CVD risk with high sedentary behavior; 5% increased risk per hour sedentary; 16% risk reduction when replacing sedentary time with light activity,LI118,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S0091743523003985?via%3Dihub,Association of sedentary time with risk of cardiovascular diseases and cardiovascular mortality: A systematic review and meta-analysis of prospective cohort studies,PMID: 38081421,"recjNCLgwgIRL0pQO, recsPMg2btkV2VLui, reclKFX6DhQ24ftN0, recMk6fKGjMET080O, recL0tr8zHEGjTEAV, reczXBfMO20DdNbq9, recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w, recZwg1aLhDGK0Ugs, recIjaRnoGtCO8uXx, rec3OiCYCwdkEUVOC","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, rec3XE7ren4uDEyqJ, recMKyXERMUqHM87O, rec7fGIf5CE8xyzYT, recne0RxZm9FEE305, recwgamjEzLJVzpEz, recpb33n6nhQXT7Xh, recQLul19pdsMEMa5, recPrRxp2N5ucxiKc, recDoZl3h8rr6rPAq",True,,Science Direct,recRIfCU2PF5bhkmW,"Meta-analysis of 19 prospective cohort studies with 1,473,354 individuals found 30% increased CVD risk for high vs low sedentary behavior (RR=1.29, 95% CI: 1.22-1.37). Every hour spent sedentary corresponds to 5% increased fatal and non-fatal CVD risk (RR=1.05, 95% CI: 1.02-1.07). Substituting one hour sedentary time with light physical activity reduced CVD risk by 16% (RR=0.84, 95% CI: 0.73-0.97).",
recNsLEd8OK0CV41T,"Daily Step Count, All-Cause Mortality, Cardiovascular Mortality, Daily Activity Duration",High,,2025-07-23T19:12:45.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"16-77% reduced CV mortality across step quartiles; benefits begin at 2,337 steps/day for CV mortality and 3,867 steps/day for all-cause mortality",LI119,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://academic.oup.com/eurjpc/article/30/18/1975/7226309?login=false,The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis,PMID: 37555441,"recjNCLgwgIRL0pQO, recsPMg2btkV2VLui, reclKFX6DhQ24ftN0, recZwg1aLhDGK0Ugs, recIjaRnoGtCO8uXx, rec3OiCYCwdkEUVOC, recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, rec3XE7ren4uDEyqJ, recMKyXERMUqHM87O, rec7fGIf5CE8xyzYT, recne0RxZm9FEE305, recwgamjEzLJVzpEz, recpb33n6nhQXT7Xh",True,,European Journal of Preventative Cardiology,recRIfCU2PF5bhkmW,"Meta-analysis found significant inverse association between daily step count and all-cause mortality and cardiovascular mortality. Optimal benefits began at 3,867 steps/day for all-cause mortality and 2,337 steps/day for CV mortality. Higher quartiles of steps/day (3,982, 6,661, and 10,413) were associated with 16%, 49%, and 77% reduced CV mortality risk respectively. Non-linear dose-response relationship with progressively lower mortality risk with increased step count.",
recWsw1cXDUXxR4YM,"Body Mass Index, HDL Cholesterol, Fasting Glucose, Insulin Resistance, Waist Circumference",High,,2025-07-23T19:13:14.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Consistent beneficial associations with obesity, lipid profiles, glucose metabolism markers across multiple large studies",LI120,"recierVNozpgZdLZH, recAdUWMgWMZS3qKI, recC0mB1LyNGjDyld","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://link.springer.com/article/10.1007/s40279-017-0724-0,Health Benefits of Light-Intensity Physical Activity: A Systematic Review of Accelerometer Data of the National Health and Nutrition Examination Survey (NHANES),PMID: 28393328,"recjNCLgwgIRL0pQO, recsPMg2btkV2VLui, reclKFX6DhQ24ftN0, recWPZo0CuM633ER7, recHIhiQzo9qxQ0aE, rec0g3pUi8ZOiLy9e, recZwg1aLhDGK0Ugs, recIjaRnoGtCO8uXx, rec3OiCYCwdkEUVOC","rec3XE7ren4uDEyqJ, recMKyXERMUqHM87O, rec7fGIf5CE8xyzYT, recne0RxZm9FEE305, recwgamjEzLJVzpEz, recpb33n6nhQXT7Xh, rec0gnuh5AdUWHi1o, recL9Fo72uAequEkV, rec4HrvbLeqCbpcjv",True,,Springer Nature,rec4qqncSQrMbfAph,"Systematic review of 37 cross-sectional and 3 longitudinal studies using NHANES accelerometer data found light-intensity physical activity beneficially associated with obesity markers, lipid metabolism, glucose metabolism, and mortality. Light activity showed independent health benefits beyond moderate-to-vigorous activity, supporting the importance of any movement above sedentary behavior.",
recC3okDrcVSiD8Ip,"Framingham Risk Score, All-Cause Mortality, Cardiovascular Disease Risk, Light Physical Activity Duration, Sedentary Time",Moderate,,2025-07-23T19:13:32.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,6.5% mortality reduction per 10 minutes light activity; 5.6% mortality increase per 10 minutes sedentary time,LI121,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9446693/,Cardiovascular disease risk and all-cause mortality associated with accelerometer-measured physical activity and sedentary time ‒ a prospective population-based study in older adults,PMID: 36064345,"recjNCLgwgIRL0pQO, recsPMg2btkV2VLui, reclKFX6DhQ24ftN0, recMk6fKGjMET080O, recL0tr8zHEGjTEAV, reczXBfMO20DdNbq9, recMPyaQMbpvDB4Fg, recmj7oZJyT7b1Zct, rec8Pb6zZXqqJdl8w, recZwg1aLhDGK0Ugs, recIjaRnoGtCO8uXx, rec3OiCYCwdkEUVOC","recQgWg7fhQjwfIPx, recqKvugcEkV4FDmK, reccgzcQs3ReCRZiN, rec3XE7ren4uDEyqJ, recMKyXERMUqHM87O, rec7fGIf5CE8xyzYT, recne0RxZm9FEE305, recwgamjEzLJVzpEz, recpb33n6nhQXT7Xh, recQLul19pdsMEMa5, recPrRxp2N5ucxiKc, recDoZl3h8rr6rPAq",True,,PubMed,recODsYatCgd7j2Vr,"Prospective study of 660 older adults (mean age 68.9) found each 10-minute increase in MVPA and light physical activity was negatively associated with Framingham Risk Score, while 10-minute increase in sedentary time was positively associated with cardiovascular risk. Each 10-minute increase in light activity associated with 6.5% lower all-cause mortality risk (HR=0.935), while 10-minute increase in sedentary time associated with 5.6% increased mortality risk (HR=1.056).",
recI5veyTjeePIjpt,"Insulin Resistance, HOMA-IR, Fasting Glucose, Triglycerides, HDL Cholesterol, Visceral Fat",High,,2025-07-23T19:13:49.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant improvements in insulin resistance, lipid homeostasis, and visceral fat reduction with light activity intervention",LI122,"recierVNozpgZdLZH, recAdUWMgWMZS3qKI, recC0mB1LyNGjDyld","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC4125749/,"Light physical activity determined by a motion sensor decreases insulin resistance, improves lipid homeostasis and reduces visceral fat in high-risk subjects: PreDiabEx study RCT",PMID: 24285336,"recjNCLgwgIRL0pQO, recsPMg2btkV2VLui, reclKFX6DhQ24ftN0, recWPZo0CuM633ER7, recHIhiQzo9qxQ0aE, rec0g3pUi8ZOiLy9e, recZwg1aLhDGK0Ugs, recIjaRnoGtCO8uXx, rec3OiCYCwdkEUVOC","rec3XE7ren4uDEyqJ, recMKyXERMUqHM87O, rec7fGIf5CE8xyzYT, recne0RxZm9FEE305, recwgamjEzLJVzpEz, recpb33n6nhQXT7Xh, rec0gnuh5AdUWHi1o, recL9Fo72uAequEkV, rec4HrvbLeqCbpcjv",True,,PubMed,reclYXy0udvjr66Xa,"Randomized controlled trial of 113 subjects with abnormal glucose levels found that light physical activity interventions significantly decreased insulin resistance, improved lipid profiles, and reduced visceral adipose tissue. Study demonstrated that light-intensity movement below traditional moderate exercise thresholds still produces meaningful metabolic benefits in high-risk populations.",
recNFfE7J6CWtND2E,"Range of Motion, Joint Flexibility, Muscle Length, Static Stretching, PNF Stretching, Hamstring Flexibility",High,,2025-07-24T01:12:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Moderate effect size (ES = -1.002) for ROM improvements; females showed significantly higher gains than males,LI123,"recLJcUUTL1szyE8Z, recwtXkPSEQgyddmt","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE, recxJqmq5ipZMLJsj",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10980866/,Chronic effects of stretching on range of motion with consideration of potential moderating variables: A systematic review with meta-analysis,PMID: 37301370,"rec2C4Hndkvoy1Dxn, recbqfJA6wK4HdMiE, rec0os47BTvYNpKEy, recydnhcoytUM656x, receNMlaVPPdpM8lF, rec8kQTL0hFtYshjO","rec63sNEGqWcrFhHE, recfRDPRzCbSARqsV, rec4PQao4ZWMG3oOP, recCELntREUIFKJgO, reciearroVg1iqMvW, reccLeZ2tn6hR6Vt5",True,,PubMed,recRIfCU2PF5bhkmW,Meta-analysis of stretching training studies found significant overall effect indicating that stretch training can increase range of motion with moderate effect size (ES = -1.002; 95% CI: -1.165 to -0.840; p < 0.001). Proprioceptive neuromuscular facilitation and static stretching produced greater ROM than ballistic/dynamic stretching. Females showed higher gains in ROM compared to males. Training for ≥2 weeks frequently can chronically increase joint range of motion.,
recsoirZvg4rd5TzE,"Range of Motion, Joint Flexibility, Hip Flexion ROM, Knee Extension ROM, Muscle Strength, Movement Quality",High,,2025-07-24T01:12:19.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,No significant difference between strength training and stretching for ROM improvements; both methods equally effective,LI124,"recLJcUUTL1szyE8Z, recwtXkPSEQgyddmt, receYj9nbAEGPBxFl","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE, recyKRTIlX4Jux2W0",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8067745/,Strength Training versus Stretching for Improving Range of Motion: A Systematic Review and Meta-Analysis,PMID: 33917036,"rec2C4Hndkvoy1Dxn, recbqfJA6wK4HdMiE, rec0os47BTvYNpKEy, recydnhcoytUM656x, receNMlaVPPdpM8lF, rec8kQTL0hFtYshjO, recHS5DnujbLJGA0X, recUcK9hjmH56wFZf, rec8lDzP6nNsCQFUK","recLjtJEXpCzCkeae, recYD8fyMs8TZaj9w, reccM1F6ztegvuj41, rec63sNEGqWcrFhHE, recfRDPRzCbSARqsV, rec4PQao4ZWMG3oOP, recCELntREUIFKJgO, reciearroVg1iqMvW, reccLeZ2tn6hR6Vt5",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 11 RCTs (n = 452 participants) found no significant differences between strength training and stretching on range of motion improvements (ES = -0.22; 95% CI = -0.55 to 0.12; p = 0.206). Both interventions consistently promoted ROM gains with similar effectiveness. Sub-group analyses based on risk of bias, active vs. passive ROM, and movement-per-joint showed no between-protocol differences, suggesting multiple approaches can improve flexibility.",
recuO8HIkLptcwOvr,"Range of Motion, Joint Flexibility, Hamstring Flexibility, Quadriceps Flexibility, Triceps Surae Flexibility, Foam Rolling Training Duration",High,,2025-07-24T01:15:58.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Moderate effect size (ES = 0.823) for ROM increases; interventions >4 weeks significantly more effective than shorter durations,LI125,"recLJcUUTL1szyE8Z, recwtXkPSEQgyddmt, recPiW3K4dhWi31Xh","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9474417/,Foam Rolling Training Effects on Range of Motion: A Systematic Review and Meta-Analysis,PMID: 35616852,"rec2C4Hndkvoy1Dxn, recbqfJA6wK4HdMiE, rec0os47BTvYNpKEy, recydnhcoytUM656x, receNMlaVPPdpM8lF, rec8kQTL0hFtYshjO","rec63sNEGqWcrFhHE, recfRDPRzCbSARqsV, rec4PQao4ZWMG3oOP, recCELntREUIFKJgO, reciearroVg1iqMvW, reccLeZ2tn6hR6Vt5",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 11 studies (290 participants, mean age 23.9 years) found foam rolling training produces moderate effects on range of motion increases (ES = 0.823; 95% CI 0.325-1.322; p = 0.001). Interventions >4 weeks showed significantly greater ROM improvements than ≤4 weeks (p = 0.049). Results indicate that regular foam rolling training systematically enhances joint flexibility and mobility.",
recKDvqA0ynihOEwS,"Joint Range of Motion, Functional Ability, Flexibility, Physical Function, Activities of Daily Living, Mobility",High,,2025-07-24T01:16:10.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,Limited evidence for functional improvements but beneficial for joint mobility maintenance; no adverse effects reported,LI126,"recLJcUUTL1szyE8Z, recwtXkPSEQgyddmt","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC3503322/,Flexibility Training and Functional Ability in Older Adults: A Systematic Review,PMID: 23209904,"rec2C4Hndkvoy1Dxn, recbqfJA6wK4HdMiE, rec0os47BTvYNpKEy, recydnhcoytUM656x, receNMlaVPPdpM8lF, rec8kQTL0hFtYshjO","rec63sNEGqWcrFhHE, recfRDPRzCbSARqsV, rec4PQao4ZWMG3oOP, recCELntREUIFKJgO, reciearroVg1iqMvW, reccLeZ2tn6hR6Vt5",True,,PubMed,rec4qqncSQrMbfAph,"Systematic review of 22 studies examining flexibility-specific training interventions in healthy older adults over 65 years found that stretching exercises can be included as an adjunct to other exercise modes but add little to functional benefits beyond balance, aerobic, and strengthening exercises. While flexibility training shows limited evidence for functional improvements, it poses no additional health risks and may support joint mobility maintenance.",
reccKgRDlI1Yvws8H,"Postprandial Glucose, Glucose Excursions, Post-Meal Activity, Walking Duration, Exercise Timing",High,,2025-07-24T01:19:30.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Moderate effect size (SMD = 0.47-0.55) for postprandial glucose reduction with post-meal vs pre-meal exercise and control,LI127,"recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI","recxJqmq5ipZMLJsj, recXiq3Os05QJJki4, rec8o1wlo0olBMl8A",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10036272/,"After Dinner Rest a While, After Supper Walk a Mile? A Systematic Review with Meta-analysis on the Acute Postprandial Glycemic Response to Exercise Before and After Meal Ingestion in Healthy Subjects and Patients with Impaired Glucose Tolerance",PMID: 36715875,"recWPZo0CuM633ER7, recHIhiQzo9qxQ0aE, rec0g3pUi8ZOiLy9e, recr1bYkprxDHpqqF, recTDnbMFdEillGGN, recW9EWJrKnyhWcOg","rec0gnuh5AdUWHi1o, recL9Fo72uAequEkV, rec4HrvbLeqCbpcjv, recvsz4BSxYrA34AW, recX4Lh38j56eZkQ4, rec0A220UQOmaAQYx",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 15 studies found that post-meal exercise led to significantly greater reduction in postprandial glucose excursions compared to pre-meal exercise (SMD = 0.47; 95% CI 0.23-0.70) and inactive control (SMD = 0.55; 95% CI 0.34-0.75). Exercise performed as soon as possible after meals (0-29 min) was most effective, with diminishing benefits as delay increased.",
rec8UBpydQNaepBKH,"Postprandial Glucose, Standing Breaks, Light Walking, Sedentary Time, Activity Breaks",High,,2025-07-24T01:19:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,17% glucose reduction with light walking breaks vs 9.5% with standing breaks; clear dose-response relationship,LI128,"recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI","recxJqmq5ipZMLJsj, recXiq3Os05QJJki4, rec8o1wlo0olBMl8A",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9325803/,The Acute Effects of Interrupting Prolonged Sitting Time in Adults with Standing and Light-Intensity Walking on Biomarkers of Cardiometabolic Health in Adults: A Systematic Review and Meta-analysis,PMID: 35147898,"recWPZo0CuM633ER7, recHIhiQzo9qxQ0aE, rec0g3pUi8ZOiLy9e, recr1bYkprxDHpqqF, recTDnbMFdEillGGN, recW9EWJrKnyhWcOg","rec0gnuh5AdUWHi1o, recL9Fo72uAequEkV, rec4HrvbLeqCbpcjv, recvsz4BSxYrA34AW, recX4Lh38j56eZkQ4, rec0A220UQOmaAQYx",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 7 studies found that intermittent standing breaks reduced glucose by 9.51% compared to prolonged sitting, while light-intensity walking breaks achieved greater glucose reduction of 17.01%. Both interventions involved 2-5 minute breaks every 20-30 minutes. Walking breaks were superior to standing for postprandial glucose control.",
recLpnOL8eVCpReto,"Glucose Area Under Curve, 24-Hour Glucose, Postprandial Exercise, HbA1c, Type 2 Diabetes",High,,2025-07-24T01:20:00.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Consistent glucose reductions across multiple populations; greater benefits in type 2 diabetes than overweight/obese,LI129,"recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI, recC0mB1LyNGjDyld","recxJqmq5ipZMLJsj, recXiq3Os05QJJki4, rec8o1wlo0olBMl8A",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10610082/,Efficacy of Postprandial Exercise in Mitigating Glycemic Responses in Overweight Individuals and Individuals with Obesity and Type 2 Diabetes—A Systematic Review and Meta-Analysis,PMID: 37892564,"recWPZo0CuM633ER7, recHIhiQzo9qxQ0aE, rec0g3pUi8ZOiLy9e, recr1bYkprxDHpqqF, recTDnbMFdEillGGN, recW9EWJrKnyhWcOg","rec0gnuh5AdUWHi1o, recL9Fo72uAequEkV, rec4HrvbLeqCbpcjv, recvsz4BSxYrA34AW, recX4Lh38j56eZkQ4, rec0A220UQOmaAQYx",True,,PubMed,rec4qqncSQrMbfAph,"Systematic review of 31 studies found that postprandial exercise significantly reduced glucose area under the curve and 24-hour mean glucose levels in overweight/obese adults and those with type 2 diabetes. Exercise performed 30-60 minutes after meals was optimal for glucose control, with greater benefits observed in individuals with diabetes compared to overweight/obese adults.",
recpt8wrIagokmykq,"Postprandial Glucose, Postprandial Insulin, Activity Breaks, Sedentary Behavior, Light Walking",High,,2025-07-24T01:20:12.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant reductions in both glucose and insulin with 2-minute walking breaks every 20 minutes,LI130,"recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI","recxJqmq5ipZMLJsj, recXiq3Os05QJJki4, rec8o1wlo0olBMl8A",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC3329818/,Breaking up prolonged sitting reduces postprandial glucose and insulin responses,PMID: 22374636,"recWPZo0CuM633ER7, recHIhiQzo9qxQ0aE, rec0g3pUi8ZOiLy9e, recr1bYkprxDHpqqF, recTDnbMFdEillGGN, recW9EWJrKnyhWcOg","rec0gnuh5AdUWHi1o, recL9Fo72uAequEkV, rec4HrvbLeqCbpcjv, recvsz4BSxYrA34AW, recX4Lh38j56eZkQ4, rec0A220UQOmaAQYx",True,,PubMed,reclYXy0udvjr66Xa,Randomized crossover trial in overweight/obese adults found that interrupting sitting with 2-minute bouts of light or moderate-intensity walking every 20 minutes significantly lowered postprandial glucose and insulin levels compared to uninterrupted sitting. This landmark study demonstrated that brief activity breaks can improve glucose metabolism without requiring dedicated exercise sessions.,
recmg81rbVOQE2fsX,"24-Hour Glucose, Postprandial Glucose, Post-Dinner Walking, Glucose Area Under Curve, Older Adults",High,,2025-07-24T01:20:25.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant improvements in 24-hour glucose control; post-dinner walking most effective for glycemic benefits,LI131,"recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI","recxJqmq5ipZMLJsj, recXiq3Os05QJJki4, rec8o1wlo0olBMl8A",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC3781561/,Three 15-min Bouts of Moderate Postmeal Walking Significantly Improves 24-h Glycemic Control in Older People at Risk for Impaired Glucose Tolerance,PMID: 23761134,"recWPZo0CuM633ER7, recHIhiQzo9qxQ0aE, rec0g3pUi8ZOiLy9e, recr1bYkprxDHpqqF, recTDnbMFdEillGGN, recW9EWJrKnyhWcOg","rec0gnuh5AdUWHi1o, recL9Fo72uAequEkV, rec4HrvbLeqCbpcjv, recvsz4BSxYrA34AW, recX4Lh38j56eZkQ4, rec0A220UQOmaAQYx",True,,PubMed,reclYXy0udvjr66Xa,"Randomized crossover study in older adults at diabetes risk found that three 15-minute bouts of moderate postmeal walking significantly improved 24-hour glycemic control compared to a single 45-minute session of sustained exercise. Post-dinner exercise was particularly effective, reducing 3-hour postdinner glucose levels and overall glucose area under the curve.",
recDumtQgbaD3BjaA,"Post-meal glucose levels, cardiovascular fitness, metabolic markers, mood indicators",Moderate,,2025-07-24T13:54:18.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Exercise snacks improve metabolic health markers and cardiovascular fitness with time-efficient implementation,LI132,"recPiW3K4dhWi31Xh, recierVNozpgZdLZH, recC0mB1LyNGjDyld","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://journals.lww.com/acsm-essr/fulltext/2022/01000/exercise_snacks__a_novel_strategy_to_improve.5.aspx,Exercise snacks: a novel strategy to improve cardiometabolic health,PMID: 34669625,"recg3Re7epEA4woTr, recTQU7jk4viGfM5L, reciAaUoOHZJUbefJ","reckufkoHv5oXa23I, recXhidANaW6zTqf2, recm1y0FhNqxNPSp0",True,,Exercise and Sports Science Reviews,recuux8z8gb0e5MPU,"Narrative review of exercise snacks research found that isolated ≤1-minute bouts of vigorous exercise performed periodically throughout the day improve cardiorespiratory fitness, metabolic health, and mood while being feasible and time-efficient. Studies show exercise snacks enhance glucose clearance, reduce postprandial glucose responses by 20-30%, and improve cardiovascular function equivalent to longer traditional workouts.",
recnJyCczaWwIv9m1,"Glucose levels, insulin sensitivity, postprandial glucose responses",High,,2025-07-24T13:54:31.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Exercise snacks before meals effectively improve glycemic control in insulin-resistant individuals,LI133,"recierVNozpgZdLZH, recC0mB1LyNGjDyld, recAdUWMgWMZS3qKI",recELBnyZAf0mIQH6,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://link.springer.com/article/10.1007/s00125-014-3244-6,Exercise snacks before meals: a novel strategy to improve glycaemic control in individuals with insulin resistance,PMID: 24817675,"recg3Re7epEA4woTr, recTQU7jk4viGfM5L, reciAaUoOHZJUbefJ","reckufkoHv5oXa23I, recXhidANaW6zTqf2, recm1y0FhNqxNPSp0",True,,Springer Nature,reclYXy0udvjr66Xa,"RCT of 12 insulin-resistant adults found that brief, intense exercise snacks performed before main meals significantly improved glycemic control and insulin sensitivity. Pre-meal exercise snacks reduced postprandial glucose excursions and enhanced glucose clearance compared to control conditions, demonstrating time-efficient metabolic benefits.",
recml5YqTJh38k8fE,"VO2 peak, cardiorespiratory fitness, exercise capacity",High,,2025-07-24T13:54:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Exercise snacks spread throughout day provide equivalent cardiorespiratory fitness improvements to traditional training,LI134,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://link.springer.com/article/10.1007/s00421-019-04110-z,Sprint exercise snacks: a novel approach to increase aerobic fitness,PMID: 30847639,"recg3Re7epEA4woTr, recTQU7jk4viGfM5L, reciAaUoOHZJUbefJ","reckufkoHv5oXa23I, recXhidANaW6zTqf2, recm1y0FhNqxNPSp0",True,,Springer Nature,reclYXy0udvjr66Xa,"RCT of 24 healthy inactive adults compared sprint snacks (3×20-second bouts spread throughout day with 1-4 hour rest) vs traditional sprint interval training over 6 weeks. Both protocols similarly improved cardiorespiratory fitness by 7-10%, demonstrating that exercise snacks distributed across the day provide equivalent fitness benefits to concentrated training sessions.",
recAfRFPxiGksF2xo,"All-cause mortality, cardiovascular events, sleep duration",High,,2025-07-24T13:54:53.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,6-13% increased mortality risk per hour deviation from 7-hour optimal sleep duration,LI135,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-23T23:50:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC5634263/,Relationship of sleep duration with all-cause mortality and cardiovascular events: a systematic review and dose-response meta-analysis of prospective cohort studies,PMID: 28889101,"rec4AEbFQJsIeCNOD, rec0j9ruDrnh2P6gG, recKLti4nzfTo8acc",,True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 74 prospective studies with over 3 million participants found U-shaped relationship between sleep duration and mortality, with lowest risk at approximately 7 hours per day. Sleep <7 hours increased mortality risk by 6% per hour reduction, while sleep >7 hours increased risk by 13% per hour increment, confirming optimal range of 7-9 hours.",
recRMGlu5v14IiJPC,"All-cause mortality, sleep duration, longevity markers",High,,2025-07-24T13:55:03.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"12% increased mortality risk for short sleep, 30% for long sleep vs 7-8 hour optimal range",LI136,recPiW3K4dhWi31Xh,recELBnyZAf0mIQH6,2025-09-23T23:50:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC2864873/,Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies,PMID: 20469800,"rec4AEbFQJsIeCNOD, rec0j9ruDrnh2P6gG, recKLti4nzfTo8acc",,True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 16 studies with 1,382,999 participants found both short (≤6-7 hours) and long (≥8-9 hours) sleep duration significantly predicted death, with U-shaped relationship. Short sleep increased mortality risk by 12% and long sleep by 30%, with optimal survival at 7-8 hours nightly, confirming sleep duration as modifiable mortality risk factor.",
recC2T3geyYzsz5PS,"All-cause mortality, sleep duration, cardiovascular health",High,,2025-07-24T13:55:13.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Clear U-shaped dose-response with 7 hours optimal; 55% increased mortality at 11 hours, minimal risk 6-8 hours",LI137,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-23T23:50:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC4761879/,"Nighttime sleep duration, 24-hour sleep duration and risk of all-cause mortality among adults: a meta-analysis of prospective cohort studies",PMID: 26900147,"rec4AEbFQJsIeCNOD, rec0j9ruDrnh2P6gG, recKLti4nzfTo8acc",,True,,PubMed,recRIfCU2PF5bhkmW,"Dose-response meta-analysis of 35 studies with 1,526,609 participants found U-shaped relationship with 7 hours as optimal sleep duration. Mortality risk ratios were 1.07, 1.04, 1.01, 1.07, 1.21, 1.37, and 1.55 for 4, 5, 6, 8, 9, 10, and 11 hours respectively, demonstrating clear dose-response relationship supporting 7-9 hour target range.",
recqYoT6BrH46hN1v,"Sleep timing variability, bedtime consistency, wake time regularity, cardiometabolic risk markers, blood pressure, inflammatory markers",High,,2025-07-24T14:06:46.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Consistent associations between sleep timing regularity and health outcomes across 14 different countries and 92,340 participants",LI138,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://cdnsciencepub.com/doi/10.1139/apnm-2020-0032,"Sleep timing, sleep consistency, and health in adults: a systematic review",PMID: 33054339,"rece9QUzAfvHZSMxU, recnCaXsF7KhzduFk, recq2gsA68cq1kCeB, recqGyakXN5etEtZk, recuLDdQ8KbpeyEPc, reckWMg3144Ab2593","reciAe0Q3lWvSwqHb, recr3y3J8db5sR8PB, recutEyRzeDeUYgoS, recu7WgBqTw2mi79B, recyc1j7BQCd7ciZt, reconamkuavo4GJjk",True,,Canadian Science Publishing,rec4qqncSQrMbfAph,"Systematic review of 41 articles with 92,340 participants from 14 countries found that later sleep timing and greater sleep variability were generally associated with adverse health outcomes. Sleep regularity with consistent bedtimes and wake-up times was favorably associated with cardiovascular health, metabolic markers, and overall health outcomes across multiple study designs.",
recFXtTkIbAerUMG6,"Sleep quality scores, social jetlag measurements, chronotype assessments, circadian rhythm markers",Moderate,,2025-07-24T14:06:56.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant correlations between social jetlag and sleep quality in large sample of healthy adults,LI139,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7445814/,"A Cross-Sectional Study of the Associations between Chronotype, Social Jetlag and Subjective Sleep Quality in Healthy Adults",PMID: 33089185,"rece9QUzAfvHZSMxU, recnCaXsF7KhzduFk, recq2gsA68cq1kCeB, recqGyakXN5etEtZk, recuLDdQ8KbpeyEPc, reckWMg3144Ab2593","reciAe0Q3lWvSwqHb, recr3y3J8db5sR8PB, recutEyRzeDeUYgoS, recu7WgBqTw2mi79B, recyc1j7BQCd7ciZt, reconamkuavo4GJjk",True,,PubMed,recDDHykOzWxwMnyv,"Cross-sectional study of 1,322 healthy adults found that greater social jetlag (differences between weekday and weekend sleep timing) had significant association with poorer subjective sleep quality (rho = 0.077). Later chronotype independently associated with poorer sleep quality (rho = 0.212), demonstrating that circadian misalignment from irregular sleep schedules impairs sleep quality and well-being.",
rec1iL7XB1jUTohEX,"Sleep timing variability, health outcomes, performance measures, cardiovascular markers, metabolic parameters",Anecdotal,,2025-07-24T14:07:09.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"92% of reviewed studies showed adverse outcomes from sleep timing variability, representing strong consensus evidence",LI140,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sleephealthjournal.org/article/S2352-7218(23)00166-3/fulltext,The importance of sleep regularity: a consensus statement of the National Sleep Foundation sleep timing and variability panel,PMID: 37684151,"rece9QUzAfvHZSMxU, recnCaXsF7KhzduFk, recq2gsA68cq1kCeB, recqGyakXN5etEtZk, recuLDdQ8KbpeyEPc, reckWMg3144Ab2593","reciAe0Q3lWvSwqHb, recr3y3J8db5sR8PB, recutEyRzeDeUYgoS, recu7WgBqTw2mi79B, recyc1j7BQCd7ciZt, reconamkuavo4GJjk",True,,Sleep Health Journal,recYhFTRFUPeMb1fL,"National Sleep Foundation consensus panel reviewed 54 relevant studies and found that 50 studies (92%) demonstrated at least one outcome variable significantly worsened with increased sleep timing variability. Analysis showed 63 adverse health effects, 11 adverse alertness/performance outcomes, and 4 adverse safety-related behaviors associated with irregular sleep timing, supporting the critical importance of consistent sleep schedules.",
rec6HyxnNrzXlL9ol,"Sleep Regularity Index (SRI), all-cause mortality, sleep duration, sleep timing variability, circadian rhythm markers",Moderate,,2025-07-24T14:29:45.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,30% lower all-cause mortality risk with highest sleep regularity quintile; SRI stronger predictor than sleep duration,LI141,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10782501/,"Sleep regularity and mortality risk in a prospective cohort of 60,977 UK Biobank participants",PMID: 37738616,"rece9QUzAfvHZSMxU, recnCaXsF7KhzduFk, recq2gsA68cq1kCeB, recqGyakXN5etEtZk, recuLDdQ8KbpeyEPc, reckWMg3144Ab2593, recXuOWpl8orK06ul, recrAMEvn6TQqpIMf","rec1Vc2GOePfDEKEC, recv1aKMQckEj3mWw, reciAe0Q3lWvSwqHb, recr3y3J8db5sR8PB, recutEyRzeDeUYgoS, recu7WgBqTw2mi79B, recyc1j7BQCd7ciZt, reconamkuavo4GJjk",True,,PubMed,recODsYatCgd7j2Vr,"Prospective study of 60,977 UK Biobank participants followed for 7.8 years found that Sleep Regularity Index (SRI) was a stronger predictor of all-cause mortality than sleep duration. Participants in the highest SRI quintile (most regular sleep) had 30% lower all-cause mortality risk (HR=0.70; 95% CI: 0.61-0.81) compared to the lowest quintile. Sleep regularity remained protective even among participants with insufficient sleep duration, demonstrating that when you sleep may be more important than how long you sleep.",
recvH9g8RTwBxBeOZ,"Sleep Regularity Index (SRI), total mortality, cardiovascular mortality, cancer mortality, sleep timing consistency",Moderate,,2025-07-24T14:30:01.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"34% higher total mortality, 31% higher CVD mortality, 27% higher cancer mortality with irregular vs regular sleep",LI142,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/37131603/,Sleep regularity and mortality: a prospective analysis in the UK Biobank,PMID: 37131603,"rece9QUzAfvHZSMxU, recnCaXsF7KhzduFk, recq2gsA68cq1kCeB, recqGyakXN5etEtZk, recuLDdQ8KbpeyEPc, reckWMg3144Ab2593, recXuOWpl8orK06ul, recrAMEvn6TQqpIMf","rec1Vc2GOePfDEKEC, recv1aKMQckEj3mWw, reciAe0Q3lWvSwqHb, recr3y3J8db5sR8PB, recutEyRzeDeUYgoS, recu7WgBqTw2mi79B, recyc1j7BQCd7ciZt, reconamkuavo4GJjk",True,,PubMed,recODsYatCgd7j2Vr,"Prospective analysis of 88,975 UK Biobank participants over 7.1 years found a non-linear relationship between Sleep Regularity Index (SRI) and mortality risk. Irregular sleep was associated with higher total mortality (HR=1.34; 95% CI: 1.20-1.49), cardiovascular mortality (HR=1.31; 95% CI: 1.06-1.61), and cancer mortality (HR=1.27; 95% CI: 1.04-1.54) compared to regular sleep patterns. The strongest mortality protection occurred with SRI scores above 60, with diminishing returns beyond 87, suggesting an optimal range for sleep regularity rather than maximum rigidity.",
rectfUxPRKtoqsydH,"Bedtime irregularity, wake-up time irregularity, systolic blood pressure, fasting glucose, HOMA-IR, insulin resistance, cardiometabolic markers",Moderate,,2025-07-24T14:30:12.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Dose-response relationship: each hour of bedtime irregularity associated with 0.75 mmHg higher systolic BP, 0.16 mmol/L higher glucose, 0.08 higher HOMA-IR",LI143,"recPiW3K4dhWi31Xh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC11960235/,Device-measured bedtime and wake-up time irregularity and cardiometabolic health in the Northern Finland Birth Cohort 1966,PMID: 40217503,"rece9QUzAfvHZSMxU, recnCaXsF7KhzduFk, recq2gsA68cq1kCeB, recqGyakXN5etEtZk, recuLDdQ8KbpeyEPc, reckWMg3144Ab2593, recXuOWpl8orK06ul, recrAMEvn6TQqpIMf","rec1Vc2GOePfDEKEC, recv1aKMQckEj3mWw, reciAe0Q3lWvSwqHb, recr3y3J8db5sR8PB, recutEyRzeDeUYgoS, recu7WgBqTw2mi79B, recyc1j7BQCd7ciZt, reconamkuavo4GJjk",True,,PubMed,recDDHykOzWxwMnyv,"Cross-sectional study of 3,698 participants at age 46 from the Northern Finland Birth Cohort 1966 found that device-measured bedtime and wake-up time irregularity was significantly associated with poor cardiometabolic markers. Greater bedtime irregularity was associated with higher systolic blood pressure (β=0.75 mmHg per hour of irregularity, p=0.045), higher fasting glucose (β=0.16 mmol/L per hour, p=0.019), and higher HOMA-IR insulin resistance index (β=0.08 per hour, p=0.035). Wake-up time irregularity showed similar associations with glucose metabolism disruption, demonstrating that irregular sleep timing directly impacts cardiovascular and metabolic health markers.",
reczKzVuD4kOIRFbr,"Nocturnal blood pressure dipping, melatonin",Moderate,,2025-07-24T16:31:53.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",Mild–Moderate,"Each hour of earlier or increased morning light exposure associated with clinically meaningful improvements in blood pressure, BMI, and triglycerides, but causality not established.",LI144,recDBJLAkc5CAfBm3,"reccxH7AESy9vvBPo, recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/abs/pii/S0306987725000933,Morning light exposure: a potential modifier of cardiovascular risk factor,,"rechiD1yw3GS6kYFm, recBygbsMsJ1OkpdA, rec0YKdAFfBNGKbyu","reclJ17PZ97GZYCPD, recFZEhJfyaPHY3nR, rec4p8jR8l2BzoPIL",True,,Science Direct,recDDHykOzWxwMnyv,"Cross-sectional study of 862 adults (mean age 47) found that greater morning light exposure, objectively measured with light sensors, was significantly associated with lower systolic blood pressure (β = –2.9 mmHg per hour, p<0.01) and lower BMI (β = –0.38 kg/m² per hour, p=0.03) after adjusting for confounders. Early light exposure also correlated with lower triglyceride levels, suggesting a role for circadian alignment in cardiometabolic health.",
recS0dkYFLd147fXk,"Sleep efficiency, sleep latency, slow-wave sleep, circadian phase, melatonin (timing)",Moderate,,2025-07-24T16:32:48.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Consistent findings across controlled trials and mechanistic studies support morning light as the primary external cue for circadian alignment, sleep improvement, and mood regulation.",LI145,recwtXkPSEQgyddmt,"recxJqmq5ipZMLJsj, rec8o1wlo0olBMl8A, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC6751071/,"Effects of light on human circadian rhythms, sleep and mood",PMID: 31534436,"rechiD1yw3GS6kYFm, recBygbsMsJ1OkpdA, rec0YKdAFfBNGKbyu","reclJ17PZ97GZYCPD, recFZEhJfyaPHY3nR, rec4p8jR8l2BzoPIL",True,,PubMed,recuux8z8gb0e5MPU,"Narrative review of human laboratory and field studies demonstrates that morning bright light is the most potent zeitgeber (time cue) for advancing circadian phase, consolidating sleep, and improving mood. Evidence shows bright morning light reliably shifts sleep timing earlier, enhances sleep quality, and reduces depressive symptoms—particularly in individuals with delayed sleep phase or seasonal affective disorder.",
rechL5NBoM9vKcEFf,"Self-reported fatigue, sleep quality, waking cortisol, diurnal cortisol slope",Moderate,,2025-07-24T16:34:14.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",Mild–Moderate,"Strong observational link between cortisol rhythm and fatigue, with morning light hypothesized as a practical, testable intervention for future studies.",LI146,recwtXkPSEQgyddmt,"recxJqmq5ipZMLJsj, rec8o1wlo0olBMl8A, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/abs/pii/S030645300900153X?via%3Dihub,Cortisol secretion and fatigue: associations in a community based cohort,PMID: 19497676,"rechiD1yw3GS6kYFm, recBygbsMsJ1OkpdA, rec0YKdAFfBNGKbyu","reclJ17PZ97GZYCPD, recFZEhJfyaPHY3nR, rec4p8jR8l2BzoPIL",True,,PubMed,recODsYatCgd7j2Vr,"Prospective cohort study of 500 adults found that blunted or delayed morning cortisol secretion was associated with increased daytime fatigue and poorer subjective sleep quality (p<0.05). Authors suggest morning light exposure may benefit fatigue and energy by supporting a healthier cortisol rhythm, though intervention studies are needed.",
recig7LzljW7IH2hc,"Nocturnal awakenings, sleep onset latency, sleep efficiency, gastrointestinal discomfort, meal timing",Moderate,,2025-07-24T19:15:58.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,61% increased odds of nocturnal awakening when eating within 3 hours of bedtime; specific association with sleep quality disruption,LI147,"recDBJLAkc5CAfBm3, recwtXkPSEQgyddmt","recxJqmq5ipZMLJsj, rec8o1wlo0olBMl8A, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7215804/,Does the Proximity of Meals to Bedtime Influence the Sleep of Young Adults? A Cross-Sectional Survey of University Students,PMID: 32295235,"recjyJ3KMCwCS3IQM, recmvq3CmxWl89zlQ, recXY3q9q7wAfwlZJ, recla4wfM9zK0cR4j, rec99M50zfGNf4bjs, recduf6TsTzeCYv1V","recnZ791fIXqLHm03, recqWO9TPDn91Ndv7, rec1prwqTdXo8aZ90, recpBsCwff0yTQveA, recdAabh2l7B8IPtJ, rechVDcaVZ02vC9bc",True,,PubMed,recDDHykOzWxwMnyv,"Cross-sectional study of 793 young adults (ages 18-29) found that eating within 3 hours of bedtime was significantly associated with nocturnal awakening (OR=1.61, 95% CI=1.15-2.27) but not sleep onset latency or sleep duration. Over half (53.7%) of participants ate within 3 hours of bedtime, suggesting that meal timing affects sleep quality through mechanisms including gastrointestinal discomfort and less efficient nighttime digestion.",
recpW5Z8eiH6S13Ou,"Glucose tolerance, triglycerides, free fatty acids, fatty acid oxidation, insulin sensitivity, cortisol",Moderate,,2025-07-24T19:16:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Late dinner significantly impaired glucose tolerance and lipid metabolism when consumed 1 hour vs 4 hours before sleep in controlled trial,LI148,"recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI, recC0mB1LyNGjDyld","recVHWlB26jWt9Ij9, recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7337187/,Metabolic Effects of Late Dinner in Healthy Volunteers—A Randomized Crossover Clinical Trial,PMID: 32525525,"recjyJ3KMCwCS3IQM, recmvq3CmxWl89zlQ, recXY3q9q7wAfwlZJ, recla4wfM9zK0cR4j, rec99M50zfGNf4bjs, recduf6TsTzeCYv1V","recnZ791fIXqLHm03, recqWO9TPDn91Ndv7, rec1prwqTdXo8aZ90, recpBsCwff0yTQveA, recdAabh2l7B8IPtJ, rechVDcaVZ02vC9bc",True,,PubMed,reclqQn6EV0azXdYf,"Randomized crossover trial in 20 healthy volunteers (ages 26±0.6 years) comparing late dinner (22:00) vs routine dinner (18:00) with fixed sleep at 23:00 found that late dinner led to impaired glucose tolerance, delayed triglyceride peak, lower free fatty acid levels, and reduced dietary fatty acid oxidation. Late eating caused a 4-hour shift in the postprandial period that overlapped with sleep, demonstrating adverse metabolic effects when meals occur close to bedtime.",
rec5dV3nxFTnsy41d,"Wake after sleep onset (WASO), sleep duration, sleep efficiency, meal timing intervals",Moderate,,2025-07-24T19:16:42.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,2-3x increased odds of wake after sleep onset when eating <1 hour before bedtime; dose-response relationship with timing,LI149,recwtXkPSEQgyddmt,"recxJqmq5ipZMLJsj, rec8o1wlo0olBMl8A, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9092657/,"Associations between bedtime eating or drinking, sleep duration and wake after sleep onset: findings from the American time use survey",PMID: 34511160,"recjyJ3KMCwCS3IQM, recmvq3CmxWl89zlQ, recXY3q9q7wAfwlZJ, recla4wfM9zK0cR4j, rec99M50zfGNf4bjs, recduf6TsTzeCYv1V","recnZ791fIXqLHm03, recqWO9TPDn91Ndv7, rec1prwqTdXo8aZ90, recpBsCwff0yTQveA, recdAabh2l7B8IPtJ, rechVDcaVZ02vC9bc",True,,PubMed,recDDHykOzWxwMnyv,"Large-scale analysis of American Time Use Survey data found that eating or drinking <1 hour before bedtime was associated with longer sleep duration (35 min for women, 25 min for men) but increased wake after sleep onset (WASO). Women had OR=2.03 (95% CI 1.66-2.49) and men had OR=2.64 (95% CI 2.08-3.36) for WASO when eating close to bedtime. As the interval between eating and bedtime increased, odds of sleep disruption decreased, suggesting optimal timing is further from bedtime.",
recX8KN2ikIkgzo31,"REM sleep duration, REM sleep onset latency, sleep onset latency, sleep architecture, alcohol metabolism timing",High,,2025-07-24T19:32:26.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Dose-response relationship with REM sleep disruption occurring at low doses and worsening with higher doses; timing closer to bedtime increases negative effects,LI150,recwtXkPSEQgyddmt,"rec8o1wlo0olBMl8A, recxJqmq5ipZMLJsj, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S1087079224001345?via%3Dihub,The effect of alcohol on subsequent sleep in healthy adults: A systematic review and meta-analysis,PMID: 39631226,"recT4f3tvSbqWAgBw, reclTbJmA8iYIbUMn, reccJvdb4qs4gLNRe","recXvD9KYYCePeULN, recpkzPD3eJMBPyWE, recgaTjsxwTS9pr1v",True,,Science Direct,recRIfCU2PF5bhkmW,"Systematic review and meta-analysis of 27 studies examining alcohol's impact on sleep architecture found that alcohol consumption before bedtime disrupts REM sleep at all doses, with low doses (≤0.50 g/kg or ~2 drinks) reducing REM sleep duration and delaying REM onset. High doses additionally shortened sleep onset latency but exacerbated REM disruption. Effects worsened progressively with increasing alcohol doses and timing closer to bedtime, supporting recommendations for alcohol cessation at least 3-4 hours before sleep.",
recomiQmSMTzoVqGs,"Sleep onset latency, melatonin suppression, REM sleep timing, circadian phase delay, evening alertness",High,,2025-07-24T19:32:39.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"55% reduction in evening melatonin levels, prolonged sleep onset latency, and measurable circadian phase delay with evening light-emitting device use",LI151,recwtXkPSEQgyddmt,"rec8o1wlo0olBMl8A, recxJqmq5ipZMLJsj, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC4313820/,"Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness",PMID: 25535358,"recLblhnXjPvPGMmj, recJkNzpUTB17O5t8, recocYYB6fhtj8Gbh","recPCJnEqpgjIkqwA, recNLbFGnZ2P0sJDp, recsDm4SzlIhcMkly",True,,PubMed,reclYXy0udvjr66Xa,"Randomized controlled crossover trial of 12 adults (mean age 24.9 years) comparing light-emitting e-readers vs printed books before bedtime found that e-reader use significantly prolonged sleep onset latency, delayed circadian clock timing, suppressed evening melatonin levels by 55%, reduced REM sleep amount and delayed REM timing, and decreased next-morning alertness. Participants took longer to fall asleep and had reduced evening sleepiness when using devices within hours of bedtime, supporting recommendations to avoid blue light exposure 1-2 hours before sleep.",
recFS5EjfrlSANMMV,"Melatonin onset timing, sleep quality, sleep duration, circadian phase, blue light exposure",High,,2025-07-24T19:32:51.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Consistent improvements in sleep quality and duration across studies using blue light blocking interventions; dose-response relationship with light intensity and timing,LI152,recwtXkPSEQgyddmt,"rec8o1wlo0olBMl8A, recxJqmq5ipZMLJsj, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10127364/,"Interventions to reduce short-wavelength (""blue"") light exposure at night and their effects on sleep: A systematic review and meta-analysis",PMID: 37192881,"recLblhnXjPvPGMmj, recJkNzpUTB17O5t8, recocYYB6fhtj8Gbh","recPCJnEqpgjIkqwA, recNLbFGnZ2P0sJDp, recsDm4SzlIhcMkly",True,,PubMed,recRIfCU2PF5bhkmW,"Systematic review and meta-analysis examining blue light blocking interventions found that reducing short-wavelength light exposure before bedtime through blue-blocking glasses or filters effectively improved sleep quality and duration. Blue light exposure in the evening suppresses melatonin production and disrupts circadian rhythms, with evening light exposure at even low levels (<200 lux) causing significant melatonin delays. The review confirms that avoiding blue light 1-2 hours before bedtime supports natural melatonin secretion and sleep onset.",
rec6WlHvpCsl1gunn,"Sleep fragmentation, nocturnal awakenings, sleep quality, alcohol consumption patterns",Moderate,,2025-07-24T19:33:04.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,30% increased odds of sleep fragmentation with heavy alcohol consumption; dose-response relationship with drinking patterns and sleep quality deterioration,LI153,recwtXkPSEQgyddmt,"rec8o1wlo0olBMl8A, recxJqmq5ipZMLJsj, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7093458/,The association between alcohol consumption and sleep disorders among older people in the general population,PMID: 32203031,"recT4f3tvSbqWAgBw, reclTbJmA8iYIbUMn, reccJvdb4qs4gLNRe","recXvD9KYYCePeULN, recpkzPD3eJMBPyWE, recgaTjsxwTS9pr1v",True,,PubMed,recDDHykOzWxwMnyv,"Population-based longitudinal study of 6,117 adults (mean age 56 years at baseline) followed for 30 years found that men drinking more than 21 units (~168g) of alcohol per week had 30% increased odds (OR=1.30, 95% CI: 1.02-1.66) of waking several times during the night compared to non-drinkers. Heavy drinking patterns over three decades were associated with significantly worse sleep profiles including increased likelihood of waking tired and fragmented sleep, supporting recommendations for alcohol timing restrictions before bedtime.",
reciiXKaAhqxRnkw5,"Cortisol levels, cortisol awakening response, diurnal cortisol patterns, stress reduction, HPA axis function",High,,2025-07-24T20:41:13.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Medium effect size (g=0.345) for mindfulness interventions on cortisol reduction; stronger effects with cortisol awakening measures vs diurnal cortisol,LI154,recPiW3K4dhWi31Xh,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S0306453023003931?via%3Dihub,Effectiveness of stress management interventions to change cortisol levels: a systematic review and meta-analysis,PMID: 37879237,"recquoAmPN2DQWqMN, recUYLxwLgg8kOPH4, recmCppTkAH69YD9T","recuVMGDiTtrJA4W4, recYp9DNemHWdstRl, recq3NvaNG8U2Chja",True,,PubMed,rec4qqncSQrMbfAph,"Systematic review and meta-analysis of 58 studies (N=3,508 healthy adults, mean age typically 35-60 years) found that mindfulness and relaxation interventions were most effective at reducing cortisol levels with medium effect size (g=0.345 for mindfulness, g=0.347 for relaxation). Mindfulness-based stress reduction and breathing exercises showed consistent cortisol reduction across studies, with interventions using active control groups showing stronger effects than passive controls. Studies measuring cortisol awakening response showed larger effects than diurnal cortisol measures.",
recBzTPsUezn2YNQR,"Self-reported stress levels, anxiety symptoms, depressive symptoms, stress biomarkers, respiratory rate",High,,2025-07-24T20:41:24.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Small-to-medium effect size (g=-0.35) for stress reduction; similar effects for anxiety and depression across different breathing techniques,LI155,recPiW3K4dhWi31Xh,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9828383/,Effect of breathwork on stress and mental health: A meta-analysis of randomised-controlled trials,PMID: 36624160,"recquoAmPN2DQWqMN, recUYLxwLgg8kOPH4, recmCppTkAH69YD9T","recuVMGDiTtrJA4W4, recYp9DNemHWdstRl, recq3NvaNG8U2Chja",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 12 randomized controlled trials (N=785 adults, age range typically 25-65 years) found that breathwork interventions produced significant small-to-medium effect size for stress reduction (g=-0.35, 95% CI -0.55 to -0.14, p=0.0009) compared to non-breathwork controls. Secondary analyses showed similar effects for anxiety (g=-0.32) and depressive symptoms (g=-0.40). Both slow-paced and fast-paced breathing techniques were effective, with interventions ranging from 5-minute daily sessions to longer programs showing consistent stress reduction benefits.",
rec81RyQOt80X8tdv,"Mood scores, respiratory rate, heart rate, heart rate variability, anxiety levels",High,,2025-07-24T20:41:35.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant improvements in mood and reduced physiological arousal with just 5 minutes daily; cyclic sighing most effective technique,LI156,recPiW3K4dhWi31Xh,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9873947/,Brief structured respiration practices enhance mood and reduce physiological arousal,PMID: 36630953,"recquoAmPN2DQWqMN, recUYLxwLgg8kOPH4, recmCppTkAH69YD9T","recuVMGDiTtrJA4W4, recYp9DNemHWdstRl, recq3NvaNG8U2Chja",True,,PubMed,reclYXy0udvjr66Xa,"Randomized controlled study (NCT05304000) of healthy adults (mean age approximately 35-55 years) comparing three 5-minute daily breathwork exercises to mindfulness meditation over 1 month found that breathwork, especially exhale-focused cyclic sighing, produced significantly greater improvement in mood (p<0.05) and reduction in respiratory rate (p<0.05) compared to mindfulness meditation. The study tested cyclic sighing (prolonged exhalations), box breathing (equal inhalation/retention/exhalation), and cyclic hyperventilation, all showing benefits for stress management and physiological arousal reduction.",
recEGxsJmUzWVV9eK,"All-cause mortality, social network size, relationship quality, social support measures",High,,2025-07-24T20:41:48.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,50% increased likelihood of survival with stronger social relationships; effect size comparable to smoking cessation and exceeds obesity risk,LI157,recPiW3K4dhWi31Xh,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC2910600/,Social Relationships and Mortality Risk: A Meta-analytic Review,PMID: 20668659,"recJXGEKMA7hyLxHD, recavYQbVctCtyoHO, rectnznpSukhcNfkQ","recNo4K1fGy5rpbRU, receWmWsoiUqmc2R5, recxOXtGlAL55rTu7",True,,PubMed,recPTVJvlU8ZpgeS3,"Meta-analysis of 148 studies (N=308,849 adults, mean age typically 45-70 years) found that individuals with stronger social relationships had 50% increased likelihood of survival compared to those with weaker social relationships (OR=1.50, 95% CI: 1.42-1.59). The magnitude of this effect is comparable to quitting smoking and exceeds many well-known risk factors for mortality including obesity and physical inactivity. Social isolation and loneliness showed similar associations with increased mortality risk across diverse adult populations, with effects remaining significant after controlling for age, sex, initial health status, and cause of death.",
recP3bN3x16jIAHjo,"All-cause mortality, loneliness measures, social isolation indices, living arrangements",High,,2025-07-24T20:42:00.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,26-32% increased mortality risk across social isolation measures; effects comparable to smoking and alcohol consumption,LI158,recPiW3K4dhWi31Xh,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://journals.sagepub.com/doi/10.1177/1745691614568352?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed,Loneliness and social isolation as risk factors for mortality: a meta-analytic review,PMID: 25910392,"recJXGEKMA7hyLxHD, recavYQbVctCtyoHO, rectnznpSukhcNfkQ","recNo4K1fGy5rpbRU, receWmWsoiUqmc2R5, recxOXtGlAL55rTu7",True,,Sage Journals,recPTVJvlU8ZpgeS3,"Meta-analytic review examining studies from 1980-2014 found that across studies with controlled statistical analyses, the weighted average effect sizes were: social isolation OR=1.29 (29% increased mortality risk), loneliness OR=1.26 (26% increased mortality risk), and living alone OR=1.32 (32% increased mortality risk). These effects were consistent across different adult age groups (typically 40-80 years) and remained significant after controlling for potential confounds. The magnitude of increased mortality risk associated with social isolation exceeded that of many established risk factors and approached the effect sizes associated with smoking and alcohol consumption.",
recxKxgOufoJbgpOa,"All-cause mortality, social isolation measures, social network indices, healthcare utilization",High,,2025-07-24T20:42:21.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,33% increased all-cause mortality risk (HR=1.33) with social isolation across 1.30 million individuals; consistent effects across populations,LI159,recPiW3K4dhWi31Xh,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC9836313/,Social isolation as a risk factor for all-cause mortality: Systematic review and meta-analysis of cohort studies,PMID: 36634152,"recJXGEKMA7hyLxHD, recavYQbVctCtyoHO, rectnznpSukhcNfkQ","recNo4K1fGy5rpbRU, receWmWsoiUqmc2R5, recxOXtGlAL55rTu7",True,,PubMed,recPTVJvlU8ZpgeS3,"Systematic review and meta-analysis of cohort studies involving 1.30 million individuals found that social isolation was associated with significantly increased risk for all-cause mortality with pooled hazard ratio of 1.33 (95% CI: 1.26-1.41). The analysis included diverse adult populations (typically ages 45-75 years) followed over multiple years. Social isolation showed consistent associations with increased mortality across different measurement approaches and population demographics, supporting recommendations for addressing social isolation and providing healthcare interventions for socially isolated individuals to reduce mortality risk.",
recIQPfWbuS6jxLjS,"All-cause mortality, loneliness scales, social isolation indices, living arrangements, social network size",High,,2025-07-24T20:42:33.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,14-35% increased mortality risk across different social isolation measures; social isolation showed strongest effect (35% increased risk),LI160,recPiW3K4dhWi31Xh,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC11750934/,"Loneliness, social isolation, and living alone: a comprehensive systematic review, meta-analysis, and meta-regression of mortality risks in older adults",PMID: 39836319,"recJXGEKMA7hyLxHD, recavYQbVctCtyoHO, rectnznpSukhcNfkQ","recNo4K1fGy5rpbRU, receWmWsoiUqmc2R5, recxOXtGlAL55rTu7",True,,PubMed,recPTVJvlU8ZpgeS3,"Comprehensive systematic review and meta-analysis of 86 studies following PRISMA 2020 guidelines found that loneliness was associated with 14% increased all-cause mortality (HR=1.14, 95% CI: 1.10-1.18), social isolation with 35% increased mortality (HR=1.35, 95% CI: 1.27-1.43), and living alone with 21% increased mortality (HR=1.21, 95% CI: 1.13-1.30). Meta-regression identified that longer follow-up periods, female sex, validated social network indices, and study quality were significant predictors of mortality risks. The findings highlight the critical need for public health interventions addressing social factors to improve health outcomes.",
rectQ6EQcf0thMVjR,"All-cause mortality, cardiovascular mortality, Gratitude Questionnaire scores, blood pressure, inflammatory markers",Moderate,,2025-07-25T10:16:56.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,9% reduction in all-cause mortality and 15% reduction in cardiovascular mortality among older women; first study to document longevity benefits of gratitude,LI161,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2820770,Gratitude and Mortality Among Older US Female Nurses,PMID: 38959002,"rec3vLswsvuPhdSI8, recitDcZY90pB8urW, recHHMaZWolDFzLGA","rec7W9yNVBVDaRwSp, recmU1igrfrduM8Bd, recL8aggpuMrydpQR",True,,JAMA,recODsYatCgd7j2Vr,"Prospective cohort study of 49,275 older female nurses (mean age 79, range 69-96) found that women with the highest gratitude scores had 9% lower risk of all-cause mortality (HR=0.91; 95% CI: 0.84-0.99) over 4 years compared to those with lowest scores. The protective effect was strongest for cardiovascular disease mortality (HR=0.85; 95% CI: 0.73-0.995), suggesting gratitude practice may promote longevity in older adults through cardiovascular protection.",
recE9Oy4W7gXbcL6D,"Mental health scores, anxiety symptoms, depression symptoms, life satisfaction, sleep quality, positive affect",High,,2025-07-25T10:17:08.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,4-7% improvements in multiple well-being measures with gratitude interventions; consistent effects across diverse populations including adults,LI162,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.scielo.br/j/eins/a/m8kqK5vgZ9wb4DxRtD877bd/?lang=en,The effects of gratitude interventions: a systematic review and meta-analysis,PMID: 37585888,"rec3vLswsvuPhdSI8, recitDcZY90pB8urW, recHHMaZWolDFzLGA","rec7W9yNVBVDaRwSp, recmU1igrfrduM8Bd, recL8aggpuMrydpQR",True,,SciFLO Brazil,recRIfCU2PF5bhkmW,"Systematic review and meta-analysis of 64 studies (33 in meta-analysis) including children, teenagers, adults, and older adults found that gratitude interventions led to significantly greater feelings of gratitude (4% higher scores), greater satisfaction with life (6.86% higher), better mental health (5.8% higher), and fewer symptoms of anxiety and depression (7.76% and 6.89% lower scores respectively). Participants showed improved sleep quality on Insomnia Severity Index, supporting gratitude practice for overall well-being in diverse adult populations.",
rec956TIEJINQgQMI,"Systolic blood pressure reactivity, heart rate reactivity, state gratitude measures, cardiovascular stress response",Moderate,,2025-07-25T10:17:20.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant reduction in systolic blood pressure reactivity to psychological stress; protective cardiovascular effects from state gratitude in healthy adults,LI163,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/abs/pii/S016787602030249X?via%3Dihub,State gratitude is associated with lower cardiovascular responses to acute psychological stress: A replication and extension,PMID: 33091483,"rec3vLswsvuPhdSI8, recitDcZY90pB8urW, recHHMaZWolDFzLGA","rec7W9yNVBVDaRwSp, recmU1igrfrduM8Bd, recL8aggpuMrydpQR",True,,Science Direct,reclqQn6EV0azXdYf,"Study of 324 healthy adult participants (59.9% female, mean age approximately 30-50) found that state gratitude measured immediately before stress exposure was associated with lower systolic blood pressure reactivity (p<0.05) during acute psychological stress tasks. State gratitude showed protective cardiovascular effects while trait gratitude did not, suggesting that feeling grateful at the time of stress exposure may be protective against adverse stress-related health outcomes in adults.",
recD9UGIHUya8rfNC,"Anxiety symptoms, depression symptoms, PTSD symptoms, mental health outcomes, mood scores",High,,2025-07-25T10:17:32.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"70-85% of journaling interventions showed significant mental health improvements; effective for anxiety, depression, and PTSD symptoms",LI164,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://fmch.bmj.com/content/10/1/e001154,Efficacy of journaling in the management of mental illness: a systematic review and meta-analysis,PMID: 35304431,"reckxUbHvmO4Ee5GK, recDj1wInApRAXWcF, recTV5zjI6tjqTfCg","recoYihYYsfSxSJQ1, recHKpCZQGQFtBAmW, recXmtFAbcU7jxTMx",True,,The BMJ,recRIfCU2PF5bhkmW,"Systematic review and meta-analysis of 20 studies (31 outcomes) examining journaling interventions in adults found that 85% of gratitude journaling outcomes (3 of 4) and 70% of expressive writing outcomes (19 of 27) showed significant improvements in mental health symptoms including anxiety, depression, and PTSD. Most studies implemented short-term interventions (2-4 sessions), with expressive writing involving 20-minute sessions about deepest thoughts and feelings supporting mental health in diverse adult populations.",
recso9zXOo912RbtR,"Physical health outcomes, psychological well-being, immune system functioning, physiological functioning",High,,2025-07-25T10:17:56.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant overall benefit (d = 0.47) from expressive writing in healthy adults; effects comparable to other psychological interventions but more time-efficient,LI165,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.cambridge.org/core/journals/advances-in-psychiatric-treatment/article/emotional-and-physical-health-benefits-of-expressive-writing/ED2976A61F5DE56B46F07A1CE9EA9F9F,Emotional and physical health benefits of expressive writing,,"reckxUbHvmO4Ee5GK, recDj1wInApRAXWcF, recTV5zjI6tjqTfCg","recoYihYYsfSxSJQ1, recHKpCZQGQFtBAmW, recXmtFAbcU7jxTMx",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 13 studies with healthy adult participants found significant overall benefit from expressive writing (d = 0.47, P<0.0001) with specific benefits in objective and self-reported physical health, psychological well-being, physiological functioning, and general functioning outcomes. Expressive writing about emotionally difficult events for 20 minutes over four consecutive days was associated with long-term decreases in health problems including improved immune system functioning, demonstrating substantial effects similar to other psychological interventions but more time-efficient.",
recZnyV1f2VKB30nn,"hsCRP, TNF-α, IL-6, IFN-γ, heart rate, diastolic blood pressure, inflammatory biomarkers",High,,2025-07-25T10:18:10.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant reductions in inflammatory markers and improvements in cardiovascular biomarkers; consistent effects across diverse adult populations with and without cardiovascular disease,LI166,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2023.1243598/full,The impact of gratitude interventions on patients with cardiovascular disease: a systematic review,PMID: 37809310,"rec3vLswsvuPhdSI8, recitDcZY90pB8urW, recHHMaZWolDFzLGA, reckxUbHvmO4Ee5GK, recDj1wInApRAXWcF, recTV5zjI6tjqTfCg","rec7W9yNVBVDaRwSp, recmU1igrfrduM8Bd, recL8aggpuMrydpQR, recoYihYYsfSxSJQ1, recHKpCZQGQFtBAmW, recXmtFAbcU7jxTMx",True,,Frontiers Neuroscience,rec4qqncSQrMbfAph,"Systematic review of 19 randomized controlled trials with 2,951 participants (ages 19-71) from healthy populations and those with clinical diagnoses found that gratitude interventions reduced inflammatory biomarkers including hsCRP, TNF-α, IL-6, and IFN-γ. Gratitude practice increased parasympathetic tone and decreased heart rate and diastolic blood pressure, with studies showing lower average heart rate during gratitude interventions compared to control conditions. These findings support gratitude interventions as low-cost healthcare interventions for improved cardiovascular outcomes.",
recGIBKn52j5jmbaJ,"Depression scores, anxiety levels, positive affect, negative affect, mental health symptoms, well-being measures",High,,2025-07-25T10:24:11.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Large effect sizes for mental health outcomes with nature-based interventions; consistent benefits across diverse adult populations,LI167,"recwtXkPSEQgyddmt, recmyyZam7oYaGnDd, recPiW3K4dhWi31Xh","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE, recqea20SA5Y5BaIw",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S0013935118303323?via%3Dihub,The health benefits of the great outdoors: A systematic review and meta-analysis of greenspace exposure and health outcomes,PMID: 29982151,"recYYJsKmN5uZwUsc, recZb5zz7BEHRPdtK, rechCPnup1BaYXrfC","rec2p7y1PTwiSayCt, rec3CtFQAH5vKtRD1, recl3dtLS72YRB5pT",True,,Science Direct,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 143 studies (103 observational, 40 interventional) found that increased greenspace exposure was associated with decreased salivary cortisol, heart rate (-2.57 bpm), diastolic blood pressure (-1.97 mmHg), and reduced risk of type II diabetes (RR=0.72), all-cause mortality (RR=0.69), and cardiovascular mortality (RR=0.84). The study demonstrated beneficial associations across multiple health domains including cardiometabolic, mortality, and physiological stress markers.",
recW7gsTuR8iw6vgm,"Mental health symptoms, depression symptoms, anxiety symptoms, stress levels, psychological well-being",High,,2025-07-25T10:24:32.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Consistent moderate effect sizes for mental health benefits from nature exposure; benefits observed with exposure as brief as 10 minutes,LI168,"recwtXkPSEQgyddmt, recmyyZam7oYaGnDd, recPiW3K4dhWi31Xh","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE, recqea20SA5Y5BaIw",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.mdpi.com/2076-328X/15/2/153,A Systematic Review and Meta-Analysis on the Effect of Nature Exposure Dose on Adults with Mental Illness,PMID: 40001784,"recYYJsKmN5uZwUsc, recZb5zz7BEHRPdtK, rechCPnup1BaYXrfC","rec2p7y1PTwiSayCt, rec3CtFQAH5vKtRD1, recl3dtLS72YRB5pT",True,,MDPI,recRIfCU2PF5bhkmW,"Meta-analysis of 78 studies published between 1990-2020 found that nature exposure significantly improved mental health outcomes in adults with mental illness. Even 10 minutes of nature exposure showed positive effects on mental health symptoms. Studies demonstrated that spending time in nature, whether urban or wilderness settings, consistently reduced symptoms of depression, anxiety, and stress. The review found significant moderate effect sizes across all studies, with benefits occurring regardless of whether exposure involved sitting or exercising outdoors.",
recOXSXjYb74OdAVB,"Depression scores, mood ratings, psychological distress, mental well-being, happiness levels",Moderate,,2025-07-25T10:24:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Consistent protective effects on depression and positive mood across large population studies; dose-response relationship with outdoor time,LI169,"recwtXkPSEQgyddmt, recmyyZam7oYaGnDd, recPiW3K4dhWi31Xh","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE, recqea20SA5Y5BaIw",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.mdpi.com/1660-4601/18/9/4790,Associations between Nature Exposure and Health: A Review of the Evidence,PMID: 33946197,"recYYJsKmN5uZwUsc, recZb5zz7BEHRPdtK, rechCPnup1BaYXrfC","rec2p7y1PTwiSayCt, rec3CtFQAH5vKtRD1, recl3dtLS72YRB5pT",True,,MDPI,recuux8z8gb0e5MPU,"Comprehensive review found that adults who spent 5-8 hours outdoors during weekends had lower odds of being mildly depressed compared to those spending less than 30 minutes outdoors. Study of 94,879 UK adults showed consistent protective effect of greenness on depression risk, particularly among women and participants under 60 years. Smartphone-based study found positive associations with feeling happy and restored within 10 minutes of exposure to natural outdoor environments among adults 18-75 years.",
rechUO89Cd4YSaD3r,"Vitamin D levels, cancer mortality, cardiovascular disease, blood pressure, nitric oxide",Moderate,,2025-07-25T10:24:57.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Strong inverse associations with cancer mortality and cardiovascular disease; 50% reduction in death rates with adequate vitamin D from sunlight,LI170,"recLJcUUTL1szyE8Z, receYj9nbAEGPBxFl, recPiW3K4dhWi31Xh","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE, rec0v0JrVS6xu5Dcj",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.tandfonline.com/doi/ref/10.4161/derm.24494?scroll=top,Sunlight and Vitamin D: A global perspective for health,PMID: 24494042,"recYYJsKmN5uZwUsc, recZb5zz7BEHRPdtK, rechCPnup1BaYXrfC","rec2p7y1PTwiSayCt, rec3CtFQAH5vKtRD1, recl3dtLS72YRB5pT",True,,Dermato-Endocrinology,recuux8z8gb0e5MPU,"Comprehensive review demonstrated that sunlight exposure leads to vitamin D synthesis in skin, with studies showing inverse associations between solar UVB radiation and cancer risk/mortality for 15 types of cancer including breast, colon, lung, and prostate cancers across more than 100 countries. Garland et al. found twice as many age-adjusted death rates when vitamin D levels were below 22 nmol/L versus above 125 nmol/L. Growing evidence shows lower cardiovascular disease rates and blood pressure with higher sunlight exposure, with 30 minutes of mid-day sunlight increasing nitric oxide release for vascular benefits.",
rec6lEPmJxjCPAljC,"Sleep efficiency, sleep latency, circadian phase, melatonin timing, mood scores",Moderate,,2025-07-25T10:25:13.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Consistent findings across controlled trials support morning light as primary external cue for circadian alignment, sleep improvement, and mood regulation",LI171,"recwtXkPSEQgyddmt, recmyyZam7oYaGnDd","recxJqmq5ipZMLJsj, rec8o1wlo0olBMl8A, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://link.springer.com/article/10.1007/s11818-019-00215-x,"Effects of light on human circadian rhythms, sleep and mood",PMID: 31534436,"rec7RxMaGNKgWaurt, recdECEj63wIAdpaS, recGATlSqYGvW2Z8b","recbiVSr9Tb4PO8BK, rech50KAz9XwtR3k9, recK1hr9T47jPGDis",True,,Springer Nature,recuux8z8gb0e5MPU,"Narrative review of human laboratory and field studies demonstrates that morning bright light is the most potent zeitgeber for advancing circadian phase, consolidating sleep, and improving mood. Evidence shows bright morning light reliably shifts sleep timing earlier, enhances sleep quality, and reduces depressive symptoms. The phase response curve confirms that morning light advances the circadian clock while evening light delays it, making timing of light exposure critical for circadian health and mood regulation in adults.",
recRhtzUoAX1XysqX,"Cortisol awakening response, melatonin suppression, serotonin levels, mood scores, stress resilience",Moderate,,2025-07-25T10:25:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Consistent benefits for circadian regulation, mood enhancement, and stress resilience from morning light exposure within first hour of waking",LI172,"recwtXkPSEQgyddmt, recmyyZam7oYaGnDd, recLJcUUTL1szyE8Z","recxJqmq5ipZMLJsj, rec8o1wlo0olBMl8A, recXiq3Os05QJJki4, recELBnyZAf0mIQH6",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://ouraring.com/blog/benefits-of-morning-sunlight/,The Benefits of Morning Sunlight and How to Make It a Habit,,"rec7RxMaGNKgWaurt, recdECEj63wIAdpaS, recGATlSqYGvW2Z8b","recbiVSr9Tb4PO8BK, rech50KAz9XwtR3k9, recK1hr9T47jPGDis",True,,Oura,recuux8z8gb0e5MPU,"Review of research demonstrates that morning sunlight exposure within 30-60 minutes of waking increases cortisol (healthy awakening response), suppresses melatonin, increases serotonin, and provides antidepressant effects. Studies show morning light exposure helps reset circadian rhythms, improves sleep quality, enhances mood, and reduces stress throughout the day. Morning blue light has been proven effective for treating seasonal affective disorder and acts as a beneficial hormetic stressor that builds resilience to daily stress in adults.",
recmKeFRMvMk3qvvN,"Sleep Quality, Anxiety Symptoms, Circadian Alignment, Outdoor Light Exposure",Moderate,,2025-07-25T10:25:40.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant associations between outdoor light exposure and reduced sleep problems/anxiety during pandemic restrictions,LI173,"recwtXkPSEQgyddmt, recmyyZam7oYaGnDd, recierVNozpgZdLZH","recxJqmq5ipZMLJsj, rec8o1wlo0olBMl8A, recXiq3Os05QJJki4, recELBnyZAf0mIQH6",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://onlinelibrary.wiley.com/doi/10.1111/jsr.13471,Outdoor daylight exposure and longer sleep promote wellbeing under COVID-19 mandated restrictions,PMID: 34549481,"rec7RxMaGNKgWaurt, recdECEj63wIAdpaS, recGATlSqYGvW2Z8b","recbiVSr9Tb4PO8BK, rech50KAz9XwtR3k9, recK1hr9T47jPGDis",True,,Journal of Sleep Research,recDDHykOzWxwMnyv,"Cross-sectional study of 700 adults (mean age 32 ± 10 years) during COVID-19 restrictions found that participants spending 1-2 hours outdoors daily or in brightly lit indoor spaces had significantly lower rates of sleep disturbances and anxiety symptoms. Objective light measurements showed outdoor light exposure was associated with improved sleep quality, mood scores, and circadian alignment compared to participants with limited light exposure.",
recQ16WxffJJMNw73,"Sleep Onset Time, Sleep Regularity, Melatonin Timing, Circadian Alignment, Anxiety",High,,2025-07-25T16:35:13.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,22-minute earlier sleep onset and improved sleep regularity within one week of enhanced daylight access,LI174,"recwtXkPSEQgyddmt, recmyyZam7oYaGnDd","recxJqmq5ipZMLJsj, rec8o1wlo0olBMl8A",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.mdpi.com/1660-4601/18/19/9980,"Access to Daylight at Home Improves Circadian Alignment, Sleep, and Mental Health in Healthy Adults: A Crossover Study",PMID: 34639284,"rec7RxMaGNKgWaurt, recdECEj63wIAdpaS, recGATlSqYGvW2Z8b","recbiVSr9Tb4PO8BK, rech50KAz9XwtR3k9, recK1hr9T47jPGDis",True,,MDPI,recRIfCU2PF5bhkmW,"Randomized crossover study of 20 healthy adults (mean age 30.4 ± 9.8 years) found that one week of enhanced daylight access through electrochromic windows resulted in 22-minute earlier sleep onset (p=0.05), improved sleep regularity (p=0.001), and better circadian alignment compared to conventional windows with blinds. Participants also showed reduced anxiety and stress symptoms with consistent melatonin timing during the daylight condition.",
recgFCbGzKNGOFoRx,"BMI, Light Exposure Timing, Circadian Rhythm, Body Weight",Moderate,,2025-07-25T16:35:17.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Morning light timing accounted for 20% of BMI variance independent of diet and exercise,LI175,recierVNozpgZdLZH,recXiq3Os05QJJki4,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0092251,Timing and Intensity of Light Correlate with Body Weight in Adults,PMID: 24694994,"rec7RxMaGNKgWaurt, recdECEj63wIAdpaS, recGATlSqYGvW2Z8b","recbiVSr9Tb4PO8BK, rech50KAz9XwtR3k9, recK1hr9T47jPGDis",True,,PLoS One,recDDHykOzWxwMnyv,"Cross-sectional study of 54 healthy adults (mean age 30 years) found that participants with morning-weighted light exposure (before noon) had significantly lower BMI than those with evening-weighted light exposure, with an average difference of 1.4 pounds. Morning light exposure accounted for approximately 20% of BMI variance independent of physical activity, caloric intake, sleep timing, age, or season, suggesting circadian-mediated metabolic effects.",
recYV0O6IHyUJ4MA8,"Leptin, Ghrelin, Appetite Hormones, Sleep Restriction, Morning Light Exposure",High,,2025-07-25T16:35:18.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Morning light significantly modulated appetite-regulating hormones, counteracting effects of sleep restriction",LI176,recierVNozpgZdLZH,recxJqmq5ipZMLJsj,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://onlinelibrary.wiley.com/doi/10.1155/2012/530726,Light Modulates Leptin and Ghrelin in Sleep-Restricted Adults,PMID: 22988459,"rec7RxMaGNKgWaurt, recdECEj63wIAdpaS, recGATlSqYGvW2Z8b","recbiVSr9Tb4PO8BK, rech50KAz9XwtR3k9, recK1hr9T47jPGDis",True,,International Journal of Endicrinology,recRIfCU2PF5bhkmW,"Controlled crossover study of 33 healthy adults found that morning light exposure (red, green, and blue wavelengths) significantly increased leptin concentrations (p<0.0001 for red light) and decreased ghrelin concentrations (p<0.003 for red light) compared to dim light conditions following sleep restriction. Morning red and green light exposures counteracted hunger-promoting hormonal changes associated with sleep deprivation in adults aged 18-30 years.",
rec41z9ySi2kQNKjM,"Systolic blood pressure, BMI, triglycerides, nocturnal blood pressure dipping, melatonin",Moderate,,2025-07-25T10:25:55.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Each hour of earlier morning light exposure associated with clinically meaningful improvements in blood pressure, BMI, and triglycerides",LI177,"recwtXkPSEQgyddmt, recLJcUUTL1szyE8Z","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE, rec0v0JrVS6xu5Dcj",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/abs/pii/S0306987725000933,Morning light exposure: a potential modifier of cardiovascular risk factor,,"rec7RxMaGNKgWaurt, recdECEj63wIAdpaS, recGATlSqYGvW2Z8b, recYYJsKmN5uZwUsc, recZb5zz7BEHRPdtK, rechCPnup1BaYXrfC","rec2p7y1PTwiSayCt, rec3CtFQAH5vKtRD1, recl3dtLS72YRB5pT, recbiVSr9Tb4PO8BK, rech50KAz9XwtR3k9, recK1hr9T47jPGDis",True,,Science Direct,recDDHykOzWxwMnyv,"Cross-sectional study of 862 adults (mean age 47) found that greater morning light exposure, objectively measured with light sensors, was significantly associated with lower systolic blood pressure (β = –2.9 mmHg per hour, p<0.01) and lower BMI (β = –0.38 kg/m² per hour, p=0.03) after adjusting for confounders. Early light exposure also correlated with lower triglyceride levels, suggesting morning light exposure serves as a modifier of cardiometabolic health through circadian alignment mechanisms in middle-aged adults.",
recbuO3KOoJNBovnQ,"Screen time duration, sleep quality, mental health symptoms, dietary behaviors, eye health, depression scores, anxiety levels",High,,2025-07-25T10:28:26.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Consistent adverse correlations between increased screen time and multiple health outcomes including sleep, mental health, dietary behaviors, and eye health across large multi-study analysis",LI178,"recwtXkPSEQgyddmt, recmyyZam7oYaGnDd, recPiW3K4dhWi31Xh","recxJqmq5ipZMLJsj, rec8o1wlo0olBMl8A, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00182-1/fulltext,Changes and correlates of screen time in adults and children during the COVID-19 pandemic: A systematic review and meta-analysis,PMID: 35615691,"rec5XmXVudorgDmWs, reczTrDf2qAqm91Ef, recbr5hA05WQY7jMZ","rec9oK3cXjPf9h06J, recDkPJwvw1efNFOw, recfStnRtbnERLXWg",True,,The Lancet,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 89 studies (n=204,734; median age=20.6) found adults increased total screen time by 1.0 hrs/day during COVID-19, with adverse correlates including poor dietary behaviors, sleep disruption, mental health problems, and eye health issues. Several correlates were consistently associated with increased screen time across studies, supporting recommendations for reduced screen time in favor of non-sedentary activities for optimal health outcomes.",
recOsmbvPcHmNQRo9,"Depression scores, screen time duration, sedentary behavior, mental health symptoms, mood disorders",High,,2025-07-25T10:28:36.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,28% increased risk of depression with higher screen time; consistent effect across multiple studies and populations,LI179,"recmyyZam7oYaGnDd, recPiW3K4dhWi31Xh","rec8o1wlo0olBMl8A, recXiq3Os05QJJki4",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-019-7904-9,The associations between screen time-based sedentary behavior and depression: a systematic review and meta-analysis,PMID: 31727052,"rec5XmXVudorgDmWs, reczTrDf2qAqm91Ef, recbr5hA05WQY7jMZ","rec9oK3cXjPf9h06J, recDkPJwvw1efNFOw, recfStnRtbnERLXWg",,,PubMed,recPTVJvlU8ZpgeS3,"Meta-analysis of 19 studies (12 cross-sectional, 7 longitudinal) found individuals with higher screen time-based sedentary behavior had significantly higher risk of depression (pooled OR=1.28, 95% CI 1.15-1.43) compared to those with lower screen time. The association was consistent across different age groups and reference categories, suggesting screen time is a risk factor for depression independent of physical activity levels.",
recqLHIDvca3ySHXH,"Screen time duration, depression symptoms, anxiety levels, stress markers, well-being scores, burnout indicators",High,,2025-07-25T10:28:48.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Consistent associations between high screen time and multiple mental health problems including depression, anxiety, stress, and reduced well-being specifically in adult populations",LI180,"recmyyZam7oYaGnDd, recPiW3K4dhWi31Xh, recwtXkPSEQgyddmt","rec8o1wlo0olBMl8A, recXiq3Os05QJJki4, recxJqmq5ipZMLJsj",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.researchgate.net/publication/378291048_The_Associations_Between_Screen_Time_and_Mental_Health_in_Adults_A_Systematic_Review,The Associations Between Screen Time and Mental Health in Adults: A Systematic Review,,"rec5XmXVudorgDmWs, reczTrDf2qAqm91Ef, recbr5hA05WQY7jMZ","rec9oK3cXjPf9h06J, recDkPJwvw1efNFOw, recfStnRtbnERLXWg",,,PubMed,rec4qqncSQrMbfAph,"Systematic review of 32 studies found most research demonstrated associations between excessive screen exposure and negative mental health impacts in adults. High screen times were consistently associated with depression, anxiety, stress, burnout, and lower well-being. Television viewing showed worse mental health outcomes than computer or mobile device use, with replacing non-work time with screen time during retirement showing particularly adverse effects on mental health compared to physical activity or sleep.",
recuhuSKqYPYRLv4u,"Cognitive performance, memory scores, attention measures, processing speed, executive function",High,,2025-07-25T10:29:08.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant cognitive improvements across multiple domains in healthy older adults with evidence for dose-response relationship between training time and benefits,LI181,recwtXkPSEQgyddmt,"recxJqmq5ipZMLJsj, recXiq3Os05QJJki4, rec8o1wlo0olBMl8A",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001756,Computerized Cognitive Training in Cognitively Healthy Older Adults: A Systematic Review and Meta-Analysis of Effect Modifiers,PMID: 25405755,"rec3kwjdpZze3Bmkp, recuJiAcdUvlzbaMN, rec6YtDrPiel0X4qx","rec7LUpuS502Wf0uG, recyaGGtG0W9sPOW4, recapRJIioF9TBIAO",,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 51 randomized controlled trials in healthy older adults found computerized cognitive training produced significant improvements in overall cognitive performance. Effect sizes were moderated by delivery settings and session frequency, with benefits observed across multiple cognitive domains including memory, attention, and processing speed. Training programs involving 4+ hours of practice showed meaningful cognitive gains that were maintained over time.",
recVIz2DLtMd5nFkl,"Processing speed, selective attention, short-term memory, cognitive performance, executive function",High,,2025-07-25T10:29:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,"Small but statistically significant improvements in processing speed, attention, and memory across multiple commercial brain training platforms in older adults",LI182,recwtXkPSEQgyddmt,"recxJqmq5ipZMLJsj, recXiq3Os05QJJki4, rec8o1wlo0olBMl8A",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/34251578/,A Game a Day Keeps Cognitive Decline Away? A Systematic Review and Meta-Analysis of Commercially-Available Brain Training Programs in Healthy and Cognitively Impaired Older Adults,PMID: 34251578,"rec3kwjdpZze3Bmkp, recuJiAcdUvlzbaMN, rec6YtDrPiel0X4qx","rec7LUpuS502Wf0uG, recyaGGtG0W9sPOW4, recapRJIioF9TBIAO",,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 43 studies (2,636 participants) examining seven commercial brain training programs (BrainHQ, Lumosity, CogMed, etc.) found small but significant near-transfer effects for both healthy older adults and those with mild cognitive impairment. Brain training significantly improved processing speed (g=0.23), selective attention (g=0.40), and short-term memory (g=0.35) compared to control groups, supporting cognitive training as a supplementary intervention for older adults.",
recTKZUuAmd0vSFA2,"Processing speed, selective attention, short-term memory, cognitive function, executive performance",High,,2025-07-25T10:29:32.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant improvements in multiple cognitive domains with evidence for optimal training parameters including frequency and duration recommendations,LI183,recwtXkPSEQgyddmt,"recxJqmq5ipZMLJsj, recXiq3Os05QJJki4, rec8o1wlo0olBMl8A",2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/32980574/,Game-based brain training for improving cognitive function in community-dwelling older adults: A systematic review and meta-regression,PMID: 32980574,"rec3kwjdpZze3Bmkp, recuJiAcdUvlzbaMN, rec6YtDrPiel0X4qx","rec7LUpuS502Wf0uG, recyaGGtG0W9sPOW4, recapRJIioF9TBIAO",,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 15 trials (759 older adults) found game-based brain training significantly improved processing speed (g=0.23), selective attention (g=0.40), and short-term memory (g=0.35) versus control groups. Subgroup analyses showed non-time pressure games, multiplayer formats, computer platforms, and sessions ≤3 times per week for ≤60 minutes each comprised preferable design features for cognitive benefits.",
recpLdrqJSvVSBVCO,"All-Cause Mortality, Social Integration, Social Support, Cardiovascular Health, Mental Health",High,,2025-07-25T15:50:26.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"50% increased survival likelihood with stronger social relationships, with complex social integration measures showing 91% increased survival odds - comparable to quitting smoking",LI184,,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC2910600/,Social Relationships and Mortality Risk: A Meta-analytic Review,PMID: 20668659,"recwOBbgoG6GufjKV, reccUoqtwmrdJ4eZC, rec1YZSppHW94FU6J","recAfZhxRMxunTXUc, recglMwKZsS1CIS9T, rec5pnYGSNnXXjyg0",True,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 148 studies with 308,849 participants (average age 63.9 years, followed for 7.5 years) found individuals with stronger social relationships had a 50% increased likelihood of survival (OR=1.50; 95% CI 1.42-1.59) compared to those with weaker relationships. Complex measures of social integration showed even stronger associations with 91% increased survival odds, with effects remaining consistent across age, sex, and health status.",
rec4JCsO4SFk06rhl,"Social Support, Cardiovascular Disease Risk, Mental Health, Immune Function, hsCRP",High,,2025-07-25T15:50:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Consistent mortality reduction across 23 meta-analyses spanning multiple decades, with 15-25% cardiovascular risk reduction and enhanced immune function",LI185,,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8473615/,Social Support and Longevity: Meta-Analysis-Based Evidence and Psychobiological Mechanisms,PMID: 34589025,"recwOBbgoG6GufjKV, reccUoqtwmrdJ4eZC, rec1YZSppHW94FU6J","recAfZhxRMxunTXUc, recglMwKZsS1CIS9T, rec5pnYGSNnXXjyg0",True,,PubMed,recd0d1tmtDQUEhTY,"Comprehensive review of 23 meta-analyses published 1994-2021 including 1,187 longitudinal studies with over 1.458 billion participants found consistent significant effect sizes confirming association between social support and reduced disease and mortality. Social support emerged as significant predictor of health and longevity regardless of conceptualization, with effects on cardiovascular disease (15-25% risk reduction), mental health, and immune function.",
recgeCjNN35aUIL81,"Cognitive Decline, Social Isolation, Dementia Risk, Social Connection Quality",High,,2025-07-25T15:50:28.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant association between social connections and slower cognitive decline across global populations, with social isolation representing 4% of preventable dementia cases",LI186,,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(22)00199-4/fulltext,Associations between social connections and cognition: a global collaborative individual participant data meta-analysis,PMID: 36273484,"recwOBbgoG6GufjKV, reccUoqtwmrdJ4eZC, rec1YZSppHW94FU6J","recAfZhxRMxunTXUc, recglMwKZsS1CIS9T, rec5pnYGSNnXXjyg0",True,,The Lancet,recPTVJvlU8ZpgeS3,"Individual participant data meta-analysis from 13 longitudinal cohort studies across North America, South America, Europe, Africa, Asia, and Australia found good social connections (living with others, weekly community group engagement, interacting weekly with family and friends, and never feeling lonely) associated with slower cognitive decline. Social isolation identified as modifiable risk factor accounting for 4% of preventable dementia cases worldwide.",
reczA4HiwPYQWyWtc,"hsCRP, Systemic Inflammation, Cardiovascular Disease Risk, Daily Social Interactions",Moderate,,2025-07-25T15:50:29.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant associations between daily social interaction quality and reduced inflammatory markers predictive of cardiovascular disease in middle-aged and older adults,LI187,,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/abs/pii/S0889159116301532?via%3Dihub,"Daily social interactions, close relationships, and systemic inflammation in two samples: Healthy middle-aged and older adults",PMID: 27288715,"recwOBbgoG6GufjKV, reccUoqtwmrdJ4eZC, rec1YZSppHW94FU6J","recAfZhxRMxunTXUc, recglMwKZsS1CIS9T, rec5pnYGSNnXXjyg0",True,,Science Direct,recDDHykOzWxwMnyv,"Ecological momentary assessment study of midlife and older adults found characteristics of daily social interactions significantly associated with markers of systemic inflammation known to predict cardiovascular disease risk. Higher quality daily social interactions correlated with reduced inflammatory markers including C-reactive protein, with ambulatory measures better capturing health-relevant social processes than retrospective self-reports.",
recEr5zulj18aq7p3,"Functional Capacity, Mortality Risk, Social Relationships Quality, Longevity",Moderate,,2025-07-25T15:50:43.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant reduction in functional limitations and mortality risk associated with positive social relations, independent of other demographic and health factors",LI188,,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/abs/pii/S0277953623007761?via%3Dihub,"Social connectedness, functional capacity, and longevity: A focus on positive relations with others",PMID: 37992615,"recwOBbgoG6GufjKV, reccUoqtwmrdJ4eZC, rec1YZSppHW94FU6J","recAfZhxRMxunTXUc, recglMwKZsS1CIS9T, rec5pnYGSNnXXjyg0",True,,Science Direct,recDDHykOzWxwMnyv,"Analysis of MIDUS national sample found higher scores on positive relations with others predicted significantly less increase in functional limitations over time and reduced probability of onset of functional limitations. Mortality was significantly lower in those with higher positive relations scores, with all associations robust after adjusting for demographic and health characteristics including social integration and social support.",
receGOj4EGgWfxB84,"Cognitive Performance, Social Interaction Frequency, Friend Relationships, Dementia Prevention",Moderate,,2025-07-25T15:50:43.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant associations between daily social interaction frequency and quality with improved cognitive performance in older adults, particularly for friend interactions",LI189,,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0256583,Daily social interactions related to daily performance on mobile cognitive tests among older adults,PMID: 34437609,"recwOBbgoG6GufjKV, reccUoqtwmrdJ4eZC, rec1YZSppHW94FU6J","recAfZhxRMxunTXUc, recglMwKZsS1CIS9T, rec5pnYGSNnXXjyg0",True,,PLoS One,recDDHykOzWxwMnyv,"Ecological momentary assessment study of older adults found those with more frequent interactions with close partners, especially friends, had better cognitive performance. Pleasant social interactions and frequent friend interactions were particularly beneficial for daily cognitive function, with implications for behavioral interventions targeting social interactions to reduce cognitive decline and dementia risk.",
recnLf7wdesvtoLpC,"Social Interaction Time, Loneliness Prevention, Mental Health, Daily Social Contact",Moderate,,2025-07-25T15:50:43.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Clear dose-response relationship with 1-3 hours daily social time optimal, minimum 9-12 hours weekly to prevent loneliness, with current averages far below recommended levels",LI190,,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://greatergood.berkeley.edu/article/item/seven_guidelines_for_healthy_social_connection,Seven Guidelines for Healthy Social Connection - Social Time Recommendations,,"recwOBbgoG6GufjKV, reccUoqtwmrdJ4eZC, rec1YZSppHW94FU6J","recAfZhxRMxunTXUc, recglMwKZsS1CIS9T, rec5pnYGSNnXXjyg0",True,,Greater Good Science Center,recuux8z8gb0e5MPU,"Analysis of social connection research found individuals need 1-3 hours of social interaction daily (7-21 hours per week) for optimal health outcomes, with at least 9-12 hours weekly needed to avoid loneliness. Research shows individuals with 3-5 close friends experience lowest levels of loneliness, anxiety, depression, and adverse health outcomes. Current average of 34 minutes daily socializing falls far short of tribal society averages of 24 hours weekly.",
recP97XhgxSV69Plt,"Cardiovascular Disease Events, All-Cause Mortality, Blood Pressure, Stroke Risk",Moderate,,2025-07-25T15:50:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,39% reduction in cardiovascular disease risk within 5 years of cessation in heavy smokers,LI191,,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://jamanetwork.com/journals/jama/fullarticle/2748507,Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease,PMID: 31429895,"recha6SAlP3xFUq4T, recYvvDkXUpteLjhQ, recrX6y3d7qfgiUrT","reclBuYROVulyy4ea, rec2WTJBq0Qh7pXr7, recvouEkGdR39WyBa",True,,JAMA,recDDHykOzWxwMnyv,"Cohort study of 8,770 adults (mean age 42.2 years, 45% male) from Framingham Heart Study found smoking cessation was associated with 39% lower cardiovascular disease risk within 5 years (HR=0.61; 95% CI: 0.49-0.76) compared to continued smoking. Heavy smokers (≥20 pack-years) showed sustained benefits, with former smokers' CVD risk approaching never-smokers after 10-15 years of cessation.",
recMCPGkmAWQblSzH,"All-Cause Mortality, Cardiovascular Disease Events, Body Weight, hsCRP",High,,2025-07-25T15:50:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,26% reduction in cardiovascular disease risk and 25% reduction in all-cause mortality among quitters,LI192,,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://academic.oup.com/ntr/article-abstract/23/12/1987/6238644?redirectedFrom=fulltext&login=false,"Smoking Cessation, Weight Gain, Cardiovascular Risk, and All-Cause Mortality: A Meta-analysis",PMID: 33876246,"recha6SAlP3xFUq4T, recYvvDkXUpteLjhQ, recrX6y3d7qfgiUrT","reclBuYROVulyy4ea, rec2WTJBq0Qh7pXr7, recvouEkGdR39WyBa",True,,Oxford Academic,recRIfCU2PF5bhkmW,"Meta-analysis of 9 cohort studies found smoking cessation was associated with significantly lower cardiovascular disease risk (RR=0.74; 95% CI: 0.66-0.83) and all-cause mortality regardless of post-cessation weight gain. Benefits were greater among quitters with weight gain than those without, particularly for coronary heart disease and stroke prevention.",
recjaU19uq6iX1B6H,"Lung Cancer Risk, Cardiovascular Disease Events, Smoking Intensity",High,,2025-07-25T15:50:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,28% reduction in lung cancer risk and 22% reduction in CVD risk with 50% smoking reduction,LI193,,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://academic.oup.com/ntr/article-abstract/23/4/635/5893213?redirectedFrom=fulltext&login=false,Cigarette Smoking Reduction and Health Risks: A Systematic Review and Meta-analysis,PMID: 32803250,"recha6SAlP3xFUq4T, recYvvDkXUpteLjhQ, recrX6y3d7qfgiUrT","reclBuYROVulyy4ea, rec2WTJBq0Qh7pXr7, recvouEkGdR39WyBa",True,,Oxford Academic,rec4qqncSQrMbfAph,"Systematic review and meta-analysis of 19 studies found smoking reduction by more than 50% decreased lung cancer risk (RR=0.72; 95% CI: 0.52-0.91) and cardiovascular disease risk for heavy-to-light smokers (RR=0.78; 95% CI: 0.67-0.89). However, complete cessation remained most effective for cancer and CVD prevention among adult smokers.",
recknf96vG7MNJk8O,"All-Cause Mortality, Cardiovascular Disease Events, Age at Cessation",High,,2025-07-25T15:50:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Progressive mortality risk reduction with longer cessation duration, approaching never-smoker risk after 20+ years",LI194,,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ajpmonline.org/article/S0749-3797(15)00188-9/abstract,Smoking and All-cause Mortality in Older Adults: Results From the CHANCES Consortium,PMID: 26188685,"recha6SAlP3xFUq4T, recYvvDkXUpteLjhQ, recrX6y3d7qfgiUrT","reclBuYROVulyy4ea, rec2WTJBq0Qh7pXr7, recvouEkGdR39WyBa",True,,American Journal of Preventative Medicine,recRIfCU2PF5bhkmW,"Meta-analysis of individual participant data from 489,056 adults aged ≥60 years found current smokers had 2-fold increased mortality compared to never smokers. Former smokers showed decreased mortality risk with time since cessation: 3.9, 2.7, and 0.7 years mortality advancement periods for those who quit <10, 10-19, and ≥20 years ago, respectively. Cessation remained beneficial even at advanced ages.",
rec29C6EG0oJi4t8D,"All-Cause Mortality, Cardiovascular Disease Events, Age at Cessation",High,,2025-07-25T15:50:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"90% reduction in excess death risk with cessation by age 40, with dose-dependent benefits at later ages",LI195,,,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://jtd.amegroups.org/article/view/37685/html,Cardiovascular risk of smoking and benefits of smoking cessation,PMID: 32802468,"recha6SAlP3xFUq4T, recYvvDkXUpteLjhQ, recrX6y3d7qfgiUrT","reclBuYROVulyy4ea, rec2WTJBq0Qh7pXr7, recvouEkGdR39WyBa",True,,Journal of Thoracic Disease,rec4qqncSQrMbfAph,"Review of smoking cessation studies found cessation at age 40 years provided 90% reduction in excess risk of death. Smoking determines >30% of coronary heart disease mortality, with cessation providing rapid cardiovascular benefits within 1-2 years. Former heavy smokers required 10-15 years to reach cardiovascular risk equivalent to never smokers, emphasizing importance of early cessation in middle-aged adults.",
recwrrDrEtAWj5CoE,"Cardiovascular Disease Events, hsCRP, Systolic Blood Pressure, Tooth Brushing Frequency",High,,2025-07-25T16:12:40.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"15% reduction in cardiovascular disease risk with highest vs lowest tooth brushing frequency across 803,019 adults",LI196,recPiW3K4dhWi31Xh,recELBnyZAf0mIQH6,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/38179951/,Association Between the Frequency of Tooth Brushing and the Risk of Cardiovascular Disease: A Systematic Review and Meta-analysis,PMID: 38179951,"recB9ri5DlUq27HpJ, recxSNdyVhznqbZ88, recYzbDRWK9fN7R6B","recFAPom6rleVLlz0, recBjbjPon0bjPDip, rec20zJ8pQA3GLvgS",,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 9 cohort studies with 803,019 adults found highest tooth brushing frequency significantly reduced cardiovascular disease risk by 15% (RR=0.85; 95% CI: 0.80-0.90) compared to lowest brushing frequency. The analysis demonstrated a clear dose-response relationship between improved oral hygiene and cardiovascular protection across diverse adult populations.",
recQYjfMJRAtjw05E,"ASCVD Risk Score, hsCRP, Systolic Blood Pressure, HDL Cholesterol, Triglycerides, Fasting Glucose",Moderate,,2025-07-25T16:13:26.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Progressive cardiovascular risk reduction: 13.7% to 7.3% 10-year ASCVD risk with increased brushing frequency,LI197,recPiW3K4dhWi31Xh,recELBnyZAf0mIQH6,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-023-03775-5,Association between toothbrushing and cardiovascular risk factors: a cross-sectional study using Korean National Health and Nutrition Examination Survey 2015–2017,,"recB9ri5DlUq27HpJ, recxSNdyVhznqbZ88, recYzbDRWK9fN7R6B","recFAPom6rleVLlz0, recBjbjPon0bjPDip, rec20zJ8pQA3GLvgS",,,PubMed,recDDHykOzWxwMnyv,"Cross-sectional study of 13,761 Korean adults aged 30+ years found estimated 10-year atherosclerotic cardiovascular disease risk was 13.7%, 9.1%, and 7.3% for those who brushed teeth 0-1, 2, and ≥3 times daily respectively. Frequent toothbrushing was associated with lower systolic blood pressure, improved lipid profiles, and reduced inflammatory markers including hsCRP.",
recpohWCrR8hlrbxm,"Cardiovascular Disease Events, CRP, Fibrinogen, Tooth Brushing Frequency",Moderate,,2025-07-25T16:13:37.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,70% increased cardiovascular disease risk with poor vs good oral hygiene over 8.1 years follow-up,LI198,recPiW3K4dhWi31Xh,recELBnyZAf0mIQH6,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC2877809/,"Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey",PMID: 20423964,"recB9ri5DlUq27HpJ, recxSNdyVhznqbZ88, recYzbDRWK9fN7R6B","recFAPom6rleVLlz0, recBjbjPon0bjPDip, rec20zJ8pQA3GLvgS",,,PubMed,recDDHykOzWxwMnyv,"Prospective cohort study of 11,869 adults (mean follow-up 8.1 years) found participants with poor oral hygiene (never/rarely brushed teeth) had 70% increased risk of cardiovascular disease events (HR=1.7; 95% CI: 1.3-2.3) compared to those who brushed twice daily. Poor oral hygiene was associated with elevated inflammatory markers including CRP and fibrinogen, suggesting inflammation mediates the oral health-cardiovascular disease relationship.",
recxMyoacAK9nW7RP,"Cardiovascular Disease Events, Periodontal Disease Status, Oral Hygiene Behaviors, hsCRP",High,,2025-07-25T16:13:50.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,34% increased cardiovascular disease risk in periodontal disease patients; stronger associations in case-control studies,LI199,recPiW3K4dhWi31Xh,recELBnyZAf0mIQH6,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S0020653920338909,Periodontal diseases and cardiovascular events: meta-analysis of observational studies,PMID: 31962203,"recB9ri5DlUq27HpJ, recxSNdyVhznqbZ88, recYzbDRWK9fN7R6B, rec2Y9nCSUJ1HYZmN, recoUg1DrrPaqjGQh, recqeRyxAIZ7eKKfF","recFAPom6rleVLlz0, recBjbjPon0bjPDip, rec20zJ8pQA3GLvgS, rec6pxtTl0aPACDw4, recuFfEO3OqV7oopW, recslE7UUxgYjXk0y",,,Science Direct,recRIfCU2PF5bhkmW,Meta-analysis of 29 observational studies found subjects with periodontal disease had 34% higher risk of developing cardiovascular disease compared to those without periodontal disease (pooled RR=1.34; 95% CI: 1.27-1.42). Case-control studies showed even stronger association with OR=2.35 (95% CI: 1.87-2.96). Poor oral hygiene including inadequate flossing contributes to periodontal disease development and subsequent cardiovascular risk.,
recmOKLKDhqc0tmO0,"Flow-Mediated Vasodilation, Major Adverse Cardiovascular Events, Endothelial Function, Tooth Brushing Duration",Moderate,,2025-07-25T16:14:01.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,3-fold increased risk of major cardiovascular events with poor vs adequate tooth brushing behavior,LI200,recPiW3K4dhWi31Xh,recELBnyZAf0mIQH6,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/abs/pii/S0167527316328741,Decreased frequency and duration of tooth brushing is a risk factor for endothelial dysfunction,PMID: 28190577,"recB9ri5DlUq27HpJ, recxSNdyVhznqbZ88, recYzbDRWK9fN7R6B","recFAPom6rleVLlz0, recBjbjPon0bjPDip, rec20zJ8pQA3GLvgS",,,Science Direct,recDDHykOzWxwMnyv,"Study of 896 subjects found low frequency and short duration tooth brushing (<2 times/day and <2 minutes/procedure) was associated with significantly impaired flow-mediated vasodilation (FMD), indicating endothelial dysfunction. In follow-up of 692 participants over 28.5 months, poor tooth brushing behavior was associated with 3-fold increased risk of major adverse cardiovascular events (HR=3.06; 95% CI: 1.24-7.63) compared to adequate brushing habits.",
recNUvwDRnvmitKxz,"Skin Aging, Photoaging, UV Protection, Microtopography, hsCRP",Moderate,,2025-07-25T16:24:40.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Complete prevention of detectable skin aging over 4.5 years with daily vs discretionary sunscreen use in middle-aged adults,LI201,recPiW3K4dhWi31Xh,recELBnyZAf0mIQH6,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/23732711/,Sunscreen and prevention of skin aging: a randomized trial,PMID: 23732711,"rec8YWJTakpmIkfe7, recyx3ZSmZqFnXafv, recGwiYo13EpOTndg","reccpkPaDqQaBYToo, recCYr59P5RtgBOpM, recKXG4Fu95dHx1nx",,,PubMed,recDDHykOzWxwMnyv,"Randomized controlled trial of 903 adults (mean age 39, range 25-55) found daily broad-spectrum sunscreen use completely prevented detectable skin aging after 4.5 years compared to discretionary use. Participants using daily sunscreen showed no measurable increase in skin microtopography aging scores while controls showed significant aging progression, demonstrating 24% reduction in skin aging rate.",
recG2YPtI4HrOdIcA,"Skin Cancer Risk, UV Protection, DNA Damage, Inflammation, hsCRP",High,,2025-07-25T16:25:37.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Consistent protection against UV-induced skin damage and pre-cancerous lesions with regular broad-spectrum sunscreen use,LI202,recPiW3K4dhWi31Xh,recELBnyZAf0mIQH6,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.cmaj.ca/content/192/50/E1802,The efficacy and safety of sunscreen use for the prevention of skin cancer,PMID: 33257353,"rec8YWJTakpmIkfe7, recyx3ZSmZqFnXafv, recGwiYo13EpOTndg","reccpkPaDqQaBYToo, recCYr59P5RtgBOpM, recKXG4Fu95dHx1nx",,,PubMed,recRIfCU2PF5bhkmW,"Systematic review and meta-analysis found sunscreen use reduces skin cancer risk through multiple mechanisms including UV radiation blocking, DNA damage prevention, and immune protection. High-quality RCTs demonstrated that consistent broad-spectrum sunscreen use (SPF 30+) provides significant photoprotection, with strongest evidence for preventing actinic keratoses and squamous cell carcinomas in adults 25-75 years.",
recxQcrGwH2rN75mN,"Skin Barrier Function, Skin Dryness, Skin Integrity, Inflammation, hsCRP",High,,2025-07-25T16:25:57.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Consistent improvements in skin barrier function and reduced dryness with regular skincare routine use in older adults,LI203,recPiW3K4dhWi31Xh,recELBnyZAf0mIQH6,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/23773110/,Maintaining skin integrity in the aged: A systematic review,PMID: 23773110,"recebZs8nlpqsDqy1, recRfQOodavyWaS3u, rec5qQKEx2EH3qAce","reciCnypQrQelh4Ii, recVGeUFGgWmPOwdL, rec9ReQV085vW4emv",,,PubMed,recRIfCU2PF5bhkmW,"Systematic review of 63 intervention studies found that basic skincare strategies including low-irritating cleansers and lipophilic humectant-containing leave-on products significantly improved skin barrier function in adults 50+ years. Studies showed moisturizers containing humectants consistently improved skin dryness and barrier integrity, while products with pH 4 enhanced skin barrier function compared to standard care.",
recpbVs7q7ddfkQF5,"Interleukin-1 beta, Interleukin-6, TNF-alpha, Systemic Inflammation, Skin Barrier Function, hsCRP",Moderate,,2025-07-25T16:26:08.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Lowered inflammatory cytokine levels to those equivalent to people 20-30 years younger after 30 days of consistent moisturizer use,LI204,recPiW3K4dhWi31Xh,recELBnyZAf0mIQH6,2025-09-27T13:14:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ucsf.edu/news/2019/03/413576/skin-repair-eliminates-inflamm-aging-linked-chronic-disease,Skin repair reduces inflamm-aging factors linked to chronic disease,,"recebZs8nlpqsDqy1, recRfQOodavyWaS3u, rec5qQKEx2EH3qAce","reciCnypQrQelh4Ii, recVGeUFGgWmPOwdL, rec9ReQV085vW4emv",,,Science Direct,reclqQn6EV0azXdYf,"Clinical pilot study of 33 older adults (ages 58-95) found that applying moisturizing cream twice daily for 30 days significantly reduced blood levels of three inflammatory cytokines: interleukin-1 beta, interleukin-6, and tumor necrosis factor alpha to levels nearly equivalent to people in their 30s. The study demonstrated that proper skincare with moisturizing cream lowered systemic inflammation levels and potentially reduces risk of age-related inflammatory diseases.",
recQHkk6LltdQkaGo,"All-Cause Mortality, Cardiovascular Mortality, Tooth Loss, Periodontal Disease, Oral Health, hsCRP, Inflammation",Moderate,,2025-07-25T16:53:48.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,59% increased all-cause mortality risk with tooth loss and 49% increased cardiovascular mortality with periodontal disease in older adults,LI205,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nature.com/articles/s41598-021-95865-z,"Oral health and all-cause, cardiovascular disease, and respiratory mortality in older people in the UK and USA",PMID: 34400695,recy0r7vtQvnKvsOL,,,recAkzxNeE75B95ae,Science Direct,recDDHykOzWxwMnyv,"Prospective cohort study of 5,222 adults (mean age 71-92 years) from the UK and USA found poor oral health was associated with significantly increased all-cause mortality. Tooth loss was associated with 59% higher all-cause mortality risk (HR=1.59; 95% CI: 1.09-2.31), while periodontal disease increased cardiovascular mortality by 49% (SHR=1.49; 95% CI: 1.01-2.20). Regular dental care and preventive examinations help maintain oral health and reduce these mortality risks.",
rectbr6ELMPtm0bh1,"Cardiovascular Events, CVD Mortality, Heart Failure Risk, Periodontal Disease, Oral Hygiene, hsCRP",High,,2025-07-25T16:53:58.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Consistent reduction in cardiovascular event risk and mortality with regular dental care and oral hygiene practices across multiple intervention studies,LI206,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.frontiersin.org/journals/oral-health/articles/10.3389/froh.2024.1364765/full,Frontiers | Can oral health care be a gateway to improve cardiovascular disease? A scoping review,PMID: 38706739,recy0r7vtQvnKvsOL,,,recAkzxNeE75B95ae,PubMed,recRIfCU2PF5bhkmW,"Scoping review of 12 intervention studies examining oral health care and cardiovascular outcomes found that periodontal therapy, regular dental cleaning, and oral hygiene practices significantly reduced cardiovascular event risk and mortality. Combined periodontal treatment and dental cleaning were associated with lower CVD risk mortality, while consistent oral hygiene routines combined with regular dental visits reduced heart failure and cardiovascular mortality risk.",
recyg29GsWSt4QG8G,"All-Cause Mortality, Preventive Care Utilization, Health Screening, Cardiovascular Risk Factors, hsCRP",High,,2025-07-25T16:54:09.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,45% lower all-cause mortality risk with annual physical examinations vs no examinations in large observational meta-analysis,LI207,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/35787845/,Should we abandon annual physical examination? A meta-analysis of annual physical examination and all-cause mortality in adults based on observational studies,PMID: 35787845,reco5igDK2bU5Dw01,,,recqpqGVvQNCWh9mu,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 7 observational studies including 633,957 adults (follow-up 2-25 years) found annual physical examinations were associated with a 45% lower hazard of all-cause mortality (HR=0.55; 95% CI: 0.48-0.64). During the follow-up periods, there were 35,055 deaths among participants, with those receiving APE showing significantly better survival outcomes. This contrasts with RCT data but provides strong observational evidence for preventive physical examinations.",
rec5upTR25pnUqa55,"Coronary Heart Disease Risk, Dental Caries, Cardiovascular Events, Atherosclerosis, hsCRP",Moderate,,2025-07-25T16:54:19.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Increased coronary heart disease risk with severe dental caries in middle-aged adults, highlighting the importance of preventive dental care",LI208,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nature.com/articles/s41598-019-47029-3,"Severity of dental caries and risk of coronary heart disease in middle-aged men and women: a population-based cohort study of Korean adults, 2002–2013",PMID: 31324849,recy0r7vtQvnKvsOL,,,recAkzxNeE75B95ae,Science Direct,recDDHykOzWxwMnyv,"Population-based cohort study of 234,597 Korean adults (mean age 52, without prior cardiovascular disease) found severe dental caries significantly increased coronary heart disease risk during 1,491,190 person-years of follow-up. Participants in the highest quartile of advanced dental caries visits had increased CHD risk compared to those without caries, demonstrating the link between poor oral health and cardiovascular outcomes prevented by regular dental care.",
recc9ADDeUjVjJp2a,"All-Cause Mortality, Independent Living, Health Risk Assessment, Preventive Care Utilization, Functional Status",High,,2025-07-25T16:54:31.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,17% mortality reduction and 23% increased likelihood of independent living with periodic preventive health visits in older adults,LI209,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685441/,Periodic preventive health visits: a more appropriate approach to delivering preventive services,PMID: 29138273,reco5igDK2bU5Dw01,,,recqpqGVvQNCWh9mu,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 19 trials examining preventive primary care interventions among adults older than 65 years found a 17% reduction in mortality and 23% increase in likelihood of living independently in the community with periodic preventive health visits. A recent RCT also found decreased 8-year mortality with health risk assessment and preventive care interventions from primary care practitioners, supporting targeted preventive examinations over annual physicals.",
recCnC0Tz1QziFnHI,"Melanoma Mortality, All-Cause Mortality, Skin Cancer Stage, Early Detection, Screening Participation",High,,2025-07-25T17:40:36.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"No population-level melanoma mortality benefit from screening programs, but consistent association between earlier stage detection and reduced mortality risk",LI210,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://jamanetwork.com/journals/jama/fullarticle/2803798,Screening for Skin Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force,PMID: 37071430,"recFNz4Jhea4AVug4, rec4rRcozI2fwN4ZO",,,"recH7Hu122MMrz7Cx, rec6LZCGkwEXnrHlh",PubMed,recRIfCU2PF5bhkmW,"Systematic review of 20 studies (N=6,053,411) evaluating skin cancer screening in adults aged 15+ years found direct evidence from 3 nonrandomized analyses of German population-based screening programs suggested no melanoma mortality benefit at the population level over 4-10 years follow-up. However, 9 studies consistently found earlier stage at melanoma detection was associated with significantly decreased melanoma-specific and all-cause mortality risk.",
recdzbFxUH0HFKBrQ,"Melanoma Incidence, Melanoma Mortality, Early Detection, Screening Effectiveness, Tumor Thickness",High,,2025-07-25T17:40:55.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,69% reduction in thick melanomas and significant reduction in melanoma mortality in workplace screening program vs general population,LI211,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124531/,State of the Science on Prevention and Screening to Reduce Melanoma Incidence and Mortality: The Time is Now,PMID: 27847176,"recFNz4Jhea4AVug4, rec4rRcozI2fwN4ZO",,,"recH7Hu122MMrz7Cx, rec6LZCGkwEXnrHlh",PubMed,recRIfCU2PF5bhkmW,"Comprehensive review of melanoma screening evidence found multiple studies support the value of early detection through clinician skin examination. The Lawrence Livermore National Laboratory (LLNL) employee screening program showed a 69% reduction in melanomas >0.75mm during the screening period (1984-1996) compared to pre-screening awareness period, with zero observed deaths vs 3.39 expected deaths (p=0.034) compared to California SEER data.",
recPmOa29GvXTMqRC,"Melanoma Stage, Tumor Thickness, Early Detection, Screening Participation, Localized Disease",Moderate,,2025-07-25T17:41:09.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Early detection of predominantly thin, localized melanomas with lower proportion of advanced disease than general population; 39% would not have sought care otherwise",LI212,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S0190962296902741,Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program,PMID: 8647990,"recFNz4Jhea4AVug4, rec4rRcozI2fwN4ZO",,,"recH7Hu122MMrz7Cx, rec6LZCGkwEXnrHlh",Science Direct,recDDHykOzWxwMnyv,"Evaluation of AAD free skin cancer screening programs from 1992-1994 involving 282,555 adults found 371 melanomas in 364 persons among 4,458 suspected cases. More than 98% had localized disease, and >90% of confirmed melanomas were in situ or thin lesions (≤1.50mm thick) with median thickness 0.30mm. Only 8.3% had advanced melanoma compared to higher proportions in general population SEER data, and 39% indicated they would not have sought physician examination without the free program.",
recgPD6lsU4UDplyt,"All-Cause Mortality, Vision Impairment, Visual Acuity, Health Outcomes, Functional Status",High,,2025-07-25T17:41:18.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Consistent association between vision impairment severity and increased all-cause mortality risk across large international cohorts,LI213,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30549-0/fulltext,Association between vision impairment and mortality: a systematic review and meta-analysis,PMID: 33607016,recl0OLC6iSTCMTZu,,,recnkWbUR6uBtqwlX,Science Direct,recRIfCU2PF5bhkmW,"Systematic review and meta-analysis of 28 studies representing 30 cohorts with 451,001 adults from 12 countries found the hazard for all-cause mortality was higher in people with vision impairment compared to those with normal vision, with magnitude of effect increasing with more severe vision impairment. Age-adjusted analyses showed consistent association between vision loss and increased mortality risk across multiple populations and healthcare systems.",
recYFEOsw5tCCvoW3,"All-Cause Mortality, Fall Risk, Vision Impairment, Cataract Surgery Outcomes, Functional Independence",High,,2025-07-25T17:41:29.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Vision impairment independently increases all-cause mortality risk and fall risk, with ophthalmic interventions reducing falls by 15-30%",LI214,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30488-5/fulltext,The Lancet Global Health Commission on Global Eye Health: vision beyond 2020,PMID: 33607014,recl0OLC6iSTCMTZu,,,recnkWbUR6uBtqwlX,Science Direct,recRIfCU2PF5bhkmW,"Comprehensive commission review found vision impairment is associated with increased risk of all-cause mortality, with several explanations for this association including effects on non-communicable diseases, mental health, and injury risk. Systematic review showed vision impairment is an independent risk factor for falls among older adults, and timely access to ophthalmic interventions such as cataract surgery can reduce fall risk by 15-30%.",
recusPbh4HcnplmLm,"Vision-Related Function, Quality of Life, Visual Acuity, Functional Limitations, Fall Risk",High,,2025-07-25T17:41:39.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,"Limited evidence for vision screening effectiveness in primary care, but early detection and treatment remain important for functional outcomes",LI215,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953576/,Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings,PMID: 29735649,recl0OLC6iSTCMTZu,,,recnkWbUR6uBtqwlX,PubMed,recRIfCU2PF5bhkmW,"Systematic review of 15 RCTs (N=10,608) evaluating vision screening in community-dwelling adults aged 65+ years found low-quality evidence that screening in primary health care settings does not appear to improve vision-related functional limitations or quality of life. However, early detection and treatment of vision problems remains important for maintaining independence and reducing fall risk, with most provincial health systems covering comprehensive eye examinations for this age group.",
rec7iKKqi5yaT4ikE,"Colorectal Cancer Incidence, Colorectal Cancer Mortality, Screening Effectiveness, All-Cause Mortality",High,,2025-07-27T01:59:38.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,52% reduction in colorectal cancer incidence and 62% reduction in mortality; consistent benefits across all age groups,LI216,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7477408/,Colonoscopic screening is associated with reduced colorectal cancer incidence and mortality: a systematic review and meta-analysis,PMID: 32884493,"recsozPfurWS0N5Ox, recwr2L9Mct7dE51H",,,"recuIHfxffyARrIa0, recyLabrx05P4iIna",PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 29 studies (13 cohort and 16 case-control studies) comprising 4,713,778 individuals found colonoscopy was associated with a 52% reduction in colorectal cancer incidence (RR: 0.48, 95% CI: 0.46-0.49) and 62% reduction in colorectal cancer mortality (RR: 0.38, 95% CI: 0.36-0.40). Subgroup analysis showed consistent benefits across different study designs, countries, and age groups, with screening having the same effect on people below and above 50 years.",
recQc7QcKXqNCDo3B,"Colorectal Cancer Mortality, All-Cause Mortality, Screening Effectiveness, Cancer Incidence",High,,2025-07-27T01:59:50.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,73% mortality reduction with 10-yearly colonoscopy; most effective screening method compared to other options,LI217,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.mdpi.com/2072-6694/15/7/1948,Effectiveness of Colorectal Cancer (CRC) Screening on All-Cause and CRC-Specific Mortality Reduction: A Systematic Review and Meta-Analysis,PMID: 37046617,"recsozPfurWS0N5Ox, recwr2L9Mct7dE51H",,,"recuIHfxffyARrIa0, recyLabrx05P4iIna",PubMed,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 10 RCTs and 47 model studies found that 10-yearly colonoscopy screening was the most effective screening method with a 73% mortality reduction (rate ratio 0.27, 95% CI: 0.21-0.35). The pooled CRC-specific mortality rate ratios for different screening methods were: biennial FIT 0.45 (0.39-0.51), biennial gFOBT 0.31 (0.28-0.34), single FS 0.61 (0.53-0.72), 10-yearly colonoscopy 0.27 (0.21-0.35), and 5-yearly FS 0.35 (0.29-0.42). Effectiveness increased with younger screening initiation ages and higher adherences.",
rec15PVPvMr0rsgO0,"Colorectal Cancer Incidence, Colorectal Cancer Mortality, All-Cause Mortality, Screening Effectiveness",High,,2025-07-27T02:00:10.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,20% reduction in colorectal cancer incidence and 26% reduction in mortality from randomized controlled trials,LI218,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1364923/full,Effectiveness of sigmoidoscopy or colonoscopy screening on colorectal cancer incidence and mortality: a systematic review and meta-analysis of randomized controlled trial,PMID: 38601892,"recsozPfurWS0N5Ox, recwr2L9Mct7dE51H",,,"recuIHfxffyARrIa0, recyLabrx05P4iIna",PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 7 randomized controlled trials involving 663,319 participants (average age 55-69) found that colonoscopy or sigmoidoscopy screening resulted in a 20% reduction in colorectal cancer incidence (RR: 0.80, 95% CI: 0.77-0.83) and a 26% decrease in colorectal cancer mortality (RR: 0.74, 95% CI: 0.69-0.80) compared to standard care. All-cause mortality remained unchanged (RR: 1.03, 95% CI: 0.99-1.07). Subgroup analysis showed sigmoidoscopy was particularly effective in reducing both morbidity and mortality.",
rec95nJH33r5g51tA,"Breast Cancer Mortality, Screening Effectiveness, Cancer Detection, Overdiagnosis Risk",High,,2025-07-27T02:00:23.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,30% reduction in breast cancer mortality for women who attend screening; 22% reduction in intention-to-treat analysis,LI219,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nature.com/articles/bjc201690,Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography,PMID: 27115573,recuVujFSHmDeJ3BG,,,recwfCJXDvYl5nGX9,Science Direct,recRIfCU2PF5bhkmW,"Meta-analysis of 9 screening mammography trials from the Independent UK Breast Screening Report found that in women aged 39-75 years invited to screen, the prevented fraction of breast cancer mortality at 13-year follow-up was 0.22 (95% CI 0.15-0.28), which increased to 0.30 (95% CI 0.20-0.39) when adjusted for adherence to screening. This represents a 30% reduction in breast cancer mortality for women who actually attend screening. Adjustment for non-adherence increased the size of the mortality benefit by up to 50%.",
recp76FjLVXuwgRdd,"Cancer Detection Rate, Breast Cancer Screening Sensitivity, Early Cancer Detection, BRCA Mutation Status",High,,2025-07-27T02:03:12.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Superior cancer detection: MRI 15.4‰ vs mammography 7.0‰; 93% sensitivity with early-stage cancer detection advantages,LI220,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997824/,Magnetic resonance imaging in screening women at high risk of breast cancer: A meta-analysis,,recuVujFSHmDeJ3BG,,,recwfCJXDvYl5nGX9,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 18 studies with 21,157 high-risk women found breast MRI had significantly superior cancer detection rate compared to mammography (15.4‰ vs 7.0‰). MRI achieved 93% sensitivity with 63% specificity. Among high-risk women, MRI plus mammography detected 16.7‰ cancers vs 15.4‰ for MRI alone, with MRI detecting smaller, earlier-stage cancers more frequently. Subgroup analysis confirmed MRI superiority across all age groups and BRCA1/2 mutation carriers.",
recKM7biSYWjqhqIX,"Cancer Mortality, Survival Rate, Cancer Detection Rate, Lymph Node Status, BRCA Mutation Status",Moderate,,2025-07-27T02:03:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,95.3% vs 73.7% 10-year survival; 93% sensitivity; zero deaths among BRCA2 carriers with MRI screening,LI221,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/24687378/,MRI breast screening in high-risk women: cancer detection and survival analysis,PMID: 24687378,recuVujFSHmDeJ3BG,,,recwfCJXDvYl5nGX9,PubMed,recODsYatCgd7j2Vr,"Prospective study of high-risk women (mean age 46 years) found MRI plus mammography achieved 93% sensitivity compared to mammography alone. High-risk women screened with MRI had significantly higher 10-year survival (95.3%) compared to no intensive screening (73.7%, p=0.002). Among 21 BRCA2 carriers receiving MRI screening, there were no deaths. Fewer MRI-detected cancers were lymph node positive, indicating earlier stage detection.",
recpfzo6K2xgUGkwa,"Sensitivity, Specificity, Cancer Detection Rate, False Positive Rate, Screening Performance",High,,2025-07-27T02:03:33.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,94% sensitivity for MRI plus mammography vs 25-59% for mammography alone; 58% incremental sensitivity benefit,LI222,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/17681781/,A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer,PMID: 17681781,recuVujFSHmDeJ3BG,,,recwfCJXDvYl5nGX9,PubMed,rec4qqncSQrMbfAph,"Systematic review of 5 studies found MRI plus mammography achieved 94% sensitivity (95% CI: 86-98%) compared to mammography alone (25-59% sensitivity). The incremental sensitivity of adding MRI was 58% (95% CI: 47-70%). Meta-analysis demonstrated consistently superior performance of MRI screening across all high-risk populations, though specificity was 3-5 fold lower, resulting in higher recall rates for false positive results.",
rechiGENwhETGS6Iu,"Cancer Detection Rate, Sensitivity, Specificity, Early Cancer Detection, High-Risk Screening",Moderate,,2025-07-27T02:03:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"20 per 1,000 cancer detection rate; 93.3% sensitivity and 83.4% specificity in high-risk women",LI223,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/38142230/,Outcomes of High-Risk Breast MRI Screening in Women Without Prior History of Breast Cancer: Effectiveness Data from a Tertiary Care Center,PMID: 38142230,recuVujFSHmDeJ3BG,,,recwfCJXDvYl5nGX9,PubMed,recODsYatCgd7j2Vr,"Retrospective study of 1,405 consecutive breast MRI examinations in 681 high-risk women (ages 25-80 years) found cancer detection rate of 20 per 1,000 screenings, with 93.3% sensitivity and 83.4% specificity. Of 28 screen-detected cancers, 64.3% were invasive and 35.7% were ductal carcinoma in situ. MRI effectively detected early-stage breast cancer with favorable outcomes in high-risk women without prior cancer history.",
rec2QJ84MfF1qyLVk,"Overall Survival, Tumor Size, Interval Cancer Rate, Cancer Stage, Breast Cancer Mortality",Moderate,,2025-07-27T02:03:54.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Improved overall survival; 73.1% vs 29.4% small tumors (≤1cm); 0% vs 40.9% interval cancers,LI224,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC6999769/,Survival Outcomes of Screening with Breast MRI in Women at Elevated Risk of Breast Cancer,,recuVujFSHmDeJ3BG,,,recwfCJXDvYl5nGX9,PubMed,recODsYatCgd7j2Vr,"Retrospective cohort study found MRI plus mammography screening improved overall survival compared to mammography alone in high-risk women diagnosed with breast cancer. In the MRI group, 73.1% of invasive tumors were ≤1 cm compared to 29.4% in mammography-only group. No invasive tumors in MRI group were >2 cm vs 11.8% in mammography-only group. Interval cancer rate was significantly lower in MRI group (0% vs 40.9%, p<0.001).",
rec48lDE1Od38Cr8U,"Cervical Cancer Incidence, Cervical Cancer Mortality, Screening Effectiveness, Early Cancer Detection",High,,2025-07-27T02:08:18.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Substantial reduction in cervical cancer incidence and mortality; odds ratios 0.35-0.90 across multiple populations,LI225,,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/2046-4053-2-35,Screening for cervical cancer: a systematic review and meta-analysis,PMID: 23702145,rec6NwTofHBGmZInJ,,,rec87EjG0vdodDlJc,Science Direct,rec4qqncSQrMbfAph,Systematic review and meta-analysis of 12 case-control studies and 1 RCT with women aged 15-70 years found that cervical cancer screening (cytology and HPV testing) significantly reduced cervical cancer incidence and mortality. Studies showed protective effects with odds ratios ranging from 0.35 to 0.90 for screening vs no screening across different populations. Meta-analysis of case-control studies demonstrated substantial reduction in cervical cancer risk.,
recl9KPdT7iNcK2IH,"Cervical Intraepithelial Neoplasia Detection, Screening Sensitivity, Screening Specificity, HPV DNA Testing",High,,2025-07-27T02:08:46.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,HPV testing 94.6% vs Pap 55.4% sensitivity; combined testing achieved 100% sensitivity for high-grade cervical lesions,LI226,,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nejm.org/doi/full/10.1056/NEJMoa071430,Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer,PMID: 17686340,rec6NwTofHBGmZInJ,,,rec87EjG0vdodDlJc,PubMed,reclYXy0udvjr66Xa,"Randomized controlled trial of 10,154 Canadian women aged 30-69 years comparing HPV DNA testing to conventional Pap testing found HPV testing achieved 94.6% sensitivity (95% CI: 84.2-100) vs 55.4% sensitivity for Pap testing (95% CI: 33.6-77.2; P=0.01) for detecting cervical intraepithelial neoplasia grade 2 or 3. Specificity was 94.1% for HPV vs 96.8% for Pap testing. Combined testing achieved 100% sensitivity with 92.5% specificity.",
recbMkErzhbnbV1lU,"Prostate Cancer Mortality, All-Cause Mortality, PSA Screening Effectiveness, Overdiagnosis Risk",High,,2025-07-27T02:08:57.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,Small effect on prostate cancer mortality (1 per 1000 men); no effect on all-cause mortality; benefits must be weighed against overdiagnosis,LI227,,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC6283370/,Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis,PMID: 30185521,"recXR6RzvDkkHzi2E, recqTL66V1gh2SjeK",,,"recZbehRgrW2ydVo7, recsdTwoGPSZTwWAd",Science Direct,rec4qqncSQrMbfAph,"Systematic review and meta-analysis of 5 randomized controlled trials enrolling 721,718 men found PSA screening probably has no effect on all-cause mortality (IRR 0.99, 95% CI 0.98-1.01) and may have no effect on prostate-specific mortality (IRR 0.96, 0.85-1.08). Sensitivity analysis of higher quality studies showed PSA screening may have small effect on prostate-specific mortality (IRR 0.79, 0.69-0.91), corresponding to 1 fewer death from prostate cancer per 1000 men screened over 10 years.",
recEt4TOJso8MbJ0A,"Prostate Cancer Mortality, Cancer Incidence, PSA Screening Adherence, Early Cancer Detection",High,,2025-07-27T02:09:07.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,20% reduction in prostate cancer mortality with screening; 27% reduction among men actually screened,LI228,,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nejm.org/doi/full/10.1056/NEJMoa0810084,Screening and Prostate-Cancer Mortality in a Randomized European Study,PMID: 19297565,"recXR6RzvDkkHzi2E, recqTL66V1gh2SjeK",,,"recZbehRgrW2ydVo7, recsdTwoGPSZTwWAd",PubMed,reclYXy0udvjr66Xa,"European Randomized Study of Screening for Prostate Cancer (ERSPC) of 182,000 men aged 50-74 years (core group: 162,243 men aged 55-69) found PSA screening reduced prostate cancer mortality by 20% (rate ratio 0.80, 95% CI 0.65-0.98) over median 9-year follow-up. In screening group, 82% accepted screening, cumulative cancer incidence was 8.2% vs 4.8% in controls. Analysis of actually screened men showed 27% reduction in prostate cancer death (rate ratio 0.73, 95% CI 0.56-0.90).",
recYNxWcaQFm2Wue0,"Cardiovascular Mortality, Myocardial Infarction, Omega-3 Index, hsCRP, Triglycerides, Total Cholesterol, HDL Cholesterol, Apolipoprotein B",High,,2025-07-27T02:16:05.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,8% reduction in cardiovascular mortality and 7% reduction in myocardial infarction across large adult population; stronger effects with EPA monotherapy,LI229,"recPiW3K4dhWi31Xh, recAAuZFrdsqJW3yd, recDBJLAkc5CAfBm3, recwtXkPSEQgyddmt, recq0JX3QgFBo5mm4","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE, recLuAlDIETnvUUtO, recqea20SA5Y5BaIw",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00277-7/fulltext,Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis,PMID: 34505026,rec1CITs0erlgrejI,,,,PubMed,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 38 randomized controlled trials involving 149,051 participants (mean age range 39-78 years) found omega-3 fatty acid supplementation reduced cardiovascular mortality by 8% (RR=0.92; 95% CI: 0.86-0.99) and myocardial infarction by 7% (RR=0.93; 95% CI: 0.88-0.97). EPA monotherapy showed greater cardiovascular benefits than EPA+DHA combinations, with median follow-up of 2.0 years across trials.",recD426nXwApna9E0
recZS6ikCatpDMOLb,"Executive Function, Cognitive Performance, Omega-3 Index, DHA levels, EPA levels, Brain-Derived Neurotrophic Factor, Neuroplasticity Markers",High,,2025-07-27T02:16:48.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Improvements in executive function with doses >500mg n-3 PUFA; dose-response relationship demonstrated with optimal benefits at 420mg EPA,LI230,"recAAuZFrdsqJW3yd, recPiW3K4dhWi31Xh, recDBJLAkc5CAfBm3","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-024-03296-0,The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis,PMID: 38468309,rec1CITs0erlgrejI,,,,PubMed,recd0d1tmtDQUEhTY,"Systematic review and dose-response meta-analysis of 24 randomized controlled trials involving 9,660 participants (aged 40+ years, follow-up 3-36 months) found omega-3 supplementation improved executive function within the initial 12 months of intervention. Beneficial effects were prominently observed with daily intake exceeding 500mg n-3 PUFA and up to 420mg EPA, particularly in middle-aged and older adults without dementia.",recD426nXwApna9E0
recG4YwowsxnZE00J,"Triglycerides, Total Cholesterol, HDL Cholesterol, LDL Cholesterol, Non-HDL Cholesterol, Apolipoprotein B, Omega-3 Index",High,,2025-07-27T02:19:55.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Linear dose-response relationship for triglycerides with 15-30% reduction at higher doses; strongest effects in hyperlipidemic populations,LI231,"recAAuZFrdsqJW3yd, recDBJLAkc5CAfBm3, recwtXkPSEQgyddmt, recq0JX3QgFBo5mm4, recLJcUUTL1szyE8Z","recLuAlDIETnvUUtO, recqea20SA5Y5BaIw, recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ahajournals.org/doi/10.1161/JAHA.123.029512,Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials,PMID: 37264945,rec1CITs0erlgrejI,,,,PubMed,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 90 randomized controlled trials involving 72,598 participants found omega-3 fatty acids showed linear dose-response relationships for triglyceride reduction (approximately 15-30% reduction with doses >2g/day) and non-HDL cholesterol. Effects were most pronounced in populations with hyperlipidemia and overweight/obesity, demonstrating clear dose-dependent benefits for lipid profile optimization in middle-aged adults.",recD426nXwApna9E0
recuUIGlY7gK5ScGI,"hsCRP, TNF-alpha, Triglycerides, Apolipoprotein AII, Apolipoprotein B, HbA1c, Fasting Insulin, HOMA-IR, Omega-3 Index",High,,2025-07-27T02:20:09.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,45 mg/dL triglyceride reduction and significant anti-inflammatory effects in diabetic and CVD patients; clinical relevance for metabolic health,LI232,"recPiW3K4dhWi31Xh, recAAuZFrdsqJW3yd, recDBJLAkc5CAfBm3, recq0JX3QgFBo5mm4, recLJcUUTL1szyE8Z, recierVNozpgZdLZH, recAdUWMgWMZS3qKI","recLuAlDIETnvUUtO, recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nature.com/articles/s41598-019-54535-x,Omega-3 Fatty Acids Effects on Inflammatory Biomarkers and Lipid Profiles among Diabetic and Cardiovascular Disease Patients: A Systematic Review and Meta-Analysis,PMID: 31827125,rec1CITs0erlgrejI,,,,PubMed,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 16 randomized controlled trials involving diabetic and cardiovascular disease patients found omega-3 fatty acids significantly reduced triglycerides by 44.88 mg/dL (95% CI: -82.6, -7.16), apolipoprotein AII by 8.0 mg/dL, and inflammatory markers. Omega-3 supplementation demonstrated anti-inflammatory effects through reduced pro-inflammatory mediators and increased production of inflammation-resolving compounds in adults with metabolic dysfunction.",recD426nXwApna9E0
recTxQ5eLX0TvgYqM,"25-Hydroxyvitamin D, Cardiovascular Events, All-Cause Mortality, hsCRP, Calcium",High,,2025-07-27T02:16:18.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,"No significant cardiovascular benefits observed; however, supplementation may benefit individuals with vitamin D deficiency for bone and immune health",LI233,"recPiW3K4dhWi31Xh, recmyyZam7oYaGnDd, rec7lljffINZr7vSi","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/31215980/,Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis,PMID: 31215980,rec3Lv7L4n0P5NRXG,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 21 randomized clinical trials involving 83,291 participants (mean follow-up 4.4 years) found vitamin D supplementation was not associated with reduced major adverse cardiovascular events (RR=1.00; 95% CI: 0.95-1.06), myocardial infarction (RR=1.00; 95% CI: 0.93-1.08), stroke (RR=1.06; 95% CI: 0.98-1.15), or all-cause mortality (RR=0.97; 95% CI: 0.93-1.02). Results were consistent across different dosages, formulations, and baseline vitamin D levels in adults.",recFdPkG1F9TcwMiY
recrfrHwRzPtJ5W77,"25-Hydroxyvitamin D, Respiratory Infection Risk, Immune Function, hsCRP, Cathelicidin",High,,2025-07-27T02:17:10.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,12% overall reduction in respiratory infections; 70% reduction in vitamin D deficient individuals with daily dosing,LI234,"recPiW3K4dhWi31Xh, recmyyZam7oYaGnDd","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/28202713/,Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data,PMID: 28202713,rec3Lv7L4n0P5NRXG,,,,PubMed,recRIfCU2PF5bhkmW,"Individual participant data meta-analysis of 25 randomized controlled trials involving 10,933 participants found vitamin D supplementation reduced acute respiratory tract infection risk by 12% overall (OR=0.88; 95% CI: 0.81-0.96). Protection was strongest in individuals with vitamin D deficiency (<25 nmol/L) receiving daily or weekly doses (OR=0.30; 95% CI: 0.17-0.53), with optimal benefits from 400-1000 IU daily doses administered consistently.",recFdPkG1F9TcwMiY
recMePg5yjVvB1dgc,"25-Hydroxyvitamin D, All-Cause Mortality, Cancer Mortality, Respiratory Disease Mortality, hsCRP",High,,2025-07-27T02:23:24.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Consistent inverse association between vitamin D status and all-cause mortality across 84 studies; strongest evidence for cancer and respiratory mortality in adults,LI235,"recmyyZam7oYaGnDd, recPiW3K4dhWi31Xh","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.mdpi.com/1660-4601/16/3/383,Vitamin D Status and Mortality: A Systematic Review of Observational Studies,PMID: 30700025,rec3Lv7L4n0P5NRXG,,,,PubMed,rec4qqncSQrMbfAph,"Systematic review of 84 observational studies investigating vitamin D status and mortality found that the vast majority reported inverse associations between 25-hydroxyvitamin D concentration and all-cause mortality in generally healthy populations (ages 30-75 years). The association appeared non-linear, with progressively lower mortality with increasing 25(OH)D up to 75-100 nmol/L, beyond which there was no further decrease. Moderate evidence showed vitamin D status inversely associated with cancer mortality and respiratory disease deaths.",recFdPkG1F9TcwMiY
recg43VmLbp5uSF1o,"25-Hydroxyvitamin D, Bone Mineral Density, Fracture Risk, Fall Risk, Calcium",High,,2025-07-27T02:23:35.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,"No clinically meaningful effects on bone health in healthy adults; benefits primarily in deficient, institutionalized elderly when combined with calcium",LI236,"recmyyZam7oYaGnDd, rec7lljffINZr7vSi","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.thelancet.com/journals/landia/article/PIIS2213-8587(18)30265-1/abstract,"Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis",PMID: 30293909,rec3Lv7L4n0P5NRXG,,,,PubMed,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 81 randomized controlled trials involving 53,601 participants (mean age 59 years) found vitamin D supplementation does not prevent fractures or falls, or have clinically meaningful effects on bone mineral density in generally healthy adults. No differences observed between higher and lower doses of vitamin D. However, combined vitamin D and calcium supplementation showed modest benefits in institutionalized elderly populations with vitamin D deficiency.",recFdPkG1F9TcwMiY
rec50mpIxR4ZYKSg9,"Sleep Onset Latency, Sleep Efficiency, Total Sleep Time, Magnesium Status, Cortisol, Melatonin",High,,2025-07-27T02:16:28.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,17-minute reduction in sleep onset latency with improvements in sleep efficiency; evidence quality was low but effects were clinically meaningful,LI237,"recPiW3K4dhWi31Xh, recbYuWTuZJPZwFNc","recELBnyZAf0mIQH6, recxJqmq5ipZMLJsj, recXiq3Os05QJJki4, rec8o1wlo0olBMl8A",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/33865376/,Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis,PMID: 33865376,recOifq6N7ttSB96g,,,,PubMed,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 3 randomized controlled trials involving 151 older adults found magnesium supplementation reduced sleep onset latency by 17.36 minutes compared to placebo (95% CI: -27.27 to -7.44, p=0.0006). Total sleep time improved by 16.06 minutes but was not statistically significant. Studies used magnesium doses less than 1g daily for 8 weeks, showing promising sleep benefits in older adults with insomnia.",recqKzD1KpCxZk4ry
recKvSITqNCLchBqU,"Systolic Blood Pressure, Diastolic Blood Pressure, Serum Magnesium, Cardiovascular Risk, Endothelial Function",High,,2025-07-27T02:26:01.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,2.0 mmHg systolic and 1.8 mmHg diastolic BP reduction with 368mg daily magnesium; clinically meaningful for cardiovascular risk reduction in adults,LI238,"recPiW3K4dhWi31Xh, recbYuWTuZJPZwFNc","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/27402922/,Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials,PMID: 27402922,recOifq6N7ttSB96g,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 34 randomized double-blind placebo-controlled trials involving 2,028 normotensive and hypertensive adults found magnesium supplementation at median dose of 368 mg/d for median duration of 3 months significantly reduced systolic BP by 2.00 mmHg (95% CI: 0.43-3.58) and diastolic BP by 1.78 mmHg (95% CI: 0.73-2.82). These reductions were accompanied by 0.05 mmol/L elevation of serum magnesium, with greater BP reductions in trials with high quality or low dropout rates.",recqKzD1KpCxZk4ry
recBdHkYbv2njsIkC,"HOMA-IR, Fasting Glucose, Insulin Sensitivity, HbA1c, Serum Magnesium",High,,2025-07-27T02:26:13.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant improvement in HOMA-IR index, with greater benefits in longer-duration studies (≥4 months) for both glucose control and insulin sensitivity",LI239,"recierVNozpgZdLZH, recAdUWMgWMZS3qKI, recC0mB1LyNGjDyld, recbYuWTuZJPZwFNc","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/abs/pii/S1043661816303085,A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control,PMID: 27329332,recOifq6N7ttSB96g,,,,Science Direct,recRIfCU2PF5bhkmW,"Systematic review and meta-analysis of 22 treatment arms from randomized controlled trials found oral magnesium supplementation significantly improved HOMA-IR index (WMD: -0.67, 95% CI: -1.20, -0.14, p=0.013) in both diabetic and non-diabetic adults. In studies with supplementation periods ≥4 months, magnesium significantly improved both fasting glucose concentrations and HOMA-IR index, indicating enhanced insulin sensitivity and metabolic control.",recqKzD1KpCxZk4ry
rec46ZfA0RvwImmfK,"C-Reactive Protein, Nitric Oxide, Inflammatory Markers, Serum Magnesium, IL-6",High,,2025-07-27T02:26:32.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant reduction in CRP and increase in nitric oxide levels; strongest effects in individuals with elevated baseline inflammation (CRP >3 mg/L),LI240,"recPiW3K4dhWi31Xh, recbYuWTuZJPZwFNc","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8838086/,Effect of Magnesium Supplementation on Inflammatory Parameters: A Meta-Analysis of Randomized Controlled Trials,PMID: 35277037,recOifq6N7ttSB96g,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 17 randomized controlled trials involving 889 participants (mean age 46 years, 62.5% female) found magnesium supplementation significantly decreased serum C-reactive protein (CRP) levels (SMD: -0.356, 95% CI: -0.659 to -0.054, p=0.02) and increased nitric oxide levels compared to placebo. Greatest anti-inflammatory benefits observed in adults with baseline CRP >3 mg/L, suggesting particular utility for managing low-grade chronic systemic inflammation.",recqKzD1KpCxZk4ry
rec1Xa5ezJi0owtmj,"Lean Body Mass, Skeletal Muscle Mass, Body Composition, Creatine Kinase, Muscle Strength",High,,2025-07-27T02:30:25.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,1.1 kg increase in lean body mass when combined with resistance training; no effect without exercise,LI241,"recntmFnf3bSSe2DB, recwtXkPSEQgyddmt","recyKRTIlX4Jux2W0, recHOTAk6Lpmb9uUz",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/abs/pii/S0899900722002040,"Influence of age, sex, and type of exercise on the efficacy of creatine supplementation on lean body mass: A systematic review and meta-analysis of randomized clinical trials",PMID: 35803547,recQcGEPeYqq9gkuZ,,,,Science Direct,recRIfCU2PF5bhkmW,"Meta-analysis of 28 randomized controlled trials found creatine supplementation combined with resistance training increased lean body mass by 1.1 kg in adults, regardless of age (young, middle-aged, and older adults). Males experienced greater increases in LBM than females during resistance training programs. Creatine supplementation alone without exercise was ineffective for LBM gains, emphasizing the importance of combining supplementation with resistance training for optimal muscle building benefits.",recsE0RKbgzugZfPh
reciFTkZ7S2D842Ta,"Lean Tissue Mass, Muscle Strength, Sarcopenia Markers, Body Composition, Muscle Quality",High,,2025-07-27T02:30:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,1.37 kg increase in lean tissue mass in older adults; significant benefits for sarcopenia prevention,LI242,"recntmFnf3bSSe2DB, recwtXkPSEQgyddmt","recyKRTIlX4Jux2W0, recHOTAk6Lpmb9uUz, recVHWlB26jWt9Ij9",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC5679696/,Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis,PMID: 29123816,recQcGEPeYqq9gkuZ,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 22 studies with 721 participants (both men and women; mean age 57-70 years) found creatine supplementation during resistance training 2-3 days/week for 7-52 weeks resulted in greater increases in lean tissue mass (mean difference = 1.37 kg, 95% CI = 0.97-1.76) and chest press strength compared to placebo. Results demonstrate creatine's effectiveness for combating age-related muscle loss (sarcopenia) and supporting healthy aging when combined with resistance exercise.",recsE0RKbgzugZfPh
rec0ELKfDPIQbNkJz,"Cognitive Function, Memory Performance, Processing Speed, Brain Creatine, Neurological Health",High,,2025-07-27T02:30:55.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant improvements in memory and processing speed; strongest effects in older adults (>65 years),LI243,"recwtXkPSEQgyddmt, recLJcUUTL1szyE8Z","recVHWlB26jWt9Ij9, rec8o1wlo0olBMl8A",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC11275561/,The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis,PMID: 39070254,recQcGEPeYqq9gkuZ,,,,PubMed,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 16 randomized controlled trials involving 492 participants (aged 20.8-76.4 years) found creatine monohydrate supplementation significantly improved memory (SMD = 0.31, 95% CI: 0.18-0.44) and attention time performance. Information processing speed was also enhanced, particularly in older adults, supporting creatine's role in brain energy metabolism and cognitive enhancement. Effects were most pronounced in adults over 65 years, suggesting greater benefits in aging populations.",recsE0RKbgzugZfPh
rec90wZdxX6lfauzJ,"Muscle Mass, Bone Mineral Density, Inflammatory Markers, Safety Markers, Creatine Kinase",High,,2025-07-27T02:31:20.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Consistent anti-sarcopenic effects with excellent safety profile; potential bone health benefits,LI244,"recntmFnf3bSSe2DB, recwtXkPSEQgyddmt, recPiW3K4dhWi31Xh","recyKRTIlX4Jux2W0, recHOTAk6Lpmb9uUz, reccxH7AESy9vvBPo",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC6518405/,Effectiveness of Creatine Supplementation on Aging Muscle and Bone: Focus on Falls Prevention and Inflammation,PMID: 31121843,recQcGEPeYqq9gkuZ,,,,PubMed,recVEgoBTZCnm3dCI,"Comprehensive review found creatine supplementation has anti-sarcopenic and anti-dynapenic effects in aging adults, increasing muscle mass and strength through enhanced high-energy phosphate metabolism, muscle protein kinetics, and growth factors. Creatine supplementation showed potential to enhance bone mineral density in some studies and demonstrated excellent safety profile with no adverse effects on liver or kidney function markers even with long-term use (up to 1 year) in aging populations.",recsE0RKbgzugZfPh
recufc5ahhDnhUVRp,"Lean Body Mass, Muscle Strength, Protein Intake, Skeletal Muscle Mass, Lower Body Strength",High,,2025-07-27T02:36:24.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Small but consistent gains in lean body mass and strength; stronger effects with protein intake ≥1.6 g/kg/day during resistance training,LI245,"recierVNozpgZdLZH, recf4HtvFUqMhyhdh, recC0mB1LyNGjDyld","recyKRTIlX4Jux2W0, recVHWlB26jWt9Ij9, reccxH7AESy9vvBPo",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8978023/,Systematic review and meta-analysis of protein intake to support muscle mass and function in healthy adults,PMID: 35187864,receIFIO0xrD92Ym4,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 74 randomized controlled trials found that increasing daily protein ingestion results in small additional gains in lean body mass (LBM) and lower body muscle strength in healthy adults during resistance exercise training. Lower-body strength gains were higher with protein intake ≥1.6 g/kg/day (SMD = 0.40, 95% CI 0.09-0.35, p < 0.01). Effects were consistent across young (<65 years) and older (≥65 years) adults, supporting protein supplementation for maintaining muscle function with aging.",recQaZVJXPAHgLTHm
recE2Z0KjDI4l2nuX,"Appendicular Skeletal Muscle Mass, Handgrip Strength, IL-6, IGF-1, Albumin, Sarcopenia Markers",High,,2025-07-27T02:36:38.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Significant improvements in muscle mass index, muscle mass, and handgrip strength in sarcopenic older adults; reduction in inflammatory markers",LI246,"recierVNozpgZdLZH, recDBJLAkc5CAfBm3, recL8dpnjNSzBJp2L","recyKRTIlX4Jux2W0, recVHWlB26jWt9Ij9, recHOTAk6Lpmb9uUz",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S127977072400263X,Improving sarcopenia in older adults: a systematic review and meta-analysis of randomized controlled trials of whey protein supplementation with or without resistance training,PMID: 38346764,receIFIO0xrD92Ym4,,,,Science Direct,recRIfCU2PF5bhkmW,"Meta-analysis of 10 randomized controlled trials involving 1,154 participants found whey protein supplementation significantly increased appendicular skeletal muscle mass index (SMD: 0.47, 95% CI: 0.23-0.71) and appendicular skeletal muscle mass (SMD: 0.28, 95% CI: 0.11-0.45) in older adults with sarcopenia. When combined with resistance training, whey protein significantly increased handgrip strength (SMD: 0.67, 95% CI: 0.29-1.04). Whey protein also significantly reduced IL-6 levels and increased IGF-1 and albumin, promoting overall physical condition in sarcopenic older adults.",recQaZVJXPAHgLTHm
rec1rFWWTKeohQDSh,"Fasting Glucose, Postprandial Glucose, Insulin Response, HOMA-IR, Glucose Homeostasis",High,,2025-07-27T02:37:15.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant stabilization of blood glucose and 63% reduction in postprandial insulin response with increased protein intake,LI247,"recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI","recVHWlB26jWt9Ij9, reccxH7AESy9vvBPo",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S0022316622156154,Increased Dietary Protein Modifies Glucose and Insulin Homeostasis in Adult Women during Weight Loss,PMID: 12589113,receIFIO0xrD92Ym4,,,,Science Direct,reclYXy0udvjr66Xa,"Randomized controlled trial of 24 adult women found that consumption of a diet with increased protein (1.6 g/kg/day) and reduced carbohydrate-to-protein ratio significantly stabilized blood glucose during nonabsorptive periods and reduced postprandial insulin response (75 ± 18 pmol/L vs 207 ± 21 pmol/L in control group). Higher protein intake maintained fasting glucose levels (4.89 ± 0.11 vs 4.34 ± 0.10 mmol/L) and postprandial glucose (4.33 ± 0.15 vs 3.77 ± 0.14 mmol/L) within healthier ranges, demonstrating protein's beneficial effects on glucose homeostasis and insulin sensitivity.",recQaZVJXPAHgLTHm
recu9sgr35jiPBYUL,"All-Cause Mortality, Protein Intake, Skeletal Muscle Mass Index, Serum Albumin, Longevity",Moderate,,2025-07-27T02:38:01.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,56% reduction in all-cause mortality risk in highest vs lowest protein intake group in very elderly adults (85-89 years),LI248,"recierVNozpgZdLZH, recDBJLAkc5CAfBm3, recq0JX3QgFBo5mm4","recyKRTIlX4Jux2W0, recLuAlDIETnvUUtO, rec8o1wlo0olBMl8A",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-023-04173-w,Dietary protein intake and all-cause mortality: results from The Kawasaki Aging and Wellbeing Project,PMID: 37553651,receIFIO0xrD92Ym4,,,,PubMed,recDDHykOzWxwMnyv,"Prospective cohort study of 833 Japanese adults aged 85-89 years with 1,218 days follow-up found protein intake was associated with reduced risk of all-cause mortality. The highest protein intake group (≥19.1% of energy) had 56% lower mortality risk compared to the lowest intake group (<14.7% of energy) (HR: 0.44, 95% CI: 0.22-0.90, p=0.020). This association remained significant after adjusting for age, sex, skeletal muscle mass index, cardiovascular disease, cancer, education, and serum albumin levels, suggesting protein intake benefits mortality independent of muscle mass in very elderly adults.",recQaZVJXPAHgLTHm
rec0bDSq0Cd3LWTIe,"All-Cause Mortality, Heart Failure Hospitalization, BNP, 6-Minute Walk Test, Cardiovascular Events",High,,2025-07-27T02:42:59.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,36% reduction in all-cause mortality and 50% reduction in heart failure hospitalization with excellent safety profile,LI249,"recPiW3K4dhWi31Xh, recDBJLAkc5CAfBm3, recq0JX3QgFBo5mm4","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE, rec8o1wlo0olBMl8A",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-024-04232-z,Efficacy and safety of coenzyme Q10 in heart failure: a meta-analysis of randomized controlled trials,PMID: 39743445,recINluftAPavksWY,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 33 studies with heart failure patients found CoQ10 supplementation significantly reduced all-cause mortality by 36% (RR=0.64, 95% CI: 0.48-0.85, p=0.002) and hospitalization for heart failure by 50% (RR=0.50, 95% CI: 0.37-0.67, p<0.00001). CoQ10 also significantly decreased BNP levels and improved 6-minute walk test distances, indicating enhanced functional capacity. No significant adverse effects were reported, supporting CoQ10's safety profile as adjunct therapy for cardiovascular health.",reckfFHaqSYeC3nhg
recmcPYpzZCIXbbcv,"Systolic Blood Pressure, Diastolic Blood Pressure, Heart Rate, Cardiovascular Risk",High,,2025-07-27T02:43:12.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,3.44 mmHg reduction in systolic blood pressure with optimal effects at <200mg/day and >8 weeks duration,LI250,"recPiW3K4dhWi31Xh, receYj9nbAEGPBxFl","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S2772487525000625,Effects of coenzyme Q10 administration on blood pressure and heart rate in adults: A systematic review and meta-analysis of randomized controlled trials,,recINluftAPavksWY,,,,Science Direct,recRIfCU2PF5bhkmW,"Meta-analysis of 45 randomized controlled trials (48 effect sizes) found CoQ10 supplementation significantly reduced systolic blood pressure by 3.44 mmHg (95% CI: -5.13 to -1.55, p<0.01), with no significant effect on diastolic BP or heart rate. Subgroup analysis indicated that lower doses (<200 mg/day) and longer interventions (>8 weeks) resulted in greater systolic BP reductions. CoQ10 demonstrated favorable safety profile with minimal side effects, supporting its potential as adjunctive therapy for blood pressure management.",reckfFHaqSYeC3nhg
reclg2oZBQ7LqvMSU,"Muscle Pain, Muscle Weakness, Muscle Cramps, Muscle Fatigue, Creatine Kinase, Statin Myopathy",High,,2025-07-27T02:43:25.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Significant improvement in all measures of statin-associated muscle symptoms without affecting creatine kinase levels,LI251,"recntmFnf3bSSe2DB, recw2hqgZfllcjFso","recxJqmq5ipZMLJsj, recXiq3Os05QJJki4",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ahajournals.org/doi/10.1161/JAHA.118.009835,Effects of Coenzyme Q10 on Statin‐Induced Myopathy: An Updated Meta‐Analysis of Randomized Controlled Trials,PMID: 30371340,recINluftAPavksWY,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 12 randomized controlled trials involving 575 patients found CoQ10 supplementation significantly ameliorated statin-associated muscle symptoms including muscle pain (WMD: -1.60, 95% CI: -1.75 to -1.44, p<0.001), muscle weakness (WMD: -2.28, 95% CI: -2.79 to -1.77, p=0.006), muscle cramps (WMD: -1.78, 95% CI: -2.31 to -1.24, p<0.001), and muscle tiredness (WMD: -1.75, 95% CI: -2.31 to -1.19, p<0.001). No reduction in plasma creatine kinase levels was observed, suggesting symptomatic rather than biochemical improvement.",reckfFHaqSYeC3nhg
reczJ8DoV5MnM5fKw,"Brain CoQ10 Levels, Mitochondrial Function, Neurological Health, Oxidative Stress, Neuroprotection",High,,2025-07-27T02:43:40.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Significant increases in brain and mitochondrial CoQ10 concentrations with neuroprotective effects and increased survival in animal models,LI252,"recPiW3K4dhWi31Xh, recw2hqgZfllcjFso","rec8o1wlo0olBMl8A, recqea20SA5Y5BaIw",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC21173/,Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects,PMID: 9671775,recINluftAPavksWY,,,,PubMed,reclYXy0udvjr66Xa,"Study in 12- and 24-month-old rats found oral CoQ10 administration (200 mg/kg) significantly increased cerebral cortex CoQ10 concentrations and brain mitochondrial CoQ10 levels. CoQ10 supplementation markedly attenuated striatal lesions from neurotoxin 3-nitropropionic acid and significantly increased lifespan in transgenic mouse model of amyotrophic lateral sclerosis. Results demonstrate that oral CoQ10 crosses blood-brain barrier, enhances brain mitochondrial function, and provides neuroprotective effects relevant for neurodegenerative disease prevention.",reckfFHaqSYeC3nhg
recU15R9UzQGL0IzN,"Fasting Blood Glucose, HbA1c, Glycemic Control, Type 2 Diabetes, Insulin Sensitivity",High,,2025-07-27T10:07:54.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,37 mg/dL reduction in fasting blood glucose in diabetic adults; dose-dependent glycemic benefits proportional to baseline glycemic control,LI253,"recf4HtvFUqMhyhdh, recC0mB1LyNGjDyld, recAdUWMgWMZS3qKI","recVHWlB26jWt9Ij9, reccxH7AESy9vvBPo",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/26561625/,"Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus",PMID: 26561625,rec9qkWiu9H6o4rZk,,,,PubMed,recRIfCU2PF5bhkmW,Meta-analysis of 35 randomized controlled trials found psyllium supplementation (mean 10g daily before meals) significantly decreased fasting blood glucose and HbA1c levels in a dose-dependent manner proportional to baseline glycemic control. Greatest effects were seen in adults being treated for type 2 diabetes (-37.0 mg/dL fasting glucose) with modest effects in pre-diabetic adults (-4.7 mg/dL). Psyllium's viscous gel-forming properties enhance glucose metabolism and insulin sensitivity.,"recLSE9drrQavNmkC, recFE14qL0S8sFnSB"
rec9pHx0ga9pUgV1o,"Cardiovascular Disease, Total Cholesterol, LDL Cholesterol, Coronary Heart Disease, Stroke Incidence",High,,2025-07-27T10:08:08.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,23-28% reduction in cardiovascular disease incidence and mortality; 9-13 mg/dL cholesterol reduction with fiber supplementation,LI254,"recw2hqgZfllcjFso, recPiW3K4dhWi31Xh","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731843/,Dietary Fiber Is Beneficial for the Prevention of Cardiovascular Disease: An Umbrella Review of Meta-analyses,PMID: 29076144,rec9qkWiu9H6o4rZk,,,,PubMed,reccTfrcrIEsBwBO4,Umbrella review of 31 meta-analyses found that adults consuming the highest versus lowest dietary fiber intake had significantly reduced cardiovascular disease incidence (RR = 0.72-0.91) and mortality (RR = 0.77-0.83). Both β-glucan and psyllium fiber supplementation significantly reduced total cholesterol (9-12 mg/dL) and LDL cholesterol (10.8-13.5 mg/dL). High fiber intake reduced coronary heart disease incidence (RR = 0.76-0.93) and stroke incidence (RR = 0.83-0.93) across multiple large studies.,"recLSE9drrQavNmkC, recFE14qL0S8sFnSB"
reczPMLffl8SEYH9Q,"All-Cause Mortality, Cardiovascular Mortality, Cancer Mortality, Dietary Fiber Intake, Longevity",High,,2025-07-27T10:08:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"23% reduction in all-cause mortality, 26% reduction in cardiovascular mortality, and 22% reduction in cancer mortality with higher fiber intake",LI255,"recPiW3K4dhWi31Xh, receYj9nbAEGPBxFl",rec8o1wlo0olBMl8A,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/abs/pii/S0261561423003631,Dietary fiber intake and all-cause and cause-specific mortality: An updated systematic review and meta-analysis of prospective cohort studies,PMID: 37981377,rec9qkWiu9H6o4rZk,,,,Science Direct,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 64 prospective cohort studies with 3,512,828 participants found that higher total dietary fiber consumption significantly decreased all-cause mortality by 23% (HR: 0.77; 95% CI: 0.73-0.82), cardiovascular mortality by 26% (HR: 0.74; 95% CI: 0.71-0.77), and cancer mortality by 22% (HR: 0.78; 95% CI: 0.68-0.87). Insoluble fiber was more effective than soluble fiber for mortality reduction, with fiber from nuts and seeds reducing cardiovascular death by 43%.","recLSE9drrQavNmkC, recFE14qL0S8sFnSB"
recvcrchJO7J57m2b,"Weight Loss, Diastolic Blood Pressure, AST, Insulin Resistance, Gut Microbiome Diversity, Bifidobacterium",High,,2025-07-27T10:08:34.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant improvements in weight loss, blood pressure, liver enzymes, and insulin sensitivity with enhanced gut microbiome diversity in obese adults",LI256,"recAdUWMgWMZS3qKI, recPiW3K4dhWi31Xh","recSy02sgRnjfOkHE, reccxH7AESy9vvBPo",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/32340903/,Link between gut microbiota and health outcomes in inulin-treated obese patients: Lessons from the Food4Gut multicenter randomized placebo-controlled trial,PMID: 32340903,"rec9qkWiu9H6o4rZk, recISyk9tLHy8M5nn",,,,PubMed,reclYXy0udvjr66Xa,"Randomized placebo-controlled trial of 150 obese adults (BMI >30) found that 16g daily inulin supplementation for 3 months significantly improved weight loss, reduced diastolic blood pressure, decreased AST levels, and lowered insulin resistance compared to placebo. Inulin enhanced beneficial gut bacteria including Bifidobacterium and Akkermansia while reducing inflammatory markers. Greatest benefits occurred in patients not taking metformin, supporting complementary metabolic effects of prebiotic fiber supplementation.","recLSE9drrQavNmkC, reckkSx4q3QCfv0IF, recFE14qL0S8sFnSB"
rectczJLrnIi1EITi,"All-Cause Mortality, Cardiovascular Mortality, Cancer Mortality, Multivitamin Use, Longevity",High,,2025-07-27T10:12:03.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,No significant mortality benefit; 4% higher mortality risk observed in first follow-up period among healthy adults,LI257,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2820369,Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts,PMID: 38912623,"recjNakoelsgINz0v, recqZ5QkKpTUNLuyR",,,,PubMed,reclYXy0udvjr66Xa,"Cohort study of 390,124 generally healthy US adults (median age 61.5 years, range 50-74) followed for over 20 years found daily multivitamin use was not associated with mortality benefit and showed no effect on all-cause mortality (HR: 1.04; 95% CI: 1.02-1.07 in first follow-up period). Study excluded individuals with chronic diseases and carefully adjusted for healthy lifestyle factors, finding no evidence to support improved longevity among healthy adults who regularly take multivitamins.","recVfuxjbDBkPwulN, rec2rp3fHH2YUupT9"
recFhon7ePAPWTucC,"Cognitive Function, Episodic Memory, Global Cognition, Brain Health, Cognitive Aging",High,,2025-07-27T10:12:15.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Equivalent to 2-year slower cognitive aging with significant improvements in global cognition and episodic memory across multiple assessment methods,LI258,recPiW3K4dhWi31Xh,recELBnyZAf0mIQH6,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://ajcn.nutrition.org/article/S0002-9165(23)66342-7/fulltext,Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COSMOS randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS,PMID: 38244989,"recjNakoelsgINz0v, recqZ5QkKpTUNLuyR",,,,PubMed,reclYXy0udvjr66Xa,"Meta-analysis of 3 COSMOS cognitive substudies including 5,203 adults aged 60+ years found daily multivitamin-mineral supplementation significantly improved global cognition and episodic memory compared to placebo over 2-3 years. The comprehensive analysis showed daily multivitamin slowed global cognitive aging by equivalent of 2 years. Particularly strong benefits were observed for episodic memory tasks, with consistent effects across telephone, web-based, and in-person cognitive assessments.","recVfuxjbDBkPwulN, rec2rp3fHH2YUupT9"
recRcCaWssPsYOamj,"Immune Function, Antibody Response, Infection Risk, Vitamin D, Vitamin C, Zinc, Iron",High,,2025-07-27T10:12:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Enhanced immune function and antibody responses with reduced infection risk; particularly beneficial for populations with inadequate dietary intake,LI259,"recPiW3K4dhWi31Xh, recmyyZam7oYaGnDd, recEf9Re7uOBSjPbu",recELBnyZAf0mIQH6,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.mdpi.com/2072-6643/12/1/236,A Review of Micronutrients and the Immune System–Working in Harmony to Reduce the Risk of Infection,PMID: 31963293,"recjNakoelsgINz0v, rec1uVBjIQODjal27",,,,PubMed,reclYXy0udvjr66Xa,"Comprehensive review of multiple studies found that adequate intake of essential micronutrients including vitamins A, D, C, E, B6, B12, folate, zinc, iron, copper, and selenium is vital for optimal immune function at every stage of immune response. Marginal micronutrient deficiencies impair immunity and increase infection risk, while supplementation above RDA levels may optimize immune function in adults. Multivitamin-mineral supplementation increased antibody titers after influenza vaccination and showed trends for reduced respiratory tract infections in older adults.","recVfuxjbDBkPwulN, recDWfOeF8XHqTgnp"
recH2mI5BxEt2rOtW,"Vitamin D Status, Vitamin B12, Folate, Micronutrient Adequacy, Functional Decline, Frailty",High,,2025-07-27T10:12:45.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,High prevalence of micronutrient inadequacies (40-100% for some vitamins) with associated functional decline and frailty in older adults,LI260,"recDwWAHjdIXhMhSV, recq0JX3QgFBo5mm4, recDBJLAkc5CAfBm3, recr9ZjdfpVef9KJR, recTyoThcQqCihtey",recELBnyZAf0mIQH6,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/micronutrient-intakes-and-potential-inadequacies-of-communitydwelling-older-adults-a-systematic-review/1F708F9E5F20DBA3957F5CDCA73AB79D,Micronutrient intakes and potential inadequacies of community-dwelling older adults: a systematic review,PMID: 25822988,"recjNakoelsgINz0v, recqZ5QkKpTUNLuyR",,,,PubMed,reclYXy0udvjr66Xa,"Systematic review of observational studies in Western countries found high prevalence of micronutrient inadequacies among community-dwelling adults aged 65+ years, particularly for vitamin D (40-100% deficient), vitamin B12, folate, and minerals. Multiple micronutrient inadequacies are well-documented and associated with functional decline, frailty, and difficulties with independent living in older adults. Review identified significant gaps between dietary intake and optimal micronutrient levels, supporting rationale for multivitamin supplementation in aging populations.","recVfuxjbDBkPwulN, rec2rp3fHH2YUupT9"
recewCukHUSLwZfCl,"Serum Ferritin, Hemoglobin, Iron Status, Soluble Transferrin Receptor",High,,2025-07-27T10:16:19.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Dose-dependent improvements in ferritin (0.51 μg/L per week) and hemoglobin levels with iron supplementation across multiple adult populations,LI261,"rec7uKDm1ll1XGOqk, rec93yl8sjy6vTsht, recEf9Re7uOBSjPbu",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S0002916523029945,Effect of iron intake on iron status: a systematic review and meta-analysis of randomized controlled trials,,rec1uVBjIQODjal27,,,,Science Direct,rec4qqncSQrMbfAph,"Systematic review of 41 randomized controlled trials found iron supplementation significantly improved iron status biomarkers with dose-dependent effects. Serum ferritin increased by 0.51 μg/L per week of supplementation (95% CI: 0.02, 1.00; P = 0.04) and by 0.10 μg/L per gram of elemental iron (95% CI: 0.01, 0.20; P = 0.036). Hemoglobin concentrations improved based on baseline iron status, with greater effects in iron-deficient adults.",recDWfOeF8XHqTgnp
recSRdihQKpHrDOIa,"Hemoglobin, Iron Status, Cognitive Function, Intelligence Quotient",High,,2025-07-27T10:16:30.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant improvements in attention/concentration (SMD 0.59) and IQ (2.5 points) in anemic adults and adolescents with iron supplementation,LI262,"rec93yl8sjy6vTsht, recEf9Re7uOBSjPbu",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC2831810/,The effects of oral iron supplementation on cognition in older children and adults: a systematic review and meta-analysis,PMID: 20100340,rec1uVBjIQODjal27,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 14 randomized controlled trials in children aged 6+, adolescents and women found iron supplementation improved attention and concentration irrespective of baseline iron status (SMD 0.59, 95% CI 0.29 to 0.90). In anemic groups, supplementation improved intelligence quotient by 2.5 points (95% CI 1.24 to 3.76) over 8-29 weeks. No RCTs were found in men or older adults, but effects were consistent across age groups.",recDWfOeF8XHqTgnp
recMccCaCE86qRIN7,"Iron Deficiency, hsCRP, Interleukin-6, Soluble Transferrin Receptor",Moderate,,2025-07-27T10:16:41.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Iron deficiency significantly increased inflammatory markers (hs-CRP by 1.62 mg/L, IL-6 by 1.33 ng/L) in older adults over 3-year follow-up",LI263,"recPiW3K4dhWi31Xh, recEf9Re7uOBSjPbu",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://link.springer.com/article/10.1007/s40520-021-01955-3,Iron deficiency and biomarkers of inflammation: a 3-year prospective analysis of the DO-HEALTH trial,,rec1uVBjIQODjal27,,,,Springer Nature,recODsYatCgd7j2Vr,"Prospective analysis of 2,141 community-dwelling European adults aged 70+ (mean age 74.9 years) found iron deficiency was associated with greater increases in inflammatory biomarkers over 3 years. Iron deficiency at baseline increased IL-6 levels by 0.52 ng/L (95% CI 0.03–1.00, P = 0.04). Iron deficiency at any time point was associated with higher increases in hs-CRP (1.62 mg/L, 95% CI 0.98–2.26, P < 0.001) and IL-6 levels (1.33 ng/L, 95% CI 0.87–1.79, P < 0.001) independent of anemic status.",recDWfOeF8XHqTgnp
recsQQl4cRWa9BANA,"Hemoglobin, Ferritin, Iron Bioavailability, Gastrointestinal Tolerance",High,,2025-07-27T10:16:53.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Ferrous bisglycinate showed superior hemoglobin improvement (SMD 0.54 g/dL) and 64% reduction in GI side effects compared to other iron forms in adults,LI264,"rec7uKDm1ll1XGOqk, rec93yl8sjy6vTsht, recEf9Re7uOBSjPbu",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://academic.oup.com/nutritionreviews/article/81/8/904/7024657,The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials,PMID: 36728680,rec1uVBjIQODjal27,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 17 randomized controlled trials found ferrous bisglycinate supplementation superior to other iron supplements. In pregnant women (4-20 weeks supplementation), ferrous bisglycinate resulted in higher hemoglobin concentrations (SMD 0.54 g/dL; 95% CI 0.15-0.94; P < 0.01) and 64% fewer gastrointestinal adverse events (IRR 0.36; 95% CI 0.17-0.76; P < 0.01) compared to other iron supplements. Four studies in non-pregnant adults showed improved bioavailability and tolerance.",recDWfOeF8XHqTgnp
recUdc4Cwlh2X1O8i,"DNA Methylation, Folate Intake, Vitamin B12 Intake, Epigenetic Regulation, Cellular Proliferation, Gene Expression",Moderate,,2025-07-27T10:55:54.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Genome-wide associations between B vitamin intake and DNA methylation patterns across 5841 individuals; strongest effects in regions related to cellular proliferation and tumor suppression genes,LI265,"recDwWAHjdIXhMhSV, recr9ZjdfpVef9KJR, recTyoThcQqCihtey",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S0002916522011911,Association of dietary folate and vitamin B-12 intake with genome-wide DNA methylation in blood: a large-scale epigenome-wide association analysis in 5841 individuals,PMID: 31165884,recqZ5QkKpTUNLuyR,,,,PubMed,reclqQn6EV0azXdYf,"Large-scale epigenome-wide association study of 5841 participants from 10 cohorts found significant associations between folate and vitamin B12 intake and genome-wide DNA methylation patterns. Higher folate intake was associated with 6 differentially methylated positions linked to genes involved in cellular processes including centrosome localization, cell proliferation, and tumorigenesis. Vitamin B12 intake was associated with 29 differentially methylated regions annotated to 48 genes, demonstrating the critical role of these B vitamins in epigenetic regulation and DNA methylation maintenance essential for cellular health and longevity.",rec2rp3fHH2YUupT9
rec5nmyogy4RG53Lo,"Transepithelial Resistance, Serum Zonulin, Endotoxin, LPS, CRP, TNF-α, IL-6, Bifidobacterium, Lactobacillus",High,,2025-07-27T10:58:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Significant improvements in multiple intestinal barrier function markers with reduced inflammatory biomarkers across 1,891 adults in 26 RCTs",LI266,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1143548/full,Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials,PMID: 37153629,recISyk9tLHy8M5nn,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 26 randomized controlled trials involving 1,891 adults found probiotic supplementation significantly improved intestinal barrier function. Probiotics increased transepithelial resistance (MD 5.27, 95% CI 3.82-6.72, P<0.00001) and reduced serum zonulin (SMD -1.58, 95% CI -2.49 to -0.66, P=0.0007), endotoxin (SMD -3.20, 95% CI -5.41 to -0.98, P=0.005), and LPS levels (SMD -0.47, 95% CI -0.85 to -0.09, P=0.02). Anti-inflammatory effects included reductions in CRP, TNF-α, and IL-6 levels while increasing beneficial Bifidobacterium and Lactobacillus abundance.",reckkSx4q3QCfv0IF
recEqOiR22IGSgLjR,"Natural Killer Cells, Lymphocytes, Monocytes, Pro-inflammatory Cytokines, IL-6, TNF-α",High,,2025-07-27T10:58:38.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Limited but measurable improvements in immune markers in healthy adults, with 44% of studies showing significant effects on immune parameters",LI267,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/abs/pii/S2212267219311220,Probiotic supplementation has a limited effect on circulating immune and inflammatory markers in healthy adults: a systematic review of randomized controlled trials,PMID: 31648930,recISyk9tLHy8M5nn,,,,PubMed,rec4qqncSQrMbfAph,"Systematic review of 18 randomized controlled trials including 819 healthy adults found probiotic supplementation had limited but significant effects on immune markers. Eight studies reported significant improvements including increases in natural killer cells, lymphocytes, and monocytes, with decreases in pro-inflammatory cytokine concentrations. Effects were most pronounced in adults aged 40-65 years with supplementation lasting 3-12 weeks using doses of 10-20 billion CFU daily. Quality varied with 13 studies rated high quality and 5 neutral quality.",reckkSx4q3QCfv0IF
recEGaHbHhtTqDgQw,"IBS Symptom Severity, Abdominal Pain, Bloating, Global IBS Response, Bifidobacterium bifidum, Lactobacillus species",High,,2025-07-27T10:58:49.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant symptom improvements in 47% of adults with IBS using specific strains, with effect sizes varying by strain and outcome measure",LI268,,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00434-X/fulltext,Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis,PMID: 34746721,recISyk9tLHy8M5nn,,,,Science Direct,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 42 randomized controlled trials (N=3,856 adults, mean age 35-55 years) found strain-specific probiotic efficacy for IBS symptoms. Six single-strain probiotics and three multi-strain mixtures showed significant efficacy for IBS outcomes. Bifidobacterium bifidum MIMBb75 at 10^9 CFU daily for 4 weeks showed 47% response rate versus 11% placebo. Multi-strain formulations containing Lactobacillus and Bifidobacterium species at 10^9-10^10 CFU daily were most effective for global IBS symptoms, abdominal pain, and bloating.",reckkSx4q3QCfv0IF
recJniegrW816o3gQ,"Polymorphonuclear Phagocytic Capacity, Natural Killer Cell Activity, Immune Function, Cellular Immunity",High,,2025-07-27T10:59:01.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Large effect size for phagocytic capacity (SMD 1.37) and moderate effect for NK cell activity (SMD 0.55) in controlled studies of healthy adults,LI269,,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S0271531718307978,Short-term probiotic supplementation enhances cellular immune function in healthy elderly: systematic review and meta-analysis of controlled studies,PMID: 30670148,recISyk9tLHy8M5nn,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 17 prospective controlled studies involving 733 healthy adults (primarily aged 65+ years, with relevance to middle-aged adults 45-65) found probiotic supplementation significantly enhanced cellular immune function. Probiotics increased polymorphonuclear phagocytic capacity (SMD 1.37, 95% CI 0.86-1.88, P<0.001) and natural killer cell tumoricidal activity (SMD 0.55, 95% CI 0.37-0.73, P<0.001) relative to controls. Supplementation duration ranged 3-12 weeks with doses typically 10^8-10^10 CFU daily.",reckkSx4q3QCfv0IF
recWupLTL0rvNFpr7,"Sleep Quality Index, ApoB, Fasting Glucose, Fasting Insulin",High,,2025-07-27T11:01:31.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,1.24-point improvement in PSQI scores represents clinically meaningful sleep quality enhancement across diverse adult populations,LI270,"receYj9nbAEGPBxFl, recf4HtvFUqMhyhdh, recierVNozpgZdLZH","recxJqmq5ipZMLJsj, recXiq3Os05QJJki4",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/33417003/,Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials,PMID: 33417003,recMuFqL0V3Vyboh5,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 23 randomized controlled trials involving 1517 adult participants found melatonin supplementation significantly improved sleep quality as assessed by Pittsburgh Sleep Quality Index (PSQI) with weighted mean difference of -1.24 (95% CI: -1.77, -0.71, p<0.001). Benefits were observed in adults with respiratory diseases, metabolic disorders, and primary sleep disorders but not in those with mental disorders or neurodegenerative diseases.",recoWZDGXdcZFUjCn
recQjt0RqlVLhQp6A,"Sleep Onset Latency, Total Sleep Time, Sleep Quality, Fasting Glucose",High,,2025-07-27T11:01:49.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Modest but consistent improvements in sleep onset and duration with dose-response relationship favoring higher doses and longer treatment,LI271,recf4HtvFUqMhyhdh,"recxJqmq5ipZMLJsj, recXiq3Os05QJJki4",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC3656905/,Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders,PMID: 23691142,recMuFqL0V3Vyboh5,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 19 studies involving 1683 adult and pediatric subjects found melatonin demonstrated significant efficacy in reducing sleep latency by 7.06 minutes (95% CI: 4.37-9.75, p<0.001) and increasing total sleep time by 8.25 minutes (95% CI: 1.74-14.75, p=0.013). Trials with longer duration and higher doses of melatonin showed greater effects on decreasing sleep latency and increasing total sleep time.",recoWZDGXdcZFUjCn
rec2wgpap3Uph2ZDK,"Inflammatory Cytokines, IL-6, TNF-alpha, ApoB, Fasting Insulin",High,,2025-07-27T11:02:03.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Large effect sizes for multiple inflammatory markers with consistent anti-inflammatory effects across diverse adult populations,LI272,"receYj9nbAEGPBxFl, recierVNozpgZdLZH","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7979486/,Anti-inflammatory effects of melatonin: A systematic review and meta-analysis of clinical trials,PMID: 33581247,recMuFqL0V3Vyboh5,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 31 clinical trials involving 1517 participants found melatonin had significant anti-inflammatory effects on interleukin-1 (SMD -1.64; 95% CI -2.86, -0.43; p=0.008), IL-6 (-3.84; -5.23, -2.46; p<0.001), IL-8 (-21.06; -27.27, -14.85; p<0.001), and tumor necrosis factor (-1.54; -2.49, -0.58; p=0.002), but not on C-reactive protein. Results suggest melatonin may be useful for prevention and adjuvant treatment of inflammatory disorders in adults.",recoWZDGXdcZFUjCn
recaLzLEsjEetQT5g,"Circadian Rhythm Markers, Sleep Quality, ApoB, Total Sleep",High,,2025-07-27T11:02:13.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Highly effective for jet lag prevention with NNT=2; greater benefit for eastward flights and longer time zone shifts,LI273,receYj9nbAEGPBxFl,recxJqmq5ipZMLJsj,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8958662/,Melatonin for the prevention and treatment of jet lag,PMID: 12076414,recMuFqL0V3Vyboh5,,,,PubMed,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 10 randomized controlled trials found melatonin remarkably effective in preventing or reducing jet lag when taken close to target bedtime (10pm-midnight) at destination. Eight of nine trials showed decreased jet lag from flights crossing 5+ time zones, with daily doses between 0.5-5mg similarly effective. Eastward travel benefits more than westward travel, with number needed to treat of 2.",recoWZDGXdcZFUjCn
recNL9LuPn7qj08wG,"Bone Mineral Density, Calcium (Serum), Calcium (Ionized), Fracture Risk",High,,2025-07-27T14:06:29.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,"0.7-1.8% increases in bone mineral density at multiple sites, but clinically insignificant for fracture prevention",LI274,"rec7lljffINZr7vSi, recVZYWGkdqlDhEL9",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.bmj.com/content/351/bmj.h4183,Calcium intake and bone mineral density: systematic review and meta-analysis,PMID: 26420598,recF3yrCOuu1R5WWn,,,,The BMJ,rec4qqncSQrMbfAph,"Systematic review and meta-analysis of 59 randomized controlled trials (n=13,790 participants, aged >50 years) found that calcium supplements increased bone mineral density by 0.7-1.8% at five skeletal sites over 1-2 years compared to placebo, but with small non-progressive increases unlikely to lead to clinically significant fracture reduction. Dietary calcium intake showed no association with fracture risk.",rechvSExLMD5YORhF
recSM3DZQDNGKvl4s,"Cardiovascular Disease Events, Coronary Heart Disease, Systolic Blood Pressure, Diastolic Blood Pressure",High,,2025-07-27T14:06:50.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"15% increased cardiovascular disease risk in postmenopausal women, concerning safety signal",LI275,,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.mdpi.com/2072-6643/13/2/368,Calcium Supplements and Risk of Cardiovascular Disease: A Meta-Analysis of Clinical Trials,PMID: 33530332,recF3yrCOuu1R5WWn,,,,MDPI,recRIfCU2PF5bhkmW,"Meta-analysis of 13 double-blind, placebo-controlled RCTs (n=28,935 intervention, 14,243 control, mean age 64 years) found calcium supplementation significantly increased cardiovascular disease risk by 15% (RR=1.15; 95% CI: 1.02-1.30) and coronary heart disease by 15% (RR=1.15; 95% CI: 1.01-1.32) in healthy postmenopausal women compared to placebo over 3.6 years median follow-up.",rechvSExLMD5YORhF
recC4qu2BH3nRj3Sv,"Systolic Blood Pressure, Diastolic Blood Pressure, Calcium (Serum)",High,,2025-07-27T14:07:02.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,"Small but statistically significant blood pressure reductions, greater benefit in calcium-deficient individuals",LI276,rec7lljffINZr7vSi,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nature.com/articles/1002038,Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials,PMID: 16673011,recF3yrCOuu1R5WWn,,,,Springer Nature,recRIfCU2PF5bhkmW,"Meta-analysis of 40 randomized controlled trials (n=2,492 non-pregnant adults, median follow-up 9.5 weeks) found calcium supplementation (mean dose 1,200 mg daily) reduced systolic blood pressure by 1.86 mmHg (95% CI: -2.91 to -0.81) and diastolic blood pressure by 0.99 mmHg (95% CI: -1.61 to -0.37). Effects were larger in people with low calcium intake (≤800 mg daily).",rechvSExLMD5YORhF
rec2Jy46MxJci7Ixw,"Fracture Incidence, Bone Mineral Density, Hip Fracture, Vertebral Fracture",High,,2025-07-27T14:07:13.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,No significant fracture prevention benefit in community-dwelling adults despite theoretical bone density improvements,LI277,,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://jamanetwork.com/journals/jama/fullarticle/2667071,Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis,PMID: 29279934,recF3yrCOuu1R5WWn,,,,JAMA,rec4qqncSQrMbfAph,"Systematic review and meta-analysis of 25 randomized clinical trials (n=50,000+ community-dwelling adults aged ≥50 years) found calcium supplementation, with or without vitamin D, was not significantly associated with lower incidence of hip, nonvertebral, vertebral, or total fractures. Results were consistent regardless of calcium dose, sex, fracture history, or baseline calcium intake over 2-7 years follow-up.",rechvSExLMD5YORhF
reclDPDNkNK7zcSmQ,"C-reactive Protein, High-sensitivity CRP, CD4+ T-cells, Immune Function, Inflammatory Markers",High,,2025-07-28T15:12:38.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,32.4 mg/L reduction in CRP and enhanced CD4+ T-cell immune function across 35 randomized trials,LI278,recPiW3K4dhWi31Xh,recXiq3Os05QJJki4,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/33356467/,Zinc supplementation and immune factors in adults: a systematic review and meta-analysis of randomized clinical trials,PMID: 33356467,reca1EA58OLPRmVpr,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 35 randomized controlled trials involving 1,995 adults found zinc supplementation significantly reduced inflammatory markers including C-reactive protein by 32.4 mg/L (95% CI: -44.45 to -19.62, p<0.001) and high-sensitivity CRP by 0.95 mg/L (95% CI: -1.01 to -0.89, p<0.001). Zinc supplementation also increased CD4+ T-cells by 1.79 (95% CI: 0.57 to 3, p=0.004), supporting enhanced immune function and reduced systemic inflammation in adults.",recMtYN056UTY5QKJ
reccedv3yoEzB5ahQ,"Serum Testosterone, Total Testosterone, Hormonal Health, Zinc Status, Male Health",Moderate,,2025-07-28T15:12:51.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,93% increase in testosterone levels in elderly men with zinc deficiency; positive correlation between zinc status and testosterone,LI279,recX6IiQRem8pQ14z,rec8o1wlo0olBMl8A,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/36577241/,Correlation between serum zinc and testosterone: A systematic review,PMID: 36577241,reca1EA58OLPRmVpr,,,,PubMed,recODsYatCgd7j2Vr,"Systematic review of 38 studies (8 clinical and 30 animal studies) found zinc deficiency consistently reduces testosterone levels while zinc supplementation improves testosterone levels in adults. In elderly men with marginal zinc deficiency, 6 months of zinc supplementation increased serum testosterone from 8.3±6.3 to 16.0±4.4 nmol/L (p=0.02), representing a 93% increase. The effect was most pronounced in zinc-deficient individuals, with serum zinc positively correlated with total testosterone levels.",recMtYN056UTY5QKJ
recBdEpSpUG4N7VG7,"DNA Integrity, DNA Strand Breaks, Oxidative Stress, Cellular Function, DNA Repair",High,,2025-07-28T15:13:04.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,47% reduction in DNA strand breaks with modest 4mg increase in zinc intake; enhanced DNA repair proteins,LI280,receYj9nbAEGPBxFl,recxJqmq5ipZMLJsj,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC5267297/,A moderate increase in dietary zinc reduces DNA strand breaks in leukocytes and alters plasma proteins without changing plasma zinc concentrations,PMID: 28003206,reca1EA58OLPRmVpr,,,,PubMed,recd0d1tmtDQUEhTY,"Controlled feeding study of 18 healthy men (mean age 30 years) found that increasing dietary zinc from 6mg to 10mg daily significantly reduced DNA strand breaks in leukocytes by 47% (from 23.0±6.3% to 12.2±3.7%, p<0.001). The study demonstrated that zinc supplementation enhanced proteins involved in DNA repair, antioxidant function, and immune responses while reducing pro-inflammatory protein markers, supporting zinc's role in cellular protection and DNA synthesis.",recMtYN056UTY5QKJ
recQM8JCLmb2Dv29H,"C-reactive Protein, TNF-α, Malondialdehyde, Total Antioxidant Capacity, Oxidative Stress, Inflammatory Markers",High,,2025-07-28T15:13:15.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant reductions in CRP and TNF-α with increased antioxidant capacity across 21 randomized trials,LI281,"recPiW3K4dhWi31Xh, recsIZzvXU1VCDEpy",recXiq3Os05QJJki4,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/abs/pii/S1043466620304129,Effects of zinc supplementation on inflammatory biomarkers and oxidative stress in adults: A systematic review and meta-analysis of randomized controlled trials,PMID: 34560424,reca1EA58OLPRmVpr,,,,Science Direct,recRIfCU2PF5bhkmW,"Meta-analysis of 21 randomized controlled trials involving 1,321 adults found zinc supplementation significantly reduced inflammatory markers including C-reactive protein (ES=-0.92 mg/L, 95% CI: -1.36 to -0.48, p<0.001) and tumor necrosis factor-α levels. Zinc supplementation also decreased malondialdehyde (oxidative stress marker) while increasing total antioxidant capacity, demonstrating zinc's dual anti-inflammatory and antioxidant benefits in supporting cellular health and reducing systemic inflammation.",recMtYN056UTY5QKJ
rec1j4kGtt8DMLYFO,"MDA, IL-8, TNF-α, IL-6, hsCRP, Homocysteine, Glutathione",High,,2025-07-28T15:17:40.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,44% reduction in MDA oxidative stress marker with consistent anti-inflammatory effects across diverse adult populations,LI282,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/32726657/,The effects of N-acetylcysteine on inflammatory and oxidative stress biomarkers: A systematic review and meta-analysis of controlled clinical trials,PMID: 32726657,recf2LUJMPK0syGHZ,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 28 randomized controlled trials (n=2,265 participants, mean age range 35-65 years) found NAC supplementation significantly decreased oxidative stress markers including MDA levels (SMD = -1.44 μmol/L; 95% CI: -2.05, -0.84) and inflammatory markers IL-8 (WMD = -2.56 pg/ml; 95% CI: -3.89, -1.23) and homocysteine levels. NAC enhanced antioxidant capacity primarily through glutathione restoration pathways.",recRu57EJ7T4zhB2h
rec2XXB7INamQ3S4Z,"ALT, AST, ALP, Liver Steatosis Grade, Spleen Size",High,,2025-07-28T15:17:59.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant ALT reduction in NAFLD patients with hepatoprotective effects demonstrated through improved liver enzymes and organ measurements,LI283,"recfQt6B5C5wmZDqn, recHHlPLn8pdw89yH, recsIZzvXU1VCDEpy",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC3270338/,N-Acetylcysteine Improves Liver Function in Patients with Non-Alcoholic Fatty Liver Disease,PMID: 22267939,recf2LUJMPK0syGHZ,,,,PubMed,recFfb6t4bEMGdz5J,"Randomized controlled trial of 30 adults with NAFLD (mean age 43 years) found NAC 600mg daily for 3 months significantly decreased serum ALT levels (p<0.05) compared to vitamin C control, independent of steatosis grade. NAC also significantly reduced spleen span, indicating improved hepatic hemodynamics. Treatment was well-tolerated with no adverse effects reported.",recRu57EJ7T4zhB2h
recFarchexVbsWqcV,"COPD Exacerbation Rate, FEV1, Respiratory Symptoms, Lung Function",High,,2025-07-28T15:18:09.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,25% reduction in COPD exacerbation risk with consistent respiratory protective effects across multiple adult populations,LI284,,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://err.ersjournals.com/content/24/137/451,Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis,PMID: 26405318,recf2LUJMPK0syGHZ,,,,Science Direct,recPTVJvlU8ZpgeS3,"Meta-analysis of 13 studies (n=4,155 adults, mean age 50-70 years) found NAC significantly reduced COPD exacerbation frequency (relative risk 0.75, 95% CI 0.66-0.84, p<0.01). Low-dose NAC (600mg daily) provided significant protection against exacerbations (RR 0.76, 95% CI 0.65-0.89), while high-quality studies confirmed respiratory benefits in adults with established COPD diagnosis.",recRu57EJ7T4zhB2h
recMxvJCgtrra5ier,"Albumin, Total Bilirubin, ALT, AST, ALP, Liver Function Tests",High,,2025-07-28T15:18:21.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant improvements in key liver function biomarkers (albumin synthesis and bilirubin clearance) demonstrating hepatoprotective effects,LI285,"recfQt6B5C5wmZDqn, recHHlPLn8pdw89yH, recsIZzvXU1VCDEpy, recp5z4Yutaf7CDEX",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/abs/pii/S2213434423000154,The efficacy of N-acetylcysteine in improving liver function: A systematic review and meta-analysis of controlled clinical trials,PMID: 37068508,recf2LUJMPK0syGHZ,,,,Science Direct,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 8 randomized controlled trials (n=450 adults, age range 35-70 years) found NAC supplementation significantly increased serum albumin levels (SMD = 1.05 pg/ml; 95% CI: 0.41-1.69, p<0.001) and decreased total bilirubin concentrations (SMD = -0.34 pg/ml; 95% CI: -0.53 to -0.14, p<0.001), indicating improved hepatic synthetic function and detoxification capacity.",recRu57EJ7T4zhB2h
recMD0Aty33OBhyak,"Fasting Glucose, HbA1c, 2-hour Postprandial Glucose, Type 2 Diabetes",High,,2025-07-28T15:46:01.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"14.8 mg/dL reduction in fasting glucose, 0.63% reduction in HbA1c, with dose-dependent glucose-lowering effects in adults with elevated baseline levels",LI286,"recf4HtvFUqMhyhdh, recC0mB1LyNGjDyld",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.1015045/full,Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis,PMID: 36467075,recvkAS7HacVMiozb,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 37 randomized controlled trials with 3,048 adults (primarily middle-aged 45-65 years) found berberine significantly reduced fasting glucose by 14.8 mg/dL (WMD = -0.82 mmol/L, 95% CI -0.95 to -0.70), HbA1c by 0.63% (95% CI -0.72 to -0.53), and 2-hour postprandial glucose by 20.9 mg/dL (WMD = -1.16 mmol/L, 95% CI -1.36 to -0.96) compared to controls. Effects were dose-dependent and greater in patients with higher baseline glucose levels.",rec7MU52EslZT1jUt
recjSzlhtOL89izWO,"Triglycerides, Total Cholesterol, LDL Cholesterol, Fasting Insulin, HOMA-IR, Systolic Blood Pressure",High,,2025-07-28T15:46:14.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Significant reductions in multiple cardiovascular risk factors including 23.7 mg/dL triglyceride reduction, 20.6 mg/dL total cholesterol reduction, and 5.5 mmHg systolic BP reduction in adults",LI287,"recDBJLAkc5CAfBm3, recierVNozpgZdLZH, recAdUWMgWMZS3qKI",recELBnyZAf0mIQH6,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2022.1013055/full,The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis,PMID: 36313096,recvkAS7HacVMiozb,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of randomized controlled trials in adults found berberine significantly reduced triglycerides by 23.7 mg/dL (95% CI -30.16 to -17.25), total cholesterol by 20.6 mg/dL (95% CI -23.65 to -17.63), LDL cholesterol by 9.6 mg/dL (95% CI -13.87 to -5.39), and systolic blood pressure by 5.5 mmHg (95% CI -8.17 to -2.76). Insulin levels decreased by 3.3 mg/dL and HOMA-IR decreased by 1.04 units, indicating improved insulin sensitivity.",rec7MU52EslZT1jUt
rec25h3FHNaUByXvS,"ALT, AST, Triglycerides, Total Cholesterol, LDL Cholesterol, HOMA-IR, Liver Function, NAFLD",High,,2025-07-28T15:46:24.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Significant improvements in liver function markers, lipid metabolism, and insulin resistance in NAFLD patients, with clinical benefits for metabolic syndrome and hepatic steatosis",LI288,"recDBJLAkc5CAfBm3, recAdUWMgWMZS3qKI",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05011-2,The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review,PMID: 38429794,recvkAS7HacVMiozb,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of randomized controlled trials involving NAFLD patients found berberine significantly improved liver function markers including reduced ALT and AST levels, decreased triglycerides, total cholesterol, and LDL cholesterol, and improved insulin resistance (HOMA-IR reduction). The analysis demonstrated berberine's efficacy in improving liver enzymes, lipid profiles, and insulin sensitivity in adults with non-alcoholic fatty liver disease, with good safety profile.",rec7MU52EslZT1jUt
rec70UQYyfpxpDmNQ,"HbA1c, Fasting Glucose, Fasting Insulin, HOMA-IR, Triglycerides, Total Cholesterol, Type 2 Diabetes, Metabolic Syndrome",High,,2025-07-28T15:46:38.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Comprehensive metabolic improvements with 0.73% HbA1c reduction, 15.5 mg/dL fasting glucose reduction, and significant improvements in insulin resistance, lipid profile, and inflammation markers",LI289,"recC0mB1LyNGjDyld, recf4HtvFUqMhyhdh, recierVNozpgZdLZH, recAdUWMgWMZS3qKI, recDBJLAkc5CAfBm3",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/34956436/,The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,PMID: 34956436,recvkAS7HacVMiozb,,,,PubMed,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 46 randomized controlled trials in adults with type 2 diabetes found berberine significantly reduced HbA1c (MD = -0.73%, 95% CI -0.97 to -0.51), fasting glucose (MD = -0.86 mmol/L, 95% CI -1.10 to -0.62), fasting insulin (MD = -2.05 mU/L, 95% CI -2.62 to -1.48), HOMA-IR (MD = -0.71, 95% CI -1.03 to -0.39), triglycerides (MD = -0.5 mmol/L), and total cholesterol (MD = -0.64 mmol/L). The analysis confirmed strong evidence supporting berberine's clinical efficacy and safety as adjunctive therapy for diabetes and metabolic syndrome.",rec7MU52EslZT1jUt
recL9srK0ySlyshNB,"Sleep Quality, Sleep Latency, Total Sleep Time, Subjective Sleep Quality",High,,2025-07-28T15:54:35.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Consistent improvements in sleep quality and latency across multiple small studies, though limited by small sample sizes and high risk of bias",LI290,,recxJqmq5ipZMLJsj,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC10828290/,The effect of glycine administration on the characteristics of physiological systems in human adults: A systematic review,PMID: 37851316,rec1PrjGHQIdyGhrF,,,,PubMed,rec4qqncSQrMbfAph,"Systematic review of 52 studies in adult humans found glycine administration improved sleep quality in healthy populations through longer-term supplementation (3-14 days). The nervous system demonstrated the most positive effects, with significant sleep improvements including reduced sleep latency and enhanced subjective sleep quality. Studies consistently showed 3g glycine before bedtime improved sleep metrics in adults aged 21-67 years.",recDhLwBE8RhFpcMX
recybnvVRi3uqaDzK,"ALT, AST, Hepatic Fat Content, Glutathione, NAFLD Progression, Liver Function",High,,2025-07-28T15:54:49.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Strong mechanistic evidence linking glycine deficiency to NAFLD pathogenesis with therapeutic potential through fatty acid oxidation and glutathione pathways,LI291,"recfQt6B5C5wmZDqn, recHHlPLn8pdw89yH, recq0JX3QgFBo5mm4",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC7982985/,"Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome",PMID: 33268508,rec1PrjGHQIdyGhrF,,,,PubMed,recRIfCU2PF5bhkmW,"Preclinical and translational study demonstrated that glycine-based treatment (DT-109) significantly improved NAFLD by stimulating hepatic fatty acid oxidation and glutathione synthesis. Meta-analysis of human liver data showed reduced glycine biosynthetic gene expression in NASH patients versus healthy controls. Lower circulating glycine was consistently associated with NAFLD across multiple human studies, suggesting impaired glycine metabolism plays a causative role in liver disease progression.",recDhLwBE8RhFpcMX
recKakSWF3VgxvkAY,"TBARS, Systolic Blood Pressure, Oxidative Stress Markers, Metabolic Syndrome, hsCRP",High,,2025-07-28T15:55:00.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,25% reduction in oxidative stress with clinically meaningful 7.7 mmHg systolic blood pressure reduction in men with metabolic syndrome,LI292,recPiW3K4dhWi31Xh,recELBnyZAf0mIQH6,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/24144057/,"Oral supplementation with glycine reduces oxidative stress in patients with metabolic syndrome, improving their systolic blood pressure",PMID: 24144057,rec1PrjGHQIdyGhrF,,,,PubMed,recFfb6t4bEMGdz5J,"Randomized controlled trial of 60 adults with metabolic syndrome (mean age 52 years) found 15g daily glycine supplementation for 3 months significantly reduced oxidative stress markers (25% decrease in TBARS vs placebo), improved antioxidant enzyme activity, and decreased systolic blood pressure by 7.7 mmHg in men (p=0.043). The study demonstrated glycine's role in balancing redox reactions and protecting against oxidative damage in metabolic syndrome patients.",recDhLwBE8RhFpcMX
recZZu138im52nLvU,"Coronary Heart Disease Risk, Cardiovascular Disease Events, Blood Pressure, Glycine Levels",High,,2025-07-28T15:55:10.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Genetic evidence supporting causal relationship between higher glycine levels and reduced coronary heart disease risk in large population study,LI293,,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC6400990/,Assessing the causal association of glycine with risk of cardio-metabolic diseases,PMID: 30842415,rec1PrjGHQIdyGhrF,,,,PubMed,recRIfCU2PF5bhkmW,"Genome-wide meta-analysis of 80,003 individuals identified 27 genetic loci for glycine and found evidence for a protective causal effect of glycine on coronary heart disease risk. Higher genetically predicted glycine levels were associated with lower CHD risk, potentially mediated through blood pressure pathways. The study strengthened epidemiological evidence showing circulating glycine levels inversely associated with cardiovascular disease incidence in middle-aged adults.",recDhLwBE8RhFpcMX
recixL7mBSTqhNkna,"Joint Pain, Physical Function, Joint Stiffness, hsCRP",High,,2025-07-28T17:50:59.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Chondroitin showed moderate efficacy for pain relief and function improvement; glucosamine demonstrated significant stiffness reduction,LI294,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://josr-online.biomedcentral.com/articles/10.1186/s13018-018-0871-5,Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials,PMID: 29973309,reckmGaZaq5z09MXR,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 26 articles describing 30 trials found chondroitin significantly alleviated osteoarthritis pain symptoms and improved physical function compared to placebo, while glucosamine showed significant effects on joint stiffness improvement. Both supplements demonstrated excellent safety profiles with no serious adverse events reported across studies in adults with knee and hip osteoarthritis.",recWO0nU7IeD7SHi9
reckgmoubE1WPxWuX,"Cardiovascular Mortality, All-Cause Mortality, hsCRP, Inflammation",Moderate,,2025-07-28T17:51:19.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,49% reduction in cardiovascular mortality with 27% lower overall mortality in large national cohort,LI295,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC8366581/,Glucosamine/Chondroitin and Mortality in a US NHANES Cohort,PMID: 33219063,reckmGaZaq5z09MXR,,,,PubMed,recODsYatCgd7j2Vr,"Prospective cohort study of 16,686 US adults (mean follow-up 107 months) found that regular glucosamine/chondroitin intake for 1+ years was associated with 49% lower cardiovascular mortality (HR=0.51; 95% CI: 0.28-0.92) and reduced all-cause mortality compared to non-users. Anti-inflammatory effects and improved endothelial function were proposed mechanisms for the cardiovascular protection observed in middle-aged and older adults.",recWO0nU7IeD7SHi9
rech0uhKe0jdMkr5I,"All-Cause Mortality, Cancer Mortality, hsCRP, Anti-inflammatory Effects",Moderate,,2025-07-28T17:51:28.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,18% reduction in total mortality for glucosamine users and 14% for chondroitin users in large prospective cohort,LI296,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557824/,Use of Glucosamine and Chondroitin in Relation to Mortality,PMID: 22992251,reckmGaZaq5z09MXR,,,,PubMed,recODsYatCgd7j2Vr,"Prospective cohort study of 77,510 Washington State residents aged 50-76 years found glucosamine use (with or without chondroitin) associated with 18% lower total mortality (HR=0.82; 95% CI: 0.75-0.90) and chondroitin use associated with 14% lower mortality (HR=0.86; 95% CI: 0.78-0.96) over 8-year follow-up. The mortality reduction was particularly notable for cancer deaths, suggesting anti-inflammatory mechanisms may underlie the longevity benefits.",recWO0nU7IeD7SHi9
recWPLJxRelJSVwCu,"Joint Pain, Physical Function, Joint Space Width, Cartilage Health, hsCRP",High,,2025-07-28T17:51:39.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Chondroitin showed moderate pain reduction and function improvement; glucosamine demonstrated structural joint preservation,LI297,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/38581640/,"Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysis",PMID: 38581640,reckmGaZaq5z09MXR,,,,PubMed,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 25 randomized controlled trials found chondroitin sulfate significantly decreased pain intensity and improved physical function in adults with knee osteoarthritis, while glucosamine sulfate showed significant reduction in joint space narrowing (a marker of cartilage preservation). The combination therapy showed mixed results but individual components demonstrated meaningful therapeutic benefits with excellent safety profiles.",recWO0nU7IeD7SHi9
recJ4vL5VemVMA5VN,"CRP, TNF-α, IL-6, MDA, Pulse Wave Velocity, Flow-Mediated Dilation, Catalase, Glutathione Peroxidase, Superoxide Dismutase",High,,2025-07-29T10:31:06.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Consistent anti-inflammatory effects across multiple meta-analyses with 0.87 mg/L reduction in CRP and significant improvements in TNF-α and IL-6 levels,LI298,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/38945354/,"The effects of curcumin supplementation on biomarkers of inflammation, oxidative stress, and endothelial function: A meta-analysis of meta-analyses",PMID: 38945354,recqRCEI6AzpyzFBa,,,,PubMed,reccTfrcrIEsBwBO4,"Meta-analysis of 21 meta-analyses revealed that curcumin supplementation significantly reduced inflammatory markers including CRP by 0.87 mg/L (95% CI: -1.14, -0.59), TNF-α by 2.72 pg/ml (95% CI: -4.05, -1.38), and IL-6 by 0.97 pg/ml (95% CI: -1.40, -0.54) in adults. Curcumin also improved oxidative stress markers and endothelial function, with optimal effects observed at doses ≤800 mg/day for <10 weeks duration.",rec2jWRD3SItFiAWs
recZzl80Pxwh2f6TC,"Postprandial Glucose, Insulin Response, Fasting Insulin, HOMA-IR, Glucose Tolerance",High,,2025-07-29T10:31:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,36% reduction in glucose AUC and 26% reduction in insulin response following curcumin supplementation in healthy adults,LI299,"recierVNozpgZdLZH, recAdUWMgWMZS3qKI",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nature.com/articles/s41598-018-32032-x,"Curcumin alleviates postprandial glycaemic response in healthy subjects: A cross-over, randomized controlled study",PMID: 30209251,recqRCEI6AzpyzFBa,,,,Science Direct,recFfb6t4bEMGdz5J,"Randomized controlled crossover study of 16 healthy adults found that 180 mg curcumin significantly reduced postprandial glucose concentrations by 60.6% at 60 minutes (P = 0.0007) and decreased area under the curve for glucose by 36% (P = 0.003) compared to placebo. Curcumin also reduced postprandial insulin demand by 26% (P = 0.01), suggesting improved insulin sensitivity and glucose metabolism.",rec2jWRD3SItFiAWs
recjIxKcwovfF1VuR,"Depression Scores, Anxiety Scores, BDNF, Cortisol, Inflammatory Cytokines",High,,2025-07-29T10:31:31.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Large effect sizes for both depression (g = -0.75) and anxiety (g = -2.62) with statistical significance in adults with mood disorders,LI300,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/31423805/,Curcumin for depression: a meta-analysis,PMID: 31423805,recqRCEI6AzpyzFBa,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 9 randomized controlled trials (531 participants) found curcumin supplementation significantly improved depressive symptoms (Hedge's g = -0.75, 95% CI -1.11 to -0.39, p < 0.001) and anxiety symptoms (Hedge's g = -2.62, 95% CI -4.06 to -1.17, p < 0.001) with large effect sizes in adults with major depressive disorder. Curcumin was generally well-tolerated with minimal adverse events reported.",rec2jWRD3SItFiAWs
rechMscowZwnUBRGt,"Joint Pain, Inflammation Markers, Functional Assessment, CRP",High,,2025-07-29T10:31:42.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Clinically meaningful reductions in pain (1.63 VAS points) and functional scores (18.85 WOMAC points) with better safety profile than NSAIDs,LI301,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S0378874123013636,Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis,PMID: 37967619,recqRCEI6AzpyzFBa,,,,Science Direct,recPTVJvlU8ZpgeS3,"Bayesian network meta-analysis of 23 studies (2,175 patients with knee osteoarthritis) found curcumin significantly reduced visual analogue scale pain scores by 1.63 points (95% CI: -2.91 to -0.45) and total WOMAC scores by 18.85 points (95% CI: -29.53 to -8.76) compared to placebo. Curcumin showed superior safety profile compared to NSAIDs with reduced adverse reactions (OR = 0.51, 95% CI: 0.25 to 0.94) while maintaining clinical efficacy.",rec2jWRD3SItFiAWs
recuhRGoqAdM1CeF8,"Fasting Glucose, Insulin, HOMA-IR, Triglycerides, LDL Cholesterol, Glucose Homeostasis",High,,2025-07-29T10:44:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant improvements in glucose homeostasis parameters (fasting glucose -0.54 SMD) and lipid profiles in adults with metabolic diseases,LI302,"recPiW3K4dhWi31Xh, recw2hqgZfllcjFso, recDBJLAkc5CAfBm3",recVHWlB26jWt9Ij9,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/29990473/,The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials,PMID: 29990473,recHKgsM8akY38ItI,,,,PubMed,recd0d1tmtDQUEhTY,"Meta-analysis of 24 randomized controlled trials with 1,407 participants (mean age 50-65 years across studies) found alpha-lipoic acid supplementation significantly decreased fasting glucose (SMD -0.54; 95% CI: -0.89, -0.19; P = 0.003), insulin levels, HOMA-IR, triglycerides, and LDL cholesterol among patients with metabolic diseases including diabetes, metabolic syndrome, and PCOS. Treatment doses ranged from 300-1800mg daily for 4-24 weeks.",recjcAFH5st2aRDO0
recye1PIDZNSe8b5U,"C-reactive protein, Interleukin-6, TNF-alpha, Inflammatory Markers, Metabolic Syndrome",High,,2025-07-29T10:45:00.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Large reductions in inflammatory markers: CRP (-1.52 SMD), IL-6 (-1.96 SMD), and TNF-α (-2.62 SMD) in adults with metabolic diseases",LI303,recPiW3K4dhWi31Xh,recVHWlB26jWt9Ij9,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC5989440/,The effects of alpha-lipoic acid supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials,PMID: 29866160,recHKgsM8akY38ItI,,,,PubMed,recd0d1tmtDQUEhTY,"Meta-analysis of 18 randomized controlled trials with 912 participants (adults with metabolic syndrome, diabetes, and related disorders) found alpha-lipoic acid supplementation significantly decreased C-reactive protein (SMD = -1.52; 95% CI: -2.25, -0.80; P < 0.001), IL-6 (SMD = -1.96; 95% CI: -2.60, -1.32), and TNF-α (SMD = -2.62; 95% CI: -3.70, -1.55) compared to placebo. Doses ranged from 300-1800mg daily for 4-24 weeks.",recjcAFH5st2aRDO0
rec4SmFL2GdVOlSlQ,"Systolic Blood Pressure, Diastolic Blood Pressure, Cardiovascular Health, Endothelial Function",High,,2025-07-29T10:45:12.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Clinically meaningful reductions in both systolic (-5.46 mmHg) and diastolic (-2.87 mmHg) blood pressure in adults,LI304,recPiW3K4dhWi31Xh,recVHWlB26jWt9Ij9,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2023.1272837/full,The effects of alpha lipoic acid (ALA) supplementation on blood pressure in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials,PMID: 37901360,recHKgsM8akY38ItI,,,,Frontiers Neuroscience,recd0d1tmtDQUEhTY,"Meta-analysis of 11 randomized controlled trials with 674 adults (mean age 52-68 years across studies) found alpha-lipoic acid supplementation significantly reduced systolic blood pressure (WMD = -5.46 mmHg; 95% CI: -9.27, -1.65; P < 0.001) and diastolic blood pressure (WMD = -2.87 mmHg; 95% CI: -5.16, -0.58; P = 0.014) compared to placebo. Cardiovascular benefits were achieved with doses of 300-1800mg daily for 8-48 weeks.",recjcAFH5st2aRDO0
rec6SOq5JXWnOvyKH,"Neuropathy Symptoms, Nerve Function, Pain Scores, Diabetic Complications",High,,2025-07-29T10:45:26.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant improvement in neuropathy symptoms and nerve function parameters in adults with diabetic neuropathy,LI305,recPiW3K4dhWi31Xh,recVHWlB26jWt9Ij9,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.mdpi.com/2072-6643/15/16/3634,Effects of Oral Alpha-Lipoic Acid Treatment on Diabetic Polyneuropathy: A Meta-Analysis and Systematic Review,PMID: 37630804,recHKgsM8akY38ItI,,,,MDPI,recd0d1tmtDQUEhTY,"Meta-analysis of 15 randomized controlled trials with 2,027 adults with diabetic polyneuropathy (mean age 58-65 years) found oral alpha-lipoic acid treatment significantly improved total symptom scores (TSS) for neuropathic pain, burning, paresthesias, and numbness (MD = -1.78; 95% CI: -2.45 to -1.10; P < 0.001). Doses of 600-1800mg daily for 3-5 weeks provided meaningful symptom relief and improved nerve function parameters.",recjcAFH5st2aRDO0
recFQ42WZEgN3f2ad,"Diastolic Blood Pressure, Systolic Blood Pressure, Astaxanthin Supplementation, Cardiovascular Risk Factors",High,,2025-07-29T11:32:34.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild," 1.21 mmHg reduction in diastolic blood pressure overall, with 2.77 mmHg reduction in patients and 2.27 mmHg reduction in Asian populations",LI306,,"recSy02sgRnjfOkHE, recELBnyZAf0mIQH6",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S1756464621005090,Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials,PMID: 32755613,rec8lhVZaga97JNPG,,True,,Science Direct,recd0d1tmtDQUEhTY,Systematic review and meta-analysis of 10 RCTs with 493 adult participants found astaxanthin supplementation reduced diastolic blood pressure by 1.21 mmHg with stronger effects in patients and higher doses.,recKNB8U7yjdesIaY
recARnf0UAbHjKdXM,"Malondialdehyde, Interleukin-6, C-reactive Protein, Superoxide Dismutase, Isoprostane, Tumor Necrosis Factor-α",High,,2025-07-29T11:33:28.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant reduction in malondialdehyde (SMD: -0.95) and interleukin-6 in T2DM patients (-0.70 pg/mL), with mild improvements in oxidative stress markers",LI307,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/abs/pii/S0271531721000725?via%3Dihub,Astaxanthin supplementation mildly reduced oxidative stress and inflammation biomarkers: a systematic review and meta-analysis of randomized controlled trials,PMID: 35091276,rec8lhVZaga97JNPG,,True,,Science Direct,recd0d1tmtDQUEhTY,Systematic review and meta-analysis of 12 RCTs with 380 adult participants found astaxanthin supplementation significantly reduced blood malondialdehyde (SMD: -0.95; 95% CI: -1.67 to -0.23) and interleukin-6 in type 2 diabetes patients (-0.70 pg/mL; 95% CI: -1.29 to -0.11). Astaxanthin improved superoxide dismutase activity and reduced serum isoprostane concentration in overweight subjects.,recKNB8U7yjdesIaY
recHJRk5CkP0r2Z8M,"LDL Cholesterol, Total Cholesterol, HDL Cholesterol, Fibrinogen, L-selectin, Fetuin-A, Insulin Sensitivity, HOMA2-IR",High,,2025-07-29T11:33:36.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"0.33 mM reduction in LDL cholesterol and 0.30 mM reduction in total cholesterol after 24 weeks in adults with prediabetes and dyslipidemia, equivalent to potential 7.5% relative reduction in cardiovascular events",LI308,"recw2hqgZfllcjFso, recBA3iQ4lGJtC2nM, recq0JX3QgFBo5mm4, recierVNozpgZdLZH, recAdUWMgWMZS3qKI",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15070,"Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia",PMID: 36999233,rec8lhVZaga97JNPG,,True,,"Diabetes, Obesity and Metabolism",recFfb6t4bEMGdz5J,"Randomized controlled trial of 34 adults with prediabetes and dyslipidemia (mean age 54.5, range 35-75) found 12mg daily astaxanthin for 24 weeks significantly decreased LDL cholesterol by 0.33 mM and total cholesterol by 0.30 mM (both p<0.05). Astaxanthin also reduced cardiovascular risk markers including fibrinogen (-473 ng/mL), L-selectin (-0.08 ng/mL) and fetuin-A (-10.3 ng/mL).",recKNB8U7yjdesIaY
recDBbUljCveQ3Fkm,"Skin Moisture Content, Skin Elasticity, Wrinkle Depth, Transepidermal Water Loss, Sebum Content, Oxidative Stress Markers",High,,2025-07-29T11:33:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant improvement in skin moisture content (SMD = 0.53) and elasticity (SMD = 0.77), but no significant effect on wrinkle depth reduction in healthy middle-aged adults",LI309,,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.mdpi.com/2072-6643/13/9/2917,Systematic Review and Meta-Analysis on the Effects of Astaxanthin on Human Skin Ageing,PMID: 34578794,rec8lhVZaga97JNPG,,True,,Nutrients,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 11 studies (9 RCTs) in healthy middle-aged adults (mean age 40-50 years) found oral astaxanthin supplementation significantly restored skin moisture content (SMD = 0.53; 95% CI: 0.05, 1.01) and improved skin elasticity (SMD = 0.77; 95% CI: 0.19, 1.35). Doses ranged from 2-12mg daily for 6-16 weeks, with greatest benefits in participants with defined age-related skin signs at baseline.",recKNB8U7yjdesIaY
recCeCFvuxsKWtuKQ,"Fasting Plasma Glucose, Fasting Insulin, HOMA-IR, Systolic Blood Pressure, Diastolic Blood Pressure",High,,2025-07-30T15:43:11.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant improvements in fasting glucose (-5.2 mg/dL), insulin reduction (-0.64 U/mL), and 26% reduction in insulin resistance in diabetic patients with dose-dependent effects",LI310,"recierVNozpgZdLZH, recAdUWMgWMZS3qKI","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://nutritionandmetabolism.biomedcentral.com/articles/10.1186/s12986-017-0217-z,Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis,PMID: 29018489,rec7fGXGOJzrAEf2H,,True,,BMC Nutrition Journal,recRIfCU2PF5bhkmW,"Meta-analysis of 9 randomized controlled trials involving 283 participants with type 2 diabetes (mean age 52-67 years) found resveratrol supplementation significantly improved fasting plasma glucose by -0.29 mmol/L (95% CI: -0.51, -0.06), reduced fasting insulin by -0.64 U/mL (95% CI: -0.95, -0.32), and decreased HOMA-IR by -0.52 (95% CI: -1.00, -0.04). High-dose resveratrol (≥100 mg/day) showed greater glucose-lowering effects than low doses in diabetic adults.",recJH0aBL1IvHnanZ
reciiD6NLX5kDO0oq,"C-reactive protein, TNF-α, IL-6, Cardiovascular Disease Risk, Inflammatory Markers",High,,2025-07-30T15:43:21.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant reductions in CRP (-0.63 mg/L) and TNF-α (-0.55) inflammatory markers in cardiovascular disease patients, with dose-dependent anti-inflammatory effects",LI311,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S0965229922000656?via%3Dihub,Anti-inflammatory effects of resveratrol in patients with cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials,PMID: 35905799,rec7fGXGOJzrAEf2H,,True,,Science Direct,recRIfCU2PF5bhkmW,"Meta-analysis of 6 randomized controlled trials in adults with cardiovascular disease (mean age 45-70 years) found resveratrol supplementation significantly reduced serum C-reactive protein levels by -0.63 mg/L (95% CI: -1.13, -0.12) and TNF-α levels by -0.55 (95% CI: -1.04, -0.06). Subgroup analysis showed dose-dependent effects with higher doses (≥300 mg/day) providing greater anti-inflammatory benefits in cardiovascular patients.",recJH0aBL1IvHnanZ
recAFagYc3JaYmpog,"Flow-mediated dilatation, Endothelial Function, Systolic Blood Pressure, Diastolic Blood Pressure, Metabolic Syndrome Markers",High,,2025-07-30T15:43:32.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant improvement in endothelial function (SMD 1.77) but no blood pressure reduction in metabolic syndrome patients, suggesting selective vascular benefits",LI312,,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://link.springer.com/article/10.1007/s40292-019-00324-6,The Effects of Resveratrol Supplementation on Endothelial Function and Blood Pressures Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis,PMID: 31264084,rec7fGXGOJzrAEf2H,,True,,High Blood Pressure & Cardiovascular Prevention,recRIfCU2PF5bhkmW,"Meta-analysis of 28 randomized controlled trials with 33 findings in adults with metabolic syndrome (mean age 35-65 years) found resveratrol supplementation significantly improved flow-mediated dilatation by SMD 1.77 (95% CI: 0.25, 3.29), indicating enhanced endothelial function. However, no significant effects were observed on systolic or diastolic blood pressure. Effects were dose-dependent with higher doses showing greater vascular benefits.",recJH0aBL1IvHnanZ
rec9cRiTfek7FNtol,"TNF-α, High-sensitivity C-reactive protein, IL-6, Inflammatory Markers, Systemic Inflammation",High,,2025-07-30T15:43:41.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant reductions in TNF-α (-0.44) and hsCRP (-0.27 mg/L) inflammatory markers across diverse adult populations, with dose-dependent anti-inflammatory effects",LI313,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.clinicaltherapeutics.com/article/S0149-2918(18)30245-5/abstract,Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials,PMID: 30017172,rec7fGXGOJzrAEf2H,,True,,Clinical Therapautics,recRIfCU2PF5bhkmW,"Meta-analysis of 17 randomized controlled trials involving 736 adult participants (mean age 40-70 years) found resveratrol supplementation significantly reduced TNF-α levels by -0.44 (95% CI: -0.71, -0.164) and high-sensitivity C-reactive protein by -0.27 mg/L (95% CI: -0.5, -0.02). No significant effect was observed on IL-6 levels. Anti-inflammatory effects were most pronounced with higher doses and longer treatment durations in adults with metabolic dysfunction.",recJH0aBL1IvHnanZ
rec3sb24qz5xilbj0,"Visual Acuity, Contrast Sensitivity, Macular Pigment Optical Density, Age-Related Macular Degeneration",High,,2025-07-30T15:47:29.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Significant improvements in macular pigment optical density, visual acuity, and contrast sensitivity with 10-20mg daily lutein in AMD patients",LI314,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0227048,Effects of lutein supplementation in age-related macular degeneration: a meta-analysis of randomized controlled trials,PMID: 31887124,recLr4qbLpkZNIcs1,,True,,PLoS One,recRIfCU2PF5bhkmW,"Meta-analysis of 9 randomized controlled trials involving 920 eyes (855 with AMD) found lutein supplementation (10-20 mg daily) significantly increased macular pigment optical density (MD 0.07; 95% CI 0.03-0.10), visual acuity (MD 0.28; 95% CI 0.06-0.50), and contrast sensitivity (MD 0.26; 95% CI 0.22-0.30) in adults with age-related macular degeneration. Stratified analyses showed greater benefits with higher doses and longer treatment duration (>6 months).",recnToD6IHt3Ur7Nj
recqfKbgd9Tv5mTKy,"Age-Related Macular Degeneration, Neovascular AMD, Late AMD Risk",High,,2025-07-30T15:47:40.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,26% reduction in late AMD risk and 32% reduction in neovascular AMD risk with high lutein/zeaxanthin intake,LI315,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/lutein-and-zeaxanthin-intake-and-the-risk-of-agerelated-macular-degeneration-a-systematic-review-and-metaanalysis/BC608EDE4A8A35C81948AD3F38388B02,Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis,PMID: 21899805,recLr4qbLpkZNIcs1,,True,,Cambridge University,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 6 longitudinal cohort studies (2,477 incident AMD cases, 120,000 participants) found high lutein and zeaxanthin intake significantly reduced late AMD risk by 26% (RR 0.74; 95% CI 0.57-0.97) and neovascular AMD risk by 32% (RR 0.68; 95% CI 0.51-0.92) in adults over 5-18 years follow-up. No significant association found for early AMD.",recnToD6IHt3Ur7Nj
recjmtOqcZXelHrt9,"Visual Episodic Memory, Cognitive Function, Macular Pigment Optical Density",High,,2025-07-30T15:48:01.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant improvements in visual episodic memory and learning performance with 10mg lutein + 2mg zeaxanthin daily,LI316,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2022.843512/full,"The Effects of Lutein and Zeaxanthin Supplementation on Cognitive Function in Adults With Self-Reported Mild Cognitive Complaints: A Randomized, Double-Blind, Placebo-Controlled Study",PMID: 35252311,recLr4qbLpkZNIcs1,,True,,Frontiers in Nutrition,recFfb6t4bEMGdz5J,Randomized controlled trial of 90 adults aged 40-75 years found 6 months of lutein (10mg) and zeaxanthin (2mg) supplementation significantly improved visual episodic memory (p=0.005) and visual learning performance compared to placebo in adults with self-reported cognitive complaints. Supplementation increased macular pigment optical density as a biomarker of brain carotenoid levels.,recnToD6IHt3Ur7Nj
rec9T72prUKfRLEdv,"Macular Pigment Optical Density, Visual Function, Ocular Health",High,,2025-07-30T15:48:11.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"Dose-dependent increases in macular pigment optical density, with significant benefits at ≥5mg daily and optimal effects at ≥20mg daily",LI317,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S2161831322005038?via%3Dihub,The Effect of Lutein/Zeaxanthin Intake on Human Macular Pigment Optical Density: A Systematic Review and Meta-Analysis,PMID: 34157098,recLr4qbLpkZNIcs1,,True,,Science Direct,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 46 studies (3,189 participants, mean age 43 years) found lutein/zeaxanthin supplementation dose-dependently increased macular pigment optical density in healthy adults. Studies with ≥20 mg/day for 3-12 months showed pooled mean increase of 0.11 units (95% CI 0.06-0.16), while 5-20 mg/day showed 0.04 units increase (95% CI 0.02-0.07). Doses <5 mg/day showed no significant benefit.",recnToD6IHt3Ur7Nj
recw8yD8LM00k1glh,"Sleep Quality, Sleep Onset Latency, Total Sleep Time, Sleep Efficiency, Cortisol",High,,2025-07-30T16:03:59.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,72% improvement in sleep quality scores with consistent benefits across multiple sleep parameters in stressed adults,LI318,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.mdpi.com/2072-6643/13/4/1047,Effects of ashwagandha (Withania somnifera) extract on sleep: a systematic review and meta-analysis,PMID: 33916371,recfr0V7Fnw7SZ4OA,,,,MDPI,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 5 randomized controlled trials with 400 adults (mean age 42.8 years, range 25-65) found ashwagandha extract 300-600mg daily improved sleep quality scores by 72% (SMD=0.59; 95% CI: 0.23-0.95) and increased total sleep time by 37 minutes compared to placebo over 6-12 weeks. Adults with stress-related sleep difficulties showed greatest improvements in sleep onset latency and sleep efficiency.",recRTk82CFFbZIZ9S
recPcuHbt6EQljnTS,"Perceived Stress Scale, Morning Cortisol, Anxiety Scores, Stress Resilience, hsCRP",High,,2025-07-30T16:04:09.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,27.9% reduction in stress scores and 23.6% reduction in cortisol levels with strong effect sizes across multiple stress biomarkers,LI319,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.mdpi.com/2072-6643/14/16/3310,The effectiveness of ashwagandha (Withania somnifera) root extract in improving anxiety and stress: A systematic review and meta-analysis,PMID: 36014810,recfr0V7Fnw7SZ4OA,,,,MDPI,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 12 randomized controlled trials with 1,002 adults (mean age 39.4 years, range 18-65) found ashwagandha extract 300-600mg daily significantly reduced perceived stress scale scores by 27.9% (SMD=-0.96; 95% CI: -1.38 to -0.54) and morning cortisol levels by 23.6% (SMD=-1.13; 95% CI: -1.66 to -0.61) compared to placebo over 8-12 weeks. Adults with chronic stress showed greater reductions in anxiety symptoms and improved stress resilience markers.",recRTk82CFFbZIZ9S
recgQFP6CsuqdN1pw,"Upper Body Strength, Lower Body Strength, VO2 Max, Testosterone, Muscle Mass, Recovery Markers",High,,2025-07-30T16:04:20.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,15-19kg increases in strength measures with significant improvements in cardiovascular fitness and testosterone in healthy adults,LI320,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.mdpi.com/2072-6643/13/12/4508,Effects of Ashwagandha (Withania somnifera) on Physical Performance: Systematic Review and Bayesian Meta-Analysis,PMID: 34960053,recfr0V7Fnw7SZ4OA,,,,MDPI,recd0d1tmtDQUEhTY,"Systematic review and Bayesian meta-analysis of 12 randomized controlled trials with 383 healthy adults (mean age 28.2 years, range 18-50) found ashwagandha supplementation 300-600mg daily for 8-12 weeks significantly improved upper body muscle strength by 15.4kg (95% CrI: 9.8-21.5kg), lower body strength by 19.1kg (95% CrI: 11.2-27.0kg), and VO2 max by 1.78 mL/kg/min (95% CrI: 0.39-3.16) compared to placebo. Testosterone levels increased by 96.2 ng/dL in men, supporting muscle building and recovery adaptations.",recRTk82CFFbZIZ9S
recIHIxgXQE6NBA0m,"Lumbar Spine BMD, Fracture Incidence, Undercarboxylated Osteocalcin, Carboxylated Osteocalcin, Bone Mineralization",High,,2025-07-30T16:11:56.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Significant improvement in lumbar spine BMD and 62% reduction in fracture incidence in postmenopausal women,LI321,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.979649/full,Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials,PMID: 36033802,recZwCmS9nIiIiDk9,,,,PubMed,recRIfCU2PF5bhkmW,"Meta-analysis of 16 RCTs with 6,425 postmenopausal women (mean age 55-70 years) found vitamin K2 supplementation significantly improved lumbar spine bone mineral density (P=0.006) and reduced fracture incidence by 62% (RR=0.38, P=0.006) after removing heterogeneous studies. VK2 significantly reduced serum undercarboxylated osteocalcin levels and promoted bone mineralization through enhanced osteocalcin carboxylation.",recBYWzN6FRmP1yFr
recCzDXebED8MF9Od,"Coronary Heart Disease Risk, Matrix Gla Protein Activity, Arterial Calcification, Cardiovascular Events",High,,2025-07-30T16:12:11.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,9% reduction in coronary heart disease risk per 10 mcg daily VK2 intake in observational studies,LI322,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566462/,Proper calcium use: vitamin K2 as a promoter of bone and cardiovascular health,PMID: 26357538,recZwCmS9nIiIiDk9,,,,PubMed,recd0d1tmtDQUEhTY,"Review of population studies including 16,000 healthy women (aged 49-70 years) found high vitamin K2 intake (MK-7, MK-8, MK-9) was associated with 9% reduced coronary heart disease risk per 10 mcg daily intake. VK2 activates matrix Gla protein (MGP) which inhibits arterial calcification, while dietary VK2 was associated with decreased coronary calcification in 564 postmenopausal women, whereas VK1 was not.",recBYWzN6FRmP1yFr
recPXpZaBQ69ibIeQ,"Femoral Neck BMD, Carboxylated Osteocalcin, Undercarboxylated Osteocalcin, Bone Turnover Biomarkers",High,,2025-07-30T16:12:42.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Significant reduction in femoral neck bone loss in postmenopausal women with improved osteocalcin carboxylation markers,LI323,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/32060566/,Effect of low-dose vitamin K2 supplementation on bone mineral density in middle-aged and elderly Chinese: a randomized controlled study,PMID: 32060566,recZwCmS9nIiIiDk9,,,,PubMed,recFfb6t4bEMGdz5J,"Randomized controlled trial of 311 community-dwelling adults (aged 50-75 years) found 90 µg/day vitamin K2 supplementation for 1 year significantly reduced bone loss at the femoral neck in postmenopausal women (P=0.006) compared to placebo. The cOC/ucOC ratio increased in intervention groups (P<0.001), indicating improved osteocalcin carboxylation and bone metabolism.",recBYWzN6FRmP1yFr
recTD6S0CoD3zysKD,"Coronary Artery Calcium Score, Cardiovascular Events, Matrix Gla Protein, Arterial Calcification",High,,2025-07-30T16:12:53.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Significant reduction in coronary calcium progression and 69% reduction in cardiovascular events in older men,LI324,recPiW3K4dhWi31Xh,"recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S2772963X23006208,Effects of vitamin K2 and D supplementation on coronary artery disease in men: A randomized controlled trial,PMID: 38058977,recZwCmS9nIiIiDk9,,,,Science Direct,recFfb6t4bEMGdz5J,"Randomized controlled trial of 304 men (mean age 71 years) with no prior coronary disease found vitamin K2 (720 µg/day) plus vitamin D supplementation for 24 months significantly reduced coronary artery calcium progression in high-risk patients (CAC ≥4400 AU: 288 vs 380 AU, P=0.047) and reduced composite cardiovascular events by 69% (1.9% vs 6.3%, P<0.05).",recBYWzN6FRmP1yFr
recJYuPQsqxn4YQux,"LDL Cholesterol, HDL Cholesterol, Triglycerides, Total Cholesterol",High,,2025-07-30T16:25:34.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Significant reductions in LDL cholesterol (10-25%) and triglycerides (20-50%) with substantial HDL increases (15-35%) at therapeutic doses,LI325,"receYj9nbAEGPBxFl, recw2hqgZfllcjFso, recDBJLAkc5CAfBm3","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.aafp.org/pubs/afp/issues/2000/1115/p2321.html,Extended-Release Niacin and Hyperlipidemia Management,,recEfZBvWw9nHwH1C,,,,The Journal of Family Practice,recFfb6t4bEMGdz5J,"Clinical trial of 131 adults (mean age 58 years) with dyslipidemia found extended-release niacin 500-2000mg daily significantly reduced LDL cholesterol by 10-25% and triglycerides by 20-50% while raising HDL cholesterol by 15-35%. Significant lipid improvements were evident at 500mg daily dose, with maximum benefits at higher doses. Extended-release formulation reduced flushing and liver toxicity compared to immediate-release preparations.",recgHjOqTOirOfCmU
recUqZTwGYdWh20kp,"HDL Cholesterol, Triglycerides, LDL Cholesterol, Total Cholesterol",High,,2025-07-30T16:25:44.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,20-35% HDL cholesterol increases with strongest responses in patients with low baseline HDL-C and elevated triglycerides,LI326,"receYj9nbAEGPBxFl, recw2hqgZfllcjFso, recDBJLAkc5CAfBm3","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC3600344/,HDL-C Response Variability to Niacin ER in US Adults,PMID: 23533734,recEfZBvWw9nHwH1C,,True,,PubMed,recFfb6t4bEMGdz5J,"Clinical study of 834 adults (aged 41-65 years) with dyslipidemia found niacin extended-release at 500mg and 1000mg daily increased HDL cholesterol levels by 20-35% with greater responses in patients with triglycerides ≥150 mg/dL. Patients with baseline HDL-C <40 mg/dL showed significant improvement (P<0.001 for 500mg group, P=0.005 for 1000mg group). The medication was most effective in patients with metabolic dyslipidemia patterns.",recgHjOqTOirOfCmU
rec4cF6tYEK95ruyo,"Dyslipidemia Risk, Total Cholesterol, Triglycerides, HDL Cholesterol",High,,2025-07-30T16:25:57.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,29% reduction in dyslipidemia risk with higher niacin intake and dose-response relationship demonstrated in large population study,LI327,"receYj9nbAEGPBxFl, recw2hqgZfllcjFso, recDBJLAkc5CAfBm3","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.clinicalnutritionjournal.com/article/S0261-5614(22)00379-X/fulltext,Dietary niacin intake and risk of dyslipidemia: A pooled analysis of three prospective cohort studies,PMID: 36372046,recEfZBvWw9nHwH1C,,True,,Clinical Nutrition,recRIfCU2PF5bhkmW,"Pooled analysis of 211,567 adults aged ≥40 years from three Korean cohort studies found higher dietary niacin intake was associated with 29% reduced risk of dyslipidemia (HR: 0.71, 95% CI: 0.62-0.82). Participants with niacin intake below recommended levels had 32% increased dyslipidemia risk compared to those above RDA. Dose-response analysis showed linear relationship between niacin intake and dyslipidemia prevention, supporting supplementation for lipid optimization.",recgHjOqTOirOfCmU
recvPyTYk8n68PpL1,"Triglycerides, LDL Cholesterol, HDL Cholesterol, Lipoprotein(a), Small Dense LDL",High,,2025-07-30T16:26:08.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Consistent 20-50% triglyceride reduction with 30% reduction demonstrated in metabolic syndrome patients at 2g daily dose,LI328,"receYj9nbAEGPBxFl, recw2hqgZfllcjFso, recDBJLAkc5CAfBm3, recPiW3K4dhWi31Xh","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ncbi.nlm.nih.gov/books/NBK425699/,Triglyceride Lowering Drugs,PMID: 28402615,recEfZBvWw9nHwH1C,,True,,PubMed,recd0d1tmtDQUEhTY,"Comprehensive clinical review found niacin 500-2000mg daily decreases triglycerides by 20-50%, reduces LDL cholesterol and Lp(a), and increases HDL cholesterol in adults with dyslipidemia. Niacin shifts small dense LDL particles to large buoyant particles, improving atherogenic lipid profile. In metabolic syndrome patients, 2g daily niacin reduced triglycerides by 30% compared to placebo, demonstrating consistent triglyceride-lowering efficacy across patient populations.",recgHjOqTOirOfCmU
rec68ty0sGlzd10Dn,"Cognitive Function, Dementia Risk, Mental Activity Level, Creative Engagement, Intellectual Stimulation",Moderate,,2025-07-30T19:02:21.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Significant dementia risk reduction with engagement in cognitive and creative activities, with strongest effects for writing and interactive games",LI329,,,2025-07-30T19:02:21.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2807256,"Writing, Games, and Other Cognitive Activities May Lower Dementia Risk",PMID: 37022707,,,,,,recODsYatCgd7j2Vr,"Study of 10,000+ Australians aged 70+ found engagement in adult literacy, creative art, and active and passive mental activities may help reduce dementia risk in late life, especially writing, playing games, doing puzzles, using computers, and taking classes. Participants with highest engagement in intellectual activities showed significantly reduced risk of developing dementia compared to those with lowest engagement.",
recgP5dXz1DG8BZZb,"Learning Performance, Working Memory, Cognitive Function, Social Contact, Subjective Cognitive Concerns",Moderate,,2025-07-30T19:02:30.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Dose-response relationship between number of modifiable risk factors and cognitive decline, with social isolation identified as key risk factor",LI330,,,2025-07-30T19:02:30.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://dx.doi.org/10.1037/neu0000900,Modifiable risk factors for learning and memory performance,PMID: 37535374,,,,,,recODsYatCgd7j2Vr,Study of adults found those with three or more modifiable risk factors showed worse learning and working memory performance and greater subjective cognitive concerns compared to individuals with no modifiable risk factors. Social contact emerged as one of the key modifiable factors affecting cognitive function.,
recK7Kf6MjF1gBkw0,"Memory Decline, Cognitive Function, Social Contact, Healthy Lifestyle, Memory Performance",Moderate,,2025-07-30T19:02:37.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Slower memory decline rates with comprehensive healthy lifestyle including social contact component,LI331,,,2025-07-30T19:02:37.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.bmj.com/content/380/bmj-2022-072691,Healthy lifestyle and memory decline,PMID: 36623783,,,,,,recODsYatCgd7j2Vr,"Study of adults found a healthy lifestyle with combination of positive behaviors including never drinking or smoking, healthy diet, regular physical exercise, active cognitive activity, and social contact was associated with slower rate of memory decline. Social contact was identified as one of the key lifestyle factors protecting against cognitive decline.",
recfRZ11HgBdonY0b,"Cognitive Reserve, Social Relationships, Brain Function, Social Diversity, Neuroimaging Markers",Moderate,,2025-07-30T19:02:47.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Neuroimaging evidence showing diverse social relationships enhance cognitive reserve through brain function improvements,LI332,,,2025-07-30T19:02:47.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/34655218/,Mental Stimulation Through Social Networking May Improve Cognitive Reserve,PMID: 34655218,,,,,,recODsYatCgd7j2Vr,Neuroimaging study found cognitive stimulation from interacting with diverse array of social relationships in multiple contexts may help promote cognitive reserve. Researchers used neuroimaging to assess subjects and found evidence that varied social interactions provide cognitive benefits through enhanced brain function.,
recwYoKb0RExY2J5A,"Social Interaction Quality, Purposefulness, Cognitive Benefits, Older Adults, Daily Variation",Moderate,,2025-07-30T19:02:55.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Daily fluctuations in social interaction quality directly predict purposefulness and cognitive benefits in older adults,LI333,,,2025-07-30T19:02:55.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/34924274/,Being Social May Be Purposeful in Older Adulthood,PMID: 34924274,,,,,,recODsYatCgd7j2Vr,"Study of older adults found those who have better social interactions are more purposeful, and on days when they have better social interactions than they normally do, they also feel more purposeful, which confers cognitive benefits. Daily variation in social quality predicted same-day purposefulness and cognitive performance.",
rec6HACtkZ38m5uHB,"Dementia Risk, Social Visits, Friend Contact, Family Contact, Protective Behaviors",Moderate,,2025-07-30T19:03:03.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"15% dementia risk reduction with friend/family visits in large prospective cohort of over 500,000 adults",LI334,,,2025-07-30T19:03:03.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/35896434/,"Exercise, Housework, Social Visits Associated With Lower Dementia Risk",PMID: 35896434,,,,,,recODsYatCgd7j2Vr,"Study of 510,000+ dementia-free subjects followed for 10.6 years found 5,185 developed dementia. Behaviors significantly associated with reduced dementia risk included frequent vigorous exercise (35% lower risk), housework (21% lower risk), and friend/family visits (15% lower risk), demonstrating social engagement as protective factor.",
rec0DgRMKqdf1UCmp,"Gray Matter Integrity, Brain Structure, Social Engagement, Cognitive Function, Neuroimaging",Moderate,,2025-07-30T19:03:11.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Neuroimaging evidence showing social engagement protects against gray matter loss and preserves cognitive function in older adults,LI335,,,2025-07-30T19:03:11.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/33219690/,Social Activity May Protect Brain's Gray Matter,PMID: 33219690,,,,,,recODsYatCgd7j2Vr,Cross-sectional analysis of 293 Health ABC study participants showed social engagement may be useful preventive mechanism against loss of gray matter integrity in older adults. Analysis using 3 Tesla magnetic resonance imaging with diffusion tensor imaging found associations between social engagement and preserved brain structure.,
rec8xcMUoMbwmIEOU,"Dementia Incidence, Intellectual Activities, Marriage Status, Social Support, Cognitive Protection",Moderate,,2025-07-30T19:03:21.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Intellectual activities reduced dementia incidence but only in married individuals, suggesting social support enhances cognitive protection",LI336,,,2025-07-30T19:03:21.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/33554903,"Reading, Hobbies Linked to Lower Dementia Incidence",PMID: 33554903,,,,,,recODsYatCgd7j2Vr,"Study of 8,030 participants aged 50+ from ELSA found increased engagement in intellectual activities showed decreased dementia incidence independent of risk of death in married individuals, but not in those who were single, divorced, or widowed. Social support through marriage appeared to enhance protective effects of intellectual engagement.",
recyahLHeYG3YVAYL,"Alzheimer's Disease, Dementia Onset, Cognitive Activity, Reading, Social Games, Library Visits",Moderate,,2025-07-30T19:03:29.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Up to 5-year delay in Alzheimer's dementia onset with cognitively-active lifestyle including social and cognitive activities,LI337,,,2025-07-30T19:03:29.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408511/,Cognitive Activity Delays AD,PMID: 34414040,,,,,,recODsYatCgd7j2Vr,"Long-term study of 1900+ adults found cognitively-active lifestyle including reading books/news/magazines, playing games, visiting library, and writing letters in old age may delay onset of Alzheimer's dementia by as much as 5 years. Social and cognitive activities combined showed greatest protective effects.",
rec2gPOEPSTEMu8dN,"Dementia Risk, Social Contact, Modifiable Risk Factors, Social Isolation, Cognitive Protection",High,,2025-07-30T19:03:37.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Low social contact identified as major modifiable dementia risk factor in landmark comprehensive analysis,LI338,,,2025-07-30T19:03:37.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/32738937/,Landmark Report IDs Modifiable Risk Factors for Dementia,PMID: 32738937,,,,,,recd0d1tmtDQUEhTY,"Comprehensive analysis found good evidence supporting modifiable risk factors for dementia including less education, hypertension, obesity, hearing loss, smoking, physical inactivity, diabetes, depression, traumatic brain injury, alcohol misuse, low social contact, and air pollution. Low social contact identified as key modifiable risk factor.",
recqp2G0VI8SRbgZj,"Hippocampal Function, Social Engagement, Cognitive Preservation, Neuroprotection, Brain Health",High,,2025-07-30T19:03:52.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Social engagement provides neuroprotective effects comparable to exercise with specific benefits for hippocampal function,LI339,,,2025-07-30T19:03:52.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/30531067/,Social Engagement Key to Resisting Cognitive Decline,PMID: 30531067,,,,,,recd0d1tmtDQUEhTY,"Research review found social engagement correlates to better hippocampal function in old age and is viable lifestyle factor to preserving cognition, akin to better understood effects of environmental enrichment and exercise. Social engagement showed neuroprotective effects similar to physical exercise.",
rectlrtDa4BxjJNuZ,"Alzheimer's Disease Risk, Cognitive Activity, Social Activities, Midlife Activities, Religious Participation",Moderate,,2025-07-30T19:04:00.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Midlife cognitive and social activities reduced Alzheimer's risk over 44-year follow-up in women,LI340,,,2025-07-30T19:04:00.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/30787164/,Cognitive Activity Lowers Dementia Risk,PMID: 30787164,,,,,,recODsYatCgd7j2Vr,"Study of 800 women aged 38-54 followed over 44 years found higher levels of cognitive activity at midlife including reading, choir singing, museum-going, arts, gardening, clubs, and religious participation were related to reduced risk of Alzheimer's disease. Social cognitive activities showed strongest protective effects.",
recwJWe4j2RVf7H7h,"Dementia Risk, Intellectual Activities, Reading, Playing Games, Social Games, Daily Participation",Moderate,,2025-07-30T19:04:09.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Daily intellectual and social activities significantly reduced dementia risk in large 5-year prospective study,LI341,,,2025-07-30T19:04:09.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/29847678/,"Reading, Playing Games Lowers Dementia Risks",PMID: 29847678,,,,,,recODsYatCgd7j2Vr,"Study of 15,000+ dementia-free Chinese adults aged 65+ followed over 5 years found daily participation in intellectual activities such as reading and playing games was associated with significantly lower risk of dementia. Social games and group activities showed particular benefit.",
recyXHgckAkpTr77I,"Cognitive Function, Social Activities, Multidomain Intervention, Cognitive Training, At-Risk Population",High,,2025-07-30T19:04:18.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,Multidomain intervention including social activities improved cognitive function in landmark randomized trial,LI342,,,2025-07-30T19:04:18.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/25771249/,FINGER Study: Addressing Multiple Risk Factors Lowers Cognitive Risks,PMID: 25771249,,,,,,recFfb6t4bEMGdz5J,"Landmark large, long-term randomized controlled trial found multidomain intervention including nutrition, exercise, social activities, cognitive training, and cardiovascular management could improve or maintain cognitive functioning in at-risk people. Social activities were key component of successful intervention.",
rec3QLNdZXGoZETdE,"Cognitive Scores, Brain Structure, Game Playing, Social Gaming, Middle-aged Adults",Moderate,,2025-07-30T19:04:25.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Regular game playing associated with higher cognitive scores and better brain structure in middle-aged adults,LI343,,,2025-07-30T19:04:25.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/25358750/,Playing Games Associated With Better Brain Structure and Cognitive Function,PMID: 25358750,,,,,,recODsYatCgd7j2Vr,"Study of 300 normal, middle-aged individuals found those involved in game playing on regular basis had higher cognitive scores and better brain structure measures. Social gaming and interactive games showed strongest associations with cognitive benefits.",
recY6gGKYVDFrx9xT,"Dementia Risk, Social Network Size, Social Support, Independent Living, Social Connections",Moderate,,2025-07-30T19:04:33.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,60% increased dementia risk with poor social networks; extensive social networks provided significant protection,LI344,,,2025-07-30T19:04:33.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/10776744/,Extensive Social Network Seems Protective Against Dementia,PMID: 10776744,,,,,,recODsYatCgd7j2Vr,"Study of 1200+ Swedish adults living independently followed for 3 years found poor or limited social network increased risk for dementia by 60%. Researchers noted that extensive social network seems protective against dementia, with dose-response relationship between social network size and dementia risk.",
rec6Qz0pryMiwkMIY,"Physical Activity, Social Influence, Behavioral Contagion, Peer Effects, Health Behaviors",Moderate,,2025-07-30T19:04:42.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Social connections directly influence physical activity levels through behavioral contagion effects,LI345,,,2025-07-30T19:04:42.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0274259,Physically active people make sedentary people more active,PMID: 36048803,,,,,,recODsYatCgd7j2Vr,"Study examining peer interactions found when sedentary people socialize with moderately active people, they become more persistently active, and vice versa. Social influence on physical activity demonstrated significant behavioral contagion effects, with social connections directly impacting health behaviors.",
recXoVC1fqKkNIWAr,,Moderate,,2025-07-30T19:07:33.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Active midlife lifestyle associated with better cognitive functioning in old age, with stronger effects in lower education individuals",LI345,,,2025-07-30T19:07:33.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/25924661/,Mid-life leisure activities and cognitive performance,PMID: 25924661,,,,,PubMed,reclqQn6EV0azXdYf,"Study found that an active lifestyle during middle adulthood may be related to better cognitive functioning in old age, particularly in individuals with a low educational level. Results suggest engaging in leisure activities during midlife supports cognitive health in later years.",
recZiN2gkKCRt2PW0,,Moderate,,2025-07-30T19:07:42.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,"Lifetime cognitive engagement associated with reduced AD pathology markers, particularly amyloid deposition",LI346,,,2025-07-30T19:07:42.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://jamanetwork.com/journals/jamaneurology/fullarticle/1149704,Higher lifetime cognitive engagement = lower amyloid deposition,PMID: 22491796,,,,,PubMed,reclqQn6EV0azXdYf,Study of adults found that the tendency to participate in cognitively stimulating activities is likely related to engagement in a variety of lifestyle practices that have been implicated in other studies showing reduced risk of AD-related pathology. Higher cognitive engagement throughout life associated with lower amyloid deposition in brain.,
recD7k3gsYJFarVrF,,Moderate,,2025-07-30T19:07:49.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Clear bidirectional social influence on physical activity levels through peer interactions,LI347,,,2025-07-30T19:07:49.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0274259,Physically active people make sedentary people more active,PMID: 36107880,,,,,PLoS One,reclqQn6EV0azXdYf,"Study examining peer interactions found that when sedentary people socialize with moderately active people, they are more persistently active—and vice versa. Socializing with sedentary people makes active ones less so. Demonstrates social contagion effect of physical activity behaviors through social networks.",
recL0UGyxRMh5d7NO,,Moderate,,2025-07-30T19:07:57.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,60% increased dementia risk with poor social networks; extensive social networks strongly protective,LI348,,,2025-07-30T19:07:57.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/10776744/,Extensive Social Network Seems Protective Against Dementia,PMID: 10776744,,,,,PubMed,recODsYatCgd7j2Vr,Study of 1200+ Swedish adults living independently and followed for 3 years found that a poor or limited social network increased the risk for dementia by 60%. The extensive social network seems protective against dementia. Demonstrates strong protective effect of social connections on cognitive health in older adults.,
recFBI5gaQoMCzBJD,"Major Cardiovascular Events, Myocardial Infarction, Major Bleeding, Cardiovascular Mortality, Platelet Count, hsCRP, ApoB",High,,2025-07-30T19:44:53.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,11% reduction in cardiovascular events balanced against 58% increase in major bleeding in adults without prior cardiovascular disease,LI349,"recDUx81XNYUkBLRH, recPiW3K4dhWi31Xh, receYj9nbAEGPBxFl",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://jamanetwork.com/journals/jama/fullarticle/2721178,Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis,PMID: 30661651,recvuhgMsucQvK38B,,,,JAMA,rec4qqncSQrMbfAph,"Meta-analysis of 13 randomized controlled trials comprising 164,225 adults (mean age 62 years, range 50-70) found low-dose aspirin reduced major adverse cardiovascular events by 11% (RR=0.89; 95% CI: 0.84-0.95) and nonfatal myocardial infarction by 17% (RR=0.83; 95% CI: 0.76-0.90) in primary prevention. Benefits were most apparent in adults aged 50-65 years with elevated cardiovascular risk, but were offset by increased major bleeding risk of 58% (RR=1.58; 95% CI: 1.31-1.91).",rec7WBtHpMlUCtYtT
recwyAHuSPh9Wym00,"Gastrointestinal Bleeding, Intracranial Hemorrhage, Platelet Count, hsCRP",High,,2025-07-30T19:45:14.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,54% increased gastrointestinal bleeding risk with particular concern in adults over age 70,LI350,"recDUx81XNYUkBLRH, recPiW3K4dhWi31Xh",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0160046,Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies,PMID: 27501355,recvuhgMsucQvK38B,,,,PLoS One,rec4qqncSQrMbfAph,"Systematic review of 39 observational studies with over 1 million adults (mean age 65 years, range 45-80) found low-dose aspirin use (75-325 mg daily) increased gastrointestinal bleeding risk by 54% (pooled RR=1.54; 95% CI: 1.30-1.82) and intracranial hemorrhage risk by 37% (pooled RR=1.37; 95% CI: 1.13-1.66). Bleeding incidence was 0.5-3.6 cases per 1000 person-years, with risk increasing markedly after age 70 and in patients with multiple comorbidities.",rec7WBtHpMlUCtYtT
recHG33xSFrAb1gEd,"Cardiovascular Mortality, Myocardial Infarction, Stroke, Platelet Count, hsCRP, ApoB",High,,2025-07-30T19:45:27.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,24-29% reduction in fatal cardiovascular events in secondary prevention with established benefit-risk profile,LI351,"recDUx81XNYUkBLRH, recPiW3K4dhWi31Xh, receYj9nbAEGPBxFl",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC4365416/,Use of Low-dose Aspirin as Secondary Prevention of Atherosclerotic Cardiovascular Disease Among US Adults,PMID: 25678571,recvuhgMsucQvK38B,,,,PubMed,rec4qqncSQrMbfAph,"Analysis of National Health Interview Survey data from 2,748 adults with established cardiovascular disease (mean age 66 years, range 40-85) found that aspirin reduced risk of fatal cardiovascular events by 25% in post-myocardial infarction patients (RR=0.75; 95% CI: 0.65-0.87), 29% in acute coronary syndrome patients (RR=0.71; 95% CI: 0.60-0.84), and 24% in stroke survivors (RR=0.76; 95% CI: 0.68-0.85). Only 70% of eligible patients were taking aspirin for secondary prevention despite clear evidence of benefit.",rec7WBtHpMlUCtYtT
recBq26uKb3AVSBC4,"Colorectal Cancer Incidence, Cancer Mortality, Platelet Count, hsCRP",High,,2025-07-30T19:45:39.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,27% reduction in colorectal cancer risk with duration-dependent benefits requiring 5-10 years of consistent use,LI352,"recDUx81XNYUkBLRH, recPiW3K4dhWi31Xh",,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.annalsofoncology.org/article/S0923-7534(20)36073-7/fulltext,Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019,PMID: 32169282,recvuhgMsucQvK38B,,,,Oxford Academic,rec4qqncSQrMbfAph,"Comprehensive meta-analysis of 113 studies with over 2 million adults (mean age 58 years, range 45-75) found regular aspirin use (≥75 mg daily for ≥5 years) reduced colorectal cancer risk by 27% (RR=0.73; 95% CI: 0.67-0.79), with greater risk reduction observed with longer duration of use (20% at 5 years, 30% at 10 years). Low-dose aspirin also reduced esophageal cancer risk by 39% (RR=0.61; 95% CI: 0.50-0.74) and gastric cancer risk by 33% (RR=0.67; 95% CI: 0.54-0.83), with effects most apparent in adults 50-70 years.",rec7WBtHpMlUCtYtT
recHJ8X1mcBrbS4JZ,"Body Weight, HbA1c, Fasting Glucose, Systolic Blood Pressure, Diastolic Blood Pressure, Triglycerides, HDL Cholesterol",High,,2025-07-30T19:51:47.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,15-22.5% weight loss in a dose-dependent manner with significant improvements in multiple cardiometabolic parameters,LI353,"recC0mB1LyNGjDyld, recierVNozpgZdLZH","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nature.com/articles/s41366-023-01321-5,Efficacy and safety of tirzepatide for treatment of overweight or obesity: A systematic review and meta-analysis,PMID: 37286773,recbyxDEVmqEJOGEm,,,,Science Direct,recd0d1tmtDQUEhTY,"Systematic review and meta-analysis of 7 randomized controlled trials with 4,887 adults (mean age 54.8 years, range 18-75) found tirzepatide produced dose-dependent weight loss of 15-22.5% from baseline compared to placebo over 40-72 weeks. Participants showed significant improvements in cardiometabolic parameters including 1.9-2.4% reduction in HbA1c, 15-20% reduction in fasting glucose, and improvements in blood pressure and lipid profiles.",recN0RQzSEzIQxBZE
recOIkO2bz4xCm6yb,"Major Adverse Cardiovascular Events, Cardiovascular Mortality, Systolic Blood Pressure, Diastolic Blood Pressure, HbA1c, ApoB",High,,2025-07-30T19:52:01.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,26% reduction in major adverse cardiovascular events with consistent benefit across all doses and subpopulations,LI354,"recC0mB1LyNGjDyld, receYj9nbAEGPBxFl","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nature.com/articles/s41591-022-02036-w,Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis,PMID: 36138150,recbyxDEVmqEJOGEm,,,,Springer Nature,recPTVJvlU8ZpgeS3,"Pre-specified meta-analysis of cardiovascular outcomes from SURPASS clinical trials with 4,887 adults with type 2 diabetes (mean age 57.2 years, range 18-85) found tirzepatide reduced major adverse cardiovascular events by 26% (HR=0.74; 95% CI: 0.51-1.08) compared to placebo and active comparators over median 1.3 years. Participants showed consistent cardiovascular risk reduction across all doses (5mg, 10mg, 15mg weekly) with greatest benefits in adults with established cardiovascular disease.",recN0RQzSEzIQxBZE
rec6NK7KjzP7sziwa,"Metabolic Syndrome Prevalence, Waist Circumference, Triglycerides, HDL Cholesterol, HbA1c, HOMA-IR",High,,2025-07-30T19:52:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,74-84% reduction in metabolic syndrome prevalence with dose-dependent benefits across all metabolic parameters,LI355,"recC0mB1LyNGjDyld, recAdUWMgWMZS3qKI","recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://cardiab.biomedcentral.com/articles/10.1186/s12933-023-01765-z,Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program,PMID: 36855129,recbyxDEVmqEJOGEm,,,,Springer Nature,rec4qqncSQrMbfAph,"Post hoc analysis of SURPASS trials with 6,244 adults with type 2 diabetes (mean age 56.2 years, range 18-80) found tirzepatide reduced prevalence of metabolic syndrome by 74-84% depending on dose (5mg: 74%, 10mg: 79%, 15mg: 84%) compared to 44-50% with comparators over median 40-52 weeks. Participants showed dose-dependent improvements in all metabolic syndrome components including waist circumference reduction (7.6-11.7 cm), triglyceride reduction (23-31%), HDL increase (6-10%), and blood pressure improvements.",recN0RQzSEzIQxBZE
recDB0nqXJftzQi9R,"Major Adverse Cardiovascular Events, HbA1c, Body Weight, Cardiovascular Death, Myocardial Infarction, Stroke",High,,2025-07-30T19:57:50.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,26% reduction in major adverse cardiovascular events with significant improvements in HbA1c (-0.7% to -1.0%) and body weight (-3.6 to -4.9 kg),LI356,"recC0mB1LyNGjDyld, recPiW3K4dhWi31Xh","reccxH7AESy9vvBPo, recELBnyZAf0mIQH6, recSy02sgRnjfOkHE",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nejm.org/doi/full/10.1056/NEJMoa1607141,Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes,PMID: 27633186,recRqbE5GobS5ypJO,,,,PubMed,recRIfCU2PF5bhkmW,"Randomized controlled trial of 3,297 adults with type 2 diabetes (mean age 64 years, range 50-85) and high cardiovascular risk found semaglutide (0.5-1.0 mg weekly) reduced major adverse cardiovascular events by 26% (HR=0.74; 95% CI: 0.58-0.95) compared to placebo over 104 weeks. Participants showed significant improvements in glycemic control, body weight, and cardiovascular biomarkers.",rectSvR0DGkWchk46
recFcpuijUskcqZtV,"Major Adverse Cardiovascular Events, Body Weight, Systolic Blood Pressure, hsCRP, Cardiovascular Death",High,,2025-07-30T19:57:59.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,20% reduction in major adverse cardiovascular events in non-diabetic adults with cardiovascular disease; 9.4% body weight reduction,LI357,recPiW3K4dhWi31Xh,"reccxH7AESy9vvBPo, recELBnyZAf0mIQH6",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nejm.org/doi/full/10.1056/NEJMoa2307563,Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes,PMID: 37952131,recRqbE5GobS5ypJO,,,,PubMed,recRIfCU2PF5bhkmW,"Randomized controlled trial of 17,604 adults with overweight/obesity (mean age 61.6 years, BMI ≥27 kg/m²) and established cardiovascular disease but without diabetes found semaglutide 2.4 mg weekly reduced major adverse cardiovascular events by 20% (HR=0.80; 95% CI: 0.72-0.90) compared to placebo over 40 months. Participants achieved 9.4% body weight reduction and significant improvements in multiple cardiovascular biomarkers.",rectSvR0DGkWchk46
recJIujgpWIaEhAAA,"Body Weight, BMI, Waist Circumference, Waist-to-Hip Ratio",High,,2025-07-30T19:58:09.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"5.3 kg mean weight loss across 15,135 participants; dose-dependent effects with semaglutide demonstrating superior efficacy",LI358,,reccxH7AESy9vvBPo,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://ajcn.nutrition.org/article/S0002-9165(23)46846-3/fulltext,The Weight-loss Effect of GLP-1RAs in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis,PMID: 37558142,recRqbE5GobS5ypJO,,,,Science Direct,recRIfCU2PF5bhkmW,"Meta-analysis of 41 randomized controlled trials involving 15,135 adults with overweight/obesity without diabetes (mean age 48 years) found GLP-1 receptor agonists significantly reduced body weight by 5.3 kg (95% CI: -6.5 to -4.2), BMI by 2.4 kg/m² (95% CI: -2.8 to -1.9), and waist circumference by 4.3 cm compared to controls. Effects were dose-dependent with semaglutide showing greatest efficacy.",rectSvR0DGkWchk46
recUWOuxNHAntuSCB,"Major Adverse Cardiovascular Events, Cardiovascular Death, HbA1c, Body Weight, Systolic Blood Pressure",High,,2025-07-30T19:58:18.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,13% reduction in major adverse cardiovascular events and 22% reduction in cardiovascular death; significant improvements in multiple metabolic parameters,LI359,recC0mB1LyNGjDyld,"reccxH7AESy9vvBPo, recELBnyZAf0mIQH6",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.nejm.org/doi/full/10.1056/NEJMoa1603827,Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes,PMID: 27424436,recRqbE5GobS5ypJO,,,,PubMed,recRIfCU2PF5bhkmW,"Randomized controlled trial of 9,340 adults with type 2 diabetes and high cardiovascular risk (mean age 64 years) found liraglutide 1.8 mg daily reduced major adverse cardiovascular events by 13% (HR=0.87; 95% CI: 0.78-0.97) and cardiovascular death by 22% (HR=0.78; 95% CI: 0.66-0.93) compared to placebo over 3.8 years. Participants showed significant reductions in HbA1c, body weight, and systolic blood pressure.",rectSvR0DGkWchk46
recRm2ApbeBAGkRR3,"Growth Hormone, IGF-1, Lean Body Mass, Body Composition, Cortisol, Fasting Insulin",High,,2025-07-30T20:01:46.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",significant,"2-10 fold increase in GH levels sustained for 6+ days, 1.5-3 fold IGF-I increase for 9-11 days in healthy adults",LI360,"recwtXkPSEQgyddmt, recierVNozpgZdLZH","recyKRTIlX4Jux2W0, recVHWlB26jWt9Ij9",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/16352683/,"Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults",PMID: 16352683,reckIdFin6Pkpdu89,,,,PubMed,recFfb6t4bEMGdz5J,"Randomized controlled trial of 74 healthy adults (ages 21-61) found subcutaneous CJC-1295 resulted in sustained, dose-dependent increases in GH levels by 2- to 10-fold for 6+ days and IGF-I levels by 1.5- to 3-fold for 9-11 days. Multiple doses maintained elevated IGF-I levels for up to 28 days with cumulative effects, supporting muscle and metabolic benefits.",recWaxSdkoYowWptr
rec4Dopelk5bwlWhp,"Growth Hormone, Cortisol, FSH, LH, Prolactin, TSH",Moderate,,2025-07-30T20:01:56.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,High GH releasing potency with unique selectivity not affecting stress hormones at 200-fold higher doses,LI361,recwtXkPSEQgyddmt,recyKRTIlX4Jux2W0,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/9849822/,"Ipamorelin, the first selective growth hormone secretagogue",PMID: 9849822,reckIdFin6Pkpdu89,,,,PubMed,rec2YzOW1s1eXdPsR,"Preclinical studies found ipamorelin is a pentapeptide with high GH releasing potency and efficacy in vitro and in vivo. Unlike other growth hormone secretagogues, ipamorelin specifically stimulates GH release without affecting ACTH, cortisol, prolactin, FSH, LH, or TSH levels, even at doses 200-fold higher than the ED50 for GH release. This selectivity makes ipamorelin a promising candidate for clinical development.",recWaxSdkoYowWptr
recJkpz67yD45h0d5,"Lean Body Mass, Body Weight, Physical Function, Growth Hormone, IGF-1",High,,2025-07-30T20:02:06.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,1.4 kg lean body mass increase and improved physical function in older adults aged 65-84,LI362,recierVNozpgZdLZH,"recyKRTIlX4Jux2W0, recVHWlB26jWt9Ij9",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/19174493/,Effects of an oral growth hormone secretagogue in older adults,PMID: 19174493,reckIdFin6Pkpdu89,,,,PubMed,recFfb6t4bEMGdz5J,"Randomized controlled trial of 395 adults (ages 65-84) found oral growth hormone secretagogue capromorelin increased lean body mass by 1.4 kg vs 0.3 kg in placebo group (P=0.001) and improved physical function measures including tandem walk and stair climbing performance. Body weight increased 1.4 kg in treatment vs -0.2 kg in placebo groups, demonstrating GH secretagogue effects on body composition and functional capacity in aging adults.",recWaxSdkoYowWptr
rec1QjfWhAnvBCLBH,"Growth Hormone, Body Composition, Fat Mass, Lean Mass, IGF-1",High,,2025-07-30T20:02:35.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",moderate,Selective GH stimulation with optimal timing profile and body composition benefits across multiple clinical trials,LI363,recierVNozpgZdLZH,"recyKRTIlX4Jux2W0, recVHWlB26jWt9Ij9",2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://onlinelibrary.wiley.com/doi/full/10.1002/rco2.9,"Growth hormone secretagogues: history, mechanism of action, and clinical development",PMID: 32175271,reckIdFin6Pkpdu89,,,,PubMed,rec4qqncSQrMbfAph,"Systematic review of growth hormone secretagogues found that ipamorelin induced GH release with peak at 0.67 hours after administration in healthy subjects, with a short terminal half-life of 2 hours. Clinical studies demonstrated ipamorelin's selective mechanism targeting ghrelin receptors without affecting other pituitary hormones. Multiple clinical trials showed GH secretagogues can improve body composition and reduce fat mass while increasing lean mass in various populations.",recWaxSdkoYowWptr
recMC5jrkGqHlfSwv,"Tendon Healing, Cell Migration, Fibroblast Activity, FAK-Paxillin Pathway, Oxidative Stress Response, Inflammatory Markers",Anecdotal,,2025-08-06T13:55:13.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,"Mechanistic evidence from preclinical models only; significant acceleration of tendon outgrowth and cell migration via FAK-paxillin pathway, but no human clinical trials",LI364,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://journals.physiology.org/doi/full/10.1152/japplphysiol.00945.2010,"The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration",PMID: 21030672,"rec21JVl1hc1NAcjF, recEiVaIfGGw9dPmm",,,,PubMed,recYhFTRFUPeMb1fL,"Preclinical in vitro study of rat Achilles tendon fibroblasts found BPC 157 significantly accelerated tendon explant outgrowth, increased cell survival under oxidative stress (H2O2), and enhanced cell migration in dose-dependent manner. BPC 157 activated FAK-paxillin pathway and promoted F-actin formation, supporting tissue repair mechanisms. Limited to animal models; human safety and efficacy unestablished.","recEt38gYzl5Uj7EX, recgKfnDcYPAgWKHE"
recnOfXJOhXcqWRlh,"Ligament Healing, Collagen Formation, Joint Function, Inflammatory Response, Tissue Regeneration",Anecdotal,,2025-08-06T13:55:24.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,"Mechanistic and preclinical evidence only; complete ligament healing with preserved function in rat models, but no human trials available",LI365,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://onlinelibrary.wiley.com/doi/full/10.1002/jor.21107,Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat,PMID: 20225319,"rec21JVl1hc1NAcjF, recEiVaIfGGw9dPmm",,,,PubMed,recYhFTRFUPeMb1fL,"Preclinical study of rat medial collateral ligament (MCL) transection found BPC 157 (10 μg or 10 ng/kg) improved ligament healing when given intraperitoneally, orally, or topically. Treatment resulted in no knee joint contracture, no valgus instability, and preserved muscle motor function throughout 90-day study period. Represents promising preclinical evidence but limited to animal models.","recEt38gYzl5Uj7EX, recgKfnDcYPAgWKHE"
recAJyQN5fsVxIQhx,"Growth Hormone Receptor, JAK2 Pathway, Fibroblast Proliferation, Tendon Repair, Growth Factors",Anecdotal,,2025-08-06T13:55:40.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,"Mechanistic insights into growth hormone receptor pathway activation, but preclinical evidence only with no human safety data",LI366,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pmc.ncbi.nlm.nih.gov/articles/PMC6271067/,Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts,PMID: 30544829,"rec21JVl1hc1NAcjF, recEiVaIfGGw9dPmm",,,,PubMed,recYhFTRFUPeMb1fL,"Preclinical study found BPC 157 dose- and time-dependently increased growth hormone receptor expression in tendon fibroblasts at both mRNA and protein levels via cDNA microarray analysis. Addition of growth hormone to BPC 157-treated fibroblasts enhanced cell proliferation and activated JAK2 phosphorylation pathway. Mechanistic evidence suggests growth hormone receptor upregulation as key pathway for healing effects, but limited to animal models.","recEt38gYzl5Uj7EX, recgKfnDcYPAgWKHE"
recjDcjOFVdna0Obz,"Wound Healing, Angiogenesis, Collagen Deposition, Keratinocyte Migration, Tissue Regeneration",Anecdotal,,2025-08-06T13:55:52.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,"Strong preclinical evidence with 42-61% acceleration in wound healing, but no human clinical trials available",LI367,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/10469335/,Thymosin beta4 accelerates wound healing,PMID: 10469335,"recLQrNqZ1MFCFp9Y, recEiVaIfGGw9dPmm",,,,PubMed,recYhFTRFUPeMb1fL,Preclinical rat full-thickness wound model found thymosin beta4 (Tβ4) increased reepithelialization by 42% over controls at 4 days and 61% at 7 days post-wounding. Treated wounds contracted 11% more than controls and showed increased collagen deposition and angiogenesis. Tβ4 stimulated keratinocyte migration 2-3 fold when as little as 10 pg was added. Represents potent wound healing effects but limited to animal models.,"recniL0lWjVJJokug, recgKfnDcYPAgWKHE"
recShlUPa5BzDuZC1,"Angiogenesis, Wound Healing, Blood Vessel Formation, Cell Migration, VEGF Expression",Anecdotal,,2025-08-06T13:56:01.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,Consistent angiogenic and wound healing effects across multiple preclinical models; early clinical trials initiated but outcomes not yet published,LI368,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://pubmed.ncbi.nlm.nih.gov/15037013/,"Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development",PMID: 15037013,"recLQrNqZ1MFCFp9Y, recEiVaIfGGw9dPmm",,,,PubMed,recYhFTRFUPeMb1fL,"Preclinical studies in normal and aged rodents found thymosin beta4 promotes angiogenesis and wound repair through increased blood vessel formation and cell migration. The peptide enhanced hair growth in both normal and aged animals by activating hair follicle stem cells. Currently in clinical trials for wound repair, representing translation toward human applications, though regulatory approval pending.","recniL0lWjVJJokug, recgKfnDcYPAgWKHE"
recApcukx2cgnxbka,"TB-500 Metabolism, Wound Healing Activity, Fibroblast Function, Metabolite Analysis",Anecdotal,,2025-08-06T13:56:12.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,"Important mechanistic insights showing active metabolite responsible for healing effects, but limited to in vitro studies",LI369,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.sciencedirect.com/science/article/pii/S1570023224000412,TB-500 and its metabolites quantification and wound healing activity evaluation,PMID: 38330002,"recLQrNqZ1MFCFp9Y, recEiVaIfGGw9dPmm",,,,Science Direct,recYhFTRFUPeMb1fL,"Recent analytical study using UHPLC-Q-Exactive orbitrap MS found that TB-500 metabolite Ac-LKKTE showed significant wound healing activity in fibroblasts compared to control, while parent TB-500 showed no direct activity. Study suggests previously reported wound-healing activity of TB-500 may be due to active metabolite rather than parent form. No cytotoxicity observed for parent or metabolites, but highlights importance of metabolic conversion.","recniL0lWjVJJokug, recgKfnDcYPAgWKHE"
recgLINzrBvSzjc3r,"Synergistic Tissue Repair, Actin Regulation, Growth Hormone Receptor Expression, Fibroblast Activity, Combined Healing Pathways",Anecdotal,,2025-08-06T13:56:46.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",mild,"Theoretical synergistic mechanisms supported by individual peptide studies, but no direct clinical trials of combination in humans",LI370,recPiW3K4dhWi31Xh,,2025-10-01T16:25:22.000Z,"{""id"": ""usrdgG7vRV8iqukqL"", ""email"": ""keegankdolan@gmail.com"", ""name"": ""Keegan Dolan""}",https://www.peptidesciences.com/bpc-157-tb-500-10mg-blend,Synergistic mechanisms of BPC-157 and TB-500 combination in tissue repair,,recEiVaIfGGw9dPmm,,,,PubMed,recYhFTRFUPeMb1fL,"Mechanistic analysis suggests BPC-157 and TB-500 work synergistically through complementary pathways: BPC-157 enhances growth hormone receptor expression on fibroblasts while TB-500 provides actin regulation for cell migration. Both peptides regulate actin dynamics essential for wound healing - BPC-157 via FAK-paxillin pathway and TB-500 via direct actin sequestering. Combined use theoretically optimizes fibroblast longevity and migration capacity, though clinical evidence limited to preclinical models.",recgKfnDcYPAgWKHE
